‫תשע"א‬/‫י"ג‬
9/2011
‫כ"ח באלול התשע"א‬
September 27 ,1122
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
Page/‫עמוד‬
Patents
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Corrections
Country codes
Indices of applications accepted
Designs
Designs registered
Designs canceled
1
4
212
211
211
211
214
333
252
242
221
223
‫פטנטים‬
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקע‬
‫פטנטים שחודשו לעשרים שנה‬
‫תיקונים‬
‫קודים למדינות‬
‫מפתחות לבקשות שהתקבלו‬
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שבוטלו‬
September 27, 2011-‫כ"ח באלול התשע"א‬
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
.‫ ירושלים‬,‫ מלחה‬5 ‫ בנין‬,‫ גנים טכנולוגיים ירושלים‬,‫רשם הפטנטים והמדגמים‬
'‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬.0-54145-5
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Authority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office
together with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
2
‫זכות היוצרים בתקצירים אלה שמורה למדינת‬
‫ אין להעתיק מתקצירים אלה אלא‬,‫ישראל‬
.‫ברשות לשכת הפטנטים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
PATENTS
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
applications complying with the provisions
of rule 32(a) of the Patent Regulations, 57281968:
Particulars of the applications are given in
the following order:
Number and date of application and the first
four symbols of the International
Classification.
Title of invention (as proposed by applicant)
Applicant
Priority right:
Convention countryNumber and date of
Foreign application
International Application Number
International Publication Number
3
‫פטנטים‬
-‫ תשכ"ז‬,‫ לחוק הפטנטים‬11 ‫הודעה לפי סעיף‬
1611
‫להלן רשימת בקשות חדשות הממלאות אחר‬
‫(א) לתקנות‬25 ‫הדרישות שנקבעו בתקנה‬
:1611-‫ תשכ"ח‬,‫הפטנטים‬
:‫פרטי הבקשות מובאים לפי סדר זה‬
‫מספר הבקשה – ותאריך הגשתה וארבעה‬
‫הסמנים הראשונים של הסיווג הבינלאומי‬
)‫שם האמצאה (כפי שהוצע ע"י המבקש‬
‫המבקש‬
– ‫מדינת האיגוד‬
:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
‫מספר בקשה בינלאומית‬
‫מספר פרסום בינלאומי‬
September 27, 2011-‫כ"ח באלול התשע"א‬
00/62/0662
161111
ENHANCED PRODUCTION OF LIPIDS
CONTAINING POLYENOIC FATTY
ACIDS BY HIGH DENSITY CULTURES
OF
EUKARYOTIC MICROBES IN
FERMENTORS
MARTEK BIOSCIENCES
CORPORATION
US
60/178588
28/01/2000
PCT/US/2001/002715
WO/2001/054510
21/6//0622
A SAFETY SYSTEM AND METHOD
FOR CONTROLLING AN ARRAY OF
SOLAR PANELS
NIRL, IOSIF
21/6//0622
‫תהליך לייצור מוגבר של ליפידים המכילים‬
‫חומצות שומניות פוליאנויות באמצעות‬
‫תרביות בריכוז גבוה של מיקרובים‬
‫יוקריוטיים במתקנים מתסיסים‬
514065
COMBINED TOILET BOWL
4
H01L )5010.01(
‫מערכת בטיחות ושיטה לבקרה על מערך‬
‫של פנלים סולריים‬
‫ יוסף‬,‫נירל‬
514106
A FAST-DEPLOYMENT PACKING
CONTAINER
DUCART PACKAGING INDUSTRIES
LTD
2//6//0622
A23D )5010.01(
F42B )5010.01(
‫מיכל אריזה מהיר–פריסה‬
‫דוקרט תעשיית אריזות בע"מ‬
514151
A47K )5010.01(
‫אסלה משולבת‬
September 27, 2011-‫כ"ח באלול התשע"א‬
‫ד"ר סיקירוב‬
DR SIKIROV
2//6//0622
514155
AN INTERNET INFORMATION
RETRIEVAL SYSTEM AND METHOD
MICHAEL GLOBINSKY
2//6//0622
‫מערכת ושיטה לאחזור מידע אינטרנטי‬
‫מיכאל גלובינסקי‬
514152
MASSAGE APPATUS FO RTHE
SHOWER
REUVEN MOSHE ZADA
2//6//0622
‫ראובן משה זאדה‬
514154
A61F )5010.01(
‫רכיב בסיס לשימוש עם עדשה תוך עינית‬
‫מסתגלת‬
514155
PEDIATRIC LARYNGOSCOPE BLADE
TRUPHATEK INTERNATIONAL LTD.
5
A47C )5010.01(
‫מכשיר עיסוי למקלחת‬
BASE MEMBER FOR USE WITH
ACCOMMODATING INTRAOCULAR
LENS
NULENS LTD.
2//6//0622
G06F )5010.01(
‫ניולנס בע"מ‬
A61B )5010.01(
‫להב לרינגוסקוף פידיאטרי‬
‫תרופאטק אינטרנשיונל בע"מ‬
September 27, 2011-‫כ"ח באלול התשע"א‬
21/6//0622
514145
SYSTEM AND METHOD FOR
LOCATION OF WIRELESS
COMMUNICATION TERMINALS
USING APPLICATION-LEVEL
LOCATION DATA
VERINT SYSTEMS LTD.
21/6//0622
G06F )5010.01(
‫מערכת ושיטה לאיתור מסופי תקשורת‬
‫אלחוטיים על ידי מידע מיקום ברמת‬
‫האפליקציה‬
‫ורינט מערכות בע"מ‬
514155
ADVANCED LLR PROCESSOR FOR
WIRELESS TELECOMMUNICATION
SYSTEM
DESIGNART NETWORKS LTD
US
12/838527
19/07/2010
06/6//0622
‫ מתקדם לתקשורת רחק‬LLR ‫מעבד‬
‫דזיינארט נטוורקס בע"מ‬
514511
LOAD TRANSPORTION PALLET AND
METHOD OF MANUFACTURING IT
KAL-KAR EIN CARMEL
GB
0909505.0
03/06/2009
WO
PCTIB2010052465 60/60/0626
6
H04L )5010.01(
B65D )5010.01(
‫משטח הובלת משא ושיטה לייצורו‬
‫קר עין כרמל‬-‫קל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
06/6//0622
514555
METHOD OF CONSTRUCTING
COMPLEX FUNCTIONS
A-ONLINE CAPITAL (A.O.C) LTD
00/62/0626
‫שיטה לבנות משבאות מורכבות‬
‫) בע"מ‬.‫סי‬.‫או‬.‫אונליין קפיטל (אי‬-‫אי‬
514555
DEVICE AND METHOD FOR
MONITORING THE OBJECT'S
BEHAVIOR
ZRRO TECHNOLOGIES (2009) LTD
US
61/147357
26/01/2009
PCT/IL/2010/000063
WO/2010/084498
20/6//0626
514551
INHIBITORS OF BETA-SECRETASE
VITAE PHARMACEUTICALS, INC.
US
61/210146
13/03/2009
02//6//10
01/60/0626
US
PCT/US/2010/027173
WO/2010/105179
61/60/0626
514551
TABLETS FOR COMBINATION
THERAPY
GILEAD SCIENCES, INC.
US
61/150652
06/02/2009
02/2/60//
60/60/0660
US
PCT/US/2010/023226
WO/2010/091197
7
G06E )5010.01(
G06F )5010.01(
‫מכשיר ושיטה לניטור התנהגות אובייקט‬
‫) בע"מ‬5006( ‫זירו טכנולוגיות‬
C07D )5010.01(
‫מעכבים של בטא–סקרטאז‬
A61K )5010.01(
‫טבליות עבור טיפול משולב‬
September 27, 2011-‫כ"ח באלול התשע"א‬
00/62/0626
514551
SOLAR THERMAL DEVICE FOR
PRODUCING FRESH WATER
4ELEMENTS INVENT LTD
AT
A129/2009
26/01/2009
PCT/EP/2010/050718
WO/2010/084168
00/62/0626
514556
A COMPOSITE AND ITS USE
SKULLE IMPLANTS OY
FI
20095084
30/01/2009
PCT/FI/2010/050052
WO/2010/086508
02/62/0626
514521
OPTICAL DEVICE AND METHOD OF
CONTROLLING A REFRCTIVE INDEX
PROFILE IN THE OPTICAL DEVICE
RAYTHEON COMPANY
US
12/358608
23/01/2009
PCT/US/2010/021640
WO/2010/085556
00/62/0626
514525
NOVEL TRICYANOBORATES
LONZA LTD.
EP
09001388.9 02/02/2009
02/2/2001
26/60/0660
US
PCT/EP/2010/000426
WO/2010/086131
8
C02F )5010.01(
‫התקן תרמי סולרי לייצור מים מתוקים‬
A61F )5010.01(
‫חומר מרוכב ושימוש בו‬
H01S )5010.01(
‫התקן אופטי ושיטה לבקרת פרופיל‬
‫אינדקס רפרקציה בהתקן האופטי‬
B01F )5010.01(
‫טריצאנובוראטים חדשים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
2//60/0626
514522
MEDICAL IMPLEMENT FOR
MANIPULATING SUTURES
PARTICULARY USEFUL IN
ARTHROSCOPIC SURGERY
T.A.G. MEDICAL DEVICES AGRICULTURE COOPERATIVE LTD.
US
61/152980
17/02/2009
PCT/IL/2010/000140
WO/2010/095131
00/62/0626
A61B )5010.01(
‫שתל רפואי לתפעול תפרים שימושי‬
‫במיוחד לניתוחים ארטרוסקופים‬
‫ אגודה שיתופית‬- ‫ מכשירים רפואיים‬.‫ג‬.‫א‬.‫ת‬
‫חקלאית בע"מ‬
514524
METHOD AND APPARATUS FOR
RESTRICTING FLOW THROUGH THE
WALL OF A LUMEN
CORNELL UNIVERSITY
US
61/205683
22/01/2009
02/0//12/
01/60/0660
US
PCT/US/2010/000159
WO/2010/085344
A61F )5010.01(
‫שיטה ומכשיר להגבלת זרימה דרך דופן‬
‫של חלל גוף‬
514525
0//60/0660
LOW-LOSS COLLIMATORS FOR USE IN
FIBER OPTIC ROTARY JOINTS
G02B )5010.01(
‫קולימטורים בעלי אובדן נמוך‬
‫לשימוש במפרקים סיבוביים בעלי‬
‫סיבים אופטיים‬
FOCAL TECHNOLOGIES CORPORATION
IB
PCT/IB2009/000347 25/02/2009
PCT/IB/2009/000347
WO/2010/097646
20/60/0626
9
514521
C07D )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
HETEROCYCLIC COMPOUNDS,
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM, AND THEIR USE
AS INHIBITORS OF THE GLYCINE
TRANSPORTER 1
ABBOTT GMBH & CO. KG
US
61/152822
16/02/2009
PCT/EP/2010/051907
WO/2010/092181
0//60/0626
‫ תכשירים רוקחיים‬,‫תרכובות הטרוציקליות‬
‫המכילים אותן ושימוש בהן כמעכבי גליצין‬
1 ‫טרנספורטר‬
514521
PRESSURIZED RESERVOIR SYSTEM
FOR STORING AND DISPENSING
LIQUIDS
G-SENSE LTD
US
61/155530
26/02/2009
PCT/IB/2010/050833
WO/2010/097774
‫שיטה למאגר דחוס לשם אחסון וחלוקת‬
‫נוזלים‬
G-SENSE LTD
514521
00/62/0626
C12Q )5010.01(
FUNCTIONALIZED MICROFLUIDIC
DEVICE FOR IMMUNOFLUORESCENCE
TETHIS S.P.A.
EP
PCT/EP2009/000465 26/01/2009
PCT/EP/2010/050820
WO/2010/084196
‫מכשיר מיקרו–נוזלי פונקציונלי‬
‫לאימונופלורסצנסיה‬
514526
G09B )5010.01(
06/62/0626
DEVICE, SYSTEM, AND METHOD OF
AUTOMATIC ASSESSMENT OF
PEDAGOGIC PARAMETERS
TIME TO KNOW ESTABLISHMENT
US
12/360940
28/01/2009
PCT/IB/2010/050256
WO/2010/086763
10
A61M )5010.01(
‫ מערכת ושיטה להערכה‬,‫מכשיר‬
‫אוטומטית של פרמטרים פדגוגיים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
0//62/0626
514540
ADAPTIVE TECHING AND
LEARNING UTILIZING SMART
DIGITAL LEARNING OBJECTS
TIME TO KNOW ESTABLISHMENT
US
12/360956
28/01/2009
PCT/IB/2010/050313
WO/2010/086780
‫הוראה ולמידה מותאמות אשר משתמשות‬
‫בעצמי למידה דיגיטלים חכמים‬
514541
00/62/0626
METHOD FOR SYNTHESIS OF (1S,2R)MILNACIPRAN
PIERRE FABRE MEDICAMENT
FR
0950552
29/01/2009
PCT/EP/2010/051045
WO/2010/086394
‫)–מילנציפרן‬S1,R2( ‫שיטה לסינתזה של‬
TREATMENT OF NEUROTROPHIC FACTOR
MEDIATED DISORDERS
PHYTOPHARM PLC
US
61/147084
24/01/2009
IN
PCT/CN2009/070319 01/62/0660
PCT/GB/2010/050098
WO/2010/084356
514542
WIRELESS EMERGENCY LIGHTING
SYSTEM AND METHOD
ELTAM EIN HASHOFET
11
C07C )5010.01(
514545
00/62/0626
02/6//0622
G09B )5010.01(
A61K )5010.01(
‫טיפול במחלות המתווכות על ידי‬
‫פקטור ניורוטופי‬
C08B )5010.01(
‫מערכת ותהליך לתאורת חירום אלחוטית‬
‫אלתם עין השופט‬
September 27, 2011-‫כ"ח באלול התשע"א‬
00/62/0626
514544
SCRIPTAID ISOSTERES AND THEIR
USE IN THERAPY
KARUS THERAPEUTICS LIMITED
GB
0901406.9
28/01/2009
6020/1/9/
20/6//0660
GB
PCT/GB/2010/050116
WO/2010/086646
20/6//0626
‫איזוסטרים סקריפטד ושימוש בהם בריפוי‬
514541
PROCESS FOR MANUFACTURING 5(2-{[6-(2,2-DIFLUORO-2PHENYLETHOXY)HEXYL]AMINO}-LHYDROXYETHYL)-8HYDROXYQUINOLIN-2(1H)-ONE
ALMIRALL, S.A.
EP
09382030.6 12/03/2009
PCT/EP/2010/001582
WO/2010/102831
6//60/0626
12
C07D )5010.01(
–5–‫–דיפלואורו‬5,5(–1[{–5(–5 ‫תהליך לייצור‬
–L–}‫פנילאתוקסי)הקסיל]אמינו‬
–5–‫–הידרוקסיקווינולין‬1–)‫הידרוקסיאתיל‬
‫)–און‬H1(
514546
IMMEDIATE RELEASE COMPOSITION
RESISTANT TO ABUSE BY INTAKE OF
ALCOHOL
EGALET LTD
DK
PA200900190 06/02/2009
02/2/6///
60/60/0660
US
02/2/2102
26/60/0660
US
PCT/EP/2010/000728
WO/2010/089132
0//62/0626
C07D )5010.01(
514550
A61K )5010.01(
‫תרכובת לשחרור מיידי העמידה לפגיעה‬
‫עקב צריכת אלכוהול‬
A61M )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
‫משאף‬
INHALER
VECTURA DELIVERY DEVICES
LIMITED
GB
0901520.7
30/01/2009
606006090
61/60/0660
GB
PCT/EP/2010/050790
WO/2010/086285
0//61/0626
514551
‫תולדות איזוקסאזול‬
ISOXAZOLE DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
09159150.3 30/04/2009
PCT/EP/2010/055591
WO/2010/125042
21/60/0626
514555
METHODS AND COMPOSITIONS FOR
DIAGNOSIS AND TREATMENT OF
CANCER
JOHANNES GUTENBERGUNIVERSITAT MAINZ
EP
09002458.9 20/02/2009
02/2/12/0
06/60/0660
US
PCT/EP/2010/001035
WO/2010/094490
20/60/0626
13
A61K )5010.01(
‫שיטות ותכשירים לאבחון וטיפול בסרטן‬
514551
METHODS AND COMPOSITIONS FOR
DIAGNOSIS AND TREATMENT OF
CANCER
JOHANNES GUTENBERGUNIVERSITAT MAINZ
EP
09002452.2 20/02/2009
02/2/120/
06/60/0660
US
606262019/
60/61/0660
EP
02/0/211/
60/61/0660
US
606212//90
22/22/0660
EP
C07D )5010.01(
C12N )5010.01(
‫שיטות ותכשירים לאבחנה וטיפול בסרטן‬
September 27, 2011-‫כ"ח באלול התשע"א‬
02/0062//
US
PCT/EP/2010/001062
WO/2010/094499
22/22/0660
514551
6//60/0626
PEPTIDES FOR VACCINE
CIRCASSIA LIMITED
GB
0901928.2
606200/91
GB
6020//190
GB
GB
PCT/GB09/001995
602/1/290
GB
PCT/GB/2010/000198
WO/2010/089554
20/60/0626
‫פפטידים עבור חיסון‬
05/02/2009
6//60/0660
06/6//0660
21/61/0660
20/26/0660
514551
DELAYED RELEASE, ORAL DOSAGE
COMPOSITIONS THAT CONTAIN
AMORPHOUS CDDO-ME
REATA PHARMACEUTICALS, INC.
US
61/152608
13/02/2009
PCT/US/2010/024127
WO/2010/093944
00/62/0626
A61K )5010.01(
‫הרכבי מינון אוראלים בעלי שחרור מושהה‬
‫ אמורפי‬ME–CDDO ‫המכילים‬
514556
STABILIZED FC POLYPEPTIDES
WITH REDUCED EFFECTOR
FUNCTION AND METHODS OF USE
BIOGEN IDEC MA INC.
US
61/146950
23/01/2009
PCT/US/2010/021853
WO/2010/085682
14
C07K )5010.01(
C12P )5010.01(
‫ עם תפקוד אפקטור‬FC ‫פוליפפטידים‬
‫מופחת ושיטות לשימוש‬
September 27, 2011-‫כ"ח באלול התשע"א‬
0//62/0626
514510
THIADIAZOLE AND OXADIAZOLE
DERIVATIVES, PREPARATION
THEREOF, AND THERAPEUTIC USE
THEREOF
SANOFI
FR
09/00359
28/01/2009
60/612//
62/60/0660
FR
PCT/FR/2010/050124
WO/2010/086551
60/60/0626
514511
SUBSURFACE INTRUSION
DETECTION SYSTEM
US ARMY CORPS OF ENGINEERS
US
61/151084
09/02/2009
PCT/US/2010/000327
WO/2010/090752
01/6//0622
514515
HIGH PRECISION IMPEDANCE
CONVERTER APPARATUS FOR
ENDODONTIC PROCEDURES
CREATIVE TEAM INSTRUMENTS
LTD
01/62/0626
‫ הכנתן‬,‫נגזרות תיאדיאזול ואוקסאדיאזול‬
‫ושימוש רפואי שלהן‬
G08B )5010.01(
‫מערכת גילוי חדירה מתחת לפני השטח‬
A61C )5010.01(
‫מכשיר בעל דיוק גבוה למדידת עכבר‬
‫קריאייטיב טים אינסטרומנטס בע"מ‬
514511
DETECTING POTENTIAL CHANGED
OBJECTS IN IMAGES
BAE SYSTEMS PLC
GB
0901369.9
28/01/2009
600//66090
01/62/0660
EP
15
C07D )5010.01(
G06T )5010.01(
‫זיהוי אובייקטים בעלי פונטציאל לשוני‬
‫בתמונות‬
September 27, 2011-‫כ"ח באלול התשע"א‬
PCT/GB/2010/050127
WO/2010/086655
0//62/0626
514516
H04N )5010.01(
‫תוכן עניינים של מדיה משותפת‬
SHARED MEDIA CONTENT LIST
BRITISH SKY BROADCASTING
LIMITED
GB
0901171.9
23/01/2009
PCT/GB/2010/000109
WO/2010/084329
0//62/0626
514510
VITAMIN D3 AND ANALOGS
THEREOF FOR ALLEVIATING SIDE
EFFECTS ASSOCIATED WITH
CHEMOTHERAPY
BERG BIOSYSTEMS, LLC
US
61/147549
27/01/2009
02/0/066/
62/60/0660
US
PCT/US/2010/022284
WO/2010/088304
0//62/0626
A61K )5010.01(
‫ ואנלוגים שלו להקלת תופעות‬D2 ‫ויטמין‬
‫לוואי הקשורות לכימותרפיה‬
514511
PHARMACEUTICAL COMPOSITON
COMPRISING RACEMIC
AMINOPTERIN
AMINOPTERIN LLC
US
61/147093
24/01/2009
PCT/US/2010/021899
WO/2010/085717
60/6//0626
16
514512
A01N )5010.01(
‫תרכובת תרופתית הכוללת אמינופטרין‬
‫ראסימי‬
B24B )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
SYSTEM FOR
MAGNETORHEOLOGICAL FINISHING
OF A SUBSTRATE
QED TECHNOLOGIES
INTERNATIONAL, INC.
US
US61/158021 06/03/2009
PCT/US/2010/025931
WO/2010/101925
00/62/0626
514514
CONTROLLED RELEASE
FORMULATION WITH CONTINUOUS
EFFICACY
EGALET A/S
DK
PA200900127 26/01/2009
02/21/2/2
00/62/0660
US
DK
PA200900782 01/60/0660
PCT/DK/2010/050016
WO/2010/083843
61/20/0660
514515
POLYMORPHS OF DARUNAVIR
MAPI PHARMA LTD
US
61/148055
29/01/2009
02/010121
20/60/0660
US
PCT/IL/2009/001158
WO/2010/086844
20/60/0626
POLYENE ANTIFUNGAL
COMPOSITIONS
DSM IP ASSETS B.V.
EP
09152968.5
6020006/96
EP
PCT/EP/2010/051892
WO/2010/094670
17
514511
‫מערכת לגימור מגנטי–זרמי של מצע‬
A61K )5010.01(
‫תכשירים לשיחרור מבוקר של תרופה‬
‫תוך שמירה על פעילות רציפה‬
A01N )5010.01(
‫פולימורפים של דרונויר‬
‫מאפי פארמה בע"מ‬
A01N )5010.01(
‫תכשירי פוליאן כנגד פטריות‬
17/02/2009
2//60/0660
September 27, 2011-‫כ"ח באלול התשע"א‬
20/60/0626
514511
CYCLOPROPYL AMIDE
DERIVATIVES TARGETING THE
HISTAMINE H3 RECEPTOR
ASTRAZENECA AB
US
61/154067
20/02/2009
PCT/SE/2010/050191
WO/2010/096011
/6/62/0626
2//60/0626
‫תולדות אמיד ציקלופרופיל המכוונות‬
H2 ‫לרצפטור להיסטמין‬
514511
CYCLOSPORIN ANALOGUES FOR
PREVENTING OR TREATING
HEPATITIS C INFECTION
ENANTA PHARMACEUTICALS, INC.
US
61/148583
30/01/2009
PCT/US/2010/022675
WO/2010/088573
FUSED RING COMPOUND AND USE
THEREOF
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
18
A61K )5010.01(
‫אנלוגים של ציקלוספורין למניעה או טיפול‬
C ‫בזיהום בהפטיטיס‬
514515
ANTIBODY MOLECULES HAVING
SPECIFICITY FOR HUMAN OX40
UCB PHARMA S.A.
US
61/153038
17/02/2009
PCT/US/2010/024377
WO/2010/096418
00/62/0626
C07D )5010.01(
514512
A61K )5010.01(
–‫מולקולות נוגדנים בעלי ספציפיות ל‬
‫ אנושי‬OX40
C07D )5010.01(
‫תרכובת טבעת מאוחה ושימוש שלה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
2009020720
PCT/JP/2010/051651
WO/2010/087515
JP
/6/62/0660
30/01/2009
514514
LAPAROSCOPIC TOOL AND METHOD
FOR A LAPAROSCOPIC SURGERY
FAYEZ ALMODHEN
A61B )5010.01(
‫כלי לפרוסקופי ושיטה לניתוח לפרוסקופי‬
PCT/CA/2009/000117
WO/2010/085869
01/62/0626
514515
EOTAXIN-2 (CCL24) INHIBITORS IN
INFLAMMATORY, AUTOIMMUNE,
AND CARDIOVASCULAR
DISORDERS
THE MEDICAL RESEARCH FUND AT
THE TEL AVIV SOURASKY MEDICAL
CENTER
US
61/202089
28/01/2009
02/011//6
00/60/0660
US
PCT/IL/2010/000073
WO/2010/086854
0//62/0626
19
‫)במחלות‬CCL54( 5–‫מעכבי אאוטוקסין‬
‫ במחלות אוטואמוניות ובמחלות‬,‫דלקתיות‬
‫לב‬
514511
METHOD AND APPARTUS FOR
TRACKING DEVICE MANAGEMENT
DATA CHANGES
RESEARCH IN MOTION LIMITED
US
12/363177
30/01/2009
PCT/CA/2010/000085
WO/2010/085875
C07K )5010.01(
‫קרן מחקרים ופיתוח תשתיות שליד‬
‫אביב ע"ש סוראסקי‬-‫המרכז הרפואי תל‬
H04W )5010.01(
‫שיטה ומערכת למכשיר מעקב לניהול‬
‫שינויים בנתונים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
21/60/0626
514511
METHOD FOR PRODUCING 2AMINOBIPHENYLENE
BASF SE
EP
09153239.0 19/02/2009
PCT/EP/2010/052033
WO/2010/094736
6//6//0626
514511
HETEROCYCLIC ANTIVIRAL
COMPOUNDS
F. HOFFMANN-LA ROCHE AG
US
61/158207
06/03/2009
PCT/EP/2010/052661
WO/2010/100178
2//26/0660
514516
COMPOSITE NANOPARTICLES,
NANOPARTICLES, NANOPARTICLES
AND METHODS FOR PRODUCING
SAME
VELETANLIC, EMINA
US
60/726184
14/10/2005
PCT/CA/2006/001686
WO/2007/041862
60/60/0626
514560
INTEGRATED TOUCH SCREEN
APPLE INC.
US
61/149340
02/02/2009
02/2/010/
0//60/0660
US
20//1/010
02/61/0660
US
PCT/US/2010/022883
20
C07C )5010.01(
‫–אמינוביפנילן‬5 ‫שיטה לייצור‬
C07D )5010.01(
‫תרכובות הטרוציקליות אנטי–ויראליות‬
B01J )5010.01(
‫ ננו–חלקיקים‬,‫ננו–חלקיקים מרוכבים‬
‫ושיטות לייצורם‬
G09G )5010.01(
‫מסך מגע משולב‬
September 27, 2011-‫כ"ח באלול התשע"א‬
WO/2010/088666
20/22/0660
514561
USE OF DEFERIPRONE FOR
TREATMENT AND PREVENTION OF
IRON-RELATED EYE DISORDERS
SPINO, MICHAEL
US
61/147245
26/01/2009
PCT/CA/2009/001639
WO/2010/083582
22/60/0626
‫שימוש בדפריפרון לטיפול ומניעה של‬
‫מחלות עיניים הקשורות לברזל‬
514565
514562
DIHYDROQUINOLINONE
DERIVATIVES
TAISHO PHARMACEUTICAL CO.,
LTD.
JP
2009-25462 06/02/2009
0660-210/// 20/60/0660
JP
PCT/JP/2010/052114
WO/2010/090347
00/6//0622
SURFACE MICRO-MACHINED
SWITCHING DEVICE
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
21
C07H )5010.01(
‫תכשירים להדברת מזיקים‬
PESTICIDAL COMPOSITIONS
DOW AGROSCIENCES LLC
US
61/151543
11/02/2009
PCT/US/2010/023831
WO/2010/093752
6//60/0626
A61K )5010.01(
C07D )5010.01(
‫נגזרות של דיהידרוקוינולינון‬
514564
B82B )5010.01(
‫מתג המיוצר בשיטת עיבוד שטח מיקרוני‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
September 27, 2011-‫כ"ח באלול התשע"א‬
00/62/0626
514565
BICYCLIC HETEROCYCLIC SPIRO
COMPOUNDS
ISRAEL INSTITUTE FOR
BIOLOGICAL RESEARCH
US
61/147143
26/01/2009
PCT/IL/2010/000064
WO/2010/084499
60/60/0626
514561
A SYSTEM, METHOD AND
APPARATUS FOR IMPLEMENTING
DENTAL IMPLANTS
MID CORP
US
61/206733
04/02/2009
02/02/6//
6//6//0660
US
02/0/60/1
6//6//0660
US
02/01//11
6//20/0660
US
PCT/IB/2010/050456
WO/2010/089698
00/6//0622
SYSTEM AND METHOD FOR
IDENTIFICATION OF WIRELESS
COMMUNICATION TERMINALS
USING SPEAKER RECOGNITION
VERINT SYSTEMS LTD.
22
514561
C07D )5010.01(
‫תרכובות ספירו ביציקלי הטרוציקלי‬
‫המכון למחקר ביולוגי בישראל‬
A61C )5010.01(
‫ שיטה והתקן להשתלת שתלים‬,‫מערכת‬
‫דנטלים‬
H04W )5010.01(
‫מערכת ושיטה לזיהוי מסופי תקשורת‬
‫אלחוטיים על ידי זיהוי דובר‬
‫ורינט מערכות בע"מ‬
September 27, 2011-‫כ"ח באלול התשע"א‬
00/6//0622
514561
PROTECTIVE ENVIRONMENT
CRADLE FOR INTERMITTENT
ASSISTED ANKLE MOTION
ORTHOFLEX LTD
01/60/2001
A61H )5010.01(
‫סד עריסה המהווה סביבה מגנה להנעת‬
‫הקרסול‬
‫אורטופלקס בע"מ‬
514566
TRANSDERMAL DELIVERY
SYSTEMS OF BUPRENORPHINE FOR
USE IN TREATING PAIN
EURO-CELTIQUE S.A.
US
60/038919
24/02/1997
06/0/0601
00/60/200/
US
PCT/US/1998/003584
WO/1998/036728
62/60/0626
‫מערכת למתן טרנסדרמלי של‬
‫בייופרנאורפין לשימוש לטיפול בכאב‬
514200
METHOD AND KIT FOR
IDENTIFICATION OF AN EXPLOSIVE
SUBSTANCE WHICH CONTAINS AN
OXIDANT
MISTRAL DETECTION LTD.
US
61/202132
30/01/2009
PCT/IB/2010/050430
WO/2010/086834
60/60/0626
METHOD FOR QUANTIFICATION OF
SMALL RNA SPECIES
EXIQON A/S
23
A61K )5010.01(
B01L )5010.01(
‫שיטה וערכה לזיהוי חומר נפיץ המכיל‬
‫מחמצן‬
‫מיסטרל דטקשון בע"מ‬
514201
C12Q )5010.01(
‫שיטות לכימות של סוג של מולקולות‬
‫ קטנות‬RNA
September 27, 2011-‫כ"ח באלול התשע"א‬
DK
PA200900156
DK
PA200901038
PCT/DK/2010/050029
WO/2010/085966
02/02/2009
2//60/0660
00/60/0626
514205
PROCESS FOR PRODUCING PHENYLSUBTITUTED HETEROCYCLIC
DERIVATIVE THROUGH COUPLING
USING TRANSITION METAL
CATALYST
TEIJIN PHARMA LIMITED
2009JP
27/02/2009
046003
0660-2////6 00/60/0660
JP
PCT/JP/2010/053043
WO/2010/098428
00/62/0626
‫תהליך להכנת נגזרת הטרוציקלית בפניל‬
‫על ידי חיבור המשתמש בזרז מתכת מעבר‬
514202
A CHEMICAL METHOD FOR SOIL
IMPROVEMENT
MIDWEST INDUSTRIAL SUPPLY, INC
US
61/148216
29/01/2009
02/00/11/
0//62/0626
US
PCT/US/2010/022534
WO/2010/088483
0//6//0622
SYSTEM AND METHOD FOR
TRACKING WIRELESS
COMMUNICATION TERMINALS
USING APPLICATION-LAYER
IDENTIFIER CORRELATION
VERINT SYSTEMS LTD.
24
C07D )5010.01(
514205
C09K )5010.01(
‫שיטה כימית לשיפור קרקע‬
H04W )5010.01(
‫מערכת ושיטה למעקב אחר מסופי‬
‫תקשורת ניידים על ידי שיוך של מזהים‬
‫משכבת האפליקציה‬
‫ורינט מערכות בע"מ‬
September 27, 2011-‫כ"ח באלול התשע"א‬
0//6//0622
514201
METHOD AND APPARATUS FOR
SHAKER FOR FAST COOLING
MORMINO GIACINTO
0//62/0626
‫שיטה ומתקן שייקר לקירור מהיר‬
‫מורמינו ג'יאשינטו‬
514201
PROCESS FOR PRODUCING A
PHOTOMASK ON A
PHOTOPOLYMERIC SURFACE
DIGIFLEX LTD
US
61/202109
29/01/2009
PCT/IL/2010/000068
WO/2010/086850
62/61/0626
514206
SUBSTITUTED PIPERIDINES AS CCR3
ANTAGONISTS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
09157653.8 08/04/2009
602/102/90
6//22/0660
EP
PCT/EP/2010/054396
WO/2010/115836
0//62/0626
514210
BIOLOGICAL SAMPLING DEVICE
GENETIC TECHNOLOGIES LIMITED
US
61/147718
27/01/2009
PCT/AU/2010/000071
25
A47J )5010.01(
G03F )5010.01(
‫תהליך ליצירת מסיכה על גבי משטח‬
‫פוטו–פולימרי‬
‫דיגיפלקס בע"מ‬
C07D )5010.01(
–‫פיפרידינים מותמרים כאנטגוניסטים ל‬
CCR2
A61B )5010.01(
‫מכשיר לדגימה ביולוגית‬
September 27, 2011-‫כ"ח באלול התשע"א‬
WO/2010/085841
01/62/0626
514211
HIGH EFFICIENCY GROUP III-V
COMPOUND SEMICONDUCTOR
SOLAR CELL WITH OXIDIZED
WINDOW LAYER
MICROLINK DEVICES, INC.
US
61/147929
28/01/2009
PCT/US/2010/022385
WO/2010/088370
0//6//0622
514215
SYSTEM AND METHOD FOR
INFORMATION LIFECYCLE
MANAGEMENT OF INVESTIGATION
CASES
VERINT SYSTEMS LTD.
6//60/0626
514214
MEDICAL SYSTEM AND METHOD
FOR PROVIDING INFORMATION FOR
GLYCEMIC CONTROL
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09001561.1 04/02/2009
PCT/EP/2010/051268
WO/2010/089307
6//60/0626
26
514215
H01L )5010.01(
‫תא סולרי מוליך למחצה מתרכובת‬
‫ בעל יעילות גבוהה עם‬III–V ‫מקבוצה‬
‫שכבת חלון מחומצנת‬
G09B )5010.01(
‫מערכת ושיטה לניהול מחזור חיים של‬
‫מידע בתיקי חקירה‬
‫ורינט מערכות בע"מ‬
A61B )5010.01(
‫מערכת תרופתית ושיטה לקבלת‬
‫אינפורמציה לגבי בקרה גליקמית‬
A61B )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
MEDICAL DEVICE AND METHOD
FOR GLYCEMIC CONTROL
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09001564.5 04/02/2009
PCT/EP/2010/051266
WO/2010/089305
6//60/0626
‫התקן תרופתי ושיטה לוויסות גליקמי‬
514211
MEDICAL SYSTEM AND METHOD
FOR PROVIDING GLYCEMIC
CONTROL BASED ON GLYCEMIC
RESPONSE INFORMATION
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09001563.7 04/02/2009
PCT/EP/2010/051267
WO/2010/089306
6//60/0626
6//60/0626
A61B )5010.01(
‫התקן תרופתי ושיטה לקבלת אינפורמציה‬
‫לגבי וויסות גליקמי‬
514211
SELECTING ONE OR MORE
PARAMETERS FOR INSPECTION OF
A WAFER
KLA-TENCOR CORPORATION
US
61/150549
06/02/2009
PCT/US/2010/023396
WO/2010/091307
27
‫מערכת תרופתית ושיטה לוויסות גליקמי‬
‫המבוססת על אינפורמציה לגבי תגובה‬
‫גליקמית‬
514211
MEDICAL DEVICE AND METHOD
FOR PROVIDING INFORMATION FOR
GLYCEMIC CONTROL
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09001560.3 04/02/2009
PCT/EP/2010/051264
WO/2010/089304
A61B )5010.01(
H01L )5010.01(
‫בחירת פרמטר אחד או יותר לבדיקת שבב‬
September 27, 2011-‫כ"ח באלול התשע"א‬
514216
6//60/0660
CHOLESTANOL DERIVATIVE FOR
COMBINED USE
OTSUKA PHARMACEUTICAL CO., LTD.
JP
PCT/JP2009/000985 04/03/2009
PCT/JP/2009/004353
WO/2010/100686
‫נגזרת של כולסטרול עבור שימוש‬
‫משולב‬
514255
B62B )5010.01(
01/6//0622
‫עגלת קניות מתקפלת‬
‫סיגלי ישראלי‬
FOLDABLE SHOPPING CART
SIGALY ISRAELI
00/62/0626
514252
REINFORCED NATURAL OR
CONGLOMERATED STONE PLATELIKE ELEMENT AND
MULTILAYERED PROTECTIVE
COATING THEREOF
SILICALIA, S.L.
EP
09380014
30/01/2009
PCT/IB/2010/000152
WO/2010/086713
02/62/0626
C04B )5010.01(
‫רכיב דמוי–לוח מאבן או מחומר טבעי‬
‫מחוזק וציפוי מגן רב–שכבתי עבורו‬
514254
TRANSPARET, WEATHER-RESISTANT
BARRIER FILM, PRODUCTION BY
LAMINATION, EXTRUSION
LAMINATION OR EXTRUSION
COATING
28
A61K )5010.01(
B32B )5010.01(
,‫ציפוי חוסם עמיד בפני בליה ושקוף‬
‫ למינצית‬,‫ייצור באמצעות למינציה‬
‫שיחול או ציפוי שיחול‬
September 27, 2011-‫כ"ח באלול התשע"א‬
EVONIK ROHM GMBH
DE
102009000450.5
PCT/EP/2010/050667
WO/2010/086272
61/61/066/
28/01/2009
514255
HUMANIZED ANTI-CMET
ANTAGONISTS
GENENTECH, INC.
US
60/598991
05/08/2004
PCT/US/2005/027626
WO/2006/015371
61/60/0626
514251
METHOD OF AMPLIFICATION OF GCRICH DNA TEMPLATES
ASURAGEN, INC.
US
12/371306
13/02/2009
PCT/US/2010/023173
WO/2010/093552
60/60/0626
514251
ACTAGARDINE DERIVATIVES
NOVACTA BIOSYSTEMS LIMITED
US
61/149857
04/02/2009
PCT/GB/2010/000188
WO/2010/089544
/2/6//0626
29
514251
C07K )5010.01(
CMET ‫אנטגוניסטים ממקור אנושי נוגדי‬
C12Q )5010.01(
–‫שיטה להגברת תבניות דנ"א עשירות ב‬
GC
C07K )5010.01(
‫תולדות אקטאגרדין‬
C07D )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
ACTAGARDINE-1-SULFONIC ACID
{3-[5-(4-CHLORO-PHENYL)-1HPYRROLO [2,3-B] PYRIDINE-3CARBONYL]-2,4-DIFLUOROPHENYL}-AMIDE COMPOSITIONS
AND USES THEREOF
PLEXXIKON, INC.
US
61/166677
03/04/2009
02/2/06/2
60/6//0660
US
602//00/96
22/22/0660
EP
PCT/US/2010/029489
WO/2010/114928
61/60/0626
–5[–2{ ‫–חומצה סולפונית‬1–‫תולדות פרופאן‬
]B–2,5[ ‫–פירולו‬H1–)‫–כלורו–פניל‬4(
–}‫–דיפלואורו–פניל‬4,5–]‫–קרבוניל‬2–‫פירידין‬
‫אמיד ושימושים בהם‬
514256
‫מבני מיקרו בולטים‬
MICRO-RELIEF STRUCTURES
OPTAGLIO S.R.O.
GB
0902000.9
09/02/2009
PCT/EP/2010/051521
WO/2010/089399
514220
20/60/0626
METHOD AND DEVICE FOR
MONITORING A PHOTOVOLTAIC UNIT
SIEMENS AKTIENGESELLSCHAFT
DE
102009009050.9 17/02/2009
PCT/EP/2010/051797
WO/2010/094631
0//6//0660
514221
METHODS OF REDUCING THE
PROLIFERATION AND VIABILITY OF
MICROBIAL AGENTS
TARTGETED DELIVERY
TECHNOLOGIES LIMITED
US
61/150288
05/02/2009
PCT/US/2009/051593
30
B32B )5010.01(
G05B )5010.01(
‫שיטה ומכשיר לניטור יחידה‬
‫פוטווולטאית‬
A61K )5010.01(
‫שיטות להקטנת השגשוג והחיות של‬
‫גורמים מיקרוביאלים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
WO/2010/090654
514225
02/60/0660
‫הארכת זמן להתקדמות המחלה או‬
‫הישרדות של חולי סרטן‬
EXTENDING TIME TO DISEASE
PROGRESSION OR SURVIVAL IN
CANCER PATIENTS
GENENTECH, INC.
US
60/655277
PCT/US/2006/006334
WO/2006/091693
60/60/0626
23/02/2005
514222
31
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬
514224
PHOTOCHEMICAL CROSS-LINKABLE
POLYMERS, METHODS OF MAKING
PHOTOCHEMICAL CROSS-LINKABLE
POLYMERS, AND METHODS OF
USING PHOTOCHEMICAL CROSSLINKABLE POLYMERS
UNIVERSITY OF GEORGIA
RESEARCH FOUNDATION INC.
US
61/153385
18/02/2009
PCT/US/2010/024422
WO/2010/096444
A61K )5010.01(
‫תרכובות קרבמואילפוספונאט כמעכבים‬
‫ושימושים בהם‬
CARBAMOYLPHOSPHONATES AS
INHIBITORS AND USES THEREOF
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD.
US
61/151041
09/02/2009
PCT/IL/2010/000115
WO/2010/089752
2//60/0626
A61K )5010.01(
C08G )5010.01(
,‫פולימרים פוטוכימיים הניתנים להצלבה‬
‫שיטות להכנת פולימרים פוטוכימיים‬
‫ ושיטות לשימוש‬,‫הניתנים להצלבה‬
‫בפולימרים פוטוכימיים הניתנים להצלבה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
60/60/0626
514225
A61F )5010.01(
‫עיצוב תומכן גמיש‬
FLEXIBLE STENT DESIGN
CORDIS CORPORATION
US
61/149244
02/02/2009
PCT/US/2010/022904
WO/2010/088676
60/60/0626
514221
‫יחידה לטיפול מקדים במים המשתמשת‬
‫בנוזל המכיל פלואור‬
WATER PRETREATMENT UNIT
USING A FLUORINATED LIQUID
GUILLAUME DE SOUZA
FR
0950643
02/02/2009
PCT/FR/2010/050169
WO/2010/086575
01/62/0626
C02F )5010.01(
514221
SUBSTITUTED 1,1,3,3TETRAOXIDOBENZO[D][1,3,2]DITHIAZOLES
AS MGLUR4 ALLOSTERIC POTENTIATORS,
COMPOSITIONS, AND METHODS OF
TREATING NEUROLOGICAL DYSFUNCTION
VANDERBILT UNIVERSITY
US
61/206271
PCT/US/2010/022430
WO/2010/088406
01/6//0622
VEHICLE MAT SYSTEM AND
METHOD
YARON MANTEL
32
C07D )5010.01(
‫–טטראאוקסידובנזו‬2,2,1,1
‫]דיתיאזולים מותמרים‬D][2,3,1[
,‫ אלוסטרים‬MGLUR4 ‫כמעצימי‬
–‫תכשירים ושיטות לטיפול באי‬
‫תפקוד נוירולוגי‬
28/01/2009
514221
B60R )5010.01(
‫מערכת ושיטה עבור מרבד לרכב‬
‫רביד פלג‬
September 27, 2011-‫כ"ח באלול התשע"א‬
00/62/0626
514226
INTERFACE DEVICE FOR
COMMUNICATION BETWEEN A
MEDICAL DEVICE AND A
COMPUTER
IVY BIOMEDICAL SYSTEMS, INC.
US
61/148259
29/01/2009
PCT/US/2010/022131
WO/2010/088218
62/60/0626
‫התקן לממשק עבור תקשורת בין מכשיר‬
‫רפואי ומחשב‬
514240
METHODS AND COMPOSITIONS FOR
TREATING ALZHEIMER'S DISEASE
GALMED INTERNATIONAL LIMITED
US
61/149100
02/02/2009
PCT/IL/2010/000088
WO/2010/086864
00/62/0626
514241
IL-1 BINDING PROTEINS
ABBOTT LABORATORIES
US
61/206250
29/01/2009
PCT/US/2010/000244
WO/2010/087972
20/60/0626
514245
INDOLE DERIVATIVES AS CRTH2
RECEPTOR ANTAGONISTS
MERCK SHARP & DOHME CORP.
US
61/154968
24/02/2009
PCT/US/2010/024713
WO/2010/099039
33
G06F )5010.01(
A61K )5010.01(
‫שיטות ותכשירים לטיפול במחלת‬
‫האלצהיימר‬
C07K )5010.01(
IL–1 ‫חלבוני קשירה‬
C07D )5010.01(
‫נגזרות אינדול כאנטגוניסטים לקולטן‬
CRTH5
September 27, 2011-‫כ"ח באלול התשע"א‬
21/62/0626
514242
RANGEFINDER PIVOTABLE
BETWEEN OBVERSE AND REVERSE
POSITIONS
PEGASUS TECHNOLOGIES LTD.
US
12/361587
29/01/2009
PCT/IB/2010/050205
WO/2010/086760
2//62/0626
‫מאתר טווח נע על ציר בין עמדות קדמית‬
‫ואחורית‬
‫פגסוס טכנולוגיות בע"מ‬
514244
SOLID-STATE RADIATION
DETECTOR WITH IMPROVED
SENSITIVITY
REDLEN TECHNOLOGIES INC.
US
12/364042
02/02/2009
PCT/US/2010/021142
WO/2010/088066
60/60/0626
METHOD FOR PRODUCING A
DENTIST TOOL
DEN-MAT HOLDINGS, LLC
34
H01L )5010.01(
‫גלאי מצב מוצק לקרינה בעל רגישות‬
‫משופרת‬
514245
INFLATABLE MINIMALLY INVASIVE
SYSTEM FOR DELIVERING AND
SECURING AN ANNULAR IMPLANT
ST, JUDE MEDICAL, CARDIOLOGY
DIVISION, INC.
US
61/151061
09/02/2009
PCT/US/2010/023546
WO/2010/091383
60/60/0626
G06F )5010.01(
A61B )5010.01(
‫מערכת מתנפחת זעיר פולשנית להחדרה‬
‫וקיבוע שתל טבעתי‬
514241
A61B )5010.01(
‫שיטה לייצור מכשיר לרופא שיניים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
EP
09151896.9
PCT/EP/2010/051261
WO/2010/086459
01/62/0626
02/02/2009
514241
COMPUTER IMPLEMENTED SYSTEM
FOR PROVIDING MUSICAL MESSAGE
CONTENT
SHEFALI KUMAR
US
12/362255
29/01/2009
PCT/US/2010/022346
WO/2010/088342
22/60/0626
00/62/0626
A61K )5010.01(
–‫–דיהידרו‬1,5(–2–‫תכשיר הכולל (–)–טרנס‬
–H1(–4–)‫–איל‬1–‫]קינולין‬JI1,5,2[‫–פירולו‬H4
‫–דיאון ביחד‬5,5–‫–איל)–פירולידין‬2–‫אינדול‬
‫עם גורם שני נגד התרבות‬
514246
COMPOSITIONS AND METHODS FOR
THE TREATMENT OF CANCER
KO, YOUNG HEE
US
61/148385
29/01/2009
PCT/US/2010/022664
WO/2010/088564
35
‫מערכת לאספקת תוכן הודעה מוזיקלי‬
‫מיישמת על ידי מחשב‬
514241
A COMPOSITION COMPRISING (-) TRANS-3-(5,6-DIHYDRO-4HPYRROLO [3,2,1-IJ] QUINOLIN-1-YL)4-(1H-INDOL-3-YL) PYRROLIDINE2,5-DIONE IN COMBINATION WITH A
SECOND ANTI-PROLIFERATIVE
AGENT
KYOWA HAKKO KIRIN CO., LTD.
US
61/152138
12/02/2009
02/2/61/2
2//61/0660
US
PCT/US/2010/023893
WO/2010/093789
H04W )5010.01(
A61K )5010.01(
‫תכשירים ושיטות לטיפול בסרטן‬
September 27, 2011-‫כ"ח באלול התשע"א‬
0//60/0626
514251
C07D )5010.01(
INHIBITORS OF BRUTON'S
TYROSINE KINASE
F. HOFFMANN-LA ROCHE AG
US
61/209021
02/03/2009
02//66601
62/60/0626
US
PCT/EP/2010/052394
WO/2010/100070
26/6//0626
‫מעכבים של ברוטונס טירוזין קינאז‬
514255
AZACYCLIC SPIRODERIVATIVES AS
HSL INHIBITORS
F. HOFFMANN-LA ROCHE AG
EP
09160026.2 12/05/2009
PCT/EP/2010/056307
WO/2010/130665
00/62/0626
C07D )5010.01(
‫פירולופירימידינדיון דימרי ושימושו בטיפול‬
‫במחלות נשימתיות‬
514254
PHARMACEUTICAL COMPOSITIONS
RESISTANT TO ABUSE
EGALET LTD
DK
PA200900192 06/02/2009
36
HSL ‫תולדות ספירו אזאציקליות כמעכבי‬
514252
DIMERIC
PYRROLOPYRIMIDINEDIONE AND
ITS USE IN THERAPY OF
RESPIRATORY DISEASES
CHIESI FARMACEUTICI S.P.A.
GB
0901616.3
30/01/2009
606160196
22/6//0660
GB
PCT/GB/2010/050092
WO/2010/086638
6//60/0626
C07D )5010.01(
A61K )5010.01(
‫תכשירים רוקחיים עמידים בפני שימוש‬
‫לרעה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
02/2/6006
US
PCT/DK/2010/000019
WO/2010/088911
60/60/0660
/6/6//0626
514255
‫ אנושי ושימושים‬TWEAK ‫נוגדנים נגד‬
‫שלהם‬
ANTIBODIES AGAINST HUMAN
TWEAK AND USES THEREOF
F. HOFFMANN-LA ROCHE AG
EP
09004905.7 02/04/2009
PCT/EP/2010/002009
WO/2010/115555
/2/6//0622
514251
WATER DRIVEN TIMING, WARNING
AND CONTROL DEVICE FOR WATER
AND ENETGY CONSERVATION
BORIS GONOREZKI
/2/6//0622
37
G08B )5010.01(
,‫ התראה ובקרה‬,‫ אזהרה‬,‫מכשיר תזמון‬
‫המופעל מזרם מים והמיועד לחיסכון במים‬
‫ובאנרגיה‬
‫בוריס גונורצקי‬
514251
ANTERIOR CHAMBER ANGLE
PROTECTOR
NULENS LTD.
22/60/0626
C07K )5010.01(
A61F )5010.01(
‫מגן זוית לשכה קידמית‬
‫ניולנס בע"מ‬
514251
H04J )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
METHOD AND NETWORK ELEMENT
FOR PERFORMING LDP IGP
SYNCHRONIZATION FOR
BROADCAST NETWORKS
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL)
US
61/157501
04/03/2009
20/10211/
60/61/0660
US
PCT/US/2010/023947
WO/2010/101705
514256
61/20/0660
MICROPUMP
SENSILE PAT AG
EP
05405726.0
6016/10096
EP
PCT/IB/2006/003596
WO/2007/074363
28/12/2005
60/22/0660
514210
SYSTEM AND METHOD FOR MAIN
PAGE IDENTIFICATION IN WEB
DECODING
VERINT SYSTEMS LTD.
G06F )5010.01(
‫מערכת ושיטה לזיהוי עמודים ראשיים‬
‫בפענוח תעבורת רשת‬
‫ורינט מערכות בע"מ‬
514211
APPARTUS FOR CLEARING TUBING
AND RELATED METHOD
GULF MEDICAL HOLDINGS, LLC
US
29/336164
29/04/2009
20/1110/0
00/60/0660
US
PCT/US/2009/049154
WO/2010/126537
38
F04B )5010.01(
‫משאבה זעירה‬
/2/6//0622
/6/60/0660
IGP ‫שיטה ואלמנט רשת לביצוע סנכרון‬
‫ עבור רשתות שידור‬LDP
A61M )5010.01(
‫מערכת לניקוי צנרת ושיטה קשורה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
61/60/0626
514215
METHOD FOR PRODUCING
HYDROXYMETHYL
DIPHENYLOXIRANES AND
CORRESPONDING 1AZOLYLMETHYL-1,2DIPHENYLOXIRANES
BASF SE
EP
09152176.5 05/02/2009
PCT/EP/2010/051380
WO/2010/089353
00/62/0626
514212
SWELLABLE (METH) ACRYLATE
SURFACES FOR CULTURING CELLS
IN CHEMICALLY DEFINED MEDIA
GERON CORPORATION
US
12/362974
30/01/2009
PCT/US/2010/022497
WO/2010/088456
00/62/0626
514214
DIMERIC
PYRROLOPYRIMIDINEDIONE AND
ITS USE IN THERAPY OF
RESPIRATORY DISEASES
PULMAGEN THERAPEUTICS
(INFLAMMATION) LIMITED
GB
0901616.3
30/01/2009
606160196
22/6//0660
GB
PCT/GB/2010/050092
WO/2010/086638
39
C07D )5010.01(
‫שיטה לייצור הידרוקסימתיל‬
–5,1–‫–אזולילמתיל‬1–‫דיפנילאוקסיראנים ו‬
‫דיפנילאוקסיראנים מקבילים‬
C12N )5010.01(
‫משטחי (מת)אקרילאט מתנפחים לגידול‬
‫תאים בתרבית במדיה מוגדרת כימית‬
C07D )5010.01(
‫פירולופירימידינאון דימרי והשימוש בו‬
‫בטיפול במחלות בדרכי הנשימה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
514215
00/62/0626
‫פפטידים אנטיביוטיים‬
ANTIBIOTIC PEPTIDES
AMP-THERAPEUTICS GMBH & CO. KG
DE
102009007381.7 29/01/2009
PCT/EP/2010/051072
WO/2010/086401
61/60/0626
514211
TREATMENT OF LUNG CANCER
WITH NITROBENZAMIDE
COMPOUNDS IN COMBINATION
WITH A GROWTH FACTOR
INHIBITOR
BIPAR SCIENCES, INC.
US
61/149977
04/02/2009
PCT/US/2010/023137
WO/2010/091140
61/22/0660
40
A01N )5010.01(
‫טיפול בסרטן הריאות עם תרכובות‬
‫ניטרובנזאמיד בתערובת על מעכב פקטור‬
‫גדילה‬
514211
METHOD FOR MANUFACTURING OF
CELLULAR BOARD, CELLULAR
BOARD, METHOD FOR PRODUCING
CELLULAR BOARD ELEMENT OF
STEEL PLATE STRIP, AND
PRODUCTION LINE
OY SHIPPAX LTD
FI
20051131
08/11/2005
066/2/0/
0//20/066/
FI
0660622/
6//60/0660
FI
0660611/
61/6//0660
FI
066060/0
60/6//0660
FI
066061/1
06/60/0660
FI
PCT/FI/2006/000359
WO/2007/054608
60/60/0626
C07K )5010.01(
514211
B21D )5010.01(
‫שיטה להפקת אלמנטים של לוח סלולר‬
‫מסרטי משטח מתכת ושורת הפקה‬
G02B )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
ALL-REFLECTIVE AFOCAL
TELESCOPE DERIVED FROM THE
FIRST TWO MIRRORS OF A FOCAL
THREE-MIRROR ANASTIGMAT
TELESCOPE
RAYTHEON COMPANY
US
12/369976
12/02/2009
PCT/US/2010/023633
WO/2010/093631
/2/6//0622
‫טלסקופ לא–מוקדי משקף–כל מופק‬
‫משתי המראות הראשונות של טלסקופ‬
‫מוקדי לא–אנסטיגמטיבעל שלוש המראות‬
514216
‫מערכת בקרת מהירות‬
‫יעקב קרן‬
SPEED CONTROL SYSTEM
YAKOV KEREN
/2/6//0622
514210
ELECTRICITY-POWERED AIRCRAFT
YARON BARAK
20/60/0626
514211
GRANULES CONTAINING
FILAMENTARY FUNGI AND
METHOD OF PREPARATION
THEREOF
UREA CASALE S.A.
EP
09002336.7 19/02/2009
PCT/EP/2010/051944
WO/2010/094689
41
B60H )5010.01(
B64C )5010.01(
‫כלי טיס על בסיס חשמלי‬
‫ירון ברק‬
A01N )5010.01(
‫גרגרים המכילים פטרייה סיבית ושיטה‬
‫להכנתם‬
September 27, 2011-‫כ"ח באלול התשע"א‬
2//60/0626
514215
MEANS AND METHODS FOR
MANUFACTURING HIGHLY PURE
NEUROTOXIN
MERZ PHARMA GMBH & CO, KGAA
US
61/207989
19/02/2009
602//0009/
20/60/0660
EP
602010/096
00/61/0660
EP
02/0//2//
00/61/0660
US
PCT/EP/2010/000985
WO/2010/094463
06/60/0661
‫אמצעים ושיטות לייצור נוירו–טוקסין טהור‬
‫ברמה גבוהה‬
514212
USE OF ADIPOSE TISSUE-DERIVED
CELLS IN THE PREPARATION OF A
COMPOSITION FOR THE
TREATMENT OF CARDIOVASCULAR
DISEASES
MACROPORE BIOSURGERY, INC.
US
60/449279
20/02/2003
06/100022
2//61/066/
US
PCT/US/2004/005117
WO/2004/074457
20/60/0626
514214
PROCESS FOR PURIFYING
LIPOPEPTIDES
XELLIA PHARMACEUTICALS APS
US
61/153660
19/02/2009
PCT/NO/2010/000066
WO/2010/095953
60/60/0626
NOVEL PEPTIDES AND METHODS
FOR PRODUCING THEM
VALIO LTD.
42
C07K )5010.01(
514215
C12N )5010.01(
‫שימוש בתאים שומניים נגזרי–רקמה‬
–‫להכנת תכשיר לטיפול במחלות קרדיו‬
‫וסקולריות‬
C07K )5010.01(
‫תהליך לטיהור ליפופפטידים‬
C07K )5010.01(
‫פפטידים חדשים ושיטות לשימוש בהם‬
September 27, 2011-‫כ"ח באלול התשע"א‬
FI
20090031
20//01201
US
PCT/FI/2010/050059
WO/2010/086512
/2/62/0626
02/02/2009
60/60/0660
514211
METHODS OF GENERATING TISSUE
USING DEVITALIZED, ACELLULAR
SCAFFOLD MATRICES DERIVED
FROM MICRO-ORGANS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD
IL
196820
01/02/2009
02/060/6/
2//60/0660
US
PCT/IL/2010/000076
WO/2010/086856
6//60/0626
514211
MEDICAMENT DELIVERY DEVICES
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09001578.5 05/02/2009
PCT/EP/2010/051275
WO/2010/089313
6//60/0626
514211
MEDICAMENT DELIVERY DEVICES
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09001577.7 05/02/2009
PCT/EP/2010/051270
WO/2010/089308
43
A61L )5010.01(
‫שיטות להכנת רקמות על מטריקסות‬
‫חסרי תאים ממיקרו–איברים‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬
A61M )5010.01(
‫התקנים לשחרור תרופה‬
A61M )5010.01(
‫התקנים לשחרור תרופה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
6//60/0626
514216
‫התקנים לשחרור תרופה‬
MEDICAMENT DELIVERY DEVICES
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09001576.9 05/02/2009
PCT/EP/2010/051272
WO/2010/089310
22/20/0660
514210
APPARATUS, METHOD AND SYSTEM
FOR CONTROL OF AC/AC
CONVERSION
POWEROFFER
US
60/749045
12/12/2005
PCT/IL/2006/001420
WO/2007/069239
6//60/0626
514211
44
C12N )5010.01(
‫מצע לתרביות לתאי גזע אפיתליאלים‬
‫ולאורגנואידים המכילים תאי גזע אלה‬
514214
AUTOMATED INTRAOCULAR LENS
INJECTOR DEVICE
ALCON RESEARCH, LTD.
US
61/151712
11/02/2009
PCT/US/2010/023544
WO/2010/093593
H03B )5010.01(
‫מכשיר שיטה ומערכת לבקרת המרת זרם‬
‫זרם חילופין‬/‫חילופין‬
CULTURE MEDIUM FOR EPITHELIAL
STEM CELLS AND ORGANOIDS
COMPRISING SAID STEM CELLS
KONINKLIJKE NEDERLANDSE
AKADEMIE VAN WETENSCHAPPEN
EP
09151970.2 03/02/2009
02/210000
6//60/0660
US
602/21/290
/6/60/0660
EP
PCT/NL/2010/000017
WO/2010/090513
60/60/0626
A61M )5010.01(
A61F )5010.01(
‫מכשיר אוטומטי להזרקת עדשה תוך עינית‬
September 27, 2011-‫כ"ח באלול התשע"א‬
20/60/0626
514215
INACTIVATED DENGUE VIRUS
VACCINE WITH ALUMINIUM-FREE
ADJUVANT
GLAXOSMITHKLINE BIOLOGICALS
S.A.
US
61/153060
17/02/2009
PCT/EP/2010/051882
WO/2010/094663
62/61/0622
‫חיסון וירוס דנגי לא פעיל עם מסייע חופשי‬
‫מאלומיניום‬
514211
MARINE GATE SYSTEM AND
METHOD
DAN RAZ LTD
20/20/066/
‫דן רז בע"מ‬
514211
514211
TRIGGERED LOCATION SERVICES
QUALCOMM INCORPORATED
US
61/151089
09/02/2009
45
G08B )5010.01(
‫מערכת ושיטה עבור שער ימי‬
SYNTHESIS OF AMINES AND
INTERMEDIATES FOR THE
SYNTHESIS THEREOF
CIBA SPECIALTY CHEMICALS
HOLDING INC.
EP
02406128.5 20/12/2002
PCT/EP/2003/050992
WO/2004/056769
60/60/0626
C07K )5010.01(
C07D )5010.01(
‫סינתיזה של אמינים ותוצרי ביניים‬
‫לסינתיזה שלהם‬
H04W )5010.01(
‫שירותי איתור מופעלים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
20//602/0
US
PCT/US/2010/023664
WO/2010/091424
61/60/0626
6//60/0626
514216
ELECTRICAL CONNECTOR
INCLUDING A BAYONET LOCKING
DEVICE
ITT MANUFACTURING
ENTERPRISES, INC.
US
12/369233
11/02/2009
PCT/US/2010/022989
WO/2010/093539
61/60/0626
62/61/0622
A METHOD AND NETWORK NODE
FOR IMPROVING BANDWIDTH
EFFICIENCY IN AN OPTICAL
NETWORK
ECI TELECOM LTD.
46
‫מחבר חשמלי הכולל התקן נעילת כידון‬
514260
DERIVATIVES OF AZAPIRANYLALKYLCARBAMATES OF 5-MEMBER
HETEROCYCLIC COMPOUNDS,
PREPARATION THEREOF AND
THERAPEUTIC USE THEREOF
SANOFI
FR
0900493
05/02/2009
PCT/FR/2010/050183
WO/2010/089510
H01R )5010.01(
C07D )5010.01(
‫נגזרות של אזאספירניל–אלקילקרבמטים‬
‫של תרכובות הטרציקליות בעלי חמישה‬
‫ הכנתן ושימוש רפואי‬,‫אטומים בטבעת‬
‫שלהן‬
514261
H04L )5010.01(
‫שיטה וצומת רשתי לשיפור היעילות של‬
‫פס רחב ברשת אופטית‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
September 27, 2011-‫כ"ח באלול התשע"א‬
00/62/0626
514265
BICYCLIC AMIDE DERIVATIVES FOR
ENHANCING GLUTAMATERGIC
SYNAPTIC RESPONSES
CORTEX PHARMACEUTICALS, INC.
US
61/206642
02/02/2009
PCT/US/2010/000255
WO/2010/087981
62/61/0622
514262
CATHETER ENTANGLEMENT
INDICATION
BIOSENSE WEBSTER (ISRAEL) LTD
US
12/851085
05/08/2010
6//60/0626
514265
NANOFABRICATED MEMBRANE
USING POLYMERIZED
PROTEOLIPOSOMES
AQUAZ A/S
US
61/149521
03/02/2009
PCT/US/2010/023043
WO/2010/091078
60/60/0626
514261
CARBA-NUCLESIDE ANALOGS FOR
ANTIVIRAL TREATMENT
GILEAD SCIENCES, INC.
US
61/151248
10/02/2009
PCT/US/2010/023586
WO/2010/093608
47
C07D )5010.01(
‫נגזרות של ביציקליות אמיד לשיפור‬
‫התגובות של גלוטמין סינפטות‬
A61M )5010.01(
‫חיווי של הסתבכות של צנתר‬
A61K )5010.01(
‫ננו ממברנה המיוצרת באמצעות‬
‫פרוטאוליפוזסומים מפולמרים‬
C07H )5010.01(
‫אנלוגים של קרבא–נוקליאוזיד לטיפול‬
‫אנטי–ויראלי‬
September 27, 2011-‫כ"ח באלול התשע"א‬
60/60/0626
514261
SYSTEM AND METHOD FOR OBJECT
RECOGNITION AND TRACKING IN A
VIDEO STREAM
EYESIGHT MOBILE
TECHONOLOGIES LTD
US
61/202157
02/02/2009
PCT/IL/2010/000092
WO/2010/086866
00/60/0626
20/60/0626
‫מערכת ושיטה לזיהוי אובייקט ומעקב‬
‫בזרם וידאו‬
‫אייסייט טכנולוגיות ניידות בע"מ‬
514261
AMORPHOUS SALT OF A
MACROCYCLIC INHIBITOR OF HCV
ORTHO-MCNEIL-JANSSEN
PHARMACEUTICALS, INC.
EP
09153964.3 27/02/2009
PCT/EP/2010/001197
WO/2010/097229
MOLECULAR PROFILING OF
TUMORS
CARIS MPI, INC.
48
C07D )5010.01(
‫ מקרוציקלי‬HCV ‫מלח אמורפי של מעכב‬
514266
METHODS OF CREATING AND
SCREENING DNA-ENCODED
LIBRARIES
X-CHEM, INC
US
61/152508
13/02/2009
PCT/US/2010/024314
WO/2010/094036
22/60/0626
G06K )5010.01(
514400
C40B )5010.01(
–‫שיטות ליצירת וניפוי ספריות מקודדות‬
‫דנ"א‬
G01N )5010.01(
‫אפיון מוליקולרי של גידולים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
US
61/151758
02/2/6/0/
US
02/000010
US
PCT/US/2010/000407
WO/2010/093465
6//60/0626
11/02/2009
2//61/0660
00/6//0660
514401
CRYSTALLINE FORM OF (R)-3-(4-(2(2-METHYLTETRAZOL-5YL)PYRIDIN-5-YL)-3FLUOROPHENYL)-5HYDROXYMETHYL OXAZOLIDIN-2ONE DIHYDROGEN PHOSPHATE
TRIUS THERAPEUTICS
US
61/149402
03/02/2009
PCT/US/2010/023122
WO/2010/091131
6//60/0626
514405
TRANSDERMAL PHARMACEUTICAL
PREPARATIONS
EGIS GYOGYSZERGYAR Nyilvanosan
Mukodo Reszvenytarsasag
HU
P0900072
06/02/2009
PCT/HU/2010/000015
WO/2010/089617
62/60/0626
514402
NOVELCELL LINES AND METHODS
CHROMOCELL CORPORATION
US
61/149311
02/02/2009
02/210/21
60/60/0660
US
02/210/02
60/60/0660
US
02/210/01
60/60/0660
US
02/0/6//0
/2/6//0660
US
02/0//212
20/61/0660
US
PCT/US/2010/022781
49
C07D )5010.01(
–R)–3–(4–(2–(2( ‫צורה גבישית של‬
–2–)‫–יל‬5–‫–יל)פירידין‬5–‫מתילטטראזול‬
‫–הידרוקסימתיל‬5–)‫פלואורופניל‬
‫–און דיהידרוגן פוספאט‬5–‫אוקסאזולידין‬
A61K )5010.01(
‫תכשירי רוקחות הניתנים דרך העור‬
C12N )5010.01(
‫שורות תאים חדשניות ושיטות‬
September 27, 2011-‫כ"ח באלול התשע"א‬
WO/2010/088633
61/60/0626
514404
DERIVATIVES OF 6-(6-NHSUBSTITUTEDTRIAZOLOPYRIDAZINESULFANYL)BENZOTHIAZOLES AND
BENZIMIDAZOLES, PREPARATION
THEREOF, USE THEREOF AS DRUGS,
AND USE THEREOF AS MET
INHIBITORS
SANOFI
FR
09/00513
06/02/2009
PCT/FR/2010/050179
WO/2010/089508
F15B )5010.01(
NON-LINEAR ACTUATOR SYSTEM AND
METHOD
CBE GLOBAL HOLDINGS, INC.
US
PCT/US2009/000825 10/02/2009
02/02//00
0//60/0660
US
PCT/US/2010/000220
WO/2010/093412
‫מערכת ושיטה למפעיל לא–לינארי‬
514401
C07D )5010.01(
61/60/0626
DERIVATIVES OF 6-(6-OSUBSTITUTEDTRIAZOLOPYRIDAZINE-SULFANYL)
BENZOTHIAZOLES AND
BENZIMIDAZOLES, PREPARATION
THEREOF, USE THEREOF AS DRUGS,
AND USE THEREOF AS MET
INHIBITORS
SANOFI
FR
0900512
06/02/2009
PCT/FR/2010/050178
50
–‫–מותמר‬NH–1(–1 ‫נגזרות‬
‫טריאזולופירידאזין–סולפאניל)בנזותיאזולים‬
‫ הכנתן שימוש בהן‬,‫ובנזימידאזולים‬
MET ‫ ושימוש בהם כמעכבי‬,‫כתרופות‬
514405
0//62/0626
C07D )5010.01(
–‫–מותמר–טריאזולופירידאזין‬0–1(–1 ‫נגזרות‬
,‫סולפאניל)בנזותיאזולים ובנזימידאזולים‬
‫ ושימוש בהם‬,‫ שימוש בהן כתרופות‬,‫הכנתן‬
MET ‫כמעכבי‬
September 27, 2011-‫כ"ח באלול התשע"א‬
WO/2010/089507
61/60/0626
514401
DERIVATIVES OF 6-(6-OCYCLOALKYL OR 6-NHCYCLOALKYLTRIAZOLOPYRIDAZINESULFANYL)BENZOTHIAZOLES AND
BENZOLES, PREPARATION
THEREOF, USE THEREOF AS DRUGS,
AND USE THEREOF AS MET
INHIBITORS
SANOFI
FR
09/00510
06/02/2009
PCT/FR/2010/050177
WO/2010/089506
61/60/0626
–HN–1 ‫–ציקלואלקיל או‬O–1(–1 ‫נגזרות‬
–‫ציקלואלקיל–טריאזולופירידאזין‬
,‫סולפאניל)בנזותיאזולים ובנזימידאזולים‬
‫ ושימוש בהם‬,‫ שימוש בהן כתרופות‬,‫הכנתן‬
MET ‫כמעכבי‬
514401
DERIVATIVES OF 6-(6SUBSTITUTEDTRIAZOLOPYIDAZINE-SULFANYL) 5FLUORO-BENZOTHIAZOLES AND 5FLUORO-BENZIMIDAZOLES,
PREPARATION THEREOF, USE
THEREOF AS DRUGS, AND USE
THEREOF AS MET INHIBITORS
SANOFI
FR
0900514
06/02/2009
PCT/FR/2010/050180
WO/2010/089509
6//60/0626
C07D )5010.01(
–‫–מותמר–טריאזולופירידאזין‬1(–1 ‫נגזרות‬
–5–‫–פלורו–בנזותיאזולים ו‬5 )‫סולפאניל‬
‫ שימוש בהן‬,‫ הכנתן‬,‫פלורו–בנזימידאזולים‬
MET ‫ ושימוש בהם כמעכבי‬,‫כתרופות‬
514406
MICRONUTRIENT FERTILIZERS AND
METHODS OF MAKING AND USING
THE SAME
VARADACHARI, CHANDRIKA
IN
184/KOL2009 03/02/2009
51
C07D )5010.01(
A23K )5010.01(
‫דשנים מיקרו–מזינים ושיטות לייצורם‬
‫ולשימוש בהם‬
September 27, 2011-‫כ"ח באלול התשע"א‬
IN
KOL2009/2000
PCT/IN/2010/000062
WO/2010/089776
02/26/0660
514410
6//60/0626
CHILDPROOF, HIGHLY INERT
INDIVIDUAL PACKAGING
LTS LOHMANN THERAPIE-SYSTEME
AG
DE
102009008217.4 10/02/2009
PCT/EP/2010/000638
WO/2010/091813
6//60/0626
514411
ENCAPSULATED NANOPARTICLES
NANOCO TECHNOLOGIES LIMITED
GB
0901857.3
05/02/2009
02/2/0//0
2//60/0660
US
PCT/GB/2010/000189
WO/2010/089545
61/60/0626
514415
NOVEL AMINO AZAHETEROCYCLIC
CARBOXAMIDES
MERCK PATENT GMBH
US
61/207354
11/02/2009
PCT/US/2010/000313
WO/2010/093419
20/6//0666
RECOMBINANT HUMAN
ADENOVIRALSEROTYPE 35
52
514412
B65D )5010.01(
‫אריזות נפרדות אינרטיות מאוד חסינות‬
‫מפני ילדים‬
G01N )5010.01(
‫ננו חלקיקים עטופים בקרום‬
C07D )5010.01(
‫קרבוקסאמידים אמינו אזאהטרוציקליים‬
‫חדשים‬
C12N )5010.01(
25 ‫אדנווירוס אנושי רקומביננטי מסוג‬
September 27, 2011-‫כ"ח באלול התשע"א‬
CRUCELL HOLLAND B.V.
EP
99201545.3 17/05/1999
PCT/NL/2000/000325
WO/2000/070071
20/60/0626
514414
FLEXIBLE RESERVATION REQUEST
AND SCHEDULING MECHANISMS IN
A MANAGED SHARED NETWORK
WITH QUALITY OF SERVICE
ENTROPIC COMMUNICATIONS, INC
US
61/154335
20/02/2009
PCT/US/2010/024837
WO/2010/096726
60/60/0626
514415
PEPTIDES, PHARMACEUTICAL
COMPOSITIONS COMPRISING SAME
AND USES THEREOF
RAMOT AT TEL-AVIV UNIVERSITY
LTD.
US
61/202162
02/02/2009
PCT/IL/2010/000093
WO/2010/086867
0//6//0626
514411
MULTI-MODAL IMAGING
ORBOTECH LTD.
US
12/409788
24/03/2009
PCT/IL/2010/000238
WO/2010/109455
60/60/0626
53
514411
H04L )5010.01(
‫מנגנונים נוחים עבור בקשה לשמירת‬
‫מקום וקביעת לוח זמנים ברשת מנוהלת‬
‫בשיתוף עם איכות שירות‬
A61K )5010.01(
‫ שימושיהם ותרכובות רפואיות‬,‫פפטידים‬
‫המכילות אותם‬
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
G01N )5010.01(
‫הדמיה מרובת אופנים‬
‫אורבוטק בע"מ‬
A01G )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
‫מערכת שליטה על אקלים בסביבה‬
‫ סביבה מרחבית‬,‫מרחבית לאורגניזמים‬
‫ מערכת שליטה ותוכנה‬,‫מותאמת‬
‫מתאימות‬
CONTROL SYSTEM FOR THE
CLIMATE IN A SPATIAL
ENVIRONMENT ADAPTED THERETO,
CONTROL SYSTEM AND PROGRAM
THEREFOR
PRIVA BV
NL
1036493
02/02/2009
PCT/NL/2010/000016
WO/2010/087699
61/60/0626
514411
H02J )5010.01(
‫ עם בורר‬,‫התקן חכם למדידה במטרים‬
‫שלבים‬
SMART METERING DEVICE WITH
PHASE SELECTOR
EANDIS
EP
09152287.0 06/02/2009
PCT/EP/2010/051511
WO/2010/089396
60/60/0626
514450
PHARMACEUTICAL COMPOSITIONS
COMPRISING TAMSULOSIN AND
SOLIFENACIN FOR ORAL
ADMINISTRATION
ASTELLAS PHARMA INC.
US
61/149854
04/02/2009
PCT/JP/2010/051393
WO/2010/090172
6//60/0626
‫תכשירי רוקחות המכילים טאמסולוסין‬
‫וסוליפנאסין למתן דרך הפה‬
514451
METHODS FOR PRODUCING HUMAN
AMNIOTIC CELL LINES
CEVEC PHARMACEUTICALS GMBH
DE
102009003439.0 05/02/2009
PCT/DE/2010/075012
WO/2010/094280
54
A61K )5010.01(
C12N )5010.01(
‫שיטות לייצור שורות תאים אנושיים‬
‫שפיריים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
6//61/0622
514455
METHOD FOR UTILIZATION OF
UNDERGROUND COLD AND A UNIT
FOR ITS IMPLEMENTATION
LEVIN VICTOR
6//61/0622
‫שיטה לניצול קור תת קרקעי ויחידה‬
‫ליישומה‬
‫ויקטור לוין‬
514452
514454
SYSTEMS AND METHODS FOR
INTERACTIVELY ACCESSING
HOSTED SERVICES USING VOICE
COMMUNICATIONS
SOFTHUS SP. Z.O.O.
US
12/364927
03/02/2009
PCT/IB/2010/000186
WO/2010/089645
60/60/0626
G10L )5010.01(
‫מערכות ושיטות לגישה אינטראקטיבית‬
‫לשירותי אירוח המשתמשות בתקשורת‬
‫קולית‬
514455
NOVEL SUBSTITUTED BICYCLIC
HETEROCYCLIC COMPOUNDS AS
GAMMA SECRETASE MODULATORS
ORTHO-MCNEIL-JANSSEN
PHARMACEUTICALS, INC.
EP
09152254.0 06/02/2009
55
B65D )5010.01(
‫שקית לכל חיתול‬
‫שי פישר‬
A BAG FOR ANY SINGLE DIAPER
SHAY FISHER
20/62/0626
B01D )5010.01(
C07D )5010.01(
‫תרכובות הטרוציקליות ביציקליות‬
‫מותמרות חדשות כמאפנני גמא סקרטאז‬
September 27, 2011-‫כ"ח באלול התשע"א‬
PCT/EP/2010/051244
WO/2010/089292
60/60/0626
514451
C07D )5010.01(
‫] פירידינים‬A–5,1[‫ ]–טריאזולו‬4 ,5 ,1 [
‫כמעכבי קינאז‬
[1,2,4] TRIAZOLLO [1,5-A] PYRIDINES
AS KINASE INHIBITORS
FOVEA PHARMACEUTICALS
EP
09360013.8 13/02/2009
PCT/EP/2010/051556
WO/2010/092041
6//60/0626
514451
C07D )5010.01(
INDOLE DERIVATIVES AS
ANTICANCER AGENTS
JANSSEN PHARMACEUTICA, N.V.
EP
09152089.0 04/02/2009
PCT/EP/2010/051316
WO/2010/089327
61/60/0626
514451
ASSEMBLIES COMPRISING BLOCK
CO-POLYMER FILMS AND
NANORODS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD.
US
61/149737
04/02/2009
02/000211
20/6//0660
US
PCT/IL/2010/000101
WO/2010/089743
21/20/0660
56
‫תולדות אינדול כגורמים נוגדי סרטן‬
C08J )5010.01(
‫מבנים המכילים שכבת בלוק–קופולימרים‬
‫וננו–מוטות‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬
514456
H04W )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
ACCESS CHANGE FOR RE-ROUTING A
CONNECTION
NOKIA CORPORATION
EP
PCT/EP09/051263 04/02/2009
PCT/FI/2009/050999
WO/2010/089445
6//60/066/
514420
TAXANE DERIVATIVES
FUNCTIONALIZED AT THE 14-POSITION
AND A PROCESS FOR THE
PREPARATION THEREOF
INDENA S.P.A.
IT
MI2002A001921 10/09/2002
PCT/EP/2003/009866
WO/2004/024706
6//60/066/
57
C07D )5010.01(
‫תולדות טקסאן פונקציונאליות בעמדה‬
‫ ותהליך להכנתן‬14
514425
TAXANE DERIVATIVES
FUNCTIONALIZED AT THE 14-POSITION
AND A PROCESS FOR THE
PREPARATION THEREREOF
INDENA S.P.A.
IT
MI2002A001921 10/09/2002
PCT/EP/2003/009866
WO/2004/024706
C07D )5010.01(
‫תולדות טקסאן פונקציונאליות בעמדה‬
‫ ותהליך להכנתן‬14
514421
TAXANE DERIVATIVES
FUNCTIONALIZED AT THE 14-POSITION
AND A PROCESS FOR THE
PREPARATION THEREOF
INDENA S.P.A.
IT
MI2002A001921 10/09/2002
PCT/EP/2003/009866
WO/2004/024706
6//60/066/
‫שינוי גישה לניתוב מחדש של חיבור‬
C07D )5010.01(
‫תולדות טקסאן פונקציונאליות בעמדה‬
‫ ותהליך להכנתן‬14
September 27, 2011-‫כ"ח באלול התשע"א‬
01/6//0626
514422
‫ ושיטות לשימוש‬FGFR2–‫נוגדנים אנטי‬
‫בהם‬
ANTI-FGFR3 ANTIBODIES AND
METHODS USING SAME
GENENTECH, INC.
US
61/163222
25/03/2009
PCT/US/2010/028470
WO/2010/111367
61/6//0626
PURIFICATION OF
IMMUNOGLOBULINS
BIOGEN IDEC MA INC.
US
61/157850
PCT/US/2010/026219
WO/2010/102114
2//60/0626
514424
05/03/2009
514425
C12N )5010.01(
‫ וחיסונים המכילים אותם‬FOXM1 ‫פפטידי‬
514421
1-HETEROCYCLYL-1,5-DIHYDROPYRAZOLO [3,4-D] PYRIMIDIN-4-ONE
DERIVATIVES AND THEIR USE AS PDE9A
MODULATORS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
VE
2009-000574
31/03/2009
58
C07K )5010.01(
‫טיהור של אימונוגלובולינים‬
FOXM1 PEPTIDES AND VACCINES
CONTAINING THE SAME
ONCOTHERAPY SCIENCE, INC.
US
61/153408
18/02/2009
PCT/JP/2010/001005
WO/2010/095428
00/6//0626
C07K )5010.01(
C07D )5010.01(
–‫–דיהידרו‬5,1–‫–הטרוציקליל‬1 ‫תולדות‬
‫–און‬4–‫] פירימידין‬D–4,2[ ‫פיראזולו‬
A9PDE ‫ושימוש בהן כמאפנני‬
September 27, 2011-‫כ"ח באלול התשע"א‬
EP
PCT/EP2009/053907
602/206090
EP
PCT/EP/2010/054050
WO/2010/112437
62/61/0660
/6/60/0660
514421
61/60/0626
PROCESS FOR THE SYNTHESIS OF
CLEISTANTHIN
GODAVARI BIOREFINERIES LTD
IN
234/MUM/2009 05/02/2009
PCT/IN/2010/000066
WO/2010/089778
60/60/0661
514426
COMBINATION THERAPY FOR
TREATING PROTEIN DEFICIENCY
DISORDERS
MOUNT SINAI SCHOOL OF
MEDICINE
US
60/444136
31/01/2003
PCT/US/2004/002973
WO/2004/069190
60/60/0661
514440
COMBINATION THERAPY FOR
TREATING PROTEIN DEFICIENCY
DISORDERS
MOUNT SINAI SCHOOL OF
MEDICINE
US
60/444136
31/01/2003
PCT/US/2004/002973
WO/2004/069190
60/60/0661
59
514441
C07D )5010.01(
‫תהליך לסינתזה של כלייסטנתין‬
A61K )5010.01(
‫תרפיה משולבת לטיפול בהפרעות‬
‫הקשורות במחסור של חלבון‬
A61K )5010.01(
‫תרפיה משולבת לטיפול בהפרעות‬
‫הקשורות במחסור של חלבון‬
A61K )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
COMBINATION THERAPY FOR
TREATING PROTEIN DEFICIENCY
DISORDERS
MOUNT SINAI SCHOOL OF
MEDICINE
US
60/444136
31/01/2003
PCT/US/2004/002973
WO/2004/069190
0//60/0626
514445
MODULAR SHOPPING CART
GREENCART INT LTD
US
61/208836
02/03/2009
PCT/IB/2010/050819
WO/2010/100583
62/6//0626
514442
ENHANCED MIGRAINE
TREATMENTS BASED ON GHRELIN
MIMETICS
HELSINN THERAPEUTICS (U.S.), INC.
US
61/156129
27/02/2009
PCT/US/2010/025725
WO/2010/099522
26/60/0626
514444
APPARATUS FOR IDENTIFYING &
TRACKING MULTIPLE TOOLS AND
DISPOSABLES
HALDOR ADVANCED
TECHNOLOGIES L.T.D.
US
12/369762
12/02/2009
PCT/IL/2010/000116
WO/2010/092570
60
‫תרפיה משולבת לטיפול בהפרעות‬
‫הקשורות במחסור של חלבון‬
B62B )5010.01(
‫עגלת קניות מודולרית‬
A61K )5010.01(
‫טיפולי מיגרנה משופרים מבוססים על‬
‫גרלין סינתטי‬
G08B )5010.01(
‫התקן ושיטה לזיהוי ומעקב אחר מבחר‬
‫כלים ומוצרים מתכלים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
0//60/0626
514445
METHOD AND SYSTEM FOR
AUTOMATIC MONITORING OF
DIABETES RELATED TREATMENTS
MOR RESEARCH APPLICATIONS
LTD.
US
61/155556
26/02/2009
02/01/62/
/6/60/0660
US
02//661/1
6//60/0626
US
PCT/IL/2010/000161
WO/2010/097796
61/60/0626
‫שיטה ומערכת לניטור אוטומטי של‬
‫טיפולים הקשורים לסכרת‬
‫יישום מחקרים בע"מ‬-‫מור‬
514441
BENZOIC ACID (1-PHENYL-2PYRIDIN-4-YL)ETHYL ESTERS AS
PHOSPHODIESTERASE INHIBITORS
A61B )5010.01(
C07D )5010.01(
–5–‫–פניל‬1( ‫אסטרים של חומצה בנזואית‬
‫–יל)אתיל כמעכבי‬4–‫פירידין‬
‫פוספודיאסטראז‬
CHIESI FARMACEUTICI S.P.A.
EP
09001660.1 06/02/2009
PCT/EP/2010/000676
WO/2010/089107
2//60/0626
514441
CORE-SHEATH TYPE CONJUGATED
YARN, KNITTED FABRIC, CLOTHING
PRODUCT, AND METHOD OF
PRODUCING CORE-SHEATH TYPE
CONJUGATED YARN
NISSHINBO TEXTILE INC
2009JP
28/10/2009
247400
PCT/JP/2010/060077
WO/2011/052262
61
D01F )5010.01(
‫ מוצר‬,‫ בד ארוג‬,‫סיב מצומד ליבה–נדן‬
–‫הלבשה ושיטה לייצור סיב מצומד ליבה‬
‫נדן‬
September 27, 2011-‫כ"ח באלול התשע"א‬
22/60/0626
514441
PREPARATION AND USE OF ZINC
AMIDES
LUDWIG-MAXIMILIANSUNIVERSITAT MUNCHEN
EP
09100112.3 13/02/2009
PCT/EP/2010/051677
WO/2010/092096
61/60/0626
61/60/0626
‫הכנה ושימוש באמידים של אבץ‬
514446
SYSTEMS AND METHODS FOR
MAINTAINING THE DOMINANCE
AND INCREASING THE BIMOSS
PRODUCTION OF
NANNOCHLOROPSIS IN AN ALGAE
CULTIVATION SYSTEM
AURORA BIOFUELS, INC
US
12/322668
04/02/2009
PCT/US/2010/000346
WO/2010/090760
PYRIDYL INHIBITORS OF
HEDGEHOG SIGNALLING
62
C12M )5010.01(
‫מערכות ושיטות לשמירה על הדומיננטיות‬
‫והגדלת ייצור הביומסה של‬
‫ במערכת גידול‬NANNOCHLOROPSIS
‫אצות‬
514450
2-MORPHOLINO-PYRIDO[3-2D]PYRIMIDINES, THEIR
PREPARATION AND
PHARMACUETICAL COMPOSITIONS
CONTAINING THEM
MERCK SERONO SA,
EP
09152709.3 12/02/2009
02/06/2/11
2//60/0660
US
PCT/EP/2010/051373
WO/2010/091996
60/60/066/
C07F )5010.01(
514451
C07D )5010.01(
,‫]פירימידינים‬D–5,2[ ‫–מורפולינו–פירידו‬5
‫הכנתם ותכשירי רוקחות המכילים אותם‬
C07D )5010.01(
‫פירידילים מעכבים איתות בקיפוד‬
September 27, 2011-‫כ"ח באלול התשע"א‬
GENENTECH, INC.
US
60/607367
PCT/US/2005/031284
WO/2006/028958
61/60/0626
02/09/2004
514455
A METHOD AND SYSTEM FOR
DETERMININIG THE QUALITY AND
AUTHENTICITY OF PRODUCTS
D.I.R. TECHNOLOGIES (DETECTION
IR) LTD
US
61/202204
05/02/2009
02/00//10
0//22/0660
US
PCT/IL/2010/000102
WO/2010/089744
62/6//0626
‫שיטה ומערכת לקביעת איכות ואותנטיות‬
‫של מוצרים‬
514452
VANGLI PEPTIDES AND VACCINES
INCLUDING THE SAME
ONCOTHERAPY SCIENCE, INC.
US
61/209242
04/03/2009
PCT/JP/2010/001366
WO/2010/100878
61/60/0626
C12N )5010.01(
‫ וחיסונים המכילים אותם‬VANGL1 ‫פפטידי‬
514454
PHARMACEUTICAL COMPOSITION
CONTAINING L-RIBOZYME FOR
TREATING ADVERSE REACTIONS BY
ADMINISTERING SPIEGELMERS
FREIE UNIVERSITAT BERLIN
DE
102009007929.7 06/02/2009
2606606/000/92
20/61/0660
DE
PCT/DE/2010/000159
WO/2010/088899
63
G01N )5010.01(
A61K )5010.01(
‫ –ריבוזים‬L ‫תכשיר רוקחות המכיל‬
‫לטיפול בתגובות שליליות ע"י מתן‬
‫ספיגלמרסים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
6//60/0626
514455
METHODS AND COMPOSITIONS FOR
TREATMENT OF
NEOVASCULARIZATION
ARRESTO BIOSCIENCES, INC.
US
61/207202
06/02/2009
PCT/US/2010/023359
WO/2010/091279
–‫שיטות ותכשירים לטיפול בהיווצרות כלי‬
‫דם חדשים‬
514451
21/61/0660
ULTRASOUND DEVICE COMPRISING
MEANS TO GENERATE ULTRASOUND
BEAM PRESENTING A CONCAVE
SEGMENT SHAPE HAVING A SINGLE
CURVATURE
INSTITUT NATIONAL DE LA SANTE ET
DE LA RECHERCHE MEDICALE
(I.N.S.E.R.M.)
EP
PCT/EP09/051892 18/02/2009
PCT/EP/2009/060678
WO/2010/094349
6//60/0626
514451
BURSTABLE LIQUID PACKAGING
AND USES THEREOF
NORTHWESTERN UNIVERSITY
US
61/150481
06/02/2009
PCT/US/2010/023310
WO/2010/091246
6//60/0626
514456
A SAFETY SYSTEM FOR FIREARMS
O'SHAUGHNESSY PATRICK
64
C12N )5010.01(
A61F )5010.01(
‫מכשיר אולטרסאונד הכולל אמצעים‬
‫לייצור קרן אולטרסאונד המציגה צורת‬
‫מקטע קעור בעל עקמומיות בודדה‬
B65B )5010.01(
‫אריזת נוזל שבירה ושימושים בה‬
F41A )5010.01(
‫מערכת בטיחות לנשקים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
IE
S2009/0099
PCT/IE/2010/000006
WO/2010/089730
2//26/066/
05/02/2009
514410
MALARIA PRIME/BOOST VACCINES
THE GOVERNMENT OF THE UNITED
STATES, AS REPRESENTED BY THE
SECRETARY OF THE ARMY, ON
BEHALF OF THE WALTER REED
ARMY INSTITUTE OF RESEARCH
US
60/619056
14/10/2004
6126/6//90
21/26/0661
EP
PCT/EP/2005/055209
WO/2006/040334
22/60/0626
514411
PESTICIDAL COMPOSITIONS
DOW AGROSCIENCES LLC
US
61/151549
11/02/2009
PCT/US/2010/023852
WO/2010/093764
20/60/0626
514415
PEPTIDES USED IN THE TREATMENT
AND/OR CARE OF THE SKIN,
MUCOUS MEMBRANES AND/OR
SCALP AND THEIR USE IN
COSMETIC OR PHARMACEUTICAL
COMPOSITIONS
LIPOTEC S.A.
ES
P200900426 16/02/2009
PCT/EP/2010/000937
WO/2010/091893
65
A61K )5010.01(
‫דחף נגד מלריה‬/‫תכשירי חיסון ראשוני‬
C07H )5010.01(
‫תכשירים להדברת מזיקים‬
C07K )5010.01(
‫ ממברנות‬,‫פפטידים לשימוש בטיפול עור‬
‫או קרקפת והשימוש בהם‬/‫ריריות ו‬
‫בתכשירים קוסמטיים ותכשירי רוקחות‬
September 27, 2011-‫כ"ח באלול התשע"א‬
22/60/0626
514412
‫מתקן לעדשות בעלות פוקוס משתנה‬
‫ממולאות בנוזל‬
VARIABLE FOCUS LIQUID FILLED
LENS APPARATUS
ADLENS BEACON, INC
US
12/370938
13/02/2009
PCT/US/2010/023830
WO/2010/093751
22/60/0626
514414
514411
514411
A METHOD AND APPARATUS FOR
ACCURATE DETERMINATION OF
PARAMETERS OF A STACK OF THIN
FILMS
BRIGHTVIEW SYSTEM LTD
US
61/160294
14/03/2009
66
G01N )5010.01(
‫מדידת פנלים פוטווולאטיים של שכבות‬
‫דקות‬
‫ויו מערכות בע"מ‬-‫ברייט‬
MEASUREMENT OF THIN FILM
PHOTOVOLTAIC SOLAR PANELS
BRIGHTVIEW SYSTEMS LTD
US
61/160374
16/03/2009
PCT/IL/2010/000175
WO/2010/106533
6//6//0626
G02B )5010.01(
‫מנגנון לעדשות בעלות פוקוס משתנה‬
‫ממולאות בנוזל‬
VARIABLE FOCUS LIQUID FILLED
LENS MECHANISM
ADLENS BEACON, INC
US
12/370938
13/02/2009
20//00/01
60/6//0660
US
PCT/US/2010/023835
WO/2010/093754
6//6//0626
G02C )5010.01(
H01L )5010.01(
‫מערכת ושיטה למדידה מדויקת של נתוני‬
‫שכבות דקות‬
‫ברייט ויו סיסטמס בע"מ‬
September 27, 2011-‫כ"ח באלול התשע"א‬
PCT/IL/2010/000174
WO/2010/106533
22/60/0626
514416
‫מוצרים קפואים ומאווררים‬
FROZEN AERATED PRODUCTS
NESTEC S.A.
US
61/152629
13/02/2009
PCT/EP/2010/051669
WO/2010/092091
20/60/0626
514410
METHOD FOR PRODUCING
PHENYLACETAMIDE COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2009JP
16/02/2009
032333
0660-2/0100 22/60/0660
JP
0660-0/0010 60/26/0660
JP
PCT/JP/2010/052486
WO/2010/093059
6//60/0626
67
C07C )5010.01(
‫הליך לייצור של תרכובת פאנילאצטאמיד‬
514415
JUN N-TERMINAL KINASE
INHIBITOR COMPOUNDS,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
ELAN PHARMACEUTICALS, INC.
US
61/207126
06/02/2009
02/011/06
02/60/0660
US
PCT/US/2010/023404
WO/2010/091310
A23G )5010.01(
C07D )5010.01(
‫–של הקינאז‬N–‫תרכובות מדכאי הקצה‬
‫ תכשירים המכילים אותן ושימושים‬,JUN
‫בהן‬
September 27, 2011-‫כ"ח באלול התשע"א‬
0//6//0660
514412
RADIO FREQUENCY TRANSCEIVER
FRONT END CIRCUIT
RFAXIS, INC
US
61/150419
06/02/2009
20/120000
00/6//0660
US
PCT/US/2009/038621
WO/2010/090649
61/60/0626
514414
CALCIUM-BINDING AGENTS,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
61/150623
06/02/2009
PCT/US/2010/023229
WO/2010/091199
61/60/0626
514415
BENZODIAZEPINE DERIVATIVES,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
IMMUNOGEN, INC.
US
61/150201
05/02/2009
PCT/US/2010/023150
WO/2010/091150
6//60/0626
514411
METHOD FOR PREDICTING BREAST
AND OVARIAN CANCER RISK
YALE UNIVERSITY
US
61/150645
06/02/2009
02/00/011
6//20/0660
US
PCT/US/2010/023412
68
H04B )5010.01(
‫מעגל קצה קדמי משדר תדר רדיו‬
A61K )5010.01(
‫ תכשירים המכילים‬,‫חומרים נקשרי–סידן‬
‫אותם ושימושים בהם‬
A01N )5010.01(
‫ תכשירים המכילים‬,‫תולדות בנזודיאזפין‬
‫אותן ושימושים בהן‬
C12Q )5010.01(
‫שיטה לנבא סיכון לסרטן השד וסרטן‬
‫השחלה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
WO/2010/101696
21/6//0626
514411
5-?,14-?-ANDROSTANE DERIVATIVES
USEFUL FOR THE TREATMENT OF
PROTEINURIA,
GLOMERULOSCLEROSIS AND
RENAL FAILURE
SIGMA-TAU INDUSTRIE
FARMACEUTICHE RIUNITE S.P.A.
EP
09155834.6 23/03/2009
PCT/EP/2010/053571
WO/2010/108855
2//60/0626
A61K )5010.01(
‫–בטא–אנדרוסטאן‬14,‫–בטא‬5 ‫תולדות‬
,‫השימושיים עבור טיפול בפרוטאינוריה‬
‫גלומרולוסקלרוזיס ואי ספיקת כליות‬
514411
G02F )5010.01(
‫מאפנן אור רב שכבתי‬
MULTILAYER LIGHT MODULATOR
RAYTHEON COMPANY
US
12/395046
27/02/2009
PCT/US/2010/024213
WO/2010/098995
514416
01/62/0626
PROCESS FOR THE EXTRACTION OF
LIPIDS FROM ALGAL BIOMASS
ENI S.P.A.
IT
MI2009A000144 04/02/2009
PCT/EP/2010/000570
WO/2010/089063
2//60/0626
514410
IMPROVED ANTI-SERUM ALBUMIN
BINDING VARIANTS
GLAXO GROUP LIMITED
69
C11B )5010.01(
‫תהליך להוצאת ליפידים מביומסה של‬
‫אלגל‬
C07K )5010.01(
‫וריאנטים משופרים קושרי אנטי–סרום‬
‫אלבומין‬
September 27, 2011-‫כ"ח באלול התשע"א‬
US
61/153746
02/20/01/
US
02/01/2/0
US
PCT/EP/2010/052008
WO/2010/094723
19/02/2009
0//6//0660
/6/60/0660
2//60/0626
514411
IMPROVED ANTI-SERUM ALBUMIN
BINDING VARIANTS
GLAXO GROUP LIMITED
US
61/153746
19/02/2009
02/20/006
0//6//0660
US
PCT/EP/2010/052007
WO/2010/094722
6//61/0622
514415
MAGNETIC ENCOLSURE AND
METHOD
LAPUNTUH-MAGNETICS LTD
6//61/0622
70
‫וריאנטים משופרים קושרי אנטי–סרום‬
‫אלבומין‬
G01R )5010.01(
‫מתחם מגנתי ושיטה‬
‫לפונטו מגנטיס בע"מ‬
514412
A SNAP FOR CLOSING PUNNET AND
A PUNNET WITH SUCH SNAPS
A.M.G PLASTICS LTD
6//61/0622
C07K )5010.01(
514414
B67B )5010.01(
‫לחצנית לסגירת אריזה ואריזה הכוללת‬
‫לחצניות כאלה‬
‫ פלסטיק בע"מ‬.‫ג‬.‫מ‬.‫א‬
B23B )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
A SCREW ANCHOR DEVICE AND
METHOD
DROR LEV
/6/60/0660
‫התקן ושיטה למיתד‬
‫דרור לב‬
514415
MAGNETICALLY DRIVEN
MICROPUMP
THE BOARD OF TRUSTEES OF THE
UNIVERSITY OF ILLINOIS
US
61/152165
12/02/2009
PCT/US/2009/059020
WO/2010/093383
21/60/0626
60/60/0626
C12N )5010.01(
‫ מבני‬,‫שיטה להקפאה קריוגנית של תאים‬
‫תא מלאכותיים או הרכבות רקמה‬
‫מורכבות תלת–מימדיות‬
514411
N-[(6-AZABICYCLO[3.2.1]OCT-1-YL)ARYL-METHYL]-BENZAMIDE
DERIVATIVES, PREPARATION
THEREOF, AND THERAPEUTIC USE
THEREOF
SANOFI
FR
09/00579
10/02/2009
PCT/FR/2010/050204
WO/2010/092287
71
‫מיקרו משאבה מונעת מגנטית‬
514411
METHOD FOR THE
CRYOPRESERVATION OF CELLS,
ARTIFICIAL CELL CONSTRUCTS OR
THREE-DIMENSIONAL COMPLEX
TISSUES ASSEMBLIES
NATURIN GMBH & CO.
EP
09153248.1 19/02/2009
PCT/EP/2010/052068
WO/2010/094747
F04B )5010.01(
C07D )5010.01(
–1–‫]אוקט‬1.5.2[‫–אזאביציקלו‬N–[(6 ‫נגזרות‬
‫ ושימוש‬,‫ הכנתן‬,‫אין)–אריל–מתיל]–בנזאמיד‬
‫רפואי שלהן‬
September 27, 2011-‫כ"ח באלול התשע"א‬
26/60/0626
514411
‫גילוי פגמים בשבב‬
DETECING DEFECTS ON A WAFER
KLA-TENCOR CORPORATION
US
61/152477
13/02/2009
PCT/US/2010/023802
WO/2010/093733
00/20/0660
514416
INTERSPINOUS PROCESS IMPLANTS
HAVING DEPLOYABLE
ENGAGEMENT ARMS
SPINAL SIMPLICITY LLC
US
61/207339
11/02/2009
20///1601
6//61/0660
US
PCT/US/2009/006730
WO/2010/093353
60/60/0626
514460
514461
DIFFRACTIVE TRIFOCAL LENS AND
METHOD OF MANUFACTURE
THEREOF
72
A61B )5010.01(
‫שתלי תהליך תוך–שדרתיים בעלי זרועות‬
‫חיבור הניתנות לפריסה‬
N-[(2-AZABICYCLO[2.1.1]HEX-1-YL)ARYL-METHYL]-BENZAMIDE
DERIVATIVES, PREPARATION
THEREOF, AND THERAPEUTIC USE
THEREOF
SANOFI
FR
0900578
10/02/2009
PCT/FR/2010/050203
WO/2010/092286
20/60/0626
H01L )5010.01(
C07D )5010.01(
–1–‫]הקס‬1.1.5[‫–אזאביציקלו‬N–](2 ‫נגזרות‬
,‫ הכנתן‬,‫איל)–אריל–מתיל]–בנזאמיד‬
‫ושימוש רפואי שלהן‬
G02B )5010.01(
‫עדשה מפזרת תלת–מוקדית ושיטה‬
‫ליצורה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
THE ARIZONA BOARD OF REGENTS
ON BEHALF OF THE UNIVERSITY OF
ARIZONA
US
61/207409
12/02/2009
PCT/US/2010/024165
WO/2010/093975
61/60/0626
514465
SPRING ORTHOTIC DEVICE
KING FAMILY KINGETICS, LLC
US
61/150789
08/02/2009
PCT/US/2010/023527
WO/2010/091377
6//61/0622
514462
514464
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
62/26/0660
514465
SHORT TRACTION AND GUIDANCE
SYSTEM FOR MINI-INVASIVE
SURGERY
BIOTECH INNOVATIONS LTDA.
73
‫מתקן סד קפיץ‬
H04R )5010.01(
‫אוזניות מתנפחות מעצמן‬
‫עידו פוריצקי‬
SELF-INFLATABLE HEAD PHONES
IDO PORITZKY
6//61/0622
A43B )5010.01(
G06F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
A61B )5010.01(
‫מערכת למשיכה ולהכוונה מרחוק‬
‫בניתוחים מיני פולשניים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
CL
279-2009
PCT/IB/2009/054307
WO/2010/089635
06/02/2009
26/60/0626
514461
SHORT B-DEFENSIN-DERIVED
PEPTIDES
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/151527
11/02/2009
PCT/IL/2010/000117
WO/2010/092571
61/6//0626
514461
DEVICE FOR A PHOTOCHEMICAL
PROCESS
ECODUNA TECHNOLOGIE GMBH
AT
A404/2009
12/03/2009
PCT/AT/2010/000068
WO/2010/102316
6//61/0622
514461
514466
PUMPING SYSTEM AND METHOD
DJERASSEM, LE BEMADJIEL
UY
1200900059 13/02/2009
74
‫פפטידים קצרים הנגזרים מבטא–דפנסין‬
‫ידע חברה למחקר ופיתוח בע"מ‬
C12M )5010.01(
‫מכשיר לתהליך פוטוכימי‬
B65H )5010.01(
‫גלילי נייר הגייני מורכב מפיסות נייר‬
‫נפרדות מאליהן‬
‫אלאלו אברהם‬
ROLLS OF SEPARATE SELFENCIRCLING SHEETS
ALALU AVRAHAM
20/62/0626
A61K )5010.01(
F03B )5010.01(
‫מערכת ושיטת שאיבה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
PCT/OA/2010/000001
WO/2010/093267
22/60/0626
514500
COMPOSITIONS AND METHODS FOR
EXTENDED THERAPY WITH
AMINOPYRIDINES
ACORDA THERAPEUTICS, INC.
US
61/151679
11/02/2009
02/0/0/0/
60/22/0660
US
02/01/1/0
22/20/0660
US
02/0110//
00/20/0660
US
02/0000/0
01/62/0626
US
PCT/US/2010/023970
WO/2010/093839
22/60/0626
514501
HISTAMINE H3 INVERSE AGONISTS
AND ANTAGONISTS AND METHODS
OF USE THEREOF
SUNOVION PHARMACEUTICALS
INC.
US
61/151817
11/02/2009
PCT/US/2010/000335
WO/2010/093425
60/60/0626
514505
DOWNLOADER CONVEYOR FOR
APPLES AND LIKE OBJECTS
PICKER TECHNOLOGIES LLC
US
61/151746
11/02/2009
PCT/US/2010/023655
WO/2010/093638
75
A61K )5010.01(
‫תכשירים ושיטות לטיפול ממושך עם‬
‫אמינופירידינים‬
C07D )5010.01(
‫אגוניסטים הופכיים ואנטגוניסטים‬
‫ ושיטות לשימוש בהם‬H3 ‫להיסטאמין‬
B65B )5010.01(
‫מסוע פורק לתפוחים ועצמים דומים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
22/60/0626
514504
FOLDING BOX
LEISCH BERATUNGS- UND
BETEILIGUNGS-GMBH
AT
A232/2009
12/02/2009
PCT/AT/2010/000040
WO/2010/091447
60/6//0660
514505
EAR MOLDING DEVICE FOR
CORRECTING MISSHAPED EARS
KENNETH C. FRENCH OF
US
12/368765
10/02/2009
PCT/US/2009/036328
WO/2010/093371
61/6//0626
514501
ANIONIC OIL-IN-WATER
EMULSIONS CONTAINING
PROSTAGLANDINS AND USES
THEREOF
NOVAGALI PHARMA SA
EP
09305203.3 04/03/2009
02/2///1/
61/6//0660
US
PCT/EP/2010/052740
WO/2010/100217
61/6//0626
514501
CATIONIC OIL-IN-WATER
EMULSIONS CONTAINING
PROSTAGLANDINS AND USES
THEREOF
NOVAGALI PHARMA SA
EP
09305202.5 04/03/2009
02/2/////
61/6//0660
US
76
B65D )5010.01(
‫קופסה מתקפלת‬
B29C )5010.01(
‫התקן לעיצוב אוזניים לתיקון אוזניים‬
‫מעוותות‬
A61K )5010.01(
‫תחליבים אניונים שמן במים המכילים‬
‫פרוסטגלנדינים ושימושים בהם‬
A61K )5010.01(
‫תחליבים קטיונים שמן במים המכילים‬
‫פרוסטגלנדינים והשימוש בהם‬
September 27, 2011-‫כ"ח באלול התשע"א‬
PCT/EP/2010/052741
WO/2010/100218
6//6//0626
514501
3-ARYLQUINAZOLIN-4-ONE
COMPOUNDS FOR COMBATING
INVERTEBRATE PESTS
BASF SE
US
61/157375
04/03/2009
PCT/EP/2010/052693
WO/2010/100189
62/6//0626
‫–און להדברת‬4–‫–ארילקווינזולין‬2 ‫תרכובות‬
‫מזיקים חסרי–חוליות‬
514506
514510
METHOD FOR CELLULAR TISSUE
MULTIPLICATION FROM JATROPHA
CURCAS
UNIVERSIDAD DE ANTIOQUIA
CO
09-040167
21/04/2009
PCT/IB/2009/007517
WO/2010/122372
20/6//0626
77
C12P )5010.01(
CURCAS ‫שיטה להכפלת רקמה תאית מ‬
JATROPHA
514511
METHOD FOR PRODUCING
CYCLOPROPANECARBOXYLIC ACID
ESTER
A61K )5010.01(
‫חומרים סופחי פוספט‬
PHOSPHATE ADSORBENT
VIFOR (INTERNATIONAL) AG.
EP
09154107.8 02/03/2009
PCT/EP/2010/052551
WO/2010/100112
20/22/0660
C07D )5010.01(
C07C )5010.01(
‫שיטה לייצור של אסטר של חומצה‬
‫ציקלופרופנקרבוקסילית‬
September 27, 2011-‫כ"ח באלול התשע"א‬
SUMITOMO CHEMICAL COMPANY,
LIMITED
2009JP
23/03/2009
069543
PCT/JP/2010/054721
WO/2010/110178
2//62/0626
514515
SYSTEM AND METHOD FOR
INSPECTING A WAFER
SEMICONDUCTOR TECHNOLOGIES
& INSTRUMENTS PTE LTD (SG)
200900229SG
13/01/2009
6
PCT/SG/2010/000004
WO/2010/082900
‫מערכת ושיטה לפיקוח על פיצול נתחים‬
514514
0//62/0626
OLIGONUCLEOTIDE PROBES AND
PRIMERS FOR DETECTION OF
HEPATITIS B VIRUS
BIGTEC PRIVATE LIMITED
IN
00314/CHE/2009 13/02/2009
PCT/IN/2010/000048
WO/2010/092595
62/6//0626
C12Q )5010.01(
‫גששים ומאיצים אוליגונוקליוטידיים‬
'‫לגילוי נגיפי הפטיטיס ב‬
514511
N-(HETERO)ARYL,2-(HETERO)ARYLSUBSTITUTED ACETAMIDES FOR
USE AS WNT SIGNALING
MODULATORS
IRM LLC
US
61/156599
02/03/2009
02/01/21/
0//60/0660
US
PCT/US/2010/025813
WO/2010/101849
78
H01L )5010.01(
C07D )5010.01(
‫–(הטרו)אריל אצטאמידים‬5,‫–(הטרו)אריל‬N
‫מותמרים לשימוש כמאפננים של סיגנל‬
WNT
September 27, 2011-‫כ"ח באלול התשע"א‬
22/6//0626
514511
ADDITION SALTS OF
TROMETHAMINE WITH
AZABIPHENYLAMINOBENZOIC
ACID DERIVATIVES AS DHODH
INHIBITORS
ALMIRALL, S.A.
EP
09382032.2 13/03/2009
PCT/EP/2010/001549
WO/2010/102825
22/6//0626
22/6//0626
C07D )5010.01(
–1,5(–5[{–5–‫–ציקלופרופיל‬5 ‫מלח נתרן של‬
–5–‫דיפלואורופניל)פירימידין‬
‫יל]אמינו}חומצה בנזואית כמעכבים של‬
DHODH
514516
ADDITION SALTS OF AMINES
CONTAINING HYDROXYL AND/OR
CARBOXYLIC GROUPS WITH AMINO
NICOTINIC ACID DERIVATIVES AS
DHODH INHIBITORS
LABORATORIOS ALMIRALL, S.A.
EP
09382031.4 13/03/2009
PCT/EP/2010/001550
WO/2010/102826
79
‫תוספי מלח של טרומתאמין עם תולדות‬
‫חומצה אזאביפנילאמינובנזואית כמעכבים‬
DHODH ‫של‬
514511
SODIUM SALT OF 5-CYCLOPROPYL2-{[2-(2,6DIFLUOROPHENYL)PYRIMIDIN-5YL]AMINO}BENZOIC ACID AS
DHODH INHIBITOR
ALMIRALL, S.A.
EP
09382033.0 13/03/2009
PCT/EP/2010/001548
WO/2010/102824
C07D )5010.01(
C07D )5010.01(
‫תוספי מלח של אמינים המכילים‬
‫או קבוצות קרבוקסיליות עם‬/‫הידרוקסיל ו‬
‫תולדות של חומצה אמינו ניקוטינית‬
DHODH ‫כמעכבים של‬
September 27, 2011-‫כ"ח באלול התשע"א‬
01/60/0626
514550
TOPICAL FOAM COMPOSITION
STIEFEL RESEARCH AUSTRALIA
PTY LTD.
US
61/202403
25/02/2009
PCT/AU/2010/000213
WO/2010/096868
61/60/0626
514551
SOLAR RECEIVER PANELS
BABCOCK POWER SERVICES INC.
US
61/152049
12/02/2009
02/2/0622
20/60/0660
US
02/2/0221
20/60/0660
US
02/2/06//
20/60/0660
US
02/2/06//
20/60/0660
US
02/2/2011
20/60/0660
US
02/2/0010
2//60/0660
US
20//1/0/6
00/61/0660
US
PCT/US/2010/023165
WO/2010/093551
61/60/0626
514555
SPRAY STATIONS FOR
TEMPERATURE CONTROL IN SOLAR
BOILERS
BABCOCK POWER SERVICES INC.
US
61/152077
12/02/2009
02/2/0622
20/60/0660
US
02/2/0221
20/60/0660
US
02/2/06//
20/60/0660
US
02/2/0610
20/60/0660
US
02/2/2011
20/60/0660
US
02/2/0010
2//60/0660
US
20/006260
2//22/0660
US
PCT/US/2010/023500
WO/2010/093582
80
A61K )5010.01(
‫תכשירי קצף מקומיים‬
F24J )5010.01(
‫פנלי קליטה סולאריים‬
F24J )5010.01(
‫תחנות השפרצה לבקרת טמפרטורה‬
‫בדודי שמש‬
September 27, 2011-‫כ"ח באלול התשע"א‬
6//60/0626
514552
CORNER STRUCTURE FOR WALLS
OF PANELS IN SOLAR BOILERS
BABCOCK POWER SERVICES INC.
US
61/152011
12/02/2009
02/2/0221
20/60/0660
US
02/2/2011
20/60/0660
US
02/2/06//
20/60/0660
US
02/2/0610
20/60/0660
US
02/2/06//
20/60/0660
US
02/2/0010
2//60/0660
US
20/02/6/1
20/22/0660
US
PCT/US/2010/023367
WO/2010/093566
60/60/0626
514554
EXPANSION JOINTS FOR PANELS IN
SOLAR BOILERS
BABCOCK POWER SERVICES INC.
US
61/152077
12/02/2009
02/2/06//
20/60/0660
US
02/2/0221
20/60/0660
US
02/2/0622
20/60/0660
US
02/2/0610
20/60/0660
US
02/2/2011
20/60/0660
US
02/2/0010
2//60/0660
US
20//62000
61/60/0626
US
PCT/US/2010/023622
WO/2010/093625
22/60/0626
514555
PANEL SUPPORT SYSTEM FOR
SOLAR BOILERS
BABCOCK POWER
ENVIRONMENTAL INC.
US
61/152114
12/02/2009
02/2/06//
20/60/0660
US
81
F24J )5010.01(
‫מבנה פינתי לקירות פנלים בדודי שמש‬
F24J )5010.01(
‫חיבורי התפשטות לפנלים בדודי שמש‬
F24J )5010.01(
‫מערכת תמיכת פנלים לדודי שמש‬
September 27, 2011-‫כ"ח באלול התשע"א‬
02/2/06//
US
02/2/0622
US
02/2/2011
US
02/2/0610
US
02/2/0010
US
20//6/102
US
PCT/US/2010/023826
WO/2010/093748
61/60/0626
20/60/0660
20/60/0660
20/60/0660
20/60/0660
2//60/0660
22/60/0626
514551
ARRANGEMENTOF TUBING IN
SOLAR BOILER PANELS
BABCOCK POWER SERVICES INC.
US
61/151984
12/02/2009
02/2/06//
20/60/0660
US
02/2/0610
20/60/0660
US
02/2/0221
20/60/0660
US
02/2/06//
20/60/0660
US
02/2/0622
20/60/0660
US
02/2/0010
2//60/0660
US
20///0/01
60/60/0660
US
PCT/US/2010/023124
WO/2010/093547
26/60/0626
514551
ANTI-MST1R ANTIBODIES AND USES
THEREOF
DAIICHI SANKYO COMPANY,
LIMITED
US
61/151411
10/02/2009
PCT/JP/2010/052479
WO/2010/093055
60/60/0626
82
514551
F24J )5010.01(
‫סידור צנרת בפנלי דוד שמש‬
A61P )5010.01(
‫ ושימושים בהם‬R1MST ‫נוגדנים נגד‬
C08G )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
LOW MOLECULAR WEIGHT
HALOGENATED AROMATIC
POLYMERS AND THEIR USE AS
FLAME RETARDANTS
CHEMTURA CORPORATION
US
61/152308
13/02/2009
PCT/US/2010/023559
WO/2010/093600
60/60/0626
514556
BIOREACTOR FOR THE
CULTIVATION OF MAMMALIAN
CELLS AND METHODS OF USE
THEREOF
LONZA BIOLOGICS PLC.
EP
09001755.9 09/02/2009
PCT/EP/2010/000783
WO/2010/089151
22/60/0626
‫פולימרים ארומטיים הלוגנים במשקל‬
‫מולקולרי נמוך ושימוש בהם לעיכוב‬
‫להבות‬
‫ביוראקטור לתרבית תאים יונקים ושיטות‬
‫לשימוש בהם‬
514521
DEVICE FOR THERMAL ADAPTION
BAE SYSTEMS HAGGLUNDS
AKTIEBOLAG
SE
0950071-1
11/02/2009
PCT/SE/2010/050162
WO/2010/093323
61/60/0626
514525
NOVEL LOCK WITH TOOLS AND
METHOD OF FORMING AND FIXING
THE LOCK
RAHAMIM KOMEMI
US
12/365904
05/02/2009
20//000/0
60/60/0660
US
PCT/IL/2010/000100
WO/2010/089742
83
C12M )5010.01(
F41H )5010.01(
‫התקן סיגול תרמי‬
E05B )5010.01(
‫מנעול חדש עם כלים ושיטה ליצירת‬
‫המעול ולתיקונו‬
‫רחמים קוממי‬
September 27, 2011-‫כ"ח באלול התשע"א‬
21/60/0626
514524
‫הרכבה של מאוורר‬
A FAN ASSEMBLY
DYSON TECHNOLOGY LIMITED
GB
0903674.0
04/03/2009
PCT/GB/2010/050268
WO/2010/100450
21/60/0626
514525
514521
514521
A NOVEL DERMACEUTICAL CREAM
MADE USING SODIUM FUSIDATE AND
STEROIDS
VANANGAMUDI, SULUR,
SUBRAMANIAM
IN
134/MUM/2009 21/01/2009
PCT/IB/2010/050242
WO/2010/084457
84
F04D )5010.01(
‫הרכבה של מאוורר‬
A FAN ASSEMBLY
DYSON TECHNOLOGY LIMITED
GB
0903682.3
04/03/2009
60222/190
00/60/0660
GB
PCT/GB/2010/050272
WO/2010/100453
06/62/0626
F04F )5010.01(
‫מאוורר‬
A FAN
DYSON TECHNOLOGY LIMITED
GB
0903680.7
04/03/2009
PCT/GB/2010/050275
WO/2010/100456
21/60/0626
F04D )5010.01(
A61K )5010.01(
‫משחה חדשה לטיפול בעור עשוי תוך‬
‫שימוש בנתרן פיוזידייט ובסטרואידים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
514521
01/62/0626
IMPROVED ATOMIZING ELECTRONIC
CIGARETTE
LIK HON
CN
200920001296.3 11/02/2009
PCT/CN/2010/000125
WO/2010/091593
60/60/0626
514526
FIBRONECTIN TYPE III DOMAIN
BASED SCAFFOLD COMPOSITIONS,
METHODS AND USES
JANSSEN BIOTECH, INC.
US
61/151987
12/02/2009
PCT/US/2010/023625
WO/2010/093627
01/60/0626
514541
TRICYLIC PYRAZOLOPYRIMIDINE
DERIVATIVES, COMPOSITIONS
COMPRISING THE SAME AND USES
THEREOF
DAIICHI SANKYO COMPANY,
LIMITED
2009JP
25/02/2009
042963
PCT/JP/2010/052855
WO/2010/098344
2//60/0626
85
514545
A24F )5010.01(
‫סיגריה אלקטרונית משופרת בפירוק‬
‫לאטומים‬
A61K )5010.01(
‫תכשירים המבוססים על פיגום של אתר‬
‫ שיטות ושימושים‬,III ‫פיברונקטין מסוג‬
C07D )5010.01(
,‫תולדות פיראזולופירימידין טריציקליות‬
‫תכשירים המכילים אותן ושימושים בהן‬
G04B )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
MEANS AND METHOD FOR
CALCULATING, MEASURING AND
DISPLAYING A MEASURABLE
QUANTITY
AVDA SHIRI
US
61/152703
15/02/2009
PCT/IL/2010/000133
WO/2010/092583
60/60/0626
‫שירי עבדה‬
514542
3-BENZOFURANYL-INDOL-2-ONE
DERIVATIVES SUBSTITUTED AT THE
3 POSITION, PREPARATION
THEREOF, AND THERAPEUTIC USE
THEREOF
SANOFI
FR
09/00622
12/02/2009
PCT/FR/2010/050207
WO/2010/092289
60/60/0626
‫ מדידה והצגה של‬,‫אמצעים ושיטה לחישוב‬
‫כמות הניתנת למדידה‬
‫–און‬5–‫–בנזופורניל–אינדול‬2 ‫נגזרות‬
‫ הכנתן ושימוש רפואי‬,2 ‫מותמרות בעמדה‬
‫שלהן‬
514544
SUBSTITUTED 3-BENZOFURANYLINDOL-2-ONE-3ACETAMIDOPIPERAZINE
DERIVATIVES, PREPARATION
THEREOF, AND THERAPEUTIC USE
THEREOF
SANOFI
FR
09/00620
12/02/2009
PCT/FR/2010/050206
WO/2010/092288
20/60/0626
514545
COMPOSITIONS AND METHODS FOR
VISUALIZING AND ELIMINATING
CANCER STEM CELLS
ONCOLIX, INC.
86
C07D )5010.01(
C07D )5010.01(
–2–‫–און‬5–‫–בנזופוראניל–אינדול‬2 ‫גזרות‬
‫ הכנתן‬,‫אצטמידופיפראזין מותמרות‬
‫ושימוש רפואי שלהן‬
A61K )5010.01(
‫תכשירים ושיטות לדמיון וחיסול תאי גזע‬
‫סרטניים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
US
61/155624
PCT/US/2010/024340
WO/2010/099003
06/60/0661
26/02/2009
514541
PILOT SIGNALS FOR USE IN MULTISECTOR CELLS
QUALCOMM INCORPORATED
US
60/449729
24/02/2003
26/011/00
0//61/066/
US
26/011/0/
0//61/066/
US
PCT/US/2004/005241
WO/2004/077685
20/60/0626
‫אותות פיילוט לשימוש בתאים רב–מדוריים‬
514541
MICROARRAY WITH
MICROCHANNELS
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY
US
12/390279
20/02/2009
PCT/US/2010/024733
WO/2010/096652
22/60/0626
514541
CORRUGATED HEATING CONDUIT
AND METHOD OF USING IN
THERMAL EXPANSION AND
SUBSIDENCE MITIGATION
RED LEAF RESOURCES, INC
US
61/152150
12/02/2009
PCT/US/2010/023935
WO/2010/093817
87
H04W )5010.01(
C40B )5010.01(
‫מיקרו מערך בעל מיקרו חריצים‬
E21B )5010.01(
‫צינור חימום גלי ושיטה לשימוש‬
‫בהתפשטות תרמית להפחתת שקיעת‬
‫אויר‬
September 27, 2011-‫כ"ח באלול התשע"א‬
22/60/0626
514546
ARTICULATED CONDUIT LINKAGE
SYSTEM
RED LEAF RESOURCES, INC
US
61/152180
12/02/2009
PCT/US/2010/023927
WO/2010/093810
22/60/0622
26/60/0626
‫מערכת לחיבור צינור מפרקי‬
514550
METHODS OF RECOVERING
MINERALS FROM
HTDROCARBONACEOUS MATERIAL
USING A CONSTRUCTED
INFERASTRUCTURE AND
ASSOCIATED SYSTEMS
MAINTAINED UNDER POSITIVE
PRESSURE
RED LEAF RESOURCES, INC
US
61/152146
12/02/2009
PCT/US/2010/023874
WO/2010/093777
88
C10G )5010.01(
–‫שיטה לחילוץ מינרלים מחומר הידרו‬
‫קרבוני תוך שימוש בתשתית בנויה‬
‫ומערכות משותפות הנשמרות תחת לחץ‬
‫חיובי‬
514551
METHODS OF RECOVRING
MINERALS FROM
HYDROCARBOCARBONACEOUS
MATERIAL USING A CONSTRUCTED
INFRASTRUCTURE AND
ASSOCIATED SYSTEMS
RED LEAF RESOURCES, INC
US
61/152207
12/02/2009
PCT/US/2010/023763
WO/2010/093700
20/60/0626
E21B )5010.01(
514555
C10G )5010.01(
–‫שיטה לחילוץ מינרלים מחומר הידרו‬
‫קרבוני תוך שימוש בתשתית בנויה‬
‫ומערכות משותפות‬
C10G )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
CONVECTIVE HEAT SYSTEMS FOR
RECOVERY OF HYDROCARBONS
FROM ENCAPSULATED
PERMEABILITY CONTROL
INFRASTRUCTURES
RED LEAF RESOURCES, INC
US
61/152141
12/02/2009
PCT/US/2010/024142
WO/2010/093957
6//60/0626
514552
VAPOR COLLECTION AND BARRIER
SYSTEMS FOR ENCAPSULATED
CONTROL INFRASTRUCTURES
RED LEAF RESOURCES, INC
US
61/152152
12/02/2009
PCT/US/2010/023399
WO/2010/093569
61/60/0626
89
C10G )5010.01(
‫איסוף ביניים של אדים באמצעות תשתיות‬
‫בקרה סגורות‬
514555
CARBON MANAGEMENT AND
SEQUESTRATION FROM
ENCAPSULATED CONTROL
INFRASTRUCTURES
RED LEAF RESOURCES, INC
US
61/152220
12/02/2009
PCT/US/2010/023740
E21B )5010.01(
‫מערכות לאיסוף וחסימת אדים לתשתיות‬
‫בקרה סגורות‬
514554
INTERMEDIATE VAPOR
COLLECTION WITHIN
ENCAPSULATED CONTROL
INFRASTRUCTURES
RED LEAF RESOURCES, INC
US
61/152157
12/02/2009
PCT/US/2010/023515
WO/2010/093584
26/60/0626
–‫מערכות להולכת חום לחילוץ הידרו‬
‫קרבונים מתשתיות בקרת חדירות סגורות‬
C10G )5010.01(
‫ניהול ובידוד פחמן מתשתיות בקרה‬
‫סגורות‬
September 27, 2011-‫כ"ח באלול התשע"א‬
WO/2010/093684
60/60/0626
BED SHEET CLASPS
SHAHAR HAYUN
US
61/150811
PCT/IL/2010/000112
WO/2010/089751
61/60/0626
514551
‫תפסנים לסדין מיטה‬
09/02/2009
514551
TRIMERIC HIV FUSION INHIBITORS
FOR TREATING OR PREVENTING
HIV INFECTION
NEW YORK BLOOD CENTER, INC.
US
61/151110
09/02/2009
PCT/US/2010/023522
WO/2010/091373
22/60/0626
90
A61K )5010.01(
‫תכשירים אנטיספטיים המכילים יוני כסף‬
‫ומנטול ושימושיהם‬
514556
SOLUBLE GUANYLATE CYCLASE
ACTIVATORS
MERCK SHARP & DOHME CORP.
US
61/208648
26/02/2009
A61K )5010.01(
‫ ושימושם‬HIV ‫מעכבים טרימרים ל‬
‫במניעת אינפקציה של הוירוס‬
514551
ANTISEPTIC COMPOSITIONS
COMPRISING SILVER IONS AND
MENTHOL AND USES THEREOF
RAMOT AT TEL-AVIV UNIVERSITY
LTD.
US
61/151539
11/02/2009
PCT/IL/2010/000128
WO/2010/092578
00/60/0626
A47C )5010.01(
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
C07D )5010.01(
‫אקטיבטורים מסיסים של גואנילאט‬
‫ציקלאז‬
September 27, 2011-‫כ"ח באלול התשע"א‬
PCT/US/2010/024853
WO/2010/099054
60/60/0626
514510
DURABLE TREATMENT WITH 4AMINOPYRIDINE IN PATIENTS WITH
DEMYELINATION
ACORDA THERAPEURICS, INC
US
61/240100
04/09/2009
PCT/US/2010/047932
WO/2011/029082
0//60/0626
60/60/0626
‫–אמינופירידין במטופלים‬4 ‫טיפול עמיד עם‬
‫עם דמיילינציה‬
514511
FLUID-ASSISTED
ELECTROSURGICAL DEVICE AND
METHODS OF USE THEREOF
SALIENT SURGICAL
TECHNOLOGIES, INC.
US
61/154623
23/02/2009
PCT/US/2010/025058
WO/2010/096809
91
A61B )5010.01(
‫מתקן אלקטרו–ניתוחי מבוסס נוזל ושיטות‬
‫שימוש בו‬
514515
DEVICE AND METHOD FOR
DISSOLVING GAS INTO A LIQUID
DIFFUSAIRE LTD
US
61/207144
10/02/2009
PCT/IL/2010/000114
WO/2010/092569
22/60/0626
A01N )5010.01(
514514
B01F )5010.01(
‫מכשיר ושיטה להמסת גז בתוך נוזל‬
‫דפיוזר בע"מ‬
B01L )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
METHODS FOR TESTING THE
ACCURACY AND THERMAL
RELIABILITY OF A PCR THERMAL
CYCLER, AND A MEANS FOR
IMPLEMENTING SAID METHODS
INSTITUT NATIONAL DE LA
RECHERCHE AGRONOMIQUE
FR
0950860
11/02/2009
PCT/EP/2010/051753
WO/2010/092137
20/60/0626
514515
NUCLEIC ACIDS SPECIFICALLY
BINDING WITH HUMAN FACTOR
VII/VIIA AND USES THEREOF
LFB-BIOTECHNOLOGIES
FR
0951082
19/02/2009
PCT/FR/2010/050291
WO/2010/094899
20/60/0626
514511
MEANS FOR PURIFYING A
COAGULATION PROTEIN, AND
METHODS FOR IMPLEMENTING
SAME
LFB-BIOTECHNOLOGIES
FR
0951081
19/02/2009
PCT/FR/2010/050293
WO/2010/094900
20/60/0626
514511
MEANS FOR PURIFYING A PROTEIN
OF BLOOD PLASMA AND METHODS
FOR IMPLEMENTING SAME
LFB-BIOTECHNOLOGIES
FR
0951083
19/02/2009
PCT/FR/2010/050294
92
‫שיטה לבדיקת דיוק ואמינות תרמית של‬
‫ תרמי ואמצעים ליישום‬PCR ‫ממחזר‬
‫השיטות הללו‬
C07H )5010.01(
‫חומצות גרעין הנקשרות במיוחד עם‬
‫ והשימוש בהן‬VIIA/VII ‫פקטור אנושי‬
C12N )5010.01(
‫אמצעים לטיהור חלבון קרישה ושיטות‬
‫ליישומו‬
C07K )5010.01(
‫אמצעים לטיהור חלבונים מפלסמת דם‬
‫ושיטות ליישומם‬
September 27, 2011-‫כ"ח באלול התשע"א‬
WO/2010/094901
26/60/0626
514511
‫תולדה הטרו טבעתית‬
HETERO RING DERIVATIVE
ASTELLAS PHARMA INC.
2009JP
12/02/2009
029759
PCT/JP/2010/051910
WO/2010/092962
22/6//0626
514516
FLUE GAS TREATMENT SYSTEM
AND THE METHOD USING
AMMONIA SOLUTION
ALSTOM TECHNOLOGY LTD.
US
61/159658
12/03/2009
602/00/192
2//20/0660
EP
PCT/IB/2010/000525
WO/2010/103392
21/6//0660
CONTROLLED RELEASE
PHARMACEUTICAL COMPOSITION
WITH RESISTANCE AGANIST THE
INFLUENCE OF ETHANOL
EMPLOYING A COATING
COMPRISING NEUTRAL VINYL
POLYMERS AND EXCIPIENTS
EVONIK ROHM GMBH
C07D )5010.01(
B01D )5010.01(
‫מערכת לטיפול בגז ארובה ושיטה לשימוש‬
‫בתמיסת אמוניה‬
514510
A61K )5010.01(
‫תכשיר רוקחות עם שחרור מבוקר בעל‬
‫עמידות כנגד השפעת אתנול המשתמש‬
‫בציפוי המכיל פולימרי ויניל נייטרלים‬
‫וחומרים שאינם פעילים‬
PCT/EP/2009/053176
WO/2010/105672
93
September 27, 2011-‫כ"ח באלול התשע"א‬
20/60/0626
514511
DEVICE FOR DISCHARGING AN
EXPLOSIVE GAS
SIEMENS AKTIENGESELLSCHAFT
EP
09002576.8 24/02/2009
PCT/EP/2010/052155
WO/2010/097348
22/60/0626
20/60/0626
‫מכשיר לפריקת גז נפיץ‬
514515
TOLL -LIKE RECEPTOR
MODULATORS AND TREATMENT OF
DISEASES
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
61/151737
11/02/2009
PCT/US/2010/000369
WO/2010/093436
514511
A61K )5010.01(
,I–A ‫פפטידי חיכוי לאפוליפופרוטין‬
‫תכשירים המכילים אותם ושימושים בהם‬
514511
STENT FOR THE POSITIONING AND
ANCHORING OF A VALVULAR
PROSTHESIS IN AN IMPLANTATION SITE
IN THE HEART OF A PATIENT
JENAVALVE TECHNOLOGY, INC.
94
C07D )5010.01(
‫ וטיפול במחלות‬TOLL ‫מאפנני קולטן דמוי‬
APOLIPOPROTEIN A-I MIMIC
PEPTIDES, COMPOSITIONS
COMPRISING THE SAME AND USES
THEREOF
CERENIS THERAPEUTICS SA
US
61/152966
16/02/2009
02/2/0006
20/60/0660
US
02/2/0000
20/60/0660
US
PCT/US/2010/024096
WO/2010/093918
0//60/0626
F24F )5010.01(
A61F )5010.01(
‫סטנט עבור מיקום ועיגון של‬
‫פרוטזת שסתום באתר השתלה‬
‫בלב חולה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
EP
PCT/EP2009/052230
PCT/EP/2010/052429
WO/2010/086460
60/60/0626
25/02/2009
514516
PHENOXY ACETIC ACID
DERIVATIVES, THEIR PREPARATION
AND PHARMACEUTICAL
COMPOSITION CONTAINING THEM
MERCK SERONO S.A.
EP
09152711.9 12/02/2009
02/06///1
2//60/0660
US
PCT/EP/2010/051567
WO/2010/092043
62/6//0626
60/6//0626
C12Q )5010.01(
SLE‫ ופגיעות ל‬BANK1‫ הקשורים ל‬SPNS
MS ‫או‬/‫ו‬
514515
ANTI-SIPHON TRAP WITH SNORKEL
FOR A WATERLESS URINAL
FALCON WATERFREE
TECHNOLOGIES
US
61/210115
12/03/2009
PCT/US/2010/000698
WO/2010/104561
95
‫ הכנתן‬,‫תולדות חומצה פנוקסי אצטית‬
‫ותכשירי רוקחות המכילים אותן‬
514510
BANK1 RELATED SNPS AND SLE
AND/OR MS SUSCEPTIBILITY
MERCK SERONO S.A.
EP
09154190.4 03/03/2009
02/2/00/6
6//6//0660
US
PCT/EP/2010/052554
WO/2010/100113
C07C )5010.01(
E03C )5010.01(
‫מלכודת נגד–סיפון עם שנורקל למשתנה‬
‫ללא מים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
514512
60/6//0626
‫פורמולציה חסינה מפני שימוש‬
‫לרעה‬
ABUSE RESISTANT FORMULATION
OREXO AB
GB
PCT/GB2009/000592
PCT/GB/2010/000374
WO/2010/100414
2//60/0626
04/03/2009
514514
SIDE-LOADED MEDICAL
IMPLEMENT PARTICULARLY
USEFUL IN ARTHROSCOPIC
SURGERY
DEPUY MITEK INC.
US
61/152982
17/02/2009
PCT/IL/2010/000141
WO/2010/095132
22/60/0626
514515
514511
APPARATUS, SUCH AS A LADDER,
COMPRISING EXTENDABLE LEGS
SMART LEVEL COMPANY B.V.
EP
09152567.5 11/02/2009
02/2/0000
6//6//0660
US
96
A61B )5010.01(
‫שתל רפואי המוזן מהצד ושימושי במיוחד‬
‫לניתוחי ארטרוסקופיה‬
SUPPORTING ELEMENT FOR AN
OBJECT AND APPARATUS
COMPRISING A SUPPORTING
ELEMENT
SMART LEVEL COMPANY B.V.
EP
09152567.5 11/02/2009
02/2/0000
6//6//0660
US
PCT/NL/2010/050064
WO/2010/093241
22/60/0626
A61K )5010.01(
E06C )5010.01(
‫מכשיר תמיכה לחפץ ומכשיר הכולל‬
‫מכשיר תמיכה‬
E06C )5010.01(
‫ הכולל רגלים‬,‫ כדוגמת סולם‬,‫מכשיר‬
‫מתארכות‬
September 27, 2011-‫כ"ח באלול התשע"א‬
PCT/NL/2010/050065
WO/2010/093242
514511
/2/6//0626
CONTROL AND VERIFICATION OF
PERMISSIONS
GREGORY AZBEL
IB
PCT/IB2009/051868 06/05/2009
PCT/IB/2010/051402
WO/2010/128410
20/60/0626
21/60/0626
G06F )5010.01(
‫ תכנית‬,‫שיטה ומערך לזיהוי מדפסות‬
–‫מחשב תואמת ואמצעי אחסון קריא‬
‫מחשב תואם‬
514516
E05B )5010.01(
PROFILED KEY FOR CYLINDER LOCKS
WINLOC AG
SE
0900207-2
18/02/2009
SE
PCT/SE2010/050006 61/62/0626
PCT/SE/2010/050189
WO/2010/096009
‫מפתח פרופילי למנעול גלילי‬
514560
F24J )5010.01(
22/60/0626
FLAG-SHAPED HEAT EXCHANGER
97
‫בקרה ואימות של הרשאות‬
514511
METHOD AND ARRANGEMENT FOR
DETECTING PRINTERS, A
CORRESPONDING COMPUTER
PROGRAM, AND A CORRESPONDING
COMPUTER-READABLE STORAGE
MEDIUM
CORTADO AG
DE
102009009445.8 13/02/2009
PCT/EP/2010/051813
WO/2010/092161
G06F )5010.01(
‫מחלף–חם דמוי דגל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
COCKERILL MAINTENANCE &
INGENIERIE S.A.
EP
09153046.9 17/02/2009
PCT/EP/2010/051740
WO/2010/094618
62/60/0626
514561
A METHOD FOR MANUFACTURING
A SOLAR RADIOTION ABSORBER
HELIOFOCUS LTD
US
61/152241
12/02/2009
02/2//0/0
20/60/0660
US
02/2011/1
/6/6//0660
US
PCT/IL/2010/000083
WO/2010/092564
2//60/0626
514565
SOLAR THERMAL SYSTEMS
HELIOFOCUS LTD
US
61/152718
15/02/2009
02/20/2//
6//61/0660
US
02/2//611
6//6//0660
US
PCT/IL/2010/000134
WO/2010/092584
6//20/0626
514562
SURFACE-COATED CUTTING TOOL
SUMITOMO ELECTRIC HARDMETAL
CORP.
2009JP
21/12/2009
288849
PCT/JP/2010/071704
WO/2011/077928
98
F24J )5010.01(
‫שיטה לתעשיית קולט קרינה סולרית‬
‫הליופוקוס בע"מ‬
H01L )5010.01(
‫מערכות תרמיות סולריות‬
‫הליופוקוס בע"מ‬
B23B )5010.01(
‫כלי חיתוך בעל משטח מצופה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
6//20/0626
514564
SURFACE-COATED CUTTING TOOL
SUMITOMO ELECTRIC HARDMETAL
CORP.
2009JP
21/12/2009
288850
PCT/JP/2010/071705
WO/2011/077929
22/60/0626
514561
SOLAR RECEIVER SYSTEM
514561
WATER WHEEL
HERMANN RIEGERBAUER
AT
A313/2009
25/02/2009
PCT/EP/2010/001130
WO/2010/097204
26/6//0626
514566
ELECTROACTIVE POLYMER
TRANSDUCERS FOR TACTILE
FEEDBACK DEVICES
BAYER MATERIALSCIENCE AG
US
61/158806
10/03/2009
02/2/012/
6//6//0660
US
PCT/US/2010/026829
WO/2010/104953
99
‫כלי חיתוך בעל משטח מצופה‬
F24J )5010.01(
‫מערכת קולטת שמש‬
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/152238
12/02/2009
02/020//0
01/60/0660
US
02/020/16
01/60/0660
US
PCT/IL/2010/000123
WO/2010/092575
01/60/0626
B23B )5010.01(
‫ידע חברה למחקר ופיתוח בע"מ‬
F03B )5010.01(
‫גלגל מים‬
G06F )5010.01(
‫מתמרי פולימר אלקטרואקטיבים עבור‬
‫מכשירי משוב משישים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
61/6//0626
514100
PROCESS FOR PREPARING
SUBSTITUTED 2-NITROBIPHENYLS
BASF SE
EP
09154619.2 09/03/2009
PCT/EP/2010/052914
WO/2010/102980
60/6//0626
‫–ניטרוביפנילים מותמרים‬5 ‫תהליך להכנת‬
514101
METHOD FOR INCREASING THE
POOL OF NGN3+ENDOCRINE
PROGENITOR CELLS AND
PANCREATIC ENDOCRINE CELL
MASS
L'ASSISTANCE PUBLIQUEHOPITAUX DE PARIS
EP
09305197.7 03/03/2009
PCT/EP/2010/052623
WO/2010/100150
2//6//0626
514105
SENSOR DEVICE POWERED
THROUGH RF HARVESTING
MASCO CORPORATION
US
12/419449
07/04/2009
PCT/US/2010/027576
WO/2010/117571
00/61/0626
514102
METHOD OF REMOTELY
CONFIGURING A CONTROLLER
RESPONSIVE TO WIRELESS SIGNALS
100
C07C )5010.01(
C07K )5010.01(
‫שיטה להגדלת המאגר של תאי אב‬
‫ ומסת תאים‬NGN2+‫אנדוקרינים‬
‫אנדוקרינים של הלבלב‬
H02J )5010.01(
‫מכשיר חיישן המופעל באמצעות קציר‬
‫תדר רדיו‬
G08C )5010.01(
‫שיטה לקביעת תצורה של בקר המגיב‬
‫לאותות אלחוטיים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
ECHOFLEX SOLUTIONS, INC
US
12/433170
30/04/2009
PCT/CA/2010/000593
WO/2010/124362
514104
6//6//0626
TANTALUM POWDER, PREPARATION
METHOD THEREOF AND
ELECTROLYTIC CAPACITOR ANODE
MADE OF TANTALUM POWDER
NINGXIA ORIENT TANTALUM
INDUSTRY CO. LTD
CN
200910119165.X 05/03/2009
PCT/CN/2010/000266
WO/2010/099701
USE OF A CONDUIT PIPE PRODUCING
A DUCT LAID IN WATER
SALZGITTER MANNESMANN LINE PIPE
GMBH
DE
102009001001.7 19/02/2009
PCT/EP/2010/050622
WO/2010/094528
6//61/0626
514101
INHIBITORS OF HIV REPLICATION
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
61/168032
09/04/2009
02/00/010
0//22/0660
US
PCT/CA/2010/000478
WO/2010/115264
101
‫ שיטה להכנתה ואנודת‬,‫אבקת טנטלום‬
‫קבל אלקרוליטית העשויה מאבקת‬
‫טנטלום‬
514105
06/62/0626
B22F )5010.01(
F16L )5010.01(
‫שימוש בצינור מוביל לייצור צינור‬
‫המונח במים‬
C07D )5010.01(
HIV ‫מעכבי שכפול‬
September 27, 2011-‫כ"ח באלול התשע"א‬
00/6//066/
514101
2,4-PYRIMIDINEDINEDIAMINE
COMPOUNDS AND THEIR USE IN
THE MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF AUTOIMMUNE
DISASES
RIGEL PHARMACEUTICALS, INC.
US
60/399673
29/07/2002
06/11/010
/2/62/066/
US
06/1/0//0
60/6//066/
US
26/0/2600
00/6//066/
US
PCT/US/2003/024087
WO/2004/014382
22/60/0626
514101
VIRTUALIZED STORAGE SYSTEM
AND METHOD OF OPERATING
THEREOF
INFINIDAT LTD
US
61/151533
11/02/2009
02/011100
61/26/0660
US
PCT/IL/2010/000124
WO/2010/092576
22/60/0626
514106
MULTI-EDGE CUTTING HEAD AND
AN INSERT USED THEREIN
SIMATATE LTD
US
61/202252
11/02/2009
PCT/IL/2010/000122
WO/2010/092574
60/60/0626
102
514110
A61K )5010.01(
‫–פירימידין דיאמין והשימוש‬4,5 ‫תרכובות‬
‫בהן להכנת תרופות לטיפול במחלות‬
‫אוטואימוניות‬
G06F )5010.01(
‫מערכת לאחסון וירטואלי ושיטה‬
‫להפעלתה‬
‫אינפינידט בע"מ‬
B23C )5010.01(
‫ראש חיתוך בעל שפות חיתוך מרובות‬
‫ושימת חיתוך לשימוש בו‬
‫שימטאטא בע"מ‬
H04B )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
DISTRIBUTED ANTENNA SYSTEM
(DAS) WITH DELAYED TRANSPORT
TO PAIRED ANTENNAS
ADC TELECOMMUNICATIONS, INC.
US
12/370474
12/02/2009
PCT/US/2010/023601
WO/2010/093613
0//6//0626
‫מערכת אנטנות מבוזרות עם עיכוב‬
‫בשליחה לאנטנות מזווגות‬
514111
BIOMARKER FOR MONITORING
PATIENTS
TRANSGENE S.A.
EP
09305256.1 24/03/2009
PCT/EP/2010/053755
WO/2010/108908
21/6//0660
‫סמנים ביולוגיים לניטור חולים‬
514115
CONTROLLED RELEASE
PHARMACEUTICAL COMPOSITION
WITH RESISTANCE AGAINST THE
INFLUENCE OF ETHANOL
EMPLOYING A COATING
COMPRISING A POLYMER MIXTURE
AND EXCIPIENTS
EVONIK ROHM GMBH
G01N )5010.01(
A61K )5010.01(
‫תכשיר רוקחות בעל שחרור מבוקר עם‬
‫עמידות בפני השפעת אתנול המשתמש‬
‫בציפוי המכיל תערובת פולימרים ותוספים‬
‫שאינם פעילים‬
PCT/EP/2009/053177
WO/2010/105673
20/6//0660
514112
PARABOLIC SOLAR COLLECTOR
MATALON ENERGY, LLC
US
12/371260
13/02/2009
PCT/US/2009/036926
WO/2010/093372
103
F24J )5010.01(
‫קולט שמש פרבולי‬
September 27, 2011-‫כ"ח באלול התשע"א‬
514114
20/6//0626
–4,5,1–‫–אריל‬5–‫–אמטאמידו‬5
‫טריאזולונים מותמרים והשימוש בהם‬
SUBSTITUTED 2-ACETAMIDO-5-ARYL1,2,4-TRIAZOLONES AND USE THEREOF
BAYER PHARMA
AKTIENGESELLSCHAFT
DE
102009013640.1 18/03/2009
26062666260190
06/62/0626
DE
PCT/EP/2010/001565
WO/2010/105770
20/60/0626
514115
A01N )5010.01(
‫הרכב אנטי פטרייתי‬
ANTI-FUNGAL FORMULATION
TOPICA PHARMACEUTICALS, INC.
US
61/152658
13/02/2009
02/200002
0//6//0660
US
PCT/US/2010/024193
WO/2010/093992
2//60/0626
C07D )5010.01(
514111
MEANS FOR DEFINING A FLOW
PASSAGE IN A DRIPPER AND
METHOD AND APPARATUS FOR ITS
IMPLEMENTATION
JOHN DEERE WATER LTD.
B05B )5010.01(
,‫אמצעי לתיחום מעבר זרימה בטפטפת‬
‫שיטה והתקן ליישומו‬
‫ג'ון דיר ווטר בעמ‬
PCT/IL/2010/000136
WO/2010/095127
26/6//0660
USE OF CONTROLLED RELEASE
FORMULATIONS OF OCTREOTIDE
ENDO PHARMACEUTICALS
SOLUTIONS INC.
104
514111
A61K )5010.01(
‫שימוש בפורמולציות אוקטראוטיד בעלות‬
‫שחרור מבוקר‬
September 27, 2011-‫כ"ח באלול התשע"א‬
US
60/660930
PCT/US/2006/008891
WO/2006/099288
11/03/2005
514116
20/60/0626
FILE FOR WORKING ON THE
INTERPROXIMAL SPACE IN
ORTHODONTICS AS WELL AS IN
CONSERVATIVE TREATMENTS AND
PROPHYLAXIS OF TEETH AND
RELATIVE DEVICE ABLE TO BE
CONNECTED TO AN OSCILLATING
HANDPIECE
SDC SWITZERLAND SA
IT
MI2009A000239 20/02/2009
PCT/IB/2010/000300
WO/2010/095017
00/60/0626
514150
METHODS FOR SELECTING
EUKARYOTIC CELLS EXPRESSING A
HETEROLOGOUS PROTEIN
NOVARTIS AG
EP
09154000.5 27/02/2009
PCT/EP/2010/001223
WO/2010/097239
00/60/0626
514151
EXPRESSION VECTOR SYSTEM
COMPRISING TWO SELECTION
MARKERS
NOVARTIS AG
EP
09153995.7 27/02/2009
PCT/EP/2010/001224
WO/2010/097240
105
A61C )5010.01(
‫פצירה לעבודה על הרווח‬
‫האינטרפרוקסימאלי באורטודנטיה וגם‬
,‫בטיפולי שימור ומניעה של שיניים‬
‫ומכשיר יחסי היכול להתחבר ליחידה‬
‫ידנית רוטטת‬
C12N )5010.01(
‫שיטות לברירת תאים אאוקריוטים‬
‫המבטאים חלבון הטרולוגי‬
C12N )5010.01(
‫מערכת וקטור ביטוי המכילה שני סמני‬
‫סלקציה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
20/60/0626
514155
PROCESSES FOR PRODUCING
PHENYL-6-(1(PHENYL)UREIDO)NICOTINAMIDES
VERTEX PHARMACEUTICALS
INCORPORATED
US
61/152653
13/02/2009
PCT/US/2010/024054
WO/2010/093890
21/60/0660
514152
METHOD FOR PROVIDING CELL
POPULATION FROM UMBILICAL
CORD BLOOD OR PLACENTA
MCL LLC
US
60/268786
14/02/2001
06/000600
2//60/0662
US
06//2600/
6//61/0662
US
06//1//10
0//26/0662
US
PCT/US/2002/004652
WO/2002/064748
20/60/0626
514154
CONTROLLED RELEASE
PHARMACEUTICAL FORMULATIONS
OF NITAZOXANIDE
ROMARK LABORATORIES, L.C.
US
61/202285
13/02/2009
PCT/US/2010/024000
WO/2010/093854
21/6//066/
106
514155
C07D )5010.01(
–1(–1–‫תהליכים להכנת פניל‬
‫פניל)אוראידו)ניקוטינאמידים‬
G01N )5010.01(
‫שיטה להשגת אוכלוסיית תאים מהדם‬
‫בחבל הטבור או משליה‬
A01N )5010.01(
‫תכשירי רוקחות המכילים ניטאזוקסאניד‬
‫עם שיחרור מבוקר‬
C07C )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
SUBSTITUTED TETRACYCLINE
COMPOUNDS
PARATEK PHARMACEUTICALS, INC.
US
60/367048
21/03/2002
06//0/61/
02/6//0660
US
06//0002/
02/6//0660
US
06//0/101
20/6//0660
US
06/116/6/
21/62/066/
US
PCT/US/2003/008324
WO/2003/079984
22/6//0626
‫תרכובות טטראציקלין מותרמות‬
514151
PRODRUG FORMS OF KINASE
INHIBITORS AND THEIR USE IN
THERAPY
AUCKLAND UNISERVICES LIMITED
NZ
575490
11/03/2009
//01/1
60/60/0660
NZ
/122/6
20/22/0660
NZ
PCT/NZ/2010/000040
WO/2010/104406
20/60/0626
6//6//0626
C12P )5010.01(
‫ ושיטות לשימוש בהם‬CD–50 ‫נוגדנים כנגד‬
514151
SUSTAINED RELEASE ORAL
DOSAGE FORMS OF AN RBACLOFEN PRODRUG
XENOPORT INC.
US
61/157114
03/03/2009
107
‫צורות פרודראג של מעכבי ושימושם‬
‫ברפואה‬
514151
HUMANIZED ANTI-CD20
ANTIBODIES AND METHODS OF USE
BIOLEX THERAPEUTICS, INC.
US
61/152778
16/02/2009
02/2//100
21/60/0660
US
PCT/US/2010/000449
WO/2010/093480
C07D )5010.01(
A61K )5010.01(
‫צורות מתן פומיות בשחרור מושהה של‬
‫–בקלופן‬R ‫פרודראג של‬
September 27, 2011-‫כ"ח באלול התשע"א‬
PCT/US/2010/026133
WO/2010/102071
514156
20/6//0660
A NOVEL ALPHA-(NSULFONAMIDO)ACETAMIDE COMPOUND
AS AN INHIBITOR OF BETA AMYLOID
PEPTIDE PRODUCTION
A61K )5010.01(
)‫–סולפונאמידו‬N(–‫תרכובת אלפא‬
‫אצטאמיד חדשה כמעכבת ייצור של‬
‫הפפטיד בטא עמילואיד‬
BRISTOL-MYERS SQUIBB COMPANY
WO
PCT/US2009/037639 19/03/2009
PCT/US/2009/037639
WO/2010/107435
22/60/0626
BIOPSY DEVICE
TIGENIX NV
GB
0902495.1
606112290
GB
PCT/EP/2010/051683
WO/2010/092100
00/60/0660
514120
‫מתקן לביופסיה‬
16/02/2009
20/6//0660
514125
IMPLANTS, TOOLS, AND METHODS
FOR SINUS LIFT AND LATERAL
RIDGE AUGMENTATION
MAXILLENT LTD.
US
12/240353
29/09/2008
20/11/200
20/60/0660
US
PCT/IL/2009/000931
WO/2010/035270
2//60/0626
108
A61B )5010.01(
A61C )5010.01(
‫ ושיטות להרמת הסינוסים‬,‫ כלים‬,‫שתלים‬
‫ושיפור הרכס הצדדי‬
514141
‫מקסילנט בע"מ‬
G01N )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
METHOD FOR INHIBITING
NEURODEGENERATION
GENENTECH, INC.
US
61/153540
18/02/2009
PCT/US/2010/024458
WO/2010/096470
2//60/0626
514141
IMPROVED ANTI-TNFR1
POLYPEPTIDES, ANTIBODY
VARIABLE DOMAINS &
ANTAGONISTS
GLAXO GROUP LIMITED
US
61/153746
19/02/2009
02/012201
26/60/0660
US
PCT/EP/2010/052005
WO/2010/094720
01/60/0626
‫שיטה לעיכוב ניוון עצבים‬
,‫ משופרים‬TNFR1–‫פוליפפטידים אנטי‬
‫תחומים משתנים של נוגדן ואנטגוניסטים‬
514146
THERMOSTATIC MIXING VALVE
WATTS INDUSTRIES FRANCE
FR
0951207
26/02/2009
PCT/FR/2010/050315
WO/2010/097545
/6/6//0626
INSERTER DEVICE
UNOMEDICAL A/S
US
61/165124
02/20/0//
US
02/20/01/
US
602016//90
US
602016129/
US
6020161/91
US
PCT/EP/2010/054235
WO/2010/112521
109
C07K )5010.01(
514150
G05D )5010.01(
‫שסתום ערבוב תרמוסטטי‬
A61M )5010.01(
‫התקן החדרה‬
31/03/2009
/2/6//0660
/2/6//0660
00/60/0660
00/60/0660
00/60/0660
September 27, 2011-‫כ"ח באלול התשע"א‬
00/62/0626
514151
CREPED TISSUE SHEETS TREATED
WITH AN ADDITIVE COMPOSITION
ACCORDING TO A PATTERN
KIMBERLY-CLARK WORLDWIDE,
INC.
US
12/407882
20/03/2009
PCT/IB/2010/050334
WO/2010/106447
‫דפי טישו קרפ שטופלו עם תכשיר מוסף‬
‫בהתאם לדוגמה‬
514155
60/6//0626
TRIAZOLE DERIVATIVES AS
VASOPRESSIN-RECEPTOR INHIBITORS
FOR TREATING CARDIAC
INSUFFICIENCY
BAYER PHARMA
AKTIENGESELLSCHAFT
DE
102009013642.8 18/03/2009
PCT/EP/2010/001442
WO/2010/105750
60/61/0626
D21H )5010.01(
514152
CONTROLLED-FRICTION LINEAR
DEVICE IN WHICH A PRESS FORCE
IS APPLIED PERPENDICULAR TO
THE MOVEMENT
C07D )5010.01(
‫תולדות טריאזול כמעכבי קולטן‬
‫וסופרסין לטיפול באי–ספיקת לב‬
F16F )5010.01(
‫מכשיר לינארי עם בקרת חיכוך אשר בו‬
‫כוח הלחץ מופעל בניצב לתנועה‬
MESSIER-BUGATTI-DOWTY
FR
09/01685
06/04/2009
PCT/EP/2010/054537
WO/2010/115894
6//6//0626
110
514154
C07C )5010.01(
September 27, 2011-‫כ"ח באלול התשע"א‬
METHOD FOR PRODUCING
AROMATIC CHLORINE AND
BROMINE COMPOUNDS
BAYER CROPSCIENCE AG
EP
09155017.8 12/03/2009
PCT/EP/2010/001395
WO/2010/102761
01/60/0626
–‫שיטה להכנת תרכובות כלורו וברומו‬
‫ארומטיות‬
514155
‫תולדות פיראזול המשמשות‬
CCR4 ‫כאנטגיוניסטים לקולטן‬
PYRAZOLE DERIVATIVES USED AS
CCR4 RECEPTOR ANTAGONISTS
GLAXO GROUP LIMITED
US
61/155702
26/02/2009
PCT/EP/2010/052307
WO/2010/097395
0//60/0626
514151
6-PHENYL-2-[((PIPERIDIN-4YLMETHYL)-PIPERAZIN-1YL)OR
PIPERAZIN 1-YLMETHYL)PIPERIDIN-1-YL)-IMIDAZO[2,1B][1,3,4]THIADIAZOLE DERIVATIVES
AND THEIR USE
URIFER LTD.
US
61/202402
25/02/2009
PCT/IL/2010/000164
WO/2010/097798
0//60/0660
111
C07D )5010.01(
–4–‫–[((פיפרידין‬5–‫–פניל‬1 ‫תולדות‬
–1–‫–איל)או פיפראזין‬1–‫אילמתיל)פיפראזין‬
–1,5[‫–איל)]–אימידזו‬1–‫אילמתיל)–פיפרידין‬
‫] תיאדיאזול והשימוש בהם‬B][4,3,1
514151
IMMUNOGENIC COMPOSITION
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0513069.5
27/06/2005
6/2/6/292
0//60/066/
GB
6/2///090
01/6//066/
GB
6/010619/
01/22/066/
GB
C07D )5010.01(
‫אוריפר בע"מ‬
A61K )5010.01(
‫תכשיר אימונוגני‬
September 27, 2011-‫כ"ח באלול התשע"א‬
6/0061692
GB
6/0061290
GB
PCT/EP/2006/006269
WO/2007/000342
20/60/0626
02/20/066/
02/20/066/
514151
TRIAZOLOPYRIDINE DERIVATIVES
AS P38 MAP KINASE INHIBITORS
CHIESI FARMACEUTICI S.P.A.
GB
0902651.9
17/02/2009
606160091
22/6//0660
GB
PCT/GB/2010/050257
WO/2010/094956
21/6//0660
20/60/0626
C07D )5010.01(
–‫–מתיל‬N–[3–(4–‫–מתיל‬4 ‫קריסטלים של‬
–‫–טריפולואורומתיל‬5–)‫–יל‬1–‫אימידזול‬
–5–‫–יל–פירימידינ‬2–‫–פירידינ‬4(–2–]‫פניל‬
‫ילאמינו)–בנזאמיד‬
514110
AGRICULTURAL COMPOSITION
STERNINI, DANIELA
EP
09425084.2 04/03/2009
PCT/EP/2010/052104
WO/2010/100040
112
‫ מאפ‬P21 ‫תולדות טריאזולופירידין כמעכבי‬
‫קינז‬
514156
CRYSTALLINE FORMS OF 4METHYL-N-[3-(4-METHYLIMIDAZOL-1-YL)-5TRIFLUOROMETHYL-PHENYL]-3-(4PYRIDIN-3-YL-PYRIMIDIN-2YLAMINO)-BENZAMIDE
NOVARTIS AG
US
60/701405
20/07/2005
06//20021
20/60/066/
US
PCT/US/2006/027875
WO/2007/015870
C07D )5010.01(
C05G )5010.01(
‫תרכובת חקלאית‬
September 27, 2011-‫כ"ח באלול התשע"א‬
21/60/0660
514115
BASE, PRODUCTS CONTAINING THE
SAME, PREPARATION METHODS
AND USES THEREOF
NESTEC S.A.
A23L )5010.01(
‫ שיטות‬,‫ מוצרים המכילים אותו‬,‫בסיס‬
‫הכנה ושימושים בהם‬
PCT/EP/2009/051932
WO/2010/094327
20/60/0626
514114
METHODS OF TREATING HAIR
RELATED CONDITIONS
GIULIANI INTERNATIONAL LIMITED
EP
09425056.0 16/02/2009
02/2/0600
21/6//0660
US
02/01/102
2//20/0660
US
PCT/EP/2010/000939
WO/2010/091894
20/60/0626
‫שיטות לטיפול במצבים הקשורים לשיער‬
514115
ALKYLAMIDO COMPOUNDS AND
USES THEREOF
GIULIANI INTERNATIONAL LIMITED
EP
09425056.0 16/02/2009
02/2/0600
21/6//0660
US
02/01/102
2//20/0660
US
PCT/EP/2010/000935
WO/2010/091892
60/6//0626
514111
BENZOFURAN DERIVATIVES
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2009JP
10/03/2009
056719
PCT/JP/2010/054286
113
A61P )5010.01(
A61P )5010.01(
‫תרכובות אלקיל–אמידו ושימושים שלהן‬
C07D )5010.01(
‫נגזרות בנזופוראן‬
September 27, 2011-‫כ"ח באלול התשע"א‬
WO/2010/104194
61/6//0661
514111
MICROORGANISM COATING
COMPONENTS, COATING AND
COATED SURFACES
C. STEVEN MCDANIEL
US
10/655345
04/09/2003
PCT/US/2004/007263
WO/2005/026269
61/6//0661
514116
MICROORGANISM COATING
COMPONENTS, COATING AND
COATED SURFACES
C. STEVEN MCDANIEL
US
10/655345
04/09/2003
PCT/US/2004/007263
WO/2005/026269
61/6//0661
514110
MICROORGANISM COATING
COMPONENTS, COATING AND
COATED SURFACES
C. STEVEN MCDANIEL
US
10/655345
04/09/2003
PCT/US/2004/007263
WO/2005/026269
61/6//0661
MICROORGANISM COATING
COMPONENTS, COATING AND
COATED SURFACES
114
514111
C09D )5010.01(
‫ משטחי ציפוי‬,‫רכיבי ציפוי חיידקים‬
‫ומשטחים מצופים‬
C09D )5010.01(
‫ משטחי ציפוי‬,‫רכיבי ציפוי חיידקים‬
‫ומשטחים מצופים‬
C09D )5010.01(
‫ משטחי ציפוי‬,‫רכיבי ציפוי חיידקים‬
‫ומשטחים מצופים‬
C09D )5010.01(
‫ משטחי ציפוי‬,‫רכיבי ציפוי חיידקים‬
‫ומשטחים מצופים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
C. STEVEN MCDANIEL
US
10/655345
PCT/US/2004/007263
WO/2005/026269
61/6//0661
04/09/2003
514115
MICROORGANISM COATING
COMPONENTS, COATING AND
COATED SURFACES
C. STEVEN MCDANIEL
US
10/655345
04/09/2003
PCT/US/2004/007263
WO/2005/026269
20/60/0626
20/61/0626
C01B )5010.01(
‫ ושימוש בהם‬,‫ שיטה להכנתן‬,‫ננומרוכבים‬
‫בהתקנים להגנה מפני גלים‬
‫אלקטרומגנטיים‬
514114
PAEDIATRIC SOLUTIONS
COMPRISING A BETA-BLOCKER
PIERRE FABRE DERMOCOSMETIQUE
EP
09290298.0 21/04/2009
PCT/IB/2010/051573
WO/2010/122442
115
‫ משטחי ציפוי‬,‫רכיבי ציפוי חיידקים‬
‫ומשטחים מצופים‬
514112
NANOCMPOSITES, METHOD FOR
PRODUCING SAME, AND USE
THEREOF IN DEVICES FOR
PROTECTING AGANIST
ELECTROMAGNETIC WAVES
ISL - INSTITUT FRANCO-ALLEMAND
DE RECHERCHES DE SAINT-LOUIS
FR
09/00695
16/02/2009
PCT/FR/2010/000128
WO/2010/092264
C09D )5010.01(
A61K )5010.01(
‫תמיסות רפואיות לילדים הכוללות חוסם‬
‫ביתא‬
September 27, 2011-‫כ"ח באלול התשע"א‬
60/60/0626
514111
PHARMACEUTICAL FORMULATION
COMPRISING KETOPROFEN AND A
POLYXYALKYLENE ESTER OF A
HYDROXY FATTY ACID
ADVANCE HOLDINGS LIMITED
EP
09155046.7 12/03/2009
PCT/EP/2010/051222
WO/2010/102862
20/61/066/
60/60/0661
B82B )5010.01(
‫מבני גרדיאנט הבאים במגע עם מיקרו–וננו‬
‫ שיטת ייצור ושימוש בהם‬,‫נוזלים‬
514105
SEMICONDUCTOR SUBSTRATE
CUTTING METHOD
HAMAMATSU PHOTONICS K.K.
2003JP
10/09/2003
318875
0661-02/100 02/6//0661
JP
PCT/JP/2004/013163
WO/2005/027212
116
‫הרכב רוקחות המכיל קטופרופן ופולי‬
‫אוקסיאלקין אסטר של חומצת שומן‬
‫הידרוקסית‬
514114
GRADIENT STRUCTURES
INTERFACING MICROFLUIDICS AND
NANOFLUIDICS, METHODS FOR
FABRICATION AND USES THEREOF
THE TRUSTEES OF PRINCETON
UNIVERSITY
US
60/373409
16/04/2002
06/120/10
21/26/0660
US
06/121006
20/61/066/
US
PCT/US/2003/011721
WO/2003/106693
A61K )5010.01(
H01L )5010.01(
‫שיטה לחיתוך בסיס למוליך למחצה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
514111
/2/6//0662
TRANS-(1R,2S)-2-(3,4DIFLUOROPHENYL)CYCLOPROPANAMINIUM(2R)2-HYDROXY-2-PHENYLETHANOATE
ASTRAZENECA AB
GB
0013487.4
6660262-1
SE
PCT/SE/2001/001240
WO/2001/092200
21/22/0660
514155
514152
514111
METER REGISTER HAVING AN
ENCODER
ARAD MEASURING TECHNOLOGIES
LTD.
US
60/612339
23/09/2004
117
A23B )5010.01(
‫מערכות וטכניקות להקפאה והפשרה של‬
‫תוצרת חקלאית‬
SELF ALIGNING DATA CONVERTER
FOR MULTIPLE CLOCK SYSTEMS
RAYTHEON COMPANY
US
10/611114
30/06/2003
PCT/US/2004/020881
WO/2005/006551
00/60/066/
–R1,S2)–2–(4,3(–‫טרנס‬
)‫דיפלואורופניל‬
R2)–(–‫ציקלופרופנאמיניומ‬
‫– פניל‬5–‫–קידרוקסי‬2
‫אתאנואט‬
02/06/2000
60/60/0666
APPARATUS AND TECHNIQUES FOR
FREEZING AND THAWING OF
AGRICULTURAL PRODUCE
FRESH DEFROST LTD
IL
172001
16/11/2005
PCT/IL/2006/001309
WO/2007/057888
/6/60/0661
C07C )5010.01(
‫פרש דיפרוסט בע"מ‬
H03K )5010.01(
‫ממיר מסלול נתונים מיישר עצמי עבור‬
‫מערכות רבי שעונים‬
G01D )5010.01(
‫מד רושם עם מקודד‬
‫ארד טכנולוגיות מדידה בע"מ‬
September 27, 2011-‫כ"ח באלול התשע"א‬
06/0/110/
US
22/0016/2
US
PCT/IL/2005/001010
WO/2006/033106
60/6//066/
0//61/066/
2//60/066/
514111
PEPTIDE-BASED COMPOUNDS
ONYX THERAPEUTICS, INC.
US
60/569885
10/05/2004
06/026616
21/60/0661
US
06/0/1/00
6//20/0661
US
PCT/US/2005/016335
WO/2005/111008
2//60/066/
514161
METHOD AND APPARATUS FOR
PRODUCING OXIDIZED COMPOUND
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2004JP
13/09/2004
265717
PCT/JP/2005/017222
WO/2006/030936
02/60/066/
514150
NOVEL GENES RELATED TO
GLUTAMINYL CYCLASE
PROBIODRUG AG
US
60/846244
21/09/2006
06/01//16
6//6//066/
US
PCT/EP/2007/060013
WO/2008/034891
118
C07K )5010.01(
‫תרכובות מבוססות פפטיד‬
C07D )5010.01(
‫שיטה והתקן לייצור תרכובת מחומצנת‬
C12N )5010.01(
‫גנים חדשים המתייחסים לגולטמיניל‬
‫ציקלאז‬
September 27, 2011-‫כ"ח באלול התשע"א‬
2//6//066/
514125
4-AMINO-4-OXOBUTANOYL
PEPTIDES AS INHIBITORS OF VIRAL
REPLICATION
ACHILLION PHARMACEUTICALS,
INC.
US
60/830488
13/07/2006
06/01//10
00/60/066/
US
PCT/US/2007/016018
WO/2008/008502
0//6//0661
119
‫ – אוקסובוטאנואילים‬4 ‫ – אמינו‬4 ‫פפטידים‬
‫כמעכבי שכפול ויראלי‬
514155
N-SUBSTITUTED-4-HETEROARYLTETRAHYDROPYRIDYL
COMPOUNDS USEFUL FOR
TREATING OR PREVENTING PAIN
AND PHARMACEUTICAL
COMPOSITION COMPRISING THE
SAME
EURO-CELTIQUE S.A.
US
60/489516
24/07/2003
PCT/US/2004/023914
WO/2005/009988
C07K )5010.01(
C07D )5010.01(
–‫– הטרואריל‬4– ‫ – מותמרות‬N ‫תרכובות‬
‫טטרהידרופירידיל השימושיות לטיפול או‬
‫מניעת כאב והרכבים רוקחיים הכוללים‬
‫אותן‬
September 27, 2011-‫כ"ח באלול התשע"א‬
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note:, patent applications published in this
journal were classified according to the
International Classification version that was
in force when this journal was prepared.
120
- ‫ לחוק הפטנטים תשכ"ז‬51 ‫הודעה לפי סעיף‬
1611
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬11 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬20 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬51 ‫הפטנטים בדרך הקבועה בתקנה‬
.1611 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
‫ בקשות הפטנטים שפורסמו ביומן‬:‫**הערה‬
‫זה סווגו בהתאם לגרסת הסיווג הבינלאומי‬
‫שהייתה בתוקף בעת הכנת הבקשות‬
.‫לפרסום‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
944001
‫שימוש במעצים פעילות פולינוקליאוטיד‬
‫ובמולקולת חומצת גרעין לייצור הרכב רוקחי‬
‫להולכת חומר גנטי לתוך תאים‬
]54[
USE OF A POLYNUCLEOTIDE
FUNCTION ENHANCER AND A
NUCLEIC ACID MOLECULE TO
MANUFACTURE A
PHARMACEUTICAL
COMPOSITION FOR
INTRODUCING GENETIC
MATERIAL INTO CELLS
]11[
]22[
26.01.1994
008342
]21[ 26.01.1993
]22[ US
113220
2231232332
US
132125
2531.32332
US
215121
1231332332
US
214301
1231332332
US
Int. Cl.(2010.01) A61K 31//70, 48//00, C12N 15//12, 15//33, 15//48, 15//87
DAVID B. WEINER, U.S.A.
WILLIAM V. WILLIAMS, U.S.A.
BIN WANG, U.S.A.
LESLIE R. CONEY, U.S.A.
MICHAEL J. MERVA, U.S.A.
VINCENT R. ZURAWSKI, JR., U.S.A.
]52[
].2[
].4[
]5.[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Use of a polynucleotide function enhancer that is selected from the group consisting
of: bipivacaine, mepivacain, lidocaine, procaine, carbocaine, and methyl bipivacaine,
and a nucleic acid molecule to manufacture a pharmaceutical composition for
introducing genetic material into cells of an individual, wherein said nucleic acid
molecule is free of retroviral particles, and wherein said polynucleotide function
enhancer enhances the uptake and expression of said nucleic acid molecule, and
wherein said nucleic acid molecule is adapted to direct expression in said cells.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
__________________
]22[]12[
121
130396
September 27, 2011-‫כ"ח באלול התשע"א‬
]54[
OB FUSION PROTEIN, NUCLEIC
ACID SEQUENCE, VECTOR,
CELL, PROCESS FOR
PRODUCING SAID PROTEIN AND
PHARMACEUTICAL
COMPOSITION
]11[
]22[
]52[
].2[
]7.[
].4[
11.12.1997
08/770973
]21[ 20.12.1996
]22[ US
Int. Cl.(2010.01) A61K 38//17, C07K 14//575, 19//00, C12N 15//62
AMGEN, INC., U.S.A.
WO/1998/028427
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The present invention relates to Fc-OB fusion protein compositions, methods of
preparation of such compositions and uses thereof. In particular, the present invention
relates to a genetic or chemical fusion protein comprising the Fc immunoglobulin
region, derivative or analog fused to the N-terminal portion of the OB protein,
derivative or analog.
]5.[
,‫ ווקטור‬,‫ רצף חומצה גרעינית‬,OB ‫חלבון היתוך‬
‫ תהליך לייצור החלבון ותכשיר פרמצבטי‬,‫תא‬
__________________
]22[]12[
134523
‫ הכנתם‬,81–‫חלבונים הקושרים אינטרלוקין‬
‫והשימוש בהם‬
]54[
INTERLEUKIN-18 BINDING
PROTEINS, THEIR
PREPARATION AND USE
]11[
]22[
13.08.1998
121554
]21[ 14.08.1997
]22[ IL
212023
1.3173233.
IL
212701
133133233.
IL
211224
103223233.
IL
215402
1131.32337
IL
Int. Cl.(2010.01) A61K 38//17, 38//19, 48//00, C07K 14//54, 14//715, 16//18, 16//28,
19//00, C12N 15//12, 15//24
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
WO/1999/009063
INTERLAB LTD.,
,‫אינטר לאב בע"מ‬
18 HAKISHON ST.
11 ‫הקישון‬
]52[
].2[
]7.[
].4[
122
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
YAVNE 81220
‫יבנה‬
Interleukin-18 binding proteins which are capable of binding IL-18 and/or modulating
and/or blocking IL-18 activity are provided. Methods for their isolation and
recombinant production, DNAs encoding them, DNA vectors expressing them, vectors
useful for their expression in humans and other mammals, antibodies against them are
also provided.
__________________
]22[]12[
155599
‫פולינוקלאוטידים מקודדי חלבונים המזרזים‬
‫אצטילציה של גליפוסאט‬
]54[
POLYNUCLEOTIDES ENCODING
PROTEINS WHICH CATALYZE
ACETYLATION OF GLYPHOSATE
]11[
]22[
]52[
].2[
29.10.2001
60/244385
]21[ 30.10.2000
]22[ US
Int. Cl.(2010.01) A01H 05//00, C07K 14//415, C12N 09//10, 15//54, 15//82
PIONEER HI-BRED
INTERNATIONAL, INC., U.S.A.
VERDIA, INC., U.S.A.
E.I.DU PONT DE NEMOURS AND
COMPANY, U.S.A.
WO/2002/036782
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Novel proteins are provided herein, including proteins capable of catalyzing the
acetylation of glyphosate and other structurally related proteins. Also provided are
novel polynucleotides capable of encoding these proteins, compositions that include
one or more of these novel proteins and/or polynucleotides, recombinant cells and
transgenic plants comprising these novel compounds, diversification methods
involving the novel compounds, and methods of using the compounds. Some of the
novel methods and compounds provided herein can be used to render an organism,
such as a plant, resistant to glyphosate.
]7.[
].4[
]5.[
The applications for division
from this application have
not yet been published
2202100
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
123
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
]54[
METHOD FOR PRODUCING THE
ANTICHOLINERGIC AGENT
TIOTROPIUM BROMIDE
]11[
]22[
]52[
].2[
12.12.2001
10064816.9
]21[ 22.12.2000
Int. Cl.(2010.01) C07D 45/1/00
BOEHRINGER INGELHEIM
PHARMA GMBH & CO. KG,
GERMANY
WO/2002/051840
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
156351
‫שיטה לייצר את התכשיר האנטיכולינרגי‬
‫טיוטרופיום ברומיד‬
]22[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a novel method for producing (1α, 2β, 4β, 5α, 7β)-7[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4-]
nonane bromide.
__________________
]22[]12[
158322
‫שימוש בחומצות שומן עבור ייצור של תרופה‬
‫ השתלת מוח‬, ‫ פצעים‬, ‫לטיפול במיילוסופריסיה‬
‫עצם או ניוטרפיניה ומוצר ותכשיר המכיל אותן‬
]54[
USE OF FATTY ACIDS FOR THE
MANUFACTURE OF A
MEDICAMENT FOR THE
TREATMENT OF A CONDITION
SELECTED FROM
MYELOSUPPRESSION, WOUNDS,
BONE MARROW
TRANSPLANTATION AND
NEUTROPENIA AND PRODUCT
AND COMPOSITION THEREOF
]11[
]22[
]52[
18.04.2002
60/284458
]21[ 18.04.2001
]22[ US
Int. Cl.(2010.01) A61K 31//095, 31//16, 31//185, 31//215, 31//70, A61P 07//00,
37//00, C07C 23/3/31, 53//126, 69//00, C07D 30/7/02, 30/7/04, C07H 15//00
124
September 27, 2011-‫כ"ח באלול התשע"א‬
].2[
]7.[
].4[
]5.[
PROMETIC BIOSCIENCES INC.,
CANADA
WO/2002/083120
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A composition and method for promoting neutrophil survival and activation such as
the treatment of neutropenia arising as an undesirable side effect of chemotherapy and
radiation therapy. A composition containing medium-chain fatty acids, such as capri
acid or caprylic acid, or salts or triglycerides thereof, or mono- or diglycerides or other
analogues thereof or medium-chain triglycerides (MCT) is administered to a human or
animal needing treatment in an amount sufficient to reduce or eliminate neutropenia.
The composition is administered in an amount effective to treat the disorder. The
methods are also useful in the management of bone narrow transplantation and in the
treatment of various neutropenic diseases.
220/066
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
158558
‫שימוש בנגזרות בקסטנוספרמין להכנת תרופות‬
C ‫לטיפול בהפטיטיס‬
]54[
USE OF CASTANOSPERMINE
DERIVATIVES FOR THE
MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF HEPATITIS C
]11[
]22[
]52[
].2[
]7.[
].4[
02.05.2002
0110832.3
]21[ 03.05.2001
]22[ GB
Int. Cl.(2010.01) A61K 31//12, 31//435, C07D 47/1/04
SANOFI, FRANCE
WO/2002/089780
REINHOLD COHN AND PARTNERS,
125
,‫ריינהולד כהן ושותפיו‬
September 27, 2011-‫כ"ח באלול התשע"א‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
Use of certain castanospermine esters in the treatment of diseases caused by
flaviviruses, in particular in the treatment of disease caused by the hepatitis C virus
(HCV) and compositions containing said esters in combination with adjunctive
therapeutic agents.
__________________
]22[]12[
159438
‫תרכובת (ציקלואלקיל)את'נאדיאמיד‬
‫ותכשירים רוקחיים המכילים אותן‬
]54[
(CYCLOALKYL)ETHANEDIAMIDE
COMPOUNDS AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]11[
]22[
20.06.2002
2001-187105
]21[ 20.06.2001
]22[ JP
1112-142140
1331731112
JP
1112-222717
1332131112
JP
1112-237.17
1732131112
JP
PCT/JP02/02683
1131231111
WO
Int. Cl.(2010.01) A61K 31//436, 31//4365, 31//437, 31//4427, 31//498, 31//501,
31//506, A61P 07//02, C07D 41/7/04, 47/1/04, 48/7/04, 49/5/04, 49/8/04, 51/3/04
DAIICHI SANKYO COMPANY,
LIMITED, JAPAN
WO/2003/000680
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
Compounds represented by the following general formula (1), salts thereof, solvates of
]52[
].2[
]7.[
].4[
]5.[
126
September 27, 2011-‫כ"ח באלול התשע"א‬
the same or N−oxides of the same: Q1−Q2−T0−N(R1)−Q3−N(R2)−T1−Q4 (1) wherein R1
and R2 represent each hydrogen, etc.; Q1 represents optionally substituted,
saturated or unsaturated 5− or 6−membered hydrocarbyl, etc.; Q 2 represents a single
bond, etc.; Q3 represents the following groups( ;wherein Q 5represents C 7−2alkylene,
etc.); and T 1and T 2represent each carbonyl, etc. These compounds are useful as
preventives and/or remedies for brain infarction, cerebral embolism, myocardial
infarction, angina, pulmonary infarction, pulmonary embolism, Buerger’s disease,
bottom venous thrombosis, disseminated intravascular coagulation, thrombosis
following artificial valve/joint replacement, thrombosis and reocclusion following
circulation reconstruction, systemic inflammatory responsive syndrome (SIRS),
multiple organ dysfunction (MODS), thrombosis in extracorporeal circulation or blood
coagulation in collecting blood3
__________________
]22[]12[
159575
‫מערכת צינון או חימום אישית המשתמשת‬
‫בזרימת נוזלים במעגל סגור‬
]54[
PERSONAL COOLING OR
WARMING SYSTEM USING
CLOSED LOOP FLUID FLOW
]11[
]22[
25.06.2002
60/300634
]21[ 25.06.2001
]22[ US
016211025
1531031112
US
016211034
1531031112
US
Int. Cl.(2010.01) A41D 13//005
PAUL A. CHAMBERS, U.S.A.
WO/2003/000079
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM ST.
21 ‫רחוב אחד העם‬
P.O.B. 2499
‫תל אביב‬5466 .‫ד‬.‫ ת‬,
TEL AVIV 65202
A garment (5) for a personal cooling or warming system, the garment comprising a
carrier (10) formed in the shape of the garment (5), and a bladder (15) comprising at
least two channel segments (20), wherein the channel segments (20) have a
]52[
].2[
]7.[
].4[
]5.[
127
September 27, 2011-‫כ"ח באלול התשע"א‬
substantially flat configuration so as to improve thermal efficiency.
__________________
]22[]12[
161007
‫נגזרות של פנתילאמיד של חומצה קרבוקסילית‬
,‫שעברו אלפא–חימצון או אלפא–תיאולציה‬
‫ שימוש בהן להכנת תכשירים‬,‫תהליכים לייצורן‬
‫ושיטה לבקרה ומניעת נגוע יבולים‬
]54[
ALPHA-OXYGENATED OR
ALPHA-THIOLATED
CARBOXYLIC ACID
PHENETHYLAMIDE
DERIVATIVES, PROCESSES FOR
THEIR PREPARATION, USE
THEREOF IN THE PREPARATION
OF COMPOSITIONS AND
METHOD FOR CONTROLLING
AND PREVENTING CROP
INFESTATION
]11[
]22[
]52[
15.11.2002
0127556.9
]21[ 16.11.2001
]22[ GB
Int. Cl.(2010.01) A01N 37//18, 43//02, 43//34, C07C 23/5/32, 23/7/18, 25/5/49,
31/7/06, 32/3/60, 32/7/44, C07D 20/9/10, 21/3/28, 21/5/06, 21/7/12, 23/1/12, 23/1/52,
23/3/64, 23/5/14, 23/7/08, 23/9/26, 24/1/12, 24/9/02, 25/3/02, 25/7/02, 25/7/08,
26/1/08, 26/3/52, 27/1/02, 27/5/02, 27/5/04, 27/7/22, 27/7/62, 28/5/02, 30/7/54,
31/7/48, 31/9/18, 33/3/04, 33/3/24
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND
WO/2003/042167
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to α-oxygenated or α-thiolated carboxylic acid phenethylamide
derivatives of the general formula I including the optical isomers thereof and mixtures
].2[
]7.[
].4[
]5.[
128
September 27, 2011-‫כ"ח באלול התשע"א‬
of such isomers, wherein A stands for optionally substituted aryl or optionally
substituted heteroaryl; X is oxygen or sulfur; Y is oxygen or sulfur; R1 is hydrogen,
alkyl, alkenyl, alkynyl, cycloalkyl, haloalkyl, haloalkenyl, haloalkynyl or
halocycloalkyl; R2 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl,
alkoxy-alkyl, alkoxy-alkenyl, alkoxy-alkynyl, whereof all alkyl- alkenyl-, alkynyl-, or
cycloalkyl-groups me be optionally substituted by halogen; or optionally substituted
arylalkyl, optionally substituted aryl-alkenyl, optionally substituted aryl-alkynyl or
optionally substituted aryloxy-alkyl; R3 is hydrogen, alkyl, alkenyl, alkynyl,
cycloalkyl, cycloalkyl-alkyl, alkoxy-alkyl, alkoxy-alkenyl, alkoxy-alkynyl, whereof all
alkyl- alkenyl-, alkynyl-, or cycloalkyl-groups me be optionally substituted by
halogen; or is optionally substituted aryl-alkyl, optionally substituted aryl-alkenyl,
optionally substituted aryl-alkynyl, optionally substituted aryloxy-alkyl, optionally
substituted heteroaryl-alkyl, optionally substituted heteroaryl-alkenyl or optionally
substituted heteroaryl-alkynyl; R4 is alkyl, alkenyl, alkynyl, alkoxy-alkyl, alkoxy,
alkenyloxy, alkynyloxy, alkylthio, alkanoyl, alkylamino, dialkylamino,
alkoxycarbonyl, whereof all alkyl- alkenyl or alkynyl-groups me be optionally
substituted by halogen; or is halogen, cyano, nitro, amino, formyl or carboxyl; R5 is
hydrogen, alkyl, alkenyl or alkynyl; n is an integer 0, 1, 2, 3, or 4; B1 represents a
bridge member -(CR10R11)q- or -(CHR10R11)r-Z-(CR12R13)s, wherein q is an
integer 2, 3 or 4; r is an integer 0, 1, 2, 3; s is an integer 1, 2 or 3, provided that (r + s)
is either 1, 2 or 3; Z is -O-, -S-, -SO- -S02-, NR6-, -CO-, -OOC-, -COO-, -NR6-CO- or
-CO-NR6- ; R6 is hydrogen or alkyl; R10, R11, R12 and R13 independently of each
other are hydrogen or alkyl ; and B2 is an alkylene bridge. These compounds possess
useful plant protecting properties and may advantageously be employed in agricultural
practice for controlling or preventing the infestation of plants by phytopathogenic
microorganisms, especially fungi.
__________________
]22[]12[
]54[
APPARATUS AND METHOD FOR
HYSTERESIS ASSESSMENT
USING ELECTROMAGNETIC
NON-CONTACT TRACKING OF
OBJECTS
]11[
]22[
18.05.2004
10/448289
129
]21[
29.05.2003
162037
‫התקן ושיטה להערכת היסטרסיס על–ידי‬
‫שימוש במעקב אלקטרומגנטי ללא מגע אחר‬
‫עצמים‬
]22[
US
September 27, 2011-‫כ"ח באלול התשע"א‬
]52[
].2[
].4[
]5.[
Int. Cl.(2010.01) G01N 27//72, G01V 03//10
BIOSENSE WEBSTER, INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
P.O.B. 33111
‫תל אביב‬22111 .‫ד‬.‫ ת‬,
TEL AVIV 61330
Assessment apparatus (16), comprising: a set of one or more radiators (34), which is
adapted to generate an energy field at at least one fundamental frequency; a receiving
sensor (22), which is adapted to generate a first signal responsive to the energy field
when a field reactive article (40) is at a first location relative to the receiving sensor,
and which is adapted to generate a second signal responsive to the energy field when
the field reactive article is at a second location relative to the receiving sensor; and a
control unit (50) characterised in that it is adapted to: receive an amplitude of the first
signal and an amplitude of the second signal and analyze them by calculating the
difference between the first and second signal and to analyze them by calculating the
difference between the first and second signal amplitudes in order to compute a
fingerprint signal characteristic of the field reactive article (40), and store, in a
database, data indicative of the fingerprint signal, in association with an identity of the
interfering article, wherein the data indicative of the fingerprint signal includes a
harmonic frequency pattern of the fundamental frequency present in the fingerprint
signal, and wherein the control unit (50) is adapted to detect the harmonic frequency
pattern by calculating a ratio of an amplitude of a first harmonic of the fundamental
frequency in the fingerprint signal to an amplitude of a second harmonic of the
fundamental frequency in the fingerprint signal and a ratio of an amplitude of at least
one harmonic frequency of the fundamental frequency present in the fingerprint signal
to an amplitude of the fundamental frequency present in the fingerprint signal, and to
store the ratios in the database, in association with the identity of the field reactive
article.
__________________
130
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
162094
‫תהליך לייצור תרבית של לאוקוציטים‬
‫פגוציטיים מונונוקליארים הומניים משופעלים‬
]54[
PROCESS FOR THE
MANUFACTURE OF A CULTURE
OF ACTIVATED HUMAN
MONONUCLEAR PHAGOCYTIC
LEUKOCYTES
]11[
]22[
]52[
].2[
21.11.2002
60/331780
]21[ 21.11.2001
]22[ US
Int. Cl.(2010.01) A61K 35//14, A61P 09//10, 25//00, C12N 05//07
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
MICHAL EISENBACH-SCHWARTZ,
‫ רונית‬,‫ ולנטין פולגה‬,‫שוורץ‬-‫מיכל אייזנבך‬
VALENTIN FULGA, RONIT
‫ איסר אש‬,‫בקימר‬-‫קליינר‬
KLEINER-BAKIMER, ISSAR ASH
WO/2003/044037
BEN-AMI & ASSOCIATES,
,'‫בן עמי ושות‬
8 MENACHEM PLAUT ST.,
1 ‫מנחם פלאוט‬
PARK TAMAR,
‫רחובות‬64 .‫ד‬.‫ ת‬,
P.O.B. 94,
REHOVOT 76100
A process for the manufacture of human mononuclear phagocytic leukocytes
comprises incubating monocytes isolated from a blood sample of an individual and
skin segments from the same individual, removing the dermis segments from the
incubation mixture and sedimenting the obtained activated mononuclear phagocytic
leukocytes by centrifugation, washing and resuspending the activated phagocytic
leukocytes in the medium, and evaluating the culture for its suitability for human
administration. Cellular therapy products are made from the obtained cultures and are
useful for promoting axonal regeneration in the CNS, wound healing and treatment of
myocardial infarction.
].1[
]7.[
].4[
]5.[
__________________
]22[]12[
162433
‫אנטגוניסט לקולטן הורמון גדילה‬
]54[
GROWTH HORMONE RECEPTOR
ANTAGONIST
]11[
]22[
]52[
06.12.2002
0130052.4
]21[ 14.12.2001
]22[ GB
Int. Cl.(2010.01) A61K 38//27, A61P 03//10, 13//12, 35//00, 43//00, C07K 14//61,
14//71, 19//00, C12N 01//15, 01//19, 01//21, 05//10, 15//62, 15//63
131
September 27, 2011-‫כ"ח באלול התשע"א‬
].2[
]7.[
].4[
]5.[
ASTERION LIMITED, UNITED
KINGDOM
WO/2003/070765
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to chimeric polypeptides wherein said polypeptides comprise a
modified binding domain of growth hormone linked to a receptor binding domain of
growth hormone receptor; and tandems/oligomers of said modified growth hormone
binding domains.
20660/0
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
]54[
MEDICAMENT DISPENSER
]11[
]22[
]52[
].2[
22.01.2003
0201677.2
]21[ 25.01.2002
Int. Cl.(2010.01) A61M 15//00
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/2003/061743
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
132
162700
‫מנפק תרופות‬
]22[
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
There is provided a medicament dispenser (600) for use with plural elongate form
medicament carriers (601), each having multiple distinct medicament dose portions
carried thereby, the dispenser (600) having a dispensing mechanism (620) for
dispensing the distinct medicament dose portions carried by each of the plural
medicament carriers (601). The mechanism comprises a receiving station (602) for
receiving each of the plural medicament carriers; a release for releasing a distinct
medicament dose portion from each of the plural medicament carriers on receipt
thereof by the receiving station; an outlet (624), positioned to be in communication
with the distinct medicament dose portions releasable by said a release (620); and an
indexer (606) for individually indexing the distinct medicament dose portions of each
of the plural medicament carriers (601).
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
162836
‫פפטידים ודמויי פפטידים בעלי פעילות נוגדת‬
‫או פעילות מסיעת חומצות גרעין‬/‫התרבות ו‬
‫או פעילות מסעית לגורמי‬/‫לגורמי נזק או טיפול ו‬
‫נזק לחומצות גרעין או לטיפולים כאלו ותכשירים‬
‫רוקחים המכילים אותם‬
]54[
PEPTIDES AND
PEPTIDOMIMETICS HAVING
ANTI-PROLIFERATIVE
ACTIVITY AND/OR THAT
AUGMENT NUCLEIC ACID
DAMAGING AGENTS OR
TREATMENTS AND
PHARMACEUTICAL
COMPOSITIONS THEREOF
]11[
]22[
]52[
].2[
]7.[
].4[
17.01.2003
60/350208
]21[ 17.01.2002
]22[ US
Int. Cl.(2010.01) A61K 38//03, A61P 35//00, C07K 07//00
CANBAS CO., LTD., JAPAN
WO/2003/059942
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
This invention provides compounds including peptides and peptidomimetics that can
be used to treat cell proliferative disorders, such as those associated with benign and
malignant tumor cells. While the invention is not limited to any particular mechanism,
the compounds of the invention appear to function at least in part by inhibiting G2 cell
cycle checkpoint. Thus, invention compounds can be used to inhibit cell growth alone
or be used in combination with a nucleic acid damaging treatment to inhibit cell
growth.
133
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
162985
‫צינור בתוך קנה הנשימה המאפשר קביעה‬
‫מדוייקת של לחץ רירי‬
]54[
ENDOTRACHEAL TUBE WHICH
PERMITS ACCURATE
DETERMINATION OF MUCOSAL
PRESSURE
]11[
]22[
08.01.2003
60/351128
]21[ 23.01.2002
]22[ US
21624423.
2231531111
US
Int. Cl.(2010.01) A61M 16//00, 25//00
INTERNATIONAL PATENTS INC.,
SEYCHELLES
WO/2003/061747
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
The disclosed endotracheal tube (19) includes a silicone tubular member (19a) that has
a proximal end, a distal end, and a lumen extending through the member to supply air
from the proximal end to the distal end. The tubular member defines a first zone (32)
and a second zone. At least a portion of the first zone (32) has a first outer diameter.
The second zone has a second outer diameter. The first outer diameter is less than the
second outer diameter. The first and second zones are adjacent to one another and are
configured for insertion into the trachea of a human patient. A silicon cuff (20) is
attached to the tubular member such that the cuff extends over at least a portion of the
first zone (32). The silicon cuff is mounted such that when the cuff is inflated in a
trachea, the cuff reaches its plateau pressure prior to circumferentially contacting the
inner wall of the trachea so that an accurate pressure reading may be taken of the
pressure the cuff exerts on an inner wall of the trachea.
]52[
].2[
]7.[
].4[
]5.[
134
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
163588
‫שיטות לאיבחון ליפת הכבד‬
]54[
METHODS OF DIAGNOSING
LIVER FIBROSIS
]11[
]22[
]52[
].2[
28.02.2003
10/087188
]21[ 28.02.2002
]22[ US
Int. Cl.(2010.01) C12Q 01//00, 01//37, G01N 33//53, 33//576, 33//66, 33//68
PROMETHEUS LABORATORIES
INC., U.S.A.
WO/2003/073822
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention provides a method of diagnosing the presence or severity of
liver fibrosis in an individual by detecting alpha2-macroglobulin (alpha2-MG) in
sample from the individual; detecting hyaluronic acid (HA) in a sample from the
individual; detecting tissue inhibitor of metalloproteinases-1 (TIMP-1) in a sample
from the individual; and diagnosing the presence or severity of liver fibrosis in the
individual based on the presence or level of alpha-MG, HA and TIMP-1.
]7.[
].4[
]5.[
135
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
164463
‫שימוש באוסטיופרוטגרין בהכנת תרופות‬
]54[
USE OF OSTEOPROTEGERIN IN
THE PREPARATION OF
MEDICAMENTS
]11[
]22[
]52[
].2[
26.03.2003
02100364.5
]21[ 14.11.2004
]22[ EP
Int. Cl.(2010.01) A61K 38//17, 38//19, A61P 19//00, C07K 14//52
MERCK SERONO S.A.,
SWITZERLAND
WO/2003/084560
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
11 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
YAVNE 81101
The invention relates to the use of osteoprotegerin for treatment and/or prevention of
fibrotic diseases, in particular of scleroderma.
]7.[
].4[
]5.[
__________________
]22[]12[
164853
‫נעל הניתנת להתאמה אישית‬
]54[
PERSONALLY ADJUSTABLE
FOOTWEAR
]11[
]52[
].2[
].1[
].4[
27.10.2004
Int. Cl.(2010.01) A43B 03//26
PEEERFECT FIT LLC, U.S.A.
OFER TVOUA, AMIR TVOUA
‫ אמיר תבואה‬,‫עופר תבואה‬
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
Personally adjustable footwear comprising:
(a) at least one sole layer including: a toe portion, a heel portion, and an intermediate
portion, said intermediate portion being integrally formed with both said toe portion
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
136
and said heel portion, said intermediate portion having a plurality of openings passing
substantially vertically through said layer so that said intermediate portion is
elastically flexible to allow relative longitudinal displacement of said toe portion and
said heel portion to vary a length of said layer without significant variation in a
thickness of said layer; and
(b) a retention mechanism associated with both said toe portion and said heel portion,
said retention mechanism being configured for retaining any of a plurality of relative
positions between said toe portion and said heel portion.
__________________
]22[]12[
164973
]54[
N-HYDROXY FORMAMIDE
COMPOUNDS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS FOR TREATING
BACTERIAL INFECTIONS
]11[
]22[
]52[
30.05.2003
60/384,457
]21[ 31.05.2002
]22[ US
Int. Cl.(2010.01) A61K 31//16, 31//4245, 31//4375, 31//4709, 31//472, 31//505,
31//5375, 31//5513, A61P 31//04, C07C 25/9/06, 26/1/02, 31/1/37, C07D 21/1/84,
21/3/77, 21/5/38, 21/7/22, 23/1/06, 23/7/22, 23/9/42, 24/1/44, 25/1/16, 25/3/10,
26/5/28, 40/1/12, 40/3/04, 40/3/14, 41/3/04, 41/3/14, 47/1/04, 48/7/04
GLAXOSMITHKLINE LLC, U.S.A.
WO/2003/101442
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Novel PDF inhibitors and novel methods for their use are provided.
].2[
]7.[
].4[
]5.[
‫ תכשירים‬,‫–הידרוקסי פורמאמיד‬N ‫תרכובות‬
‫רפויים המכילים אותן ושימושן בהכנת תרופות‬
‫לטיפול בזיהומים חידקיים‬
__________________
137
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
165812
‫מיתלה מתנתק עבור גופים עפים כגון טילים וכלי‬
‫טייס משוגרים בעזרת פסים‬
]54[
DETACHABLE HANGER FOR
RAIL-LAUNCHED FLYING
OBJECTS SUCH AS MISSILES
AND AIRBORNE PLATFORMS
]11[
]52[
].2[
16.12.2004
Int. Cl.(2010.01) F41F 07//00
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
].1[
].4[
MOSHE YOGEV
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
A system for launching a flying object from a launch platform comprising:
(a) a rail assembly comprising:
(i) a launch rail along which said flying object moves after an engine of said
flying object is fired, said launch rail fixedly attached to said launch
platform, said launch rail having a "T" shaped slot (44) in it wherein
the crossbar of said "T" shaped slot forms two parallel grooves in
said launch rail; and
(ii) a stopper rigidly attached top the bottom of said "T" shaped slot at the
forward end of said slot;
(b) a hanger assembly comprising:
(i) a "T" shaped main body section (20); the crossbar of said "T" shaped main
body section forming two projecting rails (30) that slidingly fit into
said grooves in said launch rail; and
(ii) one or more bolts that attach said main body section either directly or
indirectly to said flying object; wherein at least some of said bolts
are adapted to break when experienced shearing forces having a
magnitude equal to the force caused by said main body section
impacting upon said stopper, thereby detaching said main body
section from said flying object and allowing said main body section
to be left behind in said rail when said flying object is launched from
said launch platform.
]5.[
138
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
‫משה יוגב‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
166278
‫תמסורת תוכן ברשת כבלים על בסיס אינטרנט‬
]54[
INTERNET-BASED SUBMISSION
OF CABLE NETWORK CONTENT
]11[
]22[
]52[
].2[
]7.[
].4[
08.08.2003
60/402052
]21[ 09.08.2002
]22[ US
Int. Cl.(2010.01) G06Q 30//00
RICHARD J. BIES, U.S.A.
WO/2004/015519
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
A cable network content delivery system providing advertising information via a cable
network (5) and an advertising content interface (20) are described. An advertiser (21)
submits advertising content over an internet (24) which is then adapted for a cable
network (5). A data gateway (31) stores the advertising information. The system
processes a user command received via the cable network (5), including an advertising
information search command, and provides advertising information retrieved via the
cable network (5).
]5.[
139
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
166532
‫חומצות גרעין וחלבונים מקבילים המכונים‬
‫ תכשירים המכילים אותם ושימושים‬,P5A5202
‫בהם‬
]54[
NUCLEIC ACIDS AND
CORRESPONDING PROTEINS
ENTITLED 202P5A5,
COMPOSITIONS COMPRISING
THE SAME AND USES THEREOF
]11[
]22[
16.06.2003
60/404306
]21[ 16.08.2002
]22[ US
016412131
1232231111
US
Int. Cl.(2010.01) C07K 14//47, G01N 33//574
AGENSYS, INC., U.S.A.
WO/2004/000167
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A novel gene 202P5A5 and its encoded protein, and variants thereof, are described
wherein 202P5A5 exhibits tissue specific expression in normal adult tissue, and is
aberrantly expressed in the cancers listed in Table I. Consequently, 202P5A5 provides
a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The
202P5A5 gene or fragment thereof, or its encoded protein, or variants thereof, or a
fragment thereof, can be used to elicit a humoral or cellular immune response;
antibodies or T cells reactive with 202P5A5 can be used in active or passive
immunization.
]52[
].2[
]7.[
].4[
]5.[
__________________
140
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
166626
‫תהליך ליצור מלח קלציום של רוזוואסטאטין‬
‫והמוצר של תהליך זה‬
]54[
PROCESS FOR THE
MANUFACTURE OF THE
CALCIUM SALT OF
ROSUVASTATIN AND THE
PRODUCT OF SAID PROCESS
]11[
]22[
]52[
].2[
07.08.2003
0218781.3
]21[ 13.08.2002
]22[ GB
Int. Cl.(2010.01) C07D 23/9/42
ASTRAZENECA UK LIMITED,
UNITED KINGDOM
JOHN HORBURY, NIGEL PHILIP
TAYLOR
WO/2004/014872
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM ST.
21 ‫רחוב אחד העם‬
P.O.B. 2499
‫תל אביב‬5466 .‫ד‬.‫ ת‬,
TEL AVIV 65202
An improved process for manufacture of (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic
acid calcium salt, which is useful for the production of a pharmaceutical useful in the
treatment of, inter alia, hypercholesterolemia, hyperlipoproteinemia and
atherosclerosis, is described.
].1[
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
USE OF ANTICANCEROGENIC
LACTATE SALTS IN THE
PREPARATION OF
MEDICAMENTS AND RELATED
METHODS FOR DETERMINING
METABOLIC PROFILE
]11[
]22[
12.11.2003
60/426204
016410171
01641021.
016401203
141
]21[
13.11.2002
2232231111
2232231111
1231431112
167469
‫שימוש במלחי–לקטט אנטי סרטנים בהכנת‬
‫תרופות ושיטות לקביעת פרופיל מטבולי קשורות‬
‫לכך‬
]22[
US
US
US
US
September 27, 2011-‫כ"ח באלול התשע"א‬
]52[
].2[
]7.[
].4[
]5.[
016401432
1231431112
US
016401217
1231431112
US
01652.325
1.32231112
US
Int. Cl.(2010.01) A61K 31//4709, A61P 35//00, C07D 40/1/04
NOVARTIS VACCINES AND
DIAGNOSTICS, INC., U.S.A.
WO/2004/043389
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
Methods of treating cancer using 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1Hbenzimidazol-2-yl]quinolin-2(1H)-one are provided. In particular, the methods are
effective for the treatment of solid tumors or leukemias, including prostate, colorectal,
breast, multiple myeloma, pancreatic, small cell carcinoma, acute myelogenous
leukemia, chronic myelogenous leukemia, or myelo-proliferative disease. Further
provided are methods of measuring the amount of 4-amino-5-fluoro-3-[6-(4methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one and determining a
metabolic profile therefore.
__________________
]22[]12[
167984
‫תכשירים המכילים תרכובות דיאסטרים‬
–8–‫– פרופאן‬3 ,8 ‫פוספאטים ציקלים של‬
‫ארילדיאולים והשימוש בתרכובות אלו להכנת‬
‫תרופות‬
]54[
COMPOSITIONS COMPRISING
CYCLIC PHOSPHATE DIESTER
COMPOUNDS OF 1,3-PROPANE-1ARYL DIOLS AND THE USE OF
SAID COMPOUNDS FOR THE
PREPARATION OF PRODRUGS
]11[
]22[
31.10.2003
60/423211
]21[ 31.10.2002
]22[ US
016412153
2232131111
US
Int. Cl.(2010.01) A61P 31//12, 35//00, C07F 09//00, 09//6574, C07H 19//04
METABASIS THERAPEUTICS, INC.,
U.S.A.
WO/2004/041834
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
].2[
]7.[
].4[
]5.[
142
Compounds of Formula (I), their preparation and synthetic intermediates, and their use
in the synthesis of prodrugs; wherein: V and L are trans relative to one another; V is
September 27, 2011-‫כ"ח באלול התשע"א‬
selected from group consisting of carbocyclic aryl, substituted carbocyclic aryl,
heteroaryl, and substituted heteroaryl; and L is a leaving group selected from the group
consisting of halogen, alkyl sulfonate, aryloxy optionally substituted with 1-2
substituents, N-containing heteroaryl, and N-hydroxy-nitrogen containing heteroaryl;
and salts thereof.
__________________
]22[]12[
168035
‫נורמליזציה של פנים לזיהוי ורישום‬
]54[
FACE NORMALIZATION FOR
RECOGNITION AND
ENROLLMENT
]11[
]52[
].2[
14.04.2005
Int. Cl.(2010.01) G06K 09//00
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
].1[
].4[
TOMER MICHAELI
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
An iterative method for normalization of a probe image against the
Eigenspace learned from a database of images, said method
comprising the following steps:
(a) warping the probe image using a predefined parametric
transformation, said warping of the image is done by deforming a
rectangular grid and re-sampling the image with the deformed grid;
(b) combining a first order Taylor approximation of said re-sampled
warped image with respect to said transformation parameters with an
approximation of said re-sampled image expressed as a linear
combination of the Eigenspace basis vectors;
(c) minimizing the mean squared error between the two
approximations with respect to said transformation parameters and the
]5.[
143
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
‫תומר מיכאלי‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
September 27, 2011-‫כ"ח באלול התשע"א‬
Eigenspace coefficients and with respect to the points of the grid;
(d) obtaining from said minimization a new set of transformation
parameters and a new set of Eigenspace coefficients, said new set of
Eigenspace coefficients improves the representation of the initial
image in the said Eigenspace as compared to the representation
obtained in the previous iteration; and
(e) repeating steps (b) through (d) until said new set of transformation
parameters and said new set of Eigenspace coefficients until the
changes in said transformation parameters between two consecutive
iterations are less than a predetermined threshold.
__________________
]22[]12[
168062
‫מערכת ושיטה לאופטימיזציה של הגישה‬
‫למאגר נתונים ברשתות מאגרי נתונים‬
]54[
SYSTEM AND METHOD FOR THE
OPTIMIZATION OF DATABASE
ACCESS IN DATABASE
NETWORKS
]11[
]22[
]52[
].2[
].1[
19.10.2003
60/418220
]21[ 15.10.2002
]22[ US
Int. Cl.(2010.01) G06F 17//30, H04L 29//06, 29//08
ACTIVE-BASE LTD.
‫גן‬- ‫ רמת‬,‫בייס בע"מ‬-‫אקטיב‬
ERIC BOUKOBZA, YORAM
‫ יורם ניסנבוים‬,‫אריק בוקובזה‬
NISSENBOIM
WO/2004/036344
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A database network router (DNR) (101) in a database network includes a client access
module (113) and a database resource manager (117) that communicate with each
other using a common software interface. The client access module (113)
communicates with clients (105) including application servers and external database
servers (103); and the database resource manager (117) communicates with the
database servers (103). The DNR (101) also includes a protocol manager (115) for
handling multiple database protocols. The database network router (101) also includes
local data cache storage (137) to store commonly used data objects, results of parsed
query statement (179), non-optimized query statements.The database network router
(101) identifies and assigns a priority to each client (111) on log-in. The DNR (101)
provides a method for connections pooling, a method for balancing the load in a
database networks and a method for synchronizing the data stored in cache memory
September 27, 2011-‫כ"ח באלול התשע"א‬
]7.[
].4[
]5.[
144
with the database network and method for synchronizing the data stored in cache
memory with the database to insure datareliability. The DNR (101) also provides a
method for monitoring and optimizing data queries to improve the performance of the
database network. The DNR (101) also provides a method to migrate from an old
(404) to a new version (103) of a database.
__________________
]22[]12[
168357
‫נוגדנים חד תחומיים המכוונים נגד גורם נמק‬
‫ והשימושים בהם‬α–‫רקמתי‬
]54[
SINGLE DOMAIN ANTIBODIES
DIRECTED AGAINST TUMOUR
NECROSIS FACTOR-ALPHA AND
USES THEREOF
]11[
]22[
07.11.2003
60/425073
]21[ 08.11.2002
]22[
016415102
1732231111
1244.11534
2131231112
PCT/EP03/06581
1231031112
PCT/EP03/07313
1731.31112
Int. Cl.(2010.01) A61K 39//395, C07K 16//24
ABLYNX N.V., BELGIUM
WO/2004/041862
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
].2[
]7.[
].4[
]5.[
US
US
EP
WO
WO
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to polypeptides derived from single domain heavy chain
antibodies directed to Tumor Necrosis Factor-alpha. It further relates to single domain
antibodies that are Camelidae VHHs. It further relates to methods of administering said
polypeptides.
__________________
145
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
168417
‫ גרפיקה וממשק‬/ ‫מדפסת להדפסת טקסט‬
‫מדיה מקודד על משטח‬
]54[
PRINTER FOR PRINTING TEXT/GRAPHICS AND
CODED DATA INTERFACE ONTO SURFACE
]11[
]22[
24.05.2000
PQ0559
]21[
25.05.1999
]22[
AU
PQ1313
2131032333
AU
PQ3632
1532132333
AU
Int. Cl.(2010.01) B41F 31//08, B41L 27//10, G06F 03//03, 03//033, 03//12
DIVISION FROM 146648
SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA
WO/2000/072126
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A printer for printing on a surface, the printer comprising:
a network interface module for receiving document data from a computer system;
a processor for generating coded data using at least some of the document data, the coded data being
indicative of an identity of a region of the surface and of a plurality of locations on the surface; a printhead
for simultaneously printing visible text/graphics and the coded data onto the surface; and an ink supply for
supplying to the printhead at least one visible ink for printing said visible text/graphics and an invisible ink
for printing said coded data.
]52[
]01[
].2[
]7.[
].4[
]5.[
__________________
146
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
168661
‫ביס–אריל סולפונאמידים‬
]54[
BIS-ARYL SULFONAMIDES
]11[
]22[
]52[
18.11.2003
60/427670
]21[ 18.11.2002
]22[ US
Int. Cl.(2010.01) A61K 31//44, A61P 29//00, 35//00, 37//00, C07C 31/1/00, C07D
21/3/89
CHEMOCENTRYX, INC., U.S.A.
WO/2004/085384
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
].2[
]7.[
].4[
]5.[
Compounds are provided that act as potent antagonists of chemokine receptors. The
compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical
compositions, methods for the treatment of chemokine receptor-mediated diseases, and
as controls in assays for the identification of chemokine antagonists.
__________________
]22[]12[
168691
‫תהליך להכנת אנטאקויר‬
]54[
PROCESS FOR PREPARING
ENTECAVIR
]11[
]22[
]52[
].2[
10.12.2003
60/432549
]21[ 11.12.2002
]22[ US
Int. Cl.(2010.01) C07D 47/3/18, C07F 07//00, 07//08, 07//18
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2004/052310
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Processes are disclosed for preparing the antiviral agent entecavir. A resin adsorption
process for the isolation and purification of entecavir is also disclosed. Various
intermediates useful in the preparation of entecavir are also disclosed.
]7.[
].4[
]5.[
__________________
147
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
168715
‫הרכבים מחומצות גרעין המווסתות את מערכת‬
‫החיסונית למניעה ולטיפול במחלות‬
]54[
IMMUNE MODULATORY
NUCLEIC ACID COMPOSITIONS
FOR PREVENTING AND
TREATING DISEASE
]11[
]22[
]52[
21.11.2003
60/428643
]21[ 21.11.2002
]22[ US
Int. Cl.(2010.01) A61K 31//7088, 48//00, A61P 03//10, 25//02, C12N 15//117, 15//12,
15//17, 15//79
THE BOARD OF TRUSTEES OF THE
LELAND STANFORD JUNIOR
UNIVERSITY, U.S.A.
BAYHILL THERAPEUTICS, INC.,
U.S.A.
WO/2004/047734
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
This invention relates to methods and compositions for treating or preventing disease
comprising the administration of immune modulatory nucleic acids having one or
more immune modulatory sequences (IMSs). The invention further relates to the
means and methods for the identification of the IMSs for preventing or treating
disease, more particularly the treatment and prevention of autoimmune or
inflammatory diseases. The invention also relates to the treatment or prevention of
disease comprising the administration of the immune modulatory nucleic acids alone
or in combination with a polynucleotide encoding self-protein(s), -polypeptide(s) or peptide(s). The present invention also relates to methods and compositions for treating
diseases in a subject associated with one or more self-protein(s), -polypeptide(s) or peptide(s) that are present in the subject and involved in a non-physiological state.
].2[
]7.[
].4[
]5.[
__________________
148
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
168754
]54[
HUMANIZED ANTIBODIES THAT
BIND HUMAN CD20 AND USES
THEREOF
]11[
]22[
16.12.2003
60/434115
]21[ 16.12.2002
]22[ US
016510202
1232131112
US
Int. Cl.(2010.01) A61K 39//395, C07K 16//28, C12N 15//13, 15//63
GENENTECH, INC., U.S.A.
WO/2004/056312
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
].2[
]7.[
].4[
]5.[
‫ אנושי‬CD20 ‫נוגדנים מאונשים הקושרים‬
‫והשימוש בהם‬
The invention provides humanized and chimeric anti-CD20 antibodies for treatment of
CD20 positive malignancies and autoimmune diseases.
The applications for division
from this application have
not yet been published
202161/
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
168854
‫תכשירים שיכולים להינתן למערכת העיכול‬
‫והשימוש בהם‬
]54[
FORMULATION WHICH CAN BE
ADMINISTERED
GASTROINTESTINALLY AND
THE USE THEREOF
]11[
]22[
]52[
].2[
13.11.2003
10257360.3
]21[ 09.12.2002
]22[ DE
Int. Cl.(2010.01) A61K 31//04, 31//198, 35//00, 36//82
FRESENIUS KABI DEUTSCHLAND
GMBH, GERMANY
WO/2004/052352
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a formulation, which can be administered gastro-intestinally,
September 27, 2011-‫כ"ח באלול התשע"א‬
]7.[
].4[
]5.[
149
containing green tea extract and at least one NO donor, which is a substrate of NO
synthetase and/or a precursor of said donor. Said formulation is administered prior to
surgical interventions, to eliminate or reduce the risk of postoperative complications.
__________________
]22[]12[
168907
‫מערכת ושיטה לאתחול מערכת הפעלה מוגנת‬
‫באמצעות אישור מצב‬
]54[
SYSTEM AND METHOD FOR
PROTECTED OPERATING
SYSTEM BOOT USING STATE
VALIDATION
]11[
]22[
]52[
].2[
01.06.2005
882134
]21[ 30.06.2004
]22[ US
Int. Cl.(2010.01) G06F 01//00, 09//445, 11//00, 21//00
MICROSOFT CORPORATION,
U.S.A.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
].4[
]5.[
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A mechanism for protected operating system boot that prevents rogue components
from being loaded with the operating system, and thus prevents divulgence of the
system key under inappropriate circumstances. After a portion of the machine startup
procedure has occurred, the operating system loader is run, the loader is validated, and
a correct machine state is either verified to exist and/or created. Once the loader has
been verified to be a legitimate loader, and the machine state under which it is running
is verified to be correct, the loader's future behavior is known to protect against the
loading of rogue components that could cause divulgence of the system key. With the
loader's behavior being known to be safe for the system key, the validator may unseal
the system key and provides it to the loader.
__________________
]22[]12[
]54[
150
METHOD OF SELF-ASSEMBLING
ELECTRONIC CIRCUITRY AND
169138
‫שיטה להרכבה עצמית של מעגל חשמלי‬
‫ומעגלים חשמליים שנוצרים בשיטה זו‬
September 27, 2011-‫כ"ח באלול התשע"א‬
CIRCUITS FORMED THEREBY
]11[
]22[
]52[
].2[
]7.[
].4[
]5.[
18.12.2002
PCT/US2002/040307 ]21[ 18.12.2002
Int. Cl.(2010.01) H01L 21//98, 23//12
IBM CORPORATION, U.S.A.
WO/2004/059730
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
]22[
WO
,‫מעבדות יבמ מחלקת קנין רוחני‬
‫אוניברסיטת חיפה הר הכרמל‬
‫חיפה‬
A method of assembling a circuit includes providing a template, enabling a
semiconductor material to self-assemble on the template, and enabling self-assembly of
a connection between the semiconductor material and the template to form the circuit
and a circuit created by self-assembly.
__________________
]22[]12[
]54[
SELF-ALIGNING DATA PATH
CONVERTER FOR MULTIPLE
CLOCK SYSTEMS
]11[
]22[
]52[
].2[
]7.[
].4[
30.06.2004
10/611114
]21[ 30.06.2003
Int. Cl.(2010.01) H03K 03//011
RAYTHEON COMPANY, U.S.A.
WO/2005/006551
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]5.[
151
169630
‫ממיר מסלול נתונים מיישר עצמי עבור מערכות‬
‫רבי שעונים‬
]22[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A system and method for aligning an input signal (24) synchronized to a first clock
signal (22) with a second clock signal (26). The invention includes a mechanism (106)
for generating a third clock signal (354) and an arrangement (352) for loading the
input,signal (24) in accordance with the third clock signal (354) and reading out an
output signal in accordance with the second clock signal (26). In an illustrative
embodiment, the invention is used in a sensor system (350) to align detector input data
(24), which is synchronized to a data-capture clock (22), with a signal-processing
September 27, 2011-‫כ"ח באלול התשע"א‬
clock (26). The register (352) acts as a data path transitioning stage between the actual
time the input data is sampled and the time a processing system (102) clocks in the
sampled data.
The applications for division
from this application have
not yet been published
2021/0/
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
170057
,‫שרשרת אורך בינונית של חומצות שומניות‬
‫גלידצרידים ואנלוגים כתמריצים של‬
‫ארית'רופוייסיס‬
]54[
MEDIUM-CHAIN LENGTH FATTY
ACIDS, GLYCERIDES AND
ANALOGUES AS STIMULATORS
OF ERYTHROPOIESIS
]11[
]22[
]52[
].2[
06.02.2004
60/445454
]21[ 07.02.2003
]22[ US
Int. Cl.(2010.01) A61K 31//20, C07C 69//00
PROMETIC BIOSCIENCES INC.,
CANADA
WO/2004/069237
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
Use of a composition comprising a compound of any of formulae I, II, Ila, III and Illa;
or a combination thereof wherein each R1 is independently C7-11 alkyl; A and B are
independently H or CO-R1; R2 is H or C1-4 alkyl; M is a metal monocation (k = 1) or
dication (k = 2); Y is 0 or NH; and Z is 0, NH, CH 2O or a bond; for the manufacture of
a medicament for stimulating erythropoiesis. Preferably, the composition further
comprises human erythroporietin.
]7.[
].4[
]5.[
152
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
170094
‫תהליך לייצור תרכובת ציקלופרופאן פעילה‬
‫ חומרי ביניים ביסוקסאזולין פעילים‬,‫אופטית‬
‫אופטית עבורו והכנתם‬
]54[
PROCESS FOR PRODUCING AN
OPTICALLY ACTIVE
CYCLOPROPANE COMPOUND,
OPTICALLY ACTIVE
BISOXAZOLINE
INTERMEDIATES THEREFOR
AND THEIR PREPARATION
]11[
]22[
04.02.2004
2003-030547 ]21[ 07.02.2003
]22[ JP
1112-227012
2031531112
JP
Int. Cl.(2010.01) C07D 26/3/12, 41/3/06, C07F 01//08
SUMITOMO CHEMICAL
COMPANY, LIMITED., JAPAN
WO/2004/069815
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
Optically active bisoxazoline compounds represented by the general formula (1), a
process for producing the compounds, and a process for producing
cyclopropanecarboxylic esters by using the same: (1) wherein R1 and R2 are the same
and each represent C1-6 alkyl, substituted or unsubstituted aralkyl, or substituted or
unsubstituted phenyl or R1 and R2 together with the carbon atom of oxazoline ring to
which they are bonded form a ring; R3 is substituted or unsubstituted naphthyl; R4 and
R5 are the same and each represent hydrogen or C1-6 alkyl, or R4 and R5 together with
the carbon atom to which they are bonded form a cycloalkyl ring having 3 to 6 carbon
atoms; and * represents an asymmetric center.
]52[
].2[
]7.[
].4[
]5.[
153
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
170114
]54[
PYRIMIDINE DERIVATIVES FOR
THE PREVENTION OF HIV
INFECTION
]11[
]22[
]52[
04.02.2004
PCT/EP03/01291 ]21[ 07.02.2003
]22[ WO
Int. Cl.(2010.01) A61K 31//4192, 31//4196, 31//4245, 31//505, 31//506, 31//5375,
31//54, 31//551, A61P 31//18, C07D 23/9/47, 23/9/48, 40/1/12, 40/1/14, 40/3/12,
40/5/12, 40/9/12, 41/3/12, 41/7/12
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2004/069812
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
].2[
]7.[
].4[
]5.[
HIV ‫תולדות פירימידיניות למניעת זיהום‬
This invention concerns the use of a compound for the manufacture of a medicament
for the prevention of HIV infection via sexual intercourse and related intimate contact
between partners, wherein the compound is a compound of formula (I) a N-oxide, a
pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically
isomeric form thereof, wherein the ring containing -a1=a2-a3=a4- and -b1=b2-b3=b4represents phenyl, pyridyl, pyrimidinyl, pirazinyl, pyridazinyl; and pharmaceutical
compositions comprising them.
__________________
154
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
170138
]54[
PROCESS FOR PREPARING 5[(R)-2-(5,6-DIETHYL-INDAN-2YLAMINO)-1- HYDROXYETHYL]-8-HYDROXY-(1H)QUINOLIN-2-ONE SALT, USEFUL
AS AN ADRENOCEPTOR
AGONIST
]11[
]22[
]52[
].2[
]7.[
].4[
27.02.2004
60/450945
]21[ 28.02.2003
]22[ US
Int. Cl.(2010.01) C07D 21/5/26
NOVARTIS AG, SWITZERLAND
WO/2004/076422
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A process for preparing 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8hydroxy-(1H)-quinolin-2-one salt. The process involves forming an acid salt of 5-[(R)2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-substituted oxy-(1 H)-quinolin-2one (V); and converting the acid salt to a salt of 5-[(R)-2-(5,6-diethyl-indan-2ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1H)-quinolin-2-one (VI) without isolating the
free base of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1H)quinolin-2-one. Formula (A); (V): R = a protecting group, (VI): R = H.
]5.[
–R) – 2–( 5 , 6([ – 5 ‫תהליך להכנת מלח‬
–‫–הידרוקסי‬8–)‫–אילאמינו‬2–‫דיאתיל–אינדן‬
,‫ – און‬2–‫ )– קוינולינ‬H 8(–‫–הידרוקסי‬1–]‫אתיל‬
‫המשתמש כאגוניסט של אדרנוצפטור‬
__________________
]22[]12[
170607
‫רפליקונים של אלפא וירוס ומבנים מסייעים‬
]54[
ALPHAVIRUS REPLICONS AND
HELPER CONSTRUCTS
]11[
]22[
]52[
].2[
]7.[
].4[
19.03.2004
60/456196
]21[ 20.03.2003
]22[ US
Int. Cl.(2010.01) A61K 35//76, C07K 14//18, C12N 15//86
ALPHAVAX, INC., U.S.A.
WO/2004/085660
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
155
,‫ד"ר יצחק הס ושותפיו‬
516 ‫רחוב הירקון‬
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
The present invention provides a recombinant nucleic acid comprising: a first nucleic
acid sequence encoding a 5' alphavirus replication recognition sequence; at least one
second nucleic acid sequence encoding an alphavirus nonstructural protein; at least
one alphavirus subgenomic promoter; at least one IRES element; at least one
heterologous nucleic acid; and a third nucleic acid encoding a 3' alphavirus replication
recognition sequence. Further provided are methods of making alphavirus particles
comprising a recombinant nucleic acid of this invention and methods of using the
compositions of this invention. Also provided is a recombinant helper nucleic acid
comprising: a first nucleic acid sequence encoding a 5' alphavirus replication
recognition sequence; an alphavirus subgenomic promoter; an IRES element; a second
nucleic acid encoding an alphavirus structural protein; and a third nucleic acid
encoding a 3' alphavirus replication recognition sequence.
__________________
]22[]12[
]54[
IMAGING SYSTEM FOR
REDUCING REFLECTIONS FROM
A DETECTOR
]11[
]22[
]52[
].2[
]7.[
].4[
31.03.2004
60/459417
]21[ 31.03.2003
Int. Cl.(2010.01) G02B 05//28
CDM OPTICS, INC., U.S.A.
WO/2004/090581
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
156
170697
‫מערכת הדמיה להורדת החזרים מגלאי‬
]22[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
An imaging system for reducing reflections from a detector, comprising: optics for imaging
electromagnetic energy to the detector, the optics comprising a wavefront coding element
for modifying phase of a wavefront imaged to the detector; tilt optics having a tilt surface
that tilts away from a plane perpendicular to the imaged electromagnetic energy, for
reflecting back-scattered electromagnetic radiation to an aperture stop of the imaging
system; and a post processor for reducing distortion effects introduced by the reflections.
The applications for division from this
application have not yet been published
, 208545
‫בקשות חלוקה מבקשה‬
9‫זו שטרם פורסמו‬
__________________
]54[
]11[
]22[
]52[
].2[
].1[
157
]22[]12[
COMPOUNDS USEFUL FOR
TREATING METABOLIC
DISORDERS AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
SAME
171269
‫תרכובות המשמשות לטיפול במחלות מטבוליות‬
‫ותכשירים תרופתיים המכילים אותן‬
08.04.2004
60/462960
]21[ 15.04.2003
]22[ US
Int. Cl.(2010.01) A61K 31//195, 31//21, 31//216, A61P 03//10, 07//12, 09//10, C07C
21/7/66, 59//58, 65//21, 69//67, 69//76
WELLSTAT THERAPEUTICS
CORPORATION, U.S.A.
REID W. VON BORSTEL, SHALINI
SHARMA, KIRVIN L. HODGE,
STEPHEN D. WOLPE
September 27, 2011-‫כ"ח באלול התשע"א‬
]7.[
].4[
]5.[
WO/2004/091486
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
Agents useful for the treatment of various metabolic disorders, such as insulin
resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity,
atherosclerosis and arteriosclerosis are disclosed. Wherein n is 1 or 2; m is 0, 1, 2, 3 or
4; q is 0 or 1; t is 0 or 1; R2 is alkyl having from 1 to 3 carbon atoms; R3 is hydrogen,
halo, alkyl having from 1 to 3 carbon atoms, or alkoxy having from 1 to 3 carbon
atoms; A is phenyl, unsubstituted or substituted by 1 or 2 groups selected from: halo,
alkyl having 1 or 2 carbon atoms, perfluoromethyl, alkoxy having 1 or 2 carbon atoms,
and perfluoromethoxy; or cycloalkyl having from 3 to 6 ring carbon atoms wherein the
cycloalkyl is unsubstituted or one or two ring carbons are independently monosubstituted by methyl or ethyl; or a 5 or 6 membered heteroaromatic ring having 1 or 2
ring heteroatoms selected from N, S and 0 and the heteroaromatic ring is covalently
bound to the remainder of the compound of formula I by a ring carbon; and R 1 is
hydrogen or alkyl having 1 or 2 carbon atoms, provided that when m is 0 or 1, R 1 is
not hydrogen. Alternatively, when R1 is hydrogen, the biologically active agent can be
a pharmaceutically acceptable salt of the compound of Formula I.
__________________
]22[]12[
171315
‫גלאי קרינה‬
]54[
RADIATION DETECTOR
]11[
]22[
]52[
].2[
09.04.2004
2003-108337 ]21[ 11.04.2003
]22[ JP
Int. Cl.(2010.01) H01L 27//14, 27//146, 31//09
HAMAMATSU PHOTONICS K.K.,
JAPAN
KATSUMI SHIBAYAMA, YUTAKA
KUSUYAMA, MASAHIRO
HAYASHI
WO/2004/093194
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A radioactive ray detector includes: a radio active ray detection section (1) consisting
of a scintillator (10) and a PD array (15); signal processing elements (30, 32) for
processing a detection signal output from the PD array (15); and a wiring board section
(2) arranged between the radioactive ray detection section (1) and the signal
].1[
]7.[
].4[
]5.[
158
September 27, 2011-‫כ"ח באלול התשע"א‬
processing elements (30, 32). The wiring board section (2) has a wiring board (20)
made of glass material having the radioactive ray cut-off function and having a
conductive member (21) arranged in a through hole (20c) so as to serve as a
conductive path for conducting the detection signal. The signal processing elements
(30, 32) of the signal processing section (3) located at the downstream side of the
wiring board (20) with respect to the through hole (20c) of the wiring board (20) are
arranged while being shifted into an area other than the area on the extension of the
through hole (20c), so that the signal processing elements (30, 32) cannot be viewed
from the through hole (20c). This realizes a radioactive ray detector capable of
suppressing incoming of radiation to the signal processing means located at the
downstream side of the wiring board.
__________________
]22[]12[
171486
‫מיקרובולומטר ספקטרוסקופי משולב בעל‬
‫מערכים של מיקרו–מסננים‬
]54[
INTEGRATED SPECTROSCOPIC
MICROBOLOMETER WITH
MICROFILTER ARRAYS
]11[
]22[
]52[
].2[
]7.[
].4[
06.04.2004
10/421477
]21[ 22.04.2003
]22[ US
Int. Cl.(2010.01) G01J 05//20
RAYTHEON COMPANY, U.S.A.
WO/2004/094969
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method for forming an integrated circuit includes providing an array of detectors
proximate an outer surface of a first substrate layer. The array of detectors operate to
detect the presence or absence of one or more wavelengths within a spectrum of
transmitted energy. One or more filters are provided proximate a second substrate
layer. The one or more filters operate to affect the spectrum of transmitted energy
through the one or more filters. The second substrate layer is proximate to the outer
surface of the first substrate layer to enclose the array of detectors in a vacuum
environment.
]5.[
159
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
172499
‫שיטה לייצור תאי עצב של הרשתית מתאי גזע‬
‫עצביים הנוצרים מרקמת קשתית ותאי עצב של‬
‫הרשתית המיוצרים לפי השיטה‬
]54[
METHOD FOR PRODUCING
RETINAL NERVE CELLS FROM
STEM/PROGENITOR CELLS
DERIVED FROM IRIS TISSUE
AND RETINAL NERVE CELLS
OBTAINED BY SAME METHOD
]11[
]22[
]52[
].2[
11.06.2004
2003-166646 ]21[ 11.06.2003
]22[ JP
Int. Cl.(2010.01) C12N 05//071
JAPAN SCIENCE AND
TECHNOLOGY AGENCY, JAPAN
MITSUKO KOSAKA
WO/2004/111213
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A process for producing retinal neurocytes, comprising conducting differentiation
induction of iris pigmented epithelial cells into retinal neurocytes. The first process
comprises co-culturing iris pigmented epithelial cells derived from a mammal and
embryo retinal stem cells derived from a bird. The second process comprises isolating
iris pigmented epithelial cells of a bird, a mammal, etc. and subjecting the iris
pigmented epithelial cells to stationary culture. In these processes, retinal neurocytes
can be produced with the use of iris pigmented epithelial cells collected from a patient
per se, so that realization of highly effective regenerative medicine is promising.
].1[
]7.[
].4[
]5.[
160
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
172532
‫מערכת לתקשורת עם התקן אלקטרוני בתוך כלי‬
‫חתום‬
]54[
SYSTEM FOR COMMUNICATING
WITH ELECTRONIC DEVICE
WITHIN A SEALED VESSEL
]11[
]22[
]52[
].2[
]7.[
].4[
16.06.2004
60/482826
]21[ 26.06.2003
]22[ US
Int. Cl.(2010.01) H05K 01//18
FORMATION, INC., U.S.A.
WO/2005/002121
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A system for communicating with an electronic device (12) within a sealed vessel (26)
comprises a generally enclosed housing having an opening. A printed circuit board
(24) is provided for covering the housing opening to create a fully enclosed sealed
vessel (26). An electronic device (12) is located within the interior of the sealed vessel
(26) and an external device (10) is located outside the sealed vessel (26). At least one
conductive path (30) comprised of at least one conductive trace (42) and at least one
conductive via (56) extends through the printed circuit board (24) from the first surface
located on the outside of the sealed vessel (26) to a second surface located on the
inside of the sealed vessel (26). The conductive path (30) has a first end on the first
surface which is connected to the external device (10) and a second end on the second
surface which is connected to the electronic device (12). In this manner, a
communication path is established between the external device (10) and the electronic
device (12) within the interior of the sealed vessel (26) utilizing the at least one
conductive path (30).
]5.[
__________________
]22[]12[
]54[
THROUGH-THE EARTH RADIO
]11[
]22[
08.06.2004
60/483146
]21[ 26.06.2003
216.23410
1132231112
Int. Cl.(2010.01) H04B 13//02
THE REGENTS OF THE
]52[
].2[
161
172827
‫רדיו דרך האדמה‬
]22[
US
US
September 27, 2011-‫כ"ח באלול התשע"א‬
]7.[
].4[
]5.[
UNIVERSITY OF CALIFORNIA,
U.S.A.
WO/2005/002066
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method and apparatus for effective through-the-earth communication involves a
signal input device connected to a transmitter operating at a predetermined frequency
sufficiently low to effectively penetrate useful distances through-the earth, and having
an analog to digital converter receiving the signal input and passing the signal input to
a data compression circuit that is connected to an encoding processor, the encoding
processor output being provided to a digital to analog converter. An amplifier receives
the analog output from the digital to analog converter for amplifying said analog
output and outputting said analog output to an antenna. A receiver having an antenna
receives the analog output passes the analog signal to a band pass filter whose output is
connected to an analog to digital converter that provides a digital signal to a decoding
processor whose output is connected to an data decompressor, the data decompressor
providing a decompressed digital signal to a digital to analog converter. An audio
output device receives the analog output form the digital to analog converter for
producing audible output.
__________________
]22[]12[
172923
]54[
PYRROLO [3,4-C] PYRAZOLE
DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]11[
]22[
]52[
].2[
08.07.2004
60/485814
]21[ 09.07.2003
]22[ US
Int. Cl.(2010.01) A61K 31//4162, A61P 35//00, C07D 48/7/04
NERVIANO MEDICAL SCIENCES
162
‫] פיראזול ותכשירים‬c– 4 ,3[‫נגזרות פירולו‬
‫רפואיים המכילים אותן‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]7.[
].4[
]5.[
S.R.L., ITALY
WO/2005/005427
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Pyrrolo[3,4-c]pyrazole derivatives of formula (1) and pharmaceutically acceptable
salts thereof, as defined in the specification, process for their preparation and
pharmaceutical compositions comprising them are disclosed; the compounds of the
invention may be useful, in therapy, in the treatment of diseases associated with a
disregulated protein kinase activity, like cancer.
__________________
]22[]12[
173077
‫הרכבים הידרופוביים ושיטה להכנתם‬
]54[
HYDROPHOBIC COMPOSITES
AND METHOD FOR THEIR
PREPARATION
]11[
]22[
14.07.2004
60/486420
]21[ 14.07.2003
]22[
016470423
2431.31112
25.42.
2.31731112
Int. Cl.(2010.01) B01J 13//02, C09K 03//18
SUPERSEAL LTD.
WO/2005/005566
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
].2[
]7.[
].4[
]5.[
US
US
IL
‫ כפר שמריהו‬,‫סופרסיל בע"מ‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Novel hydrophobic composites, particularly hydrophobic particulates and free-flowing
hydrophobic aggregates and methods utilizing same are disclosed.
__________________
]22[]12[
]54[
163
PPAR ACTIVE COMPOUNDS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
173079
‫ תכשירים רוקחיים‬,PPAR ‫תרכובות פעילות‬
‫המכילים אותן ושימושים בהם להכנת תרופות‬
September 27, 2011-‫כ"ח באלול התשע"א‬
THEM AND USES THEREOF FOR
PREPARING MEDICAMENTS
]11[
]22[
]52[
].2[
]7.[
].4[
]5.[
16.07.2004
60/488523
]21[ 17.07.2003
]22[ US
016551334
2131231114
US
Int. Cl.(2010.01) A61K 31//404, 31//437, A61P 01//00, 03//04, 03//06, 03//10, 09//00,
09//10, 09//12, 13//12, 17//00, 17//06, 25//02, 27//02, 27//12, C07D 20/9/30, 40/1/12,
40/5/12, 40/9/12, 47/1/04
PLEXXIKON, INC., U.S.A.
WO/2005/009958
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
Compounds are described that are active on PPARs, including pan-active compounds.
Also described are methods for developing or identifying compounds having a desired
selectivity profile.
__________________
]22[]12[
173152
‫מערכת לאספקת הורמונים דרך העור ושיטה‬
‫לייצורה‬
]54[
TRANSDERMAL HORMONE
DELIVERY SYSTEM AND
METHOD FOR ITS
MANUFACTURE
]11[
]22[
]52[
].2[
19.07.2004
10/621711
]21[ 17.07.2003
]22[
Int. Cl.(2010.01) A61F 13//00, A61K 31//57
AGILE THERAPEUTICS, INC.,
U.S.A.
WO/2005/002482
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]7.[
].4[
]5.[
164
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A transdermal hormone delivery system (THDS) is disclosed. The THDS is useful for
control of fertility and as therapy for a variety of diseases and conditions treatable by
robust delivery of progestin and estrogen hormones, particularly the progestin,
levonorgestrel. The THDS comprises a backing layer, an adjoining adhesive polymer
matrix comprising an effective amount of at least a progestin hormone, delivery of
which is enhanced by one or more skin permeation enhancing agents present in preSeptember 27, 2011-‫כ"ח באלול התשע"א‬
determined amounts. The THDS is capable of providing effective daily doses of
progestin and estrogen hormones from a small surface area in contact with the skin,
e.g., less than 20 square centimeters. Methods of fertility control and various types of
hormone replacement therapy utilizing the THDS are also disclosed.
__________________
]22[]12[
173229
‫שיטה לקביעת ייחוס על ידי שימוש בחתימות‬
)SSK( ‫ויסות של מפתח היסט מרחבי‬
]54[
METHOD FOR DETERMINING
ATTITUDE USING SPATIAL
SHIFT KEY (SSK) MODULATION
SIGNATURES
]11[
]22[
]52[
].2[
].1[
]7.[
].4[
03.08.2004
2003904046
]21[ 04.08.2003
]22[ AU
Int. Cl.(2010.01) G01S 05//02
LOCATA CORPORATION, U.S.A.
DAVID SMALL
WO/2005/012934
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM ST.
21 ‫רחוב אחד העם‬
P.O.B. 2499
‫תל אביב‬5466 .‫ד‬.‫ ת‬,
TEL AVIV 65202
An attitude system that includes a radiating means which moves predeterminately
through three-dimensional space, such that a cyclic Doppler is superimposed upon a
transmitted signal; receiving this transmitted signal through a receiving means which
moves predeterminately through three-dimensional space, such that a cyclic Doppler is
superimposed upon the received signal; analyzing the movement of the receive means
in relation to the radiating means by interpreting the received cyclic Doppler; and
determining attitude based on the interpreted Doppler. Or alternatively, adjusting the
movement of the receive means in three-dimensional space so the superimposed cyclic
Doppler is minimized on the received signal and; determining attitude based on the
adjustment required to bring the receive means and radiating means into an alignment.
]5.[
165
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
173343
‫ תכשירים פרמצבטיים‬,‫תרכובות פיפרידין‬
‫המכילים אותן ושימושן בייצור תרופות לטיפול‬
‫או מניעה של מחלות בבעלי–חיים‬
]54[
PIPERIDINE COMPOUNDS AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND USE THEREOF IN
THE MANUFACTURE OF A
MEDICAMENT FOR TREATING
OR PREVENTING DISEASES IN
ANIMALS
]11[
]22[
]52[
23.07.2004
60/489515
]21[ 24.07.2003
]22[ US
Int. Cl.(2010.01) A61K 31//4523, 31//4545, A61P 29//00, C07D 40/1/04, 41/3/12,
41/7/14
EURO-CELTIQUE S.A.,
LUXEMBOURG
WO/2005/009987
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Piperidine compounds; compositions comprising a piperidine compound; and methods
for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder,
Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic
condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function,
Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle
spasm, a migraine, vomiting, dyskinesia ,or depression in an animal comprising
administering to an animal in need thereof an effective amount of a Piperidine
Compounds are disclosed. In an embodiment, the piperidine compound has the
formula (I): and pharmaceutically acceptable salts thereof, wherein Ar ,2Ar ,1X, R ,2
R ,4and m are as disclosed herein3
].2[
]7.[
].4[
]5.[
166
September 27, 2011-‫כ"ח באלול התשע"א‬
2061111
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
173344
]54[
N-SUBSTITUTED-4HETEROARYLTETRAHYDROPIPERIDYL
COMPOUNDS USEFUL FOR
TREATING OR PREVENTING
PAIN AND PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME
]11[
]22[
]52[
23.07.2004
60/489516
]21[ 24.07.2003
]22[ US
Int. Cl.(2010.01) A61K 31//4545, A61P 13//00, 29//00, C07D 40/1/04, 40/1/14,
41/3/04, 41/3/14, 41/7/04, 41/7/14
EURO-CELTIQUE S.A.,
LUXEMBOURG
WO/2005/009988
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
A compound of formula (I): where Ar1, Ar2, X, R3, and m are as disclosed herein or a
pharmaceutically acceptable salt thereof (a 'Tetrahydropiperidyl Compound');
compositions comprising an effective amount of a Tetrahydropiperidyl Compound;
and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive
disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a
pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain
function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a
muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal
comprising administering to an animal in need thereof an effective amount of a
Tetrahydropiperidyl Compound are disclosed herein.
].2[
]7.[
].4[
]5.[
167
–‫–הטרואריל‬4–‫– מותמרות‬N ‫תרכובת‬
‫טטרהידרופיפרידיל והשימושיות לטיפול או‬
‫מניעת כאב והרכבים רוקחיים הכוללים אותן‬
September 27, 2011-‫כ"ח באלול התשע"א‬
The applications for division
from this application have
not yet been published
20211/0
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
173522
‫ תהליכים‬,‫נגזרות של חומצה פנוקסיאצטית‬
‫ תכשירים רפואיים המכילים אותן‬,‫להכנתן‬
‫ושימושן בהכנת תרופות‬
]54[
PHENOXYACETIC ACID
DERIVATIVES, PROCESSES FOR
THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USES THEREOF IN
THE PREPARATION OF
MEDICAMENTS
]11[
]22[
18.08.2004
0302281-1
]21[ 21.08.2003
]22[ SE
142144732
1431031114
GB
Int. Cl.(2010.01) A61K 31//192, 31//44, 31//47, 31//505, A61P 11//06, C07C 20/5/38,
25/5/54, 31/1/08, 31/1/29, 31/7/22, 31/7/36, 32/3/60, 32/3/65, 32/3/67, C07D 21/3/70,
21/5/20, 21/5/36, 23/9/34
ASTRAZENECA AB, SWEDEN
ROGER VICTOR BONNERT, ANIL
PATEL, STEPHEN THOM
WO/2005/018529
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to certain 2-substituted phenoxyacetic acid derivatives of formula
(I), in which the variables are as defined in the claims, useful in the treatment of
diseases or conditions in which modulation of the CRTh2 receptor is beneficial, such
as asthma and rhinitis.
]52[
].2[
].1[
]7.[
].4[
]5.[
168
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
]54[
MAPPING OF A FILE SYSTEM
MODEL TO A DATABASE
OBJECT
]11[
]22[
]52[
].2[
01.03.2006
11/091079
]21[ 28.03.2005
Int. Cl.(2010.01) G06F 17//30
MICROSOFT CORPORATION,
U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
].4[
]5.[
174023
‫מיפוי מודל של מערכת קבצים למערכת נתונים‬
]22[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The subject invention provides a system and/or a method that facilitates mapping a
data base model to a database object. A type storage system can utilize a storage
mapping of a file storage data model. The mapping can describe the database object
created based at least in part upon a schema and how instances of the type described in
the schema are stored and/or accessed. Furthermore, a query can be provided to find at
least one of an item, a document, and/or a contact that satisfy at least one criterion. The
type storage system can receive data, wherein the data is at least one of a schema, a
data model, a type, a query, and query criteria via an interface to provide the storing
and querying. Additionally, the type storage system can generate a view that exposes
at least one instance of the type.
__________________
]22[]12[
]54[
169
COATING COMPOSITIONS
COMPRISING A FRAGMENT OF A
BIOLOGICAL CELL OR VIRUS,
SURFACES COATED THEREWITH
AND METHODS FOR MAKING AND
UTILIZING SUCH COATING
COMPOSITIONS
174122
‫תכשירי ציפוי המכילים מקטע ביולוגי או‬
‫ משטחים מצופים בהם ושיטות ליצור‬, ‫וירוס‬
‫ושימוש של תכשירי הציפוי‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]11[
]22[
]52[
].2[
]7.[
].4[
]5.[
08.03.2004
10/655345
]21[ 04.09.2003
Int. Cl.(2010.01) C09D 05//16
C. STEVEN MCDANIEL, U.S.A.
WO/2005/026269
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]22[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Disclosed herein are novel paints and coatings comprising a cell-based particulate
material. Specifically disclosed herein is cell-based particulate material prepared from
microorganisms for use as a coating component. Also disclosed herein are methods of
preparing a coating that comprises a cell-based particulate material.
The applications for
division from this
application have not yet
been published
20210/020210/220210/620210002021001
‫בקשות חלוקה מבקשה‬
9‫זו שטרם פורסמו‬
__________________
]22[]12[
174212
‫ בעלי‬,‫ מסיסים וממיסים‬,‫תכשירי דשן מוצקים‬
‫זרימה חופשית והכנתם‬
]54[
SOLUBLE AND SOLUBILIZING,
FREE-FLOWING, SOLID
FERTILIZER COMPOSITIONS
AND THE PREPARATION
THEREOF
]11[
]52[
].2[
].1[
09.03.2006
Int. Cl.(2010.01) C05B 21//00
ROTEM AMFERT NEGEV LTD.
‫רותם אמפרט נגב בע"מ‬
ALEXANDER JOSEF, YAAKOV
‫ יאיר יגיל‬,‫ יעקב אורן‬,‫אלכסנדר יוסף‬
OREN, YAIR YAGIL
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A solid, free-flowing, particulate fertilizer composition containing from about 35% wt
to about 41% wt of phosphoric acid (PA), from about 59 wt% to about 65 wt% of
monopotassium phosphate (MKP), and from 0.1 to 0.6 wt% of water.
].4[
]5.[
__________________
170
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
174372
‫שימוש במעכבים של גלוטמיניל ציקלאז להכנת‬
‫ של חומצה‬N ‫תרופה לעיכוב היפוך קצה‬
‫גלוטאמית או שייר גלוטאמין לשייר חומצה‬
‫פירוגלוטאמית‬
]54[
USE OF INHIBITORS OF
EFFECTORS OF GLUTAMINYL
CYCLASE IN THE
MANUFACTURE OF A
MEDICAMENT FOR INHIBITING
THE CONVERSION OF NTERMINAL GLUTAMIC ACID OR
GLUTAMINE RESIDUE TO
PYROGLUTAMIC ACID RESIDUE
]11[
]22[
]52[
].2[
]7.[
].4[
15.10.2004
60/512038
]21[ 15.10.2003
]22[ US
Int. Cl.(2010.01) A61K 31//10, 31//131, 31//4164, 31//4168, 31//4178, A61P 25//28
PROBIODRUG AG, GERMANY
WO/2005/039548
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]5.[
The present invention provides novel physiological substrates of mammalian
glutaminyl cyclase (QC, EC 2.3.2.5), new effectors of QC and the use of such effectors
and pharmaceutical compositions comprising such effectors for the treatment of
diseases that can be treated by modulation of QC-activity, e.g. diseases selected from
the group consisting of duodenal cancer with or w/o Heliobacter pylori infections,
colorectal cancer, Zolliger-Ellison syndrome, Familial British Dementia and Familial
Danish Dementia.
__________________
]22[]12[
174723
‫הגבלת פעולה התקפית של כלי שיט בלתי מאויש‬
]54[
RESTRICTING UNSUPERVISED
ACTIVITY OF UNMANNED
VESSELS
]11[
]52[
].2[
02.04.2006
Int. Cl.(2010.01) B63H 23//00, G05D 01//00, H04L 12//66
RAFAEL ADVANCED DEFENSE
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
SYSTEMS LTD.
‫חיפה‬
171
September 27, 2011-‫כ"ח באלול התשע"א‬
].1[
].4[
]5.[
‫ אייל וולד‬,‫ ליאור חדג'ג‬,‫יהודה יוספי‬
YEHUDA YOSEFI, LIOR ADJADI,
EYAL WALD
DR. YORAM TSIVION,
2 HATOCHEN ST.
P.O.B. 3148,
CAESAREA 38900
,‫ד"ר יורם צביון‬
‫ פארק התעשיה‬,5 ‫רח' הטוחן‬
‫קיסריה‬2141 .‫ד‬.‫ ת‬,
A process for balancing the execution of hazardous activity carried out in connection
with an unmanned boat which is remotely controlled by two independent wireless
communications channels. The process includes receiving signals from both
communications channels. Subsequently, data is extracted from the two signals. After
confirming the presence of two respective messages, one from each channel, a
command is executed relating to safety issues, relating to the execution of the
hazardous activity.
__________________
]22[]12[
174803
‫תרכובות פרמצבטיות עמידות בפני נזילות‬
‫המכילות חימר‬
]54[
SPILL RESISTANT
FORMULATIONS CONTAINING
CLAYS
]11[
]22[
]52[
].2[
28.10.2004
60/514999
]21[ 28.10.2003
]22[ US
Int. Cl.(2010.01) A61K 09//00, 09//08, 35//06
TARO PHARMACEUTICALS U.S.A.
INC., U.S.A.
WO/2005/041876
OSNAT BAR PELED, TARO
,‫ תרו תעשיה רוקחית בע"מ‬,‫אסנת בר פלד‬
PHARMACEUTICAL INDUSTRIES
‫ יקום‬,‫ בית איטליה‬,‫יורו פארק‬
LTD.,
‫קיבוץ יקום‬
YAKUM 60972
The invention relates to novel spill resistant formulations comprising either a weak
base or a weak acid as the pharmaceutical ingredient, a liquid base, a clay and a water
soluble cellulose ether. The clay and cellulose ether allow for a broader pH range into
which the pharmaceutically active agent may be dispersed or dissolved, and therefore
allows for easier preparation and formulation of the pharmaceutical composition.
]7.[
].4[
]5.[
__________________
172
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
174819
‫שער מסוף נייד‬
]54[
MOBILE-TERMINAL GATEWAY
]11[
]22[
08.10.2004
60/510558
]21[ 10.10.2003
]22[ US
0165215.7
2132131112
US
21675.211
1.31531114
US
21675.511
1.31531114
US
Int. Cl.(2010.01) H04L 12//28, 12//56, H04W 74//00, 88//00
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL), SWEDEN
WO/2005/046271
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A mobile terminal includes an access subsystem and an application subsystem. The
access subsystem includes at least one access-technology interface. The application
subsystem is inter-operably connected to the access subsystem. The application
subsystem and the access subsystem are separated via a functional split. The access
subsystem provides access by the application subsystem to a first wireless network via
a first access-technology interface of the at least one access-technology interface.
]52[
].2[
]7.[
].4[
]5.[
__________________
]22[]12[
174860
]54[
METHOD FOR PREPARATION
OF CRYSTALLINE
PERINDOPRIL ERBUMINE
]11[
]52[
].2[
21.10.2003
Int. Cl.(2010.01) C07D 20/9/42, C07K 05//062
LES LABORATOIRES SERVIER,
FRANCE
173
‫שיטה להכנת פרינדופריל ארבומין גבישי‬
September 27, 2011-‫כ"ח באלול התשע"א‬
].1[
]7.[
].4[
]5.[
GIRIJ PAL SINGH, HIMANSHU
MADHAV GODBOLE, SAGAR
PURUSHOTTAM NEHATE
WO/2005/037788
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A process for preparation of crystalline perindopril erbumine of formula (II) which
exhibits the X-ray (powder) diffraction pattern like that shown in the figure. The
process comprises reacting a solution of perindopril of formula (I), in a solvent
selected from N, N-dimethylformamide or dimethyl acetals of lower aliphatic
aldehydes and ketones with tertiary butylamine and crystallization of the erbumine salt
thus obtained by heating the reaction mixture to reflux, filtering hot, cooling gradually
to 20 ºC to 30 ºC, and further cooling to 0º C to 15 ºC for 30 minutes to 1 hour and
finally filtering off and drying the crystals.
__________________
]22[]12[
175011
‫מצעים מחוללים ללא גרעינים ושיטה ליצורם‬
]54[
CORELESS CAVITY
SUBSTRATES FOR CHIP
PACKAGING AND THEIR
FABRICATION
]11[
]52[
].2[
].1[
].4[
20.04.2006
Int. Cl.(2010.01) H01L 21//48
AMITECH LTD.
‫ מגדל העמק‬,‫עמיטק בע"מ‬
DROR HURWITZ
‫דרור הורביץ‬
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A method for fabricating an IC support for supporting a first IC die connected in series
]5.[
174
September 27, 2011-‫כ"ח באלול התשע"א‬
with a second IC die; the IC support comprising a stack of alternating layers of copper
features and vias in insulating surround, the first IC die being bondable onto the IC
support ,and the second IC die being bondable within a cavity inside the IC support,
wherein the cavity is formed by etching away a copper base and selectively etching
away built up copper.
The applications for
division from this
application have not yet
been published
202//62
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
175065
‫ תכשירים‬,‫ תהליכים להכנתן‬,‫תולדות אמיד‬
‫רוקחיים הכוללים אותן ושימושן בהכנת תרופות‬
‫לטיפול במחלות המתווכות על ידי ציטוקינים‬
]54[
AMIDE DERIVATIVES, PROCESS
FOR THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND THEIR USE IN THE
PREPARATION OF
MEDICAMENTS FOR THE
TREATMENT OF DISEASES
MEDIATED BY CYTOKINES
]11[
]22[
]52[
22.10.2004
0324790.5
]21[ 24.10.2003
]22[ GB
Int. Cl.(2010.01) A61K 31//495, 31//513, 31//5375, 31//541, 31//5513, A61P 09//10,
11//00, 17//06, 31//00, C07D 23/9/91, 40/1/00, 40/3/10, 40/3/12, 41/3/12, 41/7/10
ASTRAZENECA AB, SWEDEN
DEARG SUTHERLAND BROWN,
IAN ALUN NASH
WO/2005/042502
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention concerns a compound of the Formula (I) wherein m is 0-2 and each R1 is
a group such as hydroxy, halogeno, trifluoromethyl heterocyclyl and heterocyclyloxy;
R2 is halogeno, trifluoromethyl or (1-6C)alkyl; R3 is hydrogen, halogeno or (16C)alkyl; and R4 is (3-6C)cycloalkyl;or pharmaceutically-acceptable salts thereof;
processes for their preparation, pharmaceutical compositions containing them and their
use in the treatment of diseases or medical condions mediated by cytokines.
].2[
].1[
]7.[
].4[
]5.[
175
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
175429
‫מיכל למזרק אוטומטי לתרופה ומזרק אוטומטי‬
‫המותאם לו‬
]54[
CONTAINER FOR MEDICAMENT
AUTOMATIC INJECTOR AND
AUTOMATIC INJECTOR
ADAPTED THEREFOR
]11[
]22[
03.11.2004
60/516733
]21[ 04.11.2003
]22[ US
01652.321
1.32231112
US
Int. Cl.(2010.01) A61M 05//00, 05//20, 05//32
MERIDIAN MEDICAL
TECHNOLOGIES, INC., U.S.A.
WO/2005/046765
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Containers (10) for automatic injectors and automatic injectors adapted for those
containers are disclosed. The containers include structures adapted to retain and,
optionally, cripple the needle of the automatic injector when the automatic injector is
inserted into the container after use. Depending on the embodiment, an indicator (80)
may be included, either as part of the container or as part of the automatic injector, to
indicate whether or not the automatic injector has been used. If the indicator is
provided as a part of the automatic injector, a corresponding portion of the container
may be formed of a light permeable material. The container may also include features,
such as an eyelet over the closed end, designed to cushion the automatic injector.
Cushioning and shock absorbing features may also be provided inside the container. A
clip is also disclosed. The clip is designed to attach two or more containers together.
]52[
].2[
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
176
METHOD AND SYSTEM FOR
175450
‫שיטה ומערכת לבדיקות לא פולשניות בגוף‬
September 27, 2011-‫כ"ח באלול התשע"א‬
‫האדם‬
NON-INVASIVE MEASUREMENTS
IN A HUMAN BODY
]11[
]22[
]52[
].2[
]7.[
].4[
04.11.2004
10/702044
]21[ 06.11.2003
Int. Cl.(2010.01) A61B 05//00
ORSENSE LTD.
WO/2005/045377
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
A method and system are presented for use in non-invasive measurements in a patient's
body. A condition of artificial blood kinetics is created at a measurement location in a
patient's blood perfused fleshy medium, and this condition is maintained for a certain
time period. An external electromagnetic field is applied to the measurement location
while under the condition of artificial blood kinetics. A time variation of a response of
the blood perfused fleshy medium to this external electromagnetic field is detected,
and measured data indicative thereof is generated. The response of the medium can be
a photo-acoustic signal obtained in response to incident light, and/or impedance of the
medium in response to the applied ac electromagnetic field.
]22[
US
‫ציונה‬-‫ נס‬,‫אורסנס בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
SAMPLE COLLECTION CUP
WITH INTEGRATED
ACTIVATABLE SAMPLE
ANALYSIS SYSTEM
]11[
]22[
]52[
].2[
15.11.2004
60/519907
]21[ 14.11.2003
Int. Cl.(2010.01) G01N 31//22
ALERE SWITZERLAND GMBH,
177
175629
‫ספלון לאיסוף דגימות עם מערכת אינטגראלית‬
‫לביצוע אנליזה של הדגימות‬
]22[
US
September 27, 2011-‫כ"ח באלול התשע"א‬
].1[
]7.[
].4[
]5.[
SWITZERLAND
YUZHANG WU, LIJIAN GUO,
JIELIN DAI, HSIAOHO EDWARD
TUNG
WO/2005/050169
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
Medical and environmental diagnostic devices are described and claimed. Preferred
embodiments feature cup (1) within cup configurations wherein one cup is dedicated,
for the most part, to sample collection and another cup (2) is dedicated, for the most
part, to assay performance. Communication between the cups is afforded by what is
believed to be a unique valve assembly (3) and lid (7) tandem.
__________________
]22[]12[
]54[
APPARATUS FOR GRINDING
FACETS ON GIRDLES OF
ROUND GEMSTONES AND
METHOD
]11[
]52[
].2[
].4[
14.05.2006
Int. Cl.(2010.01) B24D 03//00
B. VARTICOVSCHI LTD.
DANIEL FREIMANN & CO.,
5 DROYANOV ST., 10TH FLOOR ,
TEL AVIV 63143
]5.[
178
175631
‫מתקן ושיטה לליטוש משטחים על החגורה של‬
‫אבני–חן עגולות‬
‫ תל אביב‬,‫ ורטיקובסקי בע"מ‬.‫ב‬
,'‫דניאל פריימן ושות‬
10 ‫ בית כלל קומה‬5 ‫דרויאנוב‬
‫תל אביב‬
An apparatus for grinding facets around the girdle of brilliant cut gemstones
comprising:
(a) a gemstone holder;
(b) a motor driven grinding wheel;
(c) first means for displacing the grinding wheel towards and away from the rim of the
September 27, 2011-‫כ"ח באלול התשע"א‬
gemstone girdle;
(d) second means for sensing torque increase of the wheel motor resulting from
friction between the girdle and the wheel;
(e) third means for activating the first means to discontinue the displacement of the
grinding wheel towards the gemstone for a pre-set time following sensing by the
second means a predetermined increase of the wheel motor torque;
(f) fourth means for activating the first means to displace the grinding wheel from the
gemstone; and
(g) fifth means for indexing the gemstone stepwisely by any given angle.
__________________
]22[]12[
175795
‫מחיצות מעכבות אש‬
]54[
FIRE RETARDANT SHADES
]11[
]22[
]52[
].2[
].1[
29.11.2004
10/729587
]21[ 06.12.2003
]22[ US
Int. Cl.(2010.01) A47H 23//08, B32B 07//12, 27//08, 27//36, 33//00, E06B 09//24
CPFILMS INC., U.S.A.
THIMOTHY M. SHIVELY, ARNIM
OTTOKAR BOTHE
WO/2005/054616
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A fire retardant solar control sun shade comprising as the shade material, a clear
]7.[
].4[
]5.[
179
September 27, 2011-‫כ"ח באלול התשע"א‬
transparent film composite comprising a first transparent film layer, preferably with a
metallized layer on one side, and a further transparent film layer adhered to said one
side of the first film layer using an adhesive, the adhesive and at least one of said two
polymeric film layers contain fire retardant material. The material may also be used for
shades having a sound deadening function.
__________________
]22[]12[
175920
‫שיטה והתקן לאיחסון ואספקת מימן‬
]54[
METHOD AND DEVICE FOR
HYDROGEN STORAGE AND
DELIVERY
]11[
]22[
24.11.2004
60/525422
]21[ 26.11.2003
]22[ US
21633.207
1232231114
US
Int. Cl.(2010.01) C01B 03//08, 03//22
ASEMBLON, INC., U.S.A.
WO/2005/053832
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
Methods, devices and assemblies involving hydrogen production. System (50) includes
a vehicle (54) having device (52) for producing hydrogen for generating energy,
service station (58), and a transportation means (60). A hydrogen producing compound
(62) (e.g., liquid organothiol) is transferred from service station (59) to storage
reservoir (64) of device (52) located within vehicle (54). The compound (62) is reacted
with a metal substrate (66), upon demand, to produce hydrogen gas and spent
compound and/or R-X compound (e.g., organothiolate) bound to the metal substrate
(66). The hydrogen gas can be delivered to hydrogen consuming device (56) for
generating energy utilized in operation of vehicle (54). The R-X compound bound to
the metal substrate (66) can be dissociated from the metal substrate (66) by application
of energy from an energy source to produce a spent compound (68) (e.g., dimeric
compound, R-X-X-R). Spent compound (68) can be stored in reservoir (70) and
transported by transportation means (60) to service station (58) for regeneration.
]52[
].2[
]7.[
].4[
]5.[
180
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
176054
‫תכשירי שמן או שומן הכוללים פוספוליפידים‬
‫ותרכובת המספקת חומצות שומניות בעלות‬
‫שרשרות ארוכות ומספר רב של אי רוויונות ומזון‬
‫המשתמש בהם‬
]54[
OIL OR FAT COMPOSITIONS
CONTAINING PHOSPHOLIPIDS
AND LONG-CHAIN
POLYUNSATURATED FATTY
ACID SUPPLYING COMPOUND
AND FOOD USING THE SAME
]11[
]22[
]52[
].2[
02.12.2004
2003/403630
]21[ 02.12.2003
]22[ JP
Int. Cl.(2010.01) A23D 09//00, A23L 01//30, C11C 03//00
SUNTORY HOLDINGS LIMITED,
JAPAN
HIROSHI KAWASHIMA, YOSHIKO
ONO, KOICHI NAKAHARA
WO/2005/054415
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A fat composition which contains an LCPUFA-supplying compound having an
LCPUFA in its structure and being capable of releasing the LCPUFA upon hydrolysis
as the first component and a phospholipid as the second component. The composition
ratio of these components is determined based on the number of the hydrolyzable fatty
acid bond structures contained in the phospholipid molecule. Thus, the phospholipid
and the LCPUFA-supplying compound are metabolized to form LCPUFA-PL in vivo
followed by the absorption of the same. Owing to this mechanism, it is possible to
obtain a fat composition by which the LCPUFA-PL level in vivo can be efficiently
elevated without resort to a phospholipid having a long-chain polyunsaturated fatty
acid (LCPUFA) as a constituent thereof (LCPUFA-PL) while taking the metabolism in
].1[
]7.[
].4[
]5.[
181
September 27, 2011-‫כ"ח באלול התשע"א‬
vivo into consideration.
__________________
]22[]12[
]54[
SPRAY PYROLYSIS METHOD
FOR THE SYNTHESIS OF
CLOSED STRUCTURE
NANOPARTICLES OF METAL
CHALCOGENIDES AND
NANOPARTICLES OF METAL
CHALCOGENIDES OBTAINED BY
SAID METHOD
]11[
]22[
]52[
].2[
06.12.2004
0314259
]21[ 04.12.2003
Int. Cl.(2010.01) B82B 01//00
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE,
FRANCE
WO/2005/056479
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
176095
‫שיטת התזה משברת להכנת חלקיקים זעירים‬
‫של מתכות קלקוגנים בעלי מבנה סגור וחלקיקים‬
‫זעירים של מתכות קלקוגנים המוכנים בשיטה זו‬
]22[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a spray pyrolysis method characterized in that it is used in the
synthesis of nanoparticles with a closed structure of metal chalcogens having a
lamellar crystallographic structure of general formula MaXb ,wherein M represents a
metal and X represents a chalcogen, a and b represent the respective proportions of
metal and chalcogen, and in that it comprises pyrolysis of a liquid aerosol obtained
from a solution of at least one metal precursor (M) and a chalcogen (X), or at least one
precursor of said metal (M) and at least one precursor of said chalcogen (X) dissolved
in a solvent, said solution being atomized into fine droplets in a suspension in a vector
gas3
__________________
]22[]12[
]54[
182
OXAZOLE DERIVATIVES OF
176162
‫ תהליך‬,‫נגזרות אוקסאזול של טטרציקלינים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
‫ הרכבים רוקחיים המכילים אותן‬,‫להכנתן‬
‫ושימושיהן ביצור תרופה‬
TETRACYCLINES, PROCESS FOR
THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE MANUFACTURE OF
MEDICAMENTS
]11[
]22[
]52[
].2[
]7.[
].4[
]5.[
07.12.2004
60/527928
]21[ 08.12.2003
]22[ US
016574712
1231.31114
US
Int. Cl.(2010.01) A61K 31//421, 31//4245, 31//425, A61P 31//04, C07D 26/3/52,
41/3/04, 41/3/06, 41/7/04, 41/9/04
WYETH LLC, U.S.A.
WO/2005/056538
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
This invention provides compounds of the formula: wherein A', X and Y are defined in
the specification. These compounds are useful as antibacterial agents.
20606/6
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
176179
]54[
PYRETHROID PESTICIDE
]11[
]22[
]52[
].2[
08.02.2005
2004-053336 ]21[ 27.02.2004
]22[
Int. Cl.(2010.01) A01N 53//00, C07D 30/7/42
SUMITOMO CHEMICAL
COMPANY, LIMITED., JAPAN
WO/2005/082877
DR. YITZHAK HESS & PARTNERS,
]7.[
].4[
183
‫מדביר מזיקים פיראת'רויד‬
JP
,‫ד"ר יצחק הס ושותפיו‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
(5-Benzyl-3-furyl)methyl 2,2-dimethyl-3-((E)-2-cyano-3-methoxy-3-oxo-1propenyl)cyclopropanecarboxylate has an excellent pesticidal activity, and a pesticidal
composition comprising it as an active ingredient is useful for controlling pests.
__________________
]22[]12[
176508
,‫ פולינוקלאוטידים‬,‫נוגדנים מונוקלונאליים‬
‫ תהליך‬,‫ווקטורים ותאים מארחים לביטויים‬
‫ תכשירים רפואיים המכילים אותם‬,‫להכנתם‬
‫ושימושם בהכנת תכשירים רפואיים‬
]54[
MONOCLONAL ANTIBODIES,
POLYNUCLEOTIDES, VECTORS
AND HOST CELLS FOR
EXPRESSING THEM, A PROCESS
FOR THEIR PRODUCTION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USES THEREOF IN
THE PREPARATION OF
PHARMACEUTICAL
COMPOSITIONS
]11[
]22[
]52[
].2[
24.12.2004
2003-431408 ]21[ 25.12.2003
]22[ JP
Int. Cl.(2010.01) A61K 39//395, A61P 37//00, C07K 16//28, C12N 15//09
KYOWA HAKKO KIRIN CO., LTD.,
JAPAN
WO/2005/063981
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
It is intended to provide mutants of anti-CD40 antibody, which is expected as
therapeutically efficacious, having been optimized as a drug by lowering the ADCC
and CDC activities thereof. Namely, an agonistic anti-CD40 monoclonal antibody
mutant in which at least the hinge region is a hinge region originating in human IgG2
and which has a mutation and/or a substitution of one or more amino acids causing
lowering in the ADCC and/or CDC activities in the constant region; and an
antagonistic anti-CD40 antibody mutant which has at least one mutation and/or
substitution causing lowering in the ADCC and/or CDC activities in the constant
region.
]7.[
].4[
]5.[
184
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
176645
‫ רשת תקשורת‬,‫שיטה ומערכת הגנה על מידע‬
‫ומוצר תוכנה הקשורים בהם‬
]54[
METHOD AND SYSTEM FOR
PROTECTING DATA, RELATED
COMMUNICATION NETWORK
AND COMPUTER PROGRAM
PRODUCT
]11[
]52[
].2[
].1[
30.12.2003
Int. Cl.(2010.01) H04L 29//06
TELECOM ITALIA S.P.A., ITALY
MANUEL LEONE, ELIO ETTORE
CAPRELLA
WO/2005/064881
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A method for securely storing at least one user's private information item, such as a
private key (KID) for cipher processing, includes the steps of: - providing a
communication network (TU, KR, IWF) wherein said user is allotted a respective
subscriber identity module (SIM), and the subscriber identity module (SIM) stores at
least one security algorithm (A8) ; - producing a cipher key (K) via said at least one
security algorithm (A8); and - providing a remote storing location (KR) accessible by
said user via the communication network wherein the user's private information items
are stored as files encrypted via the cipher key (K).
]7.[
].4[
]5.[
__________________
185
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
176740
,‫מעכבי טרנסקריפטז הפוך לא נוקלאוטידי‬
‫תכשירים רפואיים המכילים אותם ושימושם‬
–8 ‫בהכנת תרופות למניעת או טיפול בזיהום‬
HIV
]54[
NON-NUCLEOTIDE REVERSE
TRANSCRIPTASE INHIBITORS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS FOR THE
PROPHYLAXIS OR TREATMENT
OF HIV-1 INFECTIONS
]11[
]22[
30.12.2004
0400021-2
]21[ 08.01.2004
]22[ SE
1411575-0
1331231114
SE
Int. Cl.(2010.01) A61K 31//425, 31//426, A61P 31//00, C07D 21/3/75, 40/5/12,
40/5/14, 40/9/12, 40/9/14
MEDIVIR AB, SWEDEN
WO/2005/066131
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Compounds of the formula Z: where; A is CH or N; R1 is a substituent to a carbon
atom in the ring containing A selected from -S(=O)pRa, where Ra is -C1-C4 alkyl, ORx, -NRxRx, -NHNRxRx, - NHNHC(=O)ORx, -NRxOH; -C(=O)-Rb, where Rb is CT-C4-alkyl, ORx, -NRxRx, -NHNRxRx, -NHC1-C3-alkyl-C(=O)Orx -NRxRc, where
Rc is H, C1-C4 alkyl, -NRxRx; -C(=0)Rd, -CN, S(=O)pRx where Rd is Rd is C1-C4alkyl, -ORx, -NRxRx C1-C3-alkyl-O-Cl-C3alkylC(=O)ORx, -C1-C3-alkyl-COORx; C1-C3alkyl-OH or C1-C4 alkyl ethers or esters thereof (O-Cl-C3alkyl)q-O-Rx a 5 or 6
membered aromatic ring having 1-3 hetero atoms p is 1 or 2; Rx is independently
selected from H, C1-C4 alkyl or acetyl; or a pair of Rx can together with the adjacent N
atom form a ring; L is -O-, -S(=O),- or -CH2-, where r is 0, 1 or 2; R3-R7 are
substituents as defined in the specification; X is -(CR8R8')n-D-(CR8R8')m-; D is a
bond, -NR9-, -O-, -S-, -S(=O)- or -S(=O)2-; and pharmaceutically acceptable salts and
prodrugs thereof, have utility as HIV antivirals.
]52[
].2[
]7.[
].4[
]5.[
__________________
186
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
176757
‫מכשיר להזנת תחליף חלב‬
]54[
FEEDING FORMULA APPLIANCE
]11[
]22[
]52[
].2[
].1[
]7.[
].4[
13.01.2005
10/755289
]21[ 13.01.2004
]22[ US
Int. Cl.(2010.01) A47J 31//40, B67D 07//74
EYTAN BIDERMAN
‫ אביב‬-‫ תל‬,‫איתן בידרמן‬
EYTAN BIDERMAN, NOAM ZIV
‫ נועם זיו‬,‫איתן בידרמן‬
WO/2005/067385
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A device for preparing a fluid food at a desired consumption temperature on demand,
comprising two reservoirs of water, a container containing a formula, a data processor
and a controller for dispensing water of the correct temperature from each of the
reservoirs and the formula from the container into a vessel. Also provided is a method
to prepare a fluid food at a desired consumption temperature on demand.
]5.[
__________________
]22[]12[
176792
‫חישת מיקום באמצעות היבריד מבוסס על‬
‫מגנטיות ועכבה‬
]54[
HYBRID MAGNETIC-BASED AND
IMPEDANCE-BASED POSITION
SENSING
]11[
]22[
]52[
].2[
].4[
11.07.2006
11/182272
]21[ 15.07.2005
]22[ US
Int. Cl.(2010.01) A61B 05//06
BIOSENSE WEBSTER, INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
P.O.B. 33111
‫תל אביב‬22111 .‫ד‬.‫ ת‬,
TEL AVIV 61330
A position sensing system, comprising: a probe comprising a magnetic field
transducer and at least one probe electrode, said probe being adapted for introduction
into a body cavity of a subject; and a control unit configured to measure position
coordinates of the probe using the magnetic field transducer and to measure an
impedance between the at least one probe electrode and one or more points on a body
surface of the subject and to calibrate the measured impedance using the measured
position coordinates.
]5.[
187
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
176847
,‫שיטה ליצור סוכרוז סינטאז רקומביננטי‬
,‫שימושים בו ליצור ערכות לקביעת סוכרוז‬
‫–גלוקוז ושיטה לקבלת‬ADP ‫שיטה וליצור‬
‫צמחים טרנסגניים המבטאים ביתר חלבון זה‬
]54[
METHOD OF PRODUCTION OF A
RECOMBINANT SUCROSE
SYNTHASE ISOFORM, USES
THEREOF IN THE PRODUCTION
OF SUCROSE-DETERMINATION
KITS AND IN THE PRODUCTION
OF ADPGLUCOSE AND METHOD
OF OBTAINING TRANSGENIC
PLANTS OVEREXPRESSING THE
SAME
]11[
]22[
]52[
].2[
27.01.2005
P200400257
]21[ 05.02.2004
]22[ ES
Int. Cl.(2010.01) A01H 05//00, C12N 09//10, 15//29
CONSEJO SUPERIOR DE
INVESTIGACIONES CIENTIFICAS,
SPAIN
UNIVERSIDAD PUBLICA DE
NAVARRA, SPAIN
WO/2005/075649
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
188
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a method for the efficient production of large quantities of
soluble recombinant sucrose synthase (SS) in the active form thereof, with the
expression of the gene that codes for SS in a strain of Escherichia coli. The expression
vector used enables the recombinant SS thus produced to have a histidine tail which
facilitates the rapid purification thereof. In addition, the invention relates to sequences
of mutated versions of the SS gene, which code for SS isoforms that are suitable for
the production of ADPG. The invention also relates to an efficient method for the
production of ADPG and UDPG, using the wild and mutated versions of recombinant
SS. The invention further relates to the use of SS for the production of sucrose
determination test devices. Finally, the invention relates to a method of obtaining
transgenic plants which overexpress the SS gene, either constituently or in the reserve
organs or leaves thereof, and which have a high concentration (both in the leaves and
in the reserve tissues) of sucrose, ADPG, G6P and starch owing to the high ADPGsynthesising activity of SS.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
176893
‫רהיטים הניתנים להרכבה‬
]54[
ASSEMBLABLE FURNITURE
]11[
]52[
].2[
17.07.2006
Int. Cl.(2010.01) A47C 04//00, 04//02
EYAL ERLICH
AVNER AMIR
].1[
].4[
AVNER AMIR
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
Assemblable furniture comprising a base (11), a left side support part (14), a right side
support part (15), a back part (12) and a front support part (13), each of said parts,
excluding the base, having a thickness and comprising two slots, said left side support
part and said right side support part each comprising a front slot (50a, 50b) and a rear
slot (40a, 40b), said back part and front support part each comprising a right slot (30b)
and a left slot (30a), each slot disposed and dimensioned to correspond to and interfit
with another slot and a portion of a corresponding part, each slot having a width being
slightly greater than the thickness of the portion of the part to which it corresponds on
assembly, wherein when the furniture is assembled, said parts mutually interfit at said
slots to form a rectangular frame within which the base rests and said slots flare out at
an angle such that said parts upwardly flare out when the furniture is assembled.
]5.[
‫ אביב‬-‫ תל‬,‫אייל ארליך‬
‫ חדרה‬,‫אבנר אמיר‬
‫אבנר אמיר‬
,'‫זליגסון גבריאלי ושות‬
21 ‫רח' יבנה‬
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
__________________
]22[]12[
189
176974
September 27, 2011-‫כ"ח באלול התשע"א‬
‫ לעיבוד אדמה‬,‫מערכת לחיתוך משטח דשא‬
‫ולחפירת תעלות‬
]54[
TURF CUTTER/DECOMPACTOR/TRENCHER
]11[
]22[
]52[
].2[
20.01.2005
0401209.2
]21[ 20.01.2004
]22[ GB
Int. Cl.(2010.01) A01B 45//04
WILLIAM LYLE WARKE, UNITED
KINGDOM
WILLIAM LYLE WARKE
WO/2005/070189
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
An apparatus (301, 314, 351) for cutting turf, for soil de-compacting and for soil
drainage and irrigation. The apparatus (301, 314, 351) has a chassis (1) with a ground
engaging means (5, 61), an adjustable working arm (3) having a chassis-engaging end
(302) movably mounted on the chassis (1) and a tool-engaging end (303) having
means for receiving a tool. The apparatus also has means for oscillating the toolengaging end (303) of the adjustable working arm (3). The oscillating means
comprises a drive means mounted on the chassis (1) and a connecting means mounted
intermediate the drive means and the adjustable working arm (3).
].1[
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
METHOD AND APPARATUS FOR
PILOT SIGNAL TRANSMISSION
]11[
]22[
]52[
].2[
22.02.2005
10/813476
]21[ 30.03.2004
Int. Cl.(2010.01) H04J 11//00
MOTOROLA MOBILITY, INC.,
190
177171
‫שיטה והתקן להעברת אות נסיוני‬
]22[
US
September 27, 2011-‫כ"ח באלול התשע"א‬
]7.[
].4[
]5.[
U.S.A.
WO/2005/104412
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Pilot sequences are constructed from distinct 'classes' of chirp sequences that have an
optimal cross correlation property. Utilization of chirp sequences for pilot sequences
results in pilot sequences that have optimal or nearly-optimal cross correlation and
auto-correlation properties.
__________________
]22[]12[
177226
]54[
TEST STRIP FOR DETERMINING
THE CONCENTRATION OF LDL
CHOLESTEROL
]11[
]22[
03.02.2005
60/541681
]21[ 03.02.2004
]22[ US
2163011.1
2232131114
US
Int. Cl.(2010.01) C12Q 01//60, G01N 33//92
POLYMER TECHNOLOGY
SYSTEMS, INC., U.S.A.
WO/2005/074609
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Cholesterol from Low Density Lipoproteins (LDL-C) is measured directly with a test
strip at room temperature using a reagent that takes advantage of the varying surface
charge density on LDLs and non-LDLs to selectively make LDLC available for
testing.
]52[
].2[
]7.[
].4[
]5.[
191
LDL ‫שרט בדיקה לקביעת ריכוז כולסטרול‬
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
177242
]54[
ANTI CD38 HUMAN AND
HUMANIZED ANTIBODIES,
FUNCTIONAL FRAGMENTS
THEREOF AND USES THEREOF
]11[
]22[
07.02.2005
60/541911
]21[ 06.02.2004
]22[ US
01654.574
1031131114
US
016552347
2731231114
US
016533124
1031731114
US
0160244.2
1232131114
US
Int. Cl.(2010.01) C07K 16//00, 16//18, 16//28
MORPHOSYS AG, GERMANY
MICHAEL TESAR, UTE JAGER
WO/2005/103083
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
The present invention provides recombinant antigen-binding regions and antibodies
and functional fragments containing such antigen-binding regions that are specific for
CD38, which plays an integral role in various disorders or conditions. These
antibodies, accordingly, can be used to treat, for example, hematological malignancies
such as multiple myeloma. Antibodies of the invention also can be used in the
diagnostics field, as well as for investigating the role of CD38 in the progression of
disorders associated with malignancies. The invention also provides nucleic acid
sequences encoding the foregoing antibodies, vectors containing the same,
pharmaceutical compositions and kits with instructions for use. The invention also
provides isolated novel epitopes of CD38 and methods of use therefore.
]52[
].2[
].1[
]7.[
].4[
]5.[
192
,‫ שהם אנושים או מאונשים‬CD 38 ‫נוגדני אנטי‬
‫רסיסים תפקידים שלהם ושימושיהם‬
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
]54[
GASOLINE SULFUR REDUCTION
CATALYST FOR FLUID
CATALYTIC CRACKING
PROCESS
]11[
]22[
]52[
].2[
]7.[
].4[
16.03.2005
10/801424
]21[ 16.03.2004
Int. Cl.(2010.01) C10G 11//05
W.R. GRACE & CO. -CONN., U.S.A.
WO/2005/090523
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]5.[
177295
‫קטליזטור להפחתת כמות הגפרית בבנזין עבור‬
‫תהליך לפיצוח קטליטי נוזלי‬
]22[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The present invention is directed to certain catalyst compositions and processes that
are capable of reducing sulfur compounds normally found as part of the gasoline
fraction streams of fluid catalytic cracking processes. The present invention is a
cracking catalyst composition comprising a zeolite in combination with a Lewis Acid
containing component, wherein the cracking catalyst composition comprises 0.2%
Na2O or less. It has been found that sulfur compounds in hydrocarbon feeds to fluid
catalytic cracking processes can be reduced by at least 15% compared to the same
composition, which does not comprise the aforementioned Lewis Acid containing
component.
__________________
]22[]12[
193
177307
September 27, 2011-‫כ"ח באלול התשע"א‬
‫נגזרות טטראהידרואיזוקינולין‬
R1– IGF ‫וטטראהידרובנזאזפין מעכבי‬
]54[
TETRAHYDROISOQUINOLINE
AND
TETRAHYDROBENZAZEPINE
DERIVATIVES AS IGF-1R
INHIBITORS
]11[
]52[
].2[
12.03.2004
Int. Cl.(2010.01) A61K 31//472, A61P 35//00, C07D 21/7/14, 21/7/16, 40/1/04
ANALYTECON S.A.,
SWITZERLAND
JAN GUNZINGER, KURT
LEANDER
WO/2005/087743
SOROKER-AGMON,
,‫אגמון‬-‫סורוקר‬
14 SHENKAR ST.,
14 ‫ רחוב שנקר‬,‫בית נולטון‬
HERZLIYA PITUAH 46725
‫הרצליה פיתוח‬
Compounds of the formula (I): where R2, R5, R6 have the meanings as given in the
description, and U, V and W, respectively, may be CR2', CR4' and CR6', respectively
(with the definitions of R2', R4' and R6' again as in the description), or may be N,
were synthesized. They were found to down-regulate or inhibit the expression or
function of the IGF-1 receptor.
].1[
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
BIOCOMPATIBLE COATING,
METHOD AND USE OF MEDICAL
SURFACES
]11[
]22[
27.02.2005
102004009850.6 ]21[ 28.02.2004
016552.02
2231231114
Int. Cl.(2010.01) A61L 31//10, 31//14
HEMOTEQ AG, GERMANY
]52[
].2[
194
177321
‫ שיטה‬,)‫ציפוי תואם ביולוגי (ביוקומפיטבילי‬
‫ושימוש במשטחים רפואיים‬
]22[
DE
US
September 27, 2011-‫כ"ח באלול התשע"א‬
].1[
]7.[
].4[
]5.[
ERIKA HOFFMANN
WO/2005/082434
WEBB & CO.,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
,'‫ד"ר וב ושות‬
2 ‫רח' פקריס‬
‫רחובות‬5116 .‫ד‬.‫ ת‬,
The invention relates to medical products having a surface that is at least partially
covered by a polymer layer. Said polymer layer is preferably formed by
autopolymerisation. Substances containing at least one multiple bond, especially
unsaturated fatty acids comprising an alkyl chain consisting of preferably between 7
and 50 carbon atoms are polymerised. Other substances which do not participate in the
polymerisation can be added to the substances participating in the polymerisation
reaction. Said substances are preferably saturated fatty acids and fatty acid derivatives.
The invention also relates to methods for producing such medical products, and to the
use of the same.
__________________
]22[]12[
177372
]54[
C10 CYCLOPENTYL ESTER
SUBSTITUTED TAXANES AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]11[
]22[
14.02.2005
60/544755
]21[ 13.02.2004
]22[ US
016022512
1.31331114
US
Int. Cl.(2010.01) A61K 31//381, C07D 40/9/00
FLORIDA STATE UNIVERSITY
RESEARCH FOUNDATION, INC.,
U.S.A.
WO/2005/079319
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
]52[
].2[
]7.[
].4[
195
‫ ציקלופנטיל‬C 80 ‫טקסנים מותמרים באסטר‬
‫ותכשירים רפואיים המכילים אותם‬
September 27, 2011-‫כ"ח באלול התשע"א‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
A taxane having a cyclopentyl ester substituent at C10, a keto substituent at C9, a
hydroxy substituent at C2, a 2-thienyl substituent at C3' and an isopropoxycarbamate
substituent at C3'.
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]5.[
__________________
]22[]12[
177413
‫שיטה לאינוד משטחים מתכתיים‬
]54[
METHOD FOR ANODIZING
METALLIC SURFACES
]11[
]22[
]52[
].2[
16.02.2005
10/781973
]21[ 18.02.2004
]22[ US
Int. Cl.(2010.01) C23C 22//03, C25D 11//30
ALONIM HOLDINGS
‫ קיבוץ‬,‫אלונים אחזקות אגש"ח בע"מ‬
AGRICULTURAL COOPERATIVE
‫אלונים‬
SOCIETY LTD.
ILYA OSTROVSKY
‫איליה אוסטרובסקי‬
WO/2005/078165
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A method of treating metallic workpieces with an anodizing solution, compositions of
the anodizing solution and the coatings prepared with this anodizing solution for
anodizing metallic surfaces, especially surfaces of magnesium, magnesium alloys,
aluminum and aluminum alloys, are disclosed. The compositions are basic aqueous
solutions comprising a watersoluble inorganic hydroxide, phosphorus and oxygen
containing anions, at least one surfactant and an alkaline buffer based on at least one
alkaline hydrolyzed silane, on at least one alcohol showing at least one alkaline radical
group or on a mixture of them.
].1[
]7.[
].4[
]5.[
__________________
]22[]12[
196
177593
September 27, 2011-‫כ"ח באלול התשע"א‬
‫שיטה להכנת מיקרוספירות מכויילות‬
‫המתפרקות באופן טבעי‬
]54[
METHOD FOR PREPARING
CALIBRATED BIODEGRADABLE
MICROSPHERES
]11[
]22[
]52[
].2[
]7.[
].4[
03.03.2005
0402204
]21[ 03.03.2004
Int. Cl.(2010.01) B01J 13//04, 13//12
ETHYPHARM, FRANCE
WO/2005/087362
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
The invention relates to a method for preparing monodispersed biodegradable
microspheres consisting in a) preparing an emulsion containing at least one polymeric
phase and at least one aqueous phase at a viscosity ratio between the dispersed
polymeric phase and the aqueous phase ranging from 0.12 to 10, b) exposing the thus
obtained emulsion to a controlled laminar shear strength, c) removing a solvent from
the polymeric phase and in d) isolating the thus obtained microspheres. The use of the
prepared microspheres is also disclosed.
]22[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
177686
‫צינור השקייה‬
]54[
IRRIGATION PIPE
]11[
]22[
]52[
].2[
]7.[
].4[
02.03.2005
60/548957
]21[ 02.03.2004
Int. Cl.(2010.01) A01G 25//02
NETAFIM LTD.
WO/2005/084418
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
An irrigation pipe (10) with a plurality of connector elements (14) adapted for
attachment of lateral branches thereto, where the connector elements (14) are integrally
fitted to the pipe's wall during the manufacture. Connector elements (14) may be fitted
open and be adapted for closing after manufacture if not intended for use, or may be
fitted closed and be adapted for opening after manufacture to enable the attachment. A
method of production of such irrigation pipe (10) from a strip of flexible weldable or
bondable material includes fitting integrally the connector elements (14) to
predetermined locations on the strip, with or without punching the strip; bending or
197
]22[
US
‫ אביב‬-‫ תל‬,‫נטפים בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
twisting the strip so as to juxtapose or overlap lateral edges thereof; and welding or
bonding integrally the edges so as to obtain a closed pipe section.
__________________
]22[]12[
177691
‫התקן לניפוק נוזלים‬
]54[
FLUID DISPENSING DEVICE
]11[
]22[
]52[
].2[
10.03.2005
0405477.1
]21[ 11.03.2004
]22[ GB
Int. Cl.(2010.01) A61M 15//08, B05B 11//00, B65D 83//14
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/2005/087615
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
198
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a fluid dispensing device (1405) for dispensing a fluid
product having a dispensing outlet (1411) from which the fluid product is dispensable,
a supply of the fluid product, a dispensing member (1430) mounted for movement in a
dispensing direction along an axis X-X from a first position to a second position which
causes a dose of the fluid product in the supply to be dispensed from the dispensing
outlet, and a finger-operable actuator member (1420) mounted for movement in an
actuating direction which is generally transverse to the axis. The actuator member has
at least one cam surface (1422) and the dispensing member has at least one cam
follower surface (1492). The at least one cam surface has a commitment section
(1423a), oriented at a first angle to the axis, and an adjacent drive section (1423b),
which is oriented at a second angle to the axis which is greater than the first angle.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
]54[
DOLL CAPABLE OF
SIMULATING EATING PROCESS
WITH EDUCATIONAL
RESPONSE MECHANISM
]11[
]52[
].2[
24.08.2006
Int. Cl.(2010.01) A63H 03//24, 03//36
NISIM MASSIAH
GILI GEORGE
].1[
].4[
]5.[
177696
‫בובה אוכלת בעלת מנגנון תגובה לאוכל‬
‫ אור יהודה‬,‫ניסים משיח‬
‫ אור יהודה‬,'‫גילי ג'ורג‬
NISIM MASSIAH, GILI GEORGE
'‫ גילי ג'ורג‬,‫ניסים משיח‬
DR. EYAL BRESSLER,
,‫דר' אייל ברסלר עו"פ‬
11 TUVAL ST.,
11 ‫תובל‬
RAMAT GAN 52522
‫ גן‬- ‫רמת‬
A doll capable of simulating eating with a response mechanism in accordance to the
characteristics of Food Imaging Object (FIO) inserted by the user into the doll,
comprising: (a) at least one sensor identifying said objects; (b) a processor receiving
data from said sensor and activating a response mechanism in accordance to said data;
(c) at least one inlet simulating the mouth of the doll; (d) at least one outlet removing
said FIOs from the doll; and (e)
at least one volume for storing said objects inside
the doll.
__________________
199
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
177704
‫ תהליכים‬,‫טטרהידרוקרבזולים ונגזרות‬
‫ תכשירים רפואיים המכילים אותם‬,‫להכנתם‬
‫ושימושם בהכנת תרופות לטיפול‬
]54[
TETRAHYDROCARBAZOLES
AND DERIVATIVES, PROCESS
FOR THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS FOR THERAPY
]11[
]22[
]52[
17.03.2005
04101252.7
]21[ 26.03.2004
]22[ EP
Int. Cl.(2010.01) A61K 31//403, 31//4245, A61P 03//00, 25//28, 29//00, C07D
20/9/86, 20/9/88, 40/1/12, 41/3/08, 41/3/14, 41/7/08, 47/1/04
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2005/092856
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to compounds of the formula (I) wherein R 1, R2, R3, R4,
R5, X1, X2, X3, X4, n, and k are defined in the description and claims, and
pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof.
The compounds are useful for in the treatment and prophylaxis of diseases which are
modulated by LXRalpha and/or LXRß agonists, including increased lipid and
cholesterol levels, particularly low HDL-cholesterol, high LDL-cholesterol,
atherosclerotic diseases, diabetes, particularly non-insulin dependent diabetes mellitus,
metabolic syndrome, dyslipidemia, Alzheimer's disease, sepsis, inflammatory diseases
such as colitis, pancreatitis, cholestasis/fibrosis of the liver, and diseases that have an
inflammatory component such as Alzheimer's disease or impaired/improvable
cognitive function.
].2[
]7.[
].4[
]5.[
__________________
]22[]12[
200
178086
September 27, 2011-‫כ"ח באלול התשע"א‬
‫ תהליך‬,‫תרכובות קווינאולינון קרבוקסאמיד‬
‫להכנתן ותכשירי רוקחות המכילים אותן‬
HT4–5 ‫לשימוש כאגוניסטים של קולטן‬
]54[
QUINOLINONE-CARBOXAMIDE
COMPOUNDS, PROCESS FOR
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM FOR USE AS 5-HT4
RECEPTOR AGONISTS
]11[
]22[
]52[
].2[
]7.[
].4[
06.04.2005
60/560076
]21[ 07.04.2004
]22[ US
Int. Cl.(2010.01) A61K 31//46, A61P 01//00, C07D 45/1/04
THERAVANCE, INC., U.S.A.
WO/2005/100350
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist
compounds of Formula (I). The invention also provides pharmaceutical compositions
comprising such compounds, the use such compounds to treat diseases associated with
5-HT4 receptor activity, and processes and intermediates useful for preparing such
compounds: wherein; R1 is hydrogen, halo, hydroxy, C1-4 alkyl, or C1-4 alkoxy; R2 is
C3-4 alkyl, or C3-6 cycloalkyl; R3 is hydrogen or C1-3 alkyl: R4 is -S(O)2 R6 or -C(O)R7;
R5 is hydrogen, C1-3alkyl, C2-3 alkyl subtituted with -OH or C1-3 alkoxy, or -CH2pyridyl; R6 is C1-3 alkyl; or R5 and R6 taken together form C3-4 alkyenyl; and R7 is
hydrogen, C1-3alkyl, or pyridyl; or pharmaceutically-acceptable salt or solvate or
stereoisomer thereof.
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
]11[
201
METHOD OF SUPPLYING
POWER TO A WELDING ARC
AND DEVICE THEREFOR
178413
‫שיטה להזנת כוח לקשת ריתוך ומכשיר לכך‬
03.10.2006
September 27, 2011-‫כ"ח באלול התשע"א‬
]52[
].2[
].4[
]5.[
Int. Cl.(2010.01) B23K 09//06, 09//10
SHIMON VAINER
SHIMON VAINER,
ZFAT 4/16
BEER-SHEVA 84770
‫שבע‬-‫ באר‬,‫שמעון ויינר‬
,‫שמעון ויינר‬
4/11 ‫צפת‬
‫שבע‬-‫באר‬
A method of supplying power to a welding arc, wherein: low frequency voltage
supplied by a power source is converted into high frequency voltage, the welding arc
is drawn by the said high frequency voltage whereby high frequency current is caused
in the circuit of the welding arc, said high frequency current causes the power source
to supply low frequency voltage as well to the welding arc, whereupon the welding arc
is powered by both said high frequency voltage and said low frequency voltage.
__________________
]22[]12[
]54[
MAGNETIC RAIL BRAKE DEVICE
]11[
]22[
]52[
].2[
13.04.2005
102004018009.1 ]21[ 14.04.2004
Int. Cl.(2010.01) B61H 07//08
KNORR-BREMSE SYSTEME FUR
SCHIENENFAHRZEUGE GMBH,
GERMANY
WO/2005/100122
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
202
178571
‫התקן בולם מסילה מגנטי‬
]22[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a magnetic rail brake device of a railway vehicle, including a
magnetic base or carrier element, and a magnetic coil which can be connected to a
voltage source by means of a connecting mechanism that is on the base or carrier
element and is provided with at least two electrical terminals. An end face of the
connecting mechanism is disposed within an imaginary enveloping area of the base or
carrier element.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
178649
‫תהליך לייצור דיקטונים טבעתיים‬
]54[
PROCESS FOR THE
PRODUCTION OF CYCLIC
DIKETONES
]11[
]22[
]52[
].2[
29.04.2005
00766/04
]21[ 30.04.2004
]22[ CH
Int. Cl.(2010.01) C07C 17//10, 17//23, 23//32, 67//11
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND
SYNGENTA LIMITED, UNITED
KINGDOM
WO/2005/105718
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to a process for the preparation of compounds of formula
(I), wherein the substituents are as defined in claim 1, by reacting a compound of
formula (II), with a bromine or chlorine source to form a compound of formula (III),
wherein X is chlorine or bromine; reacting that compound with water to form the
compound of formula (IV), converting that compound, using a compound of formula
(V), wherein M+ is the hydrogen cation or an alkali metal ion, alkaline earth metal ion
or ammonium ion, into the compound of formula (VI), and treating that compound
with a cyanide source in the presence of a base.
]7.[
].4[
]5.[
__________________
203
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
178701
‫שיטה לייצור תוצר חומצה הילורונית מיובש‬
‫וצבור‬
]54[
METHOD FOR PRODUCING A
DRIED AND AGGLOMERATED
HYALURONIC ACID PRODUCT
]11[
]22[
26.05.2005
PA200400833 ]21[ 27.05.2004
]22[
PA200401003
1531031114
PA200500223
2531131115
Int. Cl.(2010.01) A61K 09//16, C08L 05//08
NOVOZYMES BIOPHARMA DK A/S,
DENMARK
WO/2005/116131
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
].2[
]7.[
].4[
]5.[
DK
DK
DK
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A product comprising hyaluronic acid or a salt thereof, which product is dried and
agglomerated as defined herein, various compositions and articles comprising the
product or compositions of the invention, methods of producing the product of the
invention, and uses thereof.
__________________
]22[]12[
]54[
VAPOR PHASE CATALYTIC
CHLORINATION OF ß-PICOLINE
]11[
]22[
]52[
].2[
].1[
26.04.2005
60/565466
]21[ 26.04.2004
Int. Cl.(2010.01) C07D 21/3/61
DOW AGROSCIENCES LLC, U.S.A.
KENT DOUGLAS CAMPBELL,
DANA ALAN LIVINGSTON, HAWK
SUEWAH WAN, BRIAN JOHN
SCHOEMAN, STEVEN ROY LAKSO,
KENNETH MICHAEL LARSON
WO/2005/105747
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]7.[
].4[
204
178714
–‫כלורינציה קטליטית בפאזת אדים של בטא‬
‫פיקולין‬
]22[
US
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
2-Chloro-5-trichloromethylpyridine is obtained by chlorinating beta-picoline in the
vapor phase using a Mordenite zeolite or a supported palladium catalyst.
__________________
]22[]12[
178720
‫שיטה ומתקן לטיפול מים על ידי מערכת הניתנת‬
‫לתכנות בתוך מתקן לקרור מים‬
]54[
METHOD AND APPARATUS FOR
PROGRAMABLY TREATING
WATER IN A WATER COOLER
]11[
]22[
21.04.2005
60/564178
]21[ 21.04.2004
]22[ US
226213322
1131431115
US
Int. Cl.(2010.01) B67D 07//06, F25D 11//00
S.I.P. TECHNOLOGIES L.L.C., U.S.A.
KENNETH A. DAVIS
WO/2005/118462
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
An apparatus for a programmable self sanitizing water dispenser apparatus with a
digital computer as well as a programmable method for generating ozone for cleaning
the reservoir and the water contained within it.
]52[
].2[
].1[
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
205
METHOD OF MANUFACTURING
178754
‫ ולהב‬,‫שיטה ליצור להב לטורבינות מחומר מרוכב‬
September 27, 2011-‫כ"ח באלול התשע"א‬
‫שהתקבל על ידי השיטה‬
A COMPOSITE TURBOMACHINE
BLADE AND A BLADE OBTAINED
BY THE METHOD
]11[
]22[
]52[
].2[
].4[
]5.[
19.10.2006
0510752
]21[ 21.10.2005
Int. Cl.(2010.01) F01D 05//14
SNECMA, FRANCE
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]22[
FR
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
The invention relates to a method of manufacturing a composite turbomachine blade,
the method comprising the fol- lowing steps: (a) making a preform by threedimensionally weaving yarns including tracer yarns disposed at least at the surface of
the preform;(b) cutting out said preform so as to leave intact a series of tracer yarns
situated along a reference face of the preform;(c) pre-deforming said cut-out
preform;(d)compacting and stiffening said pre-deformed preform;(e) providing an
injection mold in which said stiffened preform is placed; (f)heating said injection
mold;(g)injecting a binder into said injection mold ,the binder comprising a
thermosettable resin; and (h) extracting from the mold a composite molded part
presenting substantially the shape and the dimensions of said blade.
__________________
]22[]12[
178766
– 6 ,5([ –4 –‫ –בנזיל‬8 ‫תהליכים ליצור של‬
]‫ –איל‬2 – )‫ – אינדנונ‬8 – ‫דימתוקסי‬
‫מתילפיפרידין והידרוכלוריד שלו‬
]54[
PROCESSES FOR PRODUCING 1BENZYL-4-[(5, 6-DIMETHOXY-1INDANON)-2-YL]
METHYLPIPERIDINE AND
HYDROCHLORIDE THEREOF
]11[
]22[
]52[
].2[
27.04.2005
2004-133277 ]21[ 28.04.2004
]22[ JP
Int. Cl.(2010.01) B01J 25//02, C07D 21/1/32
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
WO/2005/105742
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Processes for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2-yl]methylpiperidine
]7.[
].4[
]5.[
206
September 27, 2011-‫כ"ח באלול התשע"א‬
(donepezil), which is useful as an intermediate for medicines, and for producing 1benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (donepezil
hydrochloride), which is useful as a medicine. The process for donepezil hydrochloride
production comprises catalytically hydrogenating the compound represented by the
structural formula (III) [1-benzyl-4-[(5,6-dimethoxy-1indanon)-2ylidene]methylpiperidine] with a Raney nickel catalyst under mild conditions and
subsequently treating it with hydrochloric acid. Thus, impurities are further
diminished. The operations are simple and the process is suitable for industrial
production.
__________________
]22[]12[
178861
‫גילוי של דפוס במערכת אבטחת רשת‬
]54[
PATTERN DISCOVERY IN A
NETWORK SECURITY SYSTEM
]11[
]22[
]52[
].2[
].1[
04.05.2005
10/839613
]21[ 04.05.2004
]22[ US
Int. Cl.(2010.01) G06F 01//00, 21//00, H04L 09//00, 29//06
ARCSIGHT, INC., U.S.A.
KUMAR SAURABH, KENNY
TIDWELL
WO/2005/107424
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
Patterns can be discovered in security events collected by a network security system
(10). In one embodiment, the present invention includes collecting and storing security
events from a variety of monitor devices (12).In one embodiment , a subset of the
stored security events is provided to a manager (14) as an event stream. In one
embodiment, the present invention further includes the manager discovering one or
more previously unknown event patterns in the event stream.
]7.[
].4[
]5.[
207
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
]54[
PREPARATION OF
NANOPARTICLE MATERIALS
]11[
]22[
]52[
].2[
27.04.2005
0409877.8
]21[ 30.04.2004
Int. Cl.(2010.01) B82B 01//00
NANOCO TECHNOLOGIES
LIMITED, UNITED KINGDOM
PAUL O'BRIEN, NIGEL PICKETT
WO/2005/106082
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
].1[
]7.[
].4[
]5.[
178874
‫הכנת חומרים המכילים ננו–חלקיקים‬
]22[
GB
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
A method of producing nanoparticles comprises effecting conversion of a nanoparticle
precursor composition to the material of the nanoparticles. The precursor composition
comprises a first precursor species containing a first ion to be incorporated into the
growing nanoparticles and a separate second precursor species containing a second ion
to be incorporated into the growing nanoparticles. The conversion is effected in the
presence of a molecular cluster compound under conditions permitting seeding and
growth of the nanoparticles.
__________________
]22[]12[
]54[
208
PEPTIDE-BASED COMPOUNDS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USES THEREOF IN
THE PREPARATION OF
MEDICAMENTS
179020
‫ תכשירים רפואים‬,‫תרכובות מבוססות פפטיד‬
‫המכילים אותן ושימושן בהכנת תרופות‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]11[
]22[
]52[
].2[
]7.[
].4[
]5.[
09.05.2005
60/569885
]21[ 10.05.2004
]22[ US
016021141
2431331114
US
016024200
1.32131114
US
Int. Cl.(2010.01) A61K 38//05, 38//06, A61P 21//00, 31//00, 31//18, 35//00, C07K
05//06, 05//08, 05//087
ONYX THERAPEUTICS, INC., U.S.A.
WO/2005/111008
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Peptide-based compounds including heteroatom-containing, three-membered rings
efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn)
hydrolases. The activities of those Ntn having multiple activities can be differentially
inhibited by the compounds described. For example, the chymotrypsinlike activity of
the 20S proteasome may be selectively inhibited with the inventive compounds. The
peptide-based compounds include an epoxide or aziridine, and functionalization at the
N-terminus. Among other therapeutic utilities, the peptide-based compounds are
expected to display anti-inflammatory properties and inhibition of cell proliferation.
2021//0
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
179194
‫טבליות פרמצבטיות ותהליך להכנת תכשירים‬
‫בעלי שחרור איטי שלהן‬
]54[
PHARMACEUTICAL TABLET
AND A PROCESS FOR
PREPARING SLOW RELEASE
FORMULATION THEREOF
]11[
]22[
]52[
].2[
]7.[
].4[
10.05.2005
10/848447
]21[ 18.05.2003
]22[ US
Int. Cl.(2010.01) A61K 09//20, 09//24, 31//135, 45//06
L. PERRIGO COMPANY, U.S.A.
WO/2005/115348
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A compressible extended release tablet or tablet layer having a drug release profile that
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
209
is not strongly dependent on tablet hardness may be prepared by dry blending a
pharmaceutically active ingredient with hydroxypropyl methylcellulose, wherein the
hydroxypropyl methylcellulose has a bimodal or multimodal number average
molecular weight distribution that includes at least one mode over 20,000 Daltons and
at least one mode under 10,000 Daltons. An additional advantage of the invention is
that the tablet formulations may be prepared without resort to wet granulation.
__________________
]22[]12[
179238
‫חומר טרום–ביוטי הכולל גלוקומנאן קוניאק‬
‫ שימוש בו‬,‫ שיטה להכנתו‬,‫שעבר הידרוליזה‬
‫להכנת תרופות לטיפול בזיהומים ודבר מאכל‬
‫הכולל אותו‬
]54[
PREBIOTIC COMPRISING
HYDROLYZED KONJAC
GLUCOMANNAN, METHOD OF
MANUFACTURE THEREOF, USE
THEREOF IN PREPARATION OF
MEDICAMENTS FOR TREATING
INFECTIONS AND FOOD STUFF
COMPRISING THE SAME
]11[
]22[
]52[
].2[
16.05.2005
0410785.0
]21[ 14.05.2004
]22[ GB
Int. Cl.(2010.01) A23L 01//09, A61K 31//715, 35//66, C12N 01//20, 01//38
GLYCOLOGIC LIMITED, UNITED
KINGDOM
WO/2005/111195
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Carbohydrates, in particular mannose containing carbohydrates, are used as a promotor
of cell growth. Specifically, polysaccharide hydrolysates are shown to have superior
efficacy in promoting the growth of cells, synbiotic foods, prebiotics and
pharmaceutical compositions containing mannose containing carbohydrates and
polysaccharide hydrolysates described.
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
210
TUBULAR RADIATION
ABSORBING DEVICE FOR A
179261
‫התקן צינורי הקולט קרינה לספק כח סולרי‬
‫של מפעל המפחית איבוד חם‬
September 27, 2011-‫כ"ח באלול התשע"א‬
SOLAR POWER PLANT WITH
REDUCED HEAT LOSSES
]11[
]22[
]52[
].2[
].4[
14.11.2006
102005057277.4 ]21[ 25.11.2005
Int. Cl.(2010.01) F24J 02//04
SCHOTT AG, GERMANY
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
Absorber tube (1) has centre tube (3) made of chrome-steel e.g. stainless steel and with
a glass cladding tube (2) surrounding the centre tube forming an annular space (6)
between centre tube and cladding tube. The inside of the centre tube has a barrier layer
(4) widely impermeable for hydrogen, which contains chromium oxide. An
independent claim is also included for the manufacturing method for centre tube of an
absorber tube.
]22[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
179296
‫תכשירים של פולימר אמפיפילי ושימושם‬
]54[
AMPHIPHILIC POLYMER
COMPOSITIONS AND THEIR USE
]11[
]22[
]52[
].2[
]7.[
].4[
07.06.2005
102004027835.0 ]21[ 08.06.2004
]22[ DE
Int. Cl.(2010.01) A01N 25//04, 25//10, C08G 18//62
BASF SE, GERMANY
WO/2005/121201
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
211
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
The invention relates to amphiphilic polymer compositions, to a method for their
production and to their use for producing aqueous active ingredient compositions of
water-insoluble active ingredients, in particular active ingredients for crop protection.
The amphiphilic polymer compositions are obtained by reacting a) at least one
hydrophobic polymer P1, which carries functional groups R1 that are reactive in
relation to isocyanate groups and which is composed of ethylenically unsaturated
monomers M1, comprising: a1) at least 10 wt. %, (in relation to the total quantity of
the monomers M1), of monomers M1a of general formula (I), in which X represents
oxygen or an N-R4 group; R1, R2, R3, and R4 are defined as cited in the claims and the
description; a2) up to 90 wt. %, (in relation to the total quantity of the monomers M1)
of neutral, monoethylenically unsaturated monomers M1b, whose solubility in water at
25 °C is less than 50 g/l and which differ from the monomers M1a; and a3) up to 30
wt. %, (in relation to the total quantity of the monomers M1, of ethylenically
unsaturated monomers M1c, which differ from the monomers M1a and M1b, b) at
least one hydrophilic polymer P2, which carries functional groups R 2 that are reactive
in relation to isocyanate groups, c) with at least one compound V, which has a
functionality of at least 1.5 in relation to the isocyanate groups.
__________________
]22[]12[
179369
‫נגזרות או מלחים של חומצה פירזינקרבוקסילית‬
‫ חומרים אגרוהורטיקולטורים‬,‫אניליד מותמרות‬
‫המכילים אותן ותוצרי ביניים שלהן‬
]54[
SUBSTITUTED
PYRAZINECARBOXYLIC ACID
ANILIDE DERIVATIVES OR
SALTS THEREOF,
AGROHORTICULTURAL
AGENTS COMPRISING THE
SAME AND INTERMEDIATES
THEREOF
]11[
]22[
]52[
].2[
26.05.2005
2004-157634 ]21[ 27.05.2004
]22[ JP
Int. Cl.(2010.01) A01N 43//60, C07C 21/1/45, 21/1/52, 21/5/68, C07D 24/1/24
NIHON NOHYAKU CO. LTD.,
JAPAN
WO/2005/115994
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
]7.[
].4[
212
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Substituted pyrazinecarboxylic acid anilide derivatives represented by the general
formula (I) or salts thereof; intermediates of them; pesticides (such as insecticides and
acaricides) for agricultural and horticultural use, containing the compounds as the
active ingredient; and usage thereof: (I) wherein R1 is H, C1-6 alkyl, halo C1-6 alkyl, or
the like; R2 is halogeno, C1-6 alkyl, or the like; G is C2-10 alkyl or the like; Z is oxygen
or sulfur; X's are each independently H, halogeno, or the like; Y's are each
independently H, halogeno, cyano, or the like; and m and n are each an integer of 1 to
3.
__________________
]22[]12[
]54[
RELEASABLE COUPLING AND
INJECTION DEVICE
]11[
]22[
]52[
].2[
27.05.2005
0412050.7
]21[ 28.05.2004
Int. Cl.(2010.01) A61M 05//20
CILAG GMBH INTERNATIONAL,
SWITZERLAND
WO/2005/115506
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
213
179450
‫התקן הזרקה ומצמד הניתן לשחרור‬
]22[
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A housing (212) receives a syringe and includes a return spring (226) for biasing the
syringe from an extended position in which its needle (218) extends from the housing
to a retracted position in which it does not. A drive spring (230) acts on a first drive
element (232) and a second drive element (234) acts upon the syringe to advance it
from its retracted position to its extended position and discharge its contents through
the needle. The first drive element is capable of movement relative to the second once
a nominal coupling position has been reached. A release mechanism is activated when
the first drive element (234) is further advanced to a nominal release position, to
release the syringe (214) from the action of the drive spring, whereupon the return
spring restores the syringe to its retracted position.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
]54[
METHOD AND APPARATUS FOR
LINK LAYER ASSISTED
HANDOFF
]11[
]22[
31.03.2006
60/676064
]21[ 29.04.2005
226252.20
2231131110
Int. Cl.(2010.01) H04W 36//00
MOTOROLA MOBILITY, INC.,
U.S.A.
WO/2006/118732
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
].2[
]7.[
].4[
]5.[
214
179477
‫שיטה והתקן להעברת שיחה בסיוע קישור‬
‫שכבה‬
]22[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Various embodiments are described to address the need for an apparatus and method
that improves upon known handoff techniques, such as Mobile IP and Fast Mobile IP,
to improve the mobility experience of an end user. OSI layer 2-originated indications
of a handoff being imminent (301, 501, 502), a link down for handoff (307, 509, 510),
and a new link up after handoff (309, 511, 512) are introduced. These indications can
be used by applications (such as real-time/streaming applications on the mobile (101))
to take suitable proactive measures prior to an actual handoff. Examples of such
measures include the buffering of data to be used during the handoff interval in a way
that improves the seamless mobility experience of the end user.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
179554
‫שולחן לקבלת אביזר לעיבוד ושיטה לעיבוד‬
‫האביזר על שולחן שכזה‬
]54[
TABLE USED TO RECEIVE A
WORKPIECE AND METHOD FOR
TREATING A WORKPIECE ON
SAID TYPE OF TABLE
]11[
]22[
]52[
].2[
27.05.2005
935/04
]21[ 03.06.2004
]22[
Int. Cl.(2010.01) B65G 49//06, C03B 33//03
OERLIKON TRADING AG,
TRUBBACH, SWITZERLAND
WO/2005/118440
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
CH
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a device which is used to treat a workpiece, in particular an
essentially flat substrate. Said device comprises a table (2) which is used to support the
workpiece (5). A flow generating device (6, 11) produces a gas flow (22) on a top side
(17.1, 17.2) of the table (2) in the region between the workpiece (5) and the top side
(17.1, 17.2) of the table (2), whereon the workpiece (5) is arranged during treatment.
__________________
]22[]12[
]54[
]11[
215
PREPARATION OF PREGABALIN
AND RELATED COMPOUNDS
179614
‫הכנת פרגבלין ותרכובות קשורות‬
09.06.2005
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[
]52[
].2[
]7.[
].4[
]5.[
60/581671
]21[ 21.06.2004
]22[ US
016013124
2732231114
US
Int. Cl.(2010.01) C07C 22/7/18, 22/9/24, 25/5/19, C07D 20/7/277
WARNER-LAMBERT COMPANY
LLC, U.S.A.
WO/2006/000904
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Materials and methods for preparing (S)-(+)-3-aminomethyl-5-methyl-hexanoic acid
and structurally related compounds via enzymatic kinetic resolution are disclosed.
__________________
]22[]12[
]54[
LOOPED NONWOVEN WEB AND
METHODS FOR PRODUCING IT
]11[
]22[
]52[
].2[
21.06.2005
60/581679
]21[ 21.06.2004
Int. Cl.(2010.01) D04H 01//74, 11//00
THE PROCTER & GAMBLE
COMPANY, U.S.A.
WO/2006/009997
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
216
179863
‫אריג לולאתי בלתי ארוג ושיטות לייצורו‬
]22[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a nonwoven web comprising a plurality of loops. At
least one of said loops having a loop circumference length to loop base length ratio
that is greater than about 4:1. The loops may also have a base length less than 0.5 cm
and a base length less than the maximum width of the loops. The present invention
also relates to articles selected from the group consisting of disposable hygiene article
September 27, 2011-‫כ"ח באלול התשע"א‬
and wipes comprising a nonwoven web wherein at least one region of the nonwoven
web comprises loops in at least about 10% of the surface area of the nonwoven web. A
method for producing a nonwoven web comprising a plurality of loops is also
included. The method comprises the steps of providing a nonwoven web; providing
means for moving fibers of the nonwoven web into the shape of a loop; and moving
fibers of the nonwoven web into the shape of a loop.
__________________
]22[]12[
179919
‫ תכשירים המכילים אותם‬,‫תאי גזע עצביים‬
‫ושיטות לקבלתם‬
]54[
NEURAL STEM CELLS,
COMPOSITIONS COMPRISING
THE SAME AND METHODS OF
OBTAINING THE SAME
]11[
]22[
09.06.2005
0412887.2
]21[ 09.06.2004
]22[ GB
151214431
2431131115
GB
151552137
2.31231115
GB
Int. Cl.(2010.01) C12N 05//0789
THE UNIVERSITY COURT OF THE
UNIVERSITY OF EDINBURGH,
UNITED KINGDOM
WO/2005/121318
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A homogenous, symmetrically dividing population of adherent neural stem cells is
obtained from ES cells or foetal or adult brain isolates, using an activator of a
signalling pathway downstream of a receptor of the EGF receptor family, optionally in
combination with an activator of a signalling pathway downstream of an FGF receptor.
The neural stem cell population is highly pure and retains the ability to differentiate
into neurons after in excess of 100 passages.
]52[
].2[
]7.[
].4[
]5.[
217
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
]54[
METHODS FOR IDENTIFYING
STEM CELLS BASED ON
NUCLEAR MORPHOTYPES
]11[
]22[
]52[
].2[
17.06.2005
60/580575
]21[ 17.06.2004
Int. Cl.(2010.01) G01N 33//50
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY, U.S.A.
WO/2006/009860
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
218
179972
‫שיטה לזיהוי תאי גזע המבוססת על מורפוטיפים‬
‫גרעיניים‬
]22[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Methods for identifying stem cells and other cells specific to embryogenesis and
carcinogenesis, classifying tissue samples, diagnosing precancerous and cancerous or
atherosclerotic lesions, testing the value of anticancer agents, discovering
macromolecules specifically expressed in particular cell types, using stem cells in
restorative tissue therapy as well as methods for preparing tissue samples so
heteromorphic nuclear morphotypes remain intact are disclosed.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
180024
‫–דיהידרופירידין ושיטה‬2 ,8 ‫גביש תרכובת של‬
‫לייצורו‬
]54[
CRYSTAL OF 1,2DIHYDROPYRIDINE COMPOUND
AND METHOD FOR PRODUCING
SAME
]11[
]22[
]52[
].2[
05.07.2005
2004-198709 ]21[ 06.07.2004
]22[ JP
Int. Cl.(2010.01) A61K 31//444, C07D 21/3/64
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
ITARU ARIMOTO, SATOSHI
NAGATO, YUKIKO SUGAYA,
YOSHIO URAWA, KOICHI ITO,
HIROYUKI NAKA, TAKAO OMAE
WO/2006/004107
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
Disclosed are a crystal of 3-(2-cyanophenyl)-5- (2-pyridyl)-1-phenyl-1,2dihydropyridine-2-one and a method for producing the same.
].1[
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
COATED CUTTING INSERT AND
MANUFACTURING METHOD
THEREOF
]11[
]22[
]52[
].2[
25.11.2005
2004-351705 ]21[ 03.12.2004
Int. Cl.(2010.01) B23B 27//14
SUMITOMO ELECTRIC
HARDMETAL CORP., JAPAN
WO/2006/059551
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
]7.[
].4[
219
180049
‫שימה מצופה ושיטה לייצורה‬
]22[
JP
,‫פרל כהן צדק לצר‬
September 27, 2011-‫כ"ח באלול התשע"א‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
An edge replacement type cutting tip (1), comprising a body (8), and base layer formed
on the body (8), and a use state indication layer partly formed on the base layer. The
base layer presents a color different from that of the use state indication layer, and the
use state indication layer is formed on the base layer at least partly on its surface
including an edge ridge line part (4) and a face (2) excluding a flank (3). The cutting
tip is characterized in that, where the surface roughness (Ra) of the breaker groove part
or the land part of the face (2) is Aμm and the surface roughness (Ra) of the flank (3)
is Bμm, the requirement of B/A ≤ 1 is established.
P.O.B. 12704,
HERZLIYA 46733
]5.[
__________________
]22[]12[
180180
–3 ‫תהליך ותוצר ביניים לייצור‬
‫פניל(תיאו)אוראצילים ודיתיאוראצילים‬
]54[
PROCESS AND INTERMEDIATE
FOR THE PRODUCTION OF 3PHENYL (THIO)URACILS AND
DITHIOURACILS
]11[
]22[
]52[
].2[
]7.[
].4[
13.07.2005
102004035656.4 ]21[ 22.07.2004
Int. Cl.(2010.01) C07D 23/9/54
BASF SE, GERMANY
WO/2006/010474
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
The invention relates to a method for the production of 3-phenyl(thio)uracils and
dithiouracils of formula I, wherein the variables have the meanings cited in the
description, characterized in that carbamates of formula II, wherein variables X1, X3,
Ar and A have the above-mentioned meanings and L1 represents a nucleophilically
displaceable nucleofuge, can be reacted with enamines of formula III, wherein
variables X2, R1, R2 and R3 have the above-mentioned meanings and L2 represents a
220
]22[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
nucleophilically displaceable nucleofuge. The invention also relates to intermediate
products for the production thereof.
__________________
]22[]12[
180227
‫אימות זמינות תחנת מנוי ניידת במצב סרק‬
‫במערכת גישה אלחוטית‬
]54[
VERIFYING AVAILABILITY OF
IDLE-MODE MOBILES
SUBSCRIBER STATION IN
WIRELESS ACCESS SYSTEM
]11[
]22[
25.06.2005
10-2004]21[ 25.06.2004
]22[ KR
0048431
21-11142131.31114
KR
1152.31
21-11141531331114
KR
11..043
21-11151731231115
KR
1123122
Int. Cl.(2010.01) H04J 03//24, H04W 68//00, 68//02
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/001673
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method of verifying availability of a mobile subscriber station that is in an idlemode includes requesting to a base station by the mobile subscriber station to enter an
idle-mode, wherein the base station is associated with a paging group comprising a
plurality of base stations, and receiving from the base station an idle-mode response
command to enter the idle-mode. The method also includes receiving from the base
station a paging command comprising an action code associated with performing
ranging while the mobile subscriber station is in the idle-mode to verify availability of
]52[
].2[
]7.[
].4[
]5.[
221
September 27, 2011-‫כ"ח באלול התשע"א‬
the mobile subscriber station with respect to the base station, wherein if the ranging is
not successfully performed with the base station during a predetermined period, the
base station continues to transmit the paging command until a paging retrial count
reaches a predetermined threshold.
__________________
]22[]12[
]54[
METHOD OF MANAGING THE
SUPPLY OF ELECTRICAL
POWER, AN ELECTRICAL
POWER SUPPLY CIRCUIT AND A
METHOD OF POWERING AN
APPLIANCE WHEN COLD
]11[
]22[
]52[
].2[
21.12.2006
0513199
]21[ 22.12.2005
Int. Cl.(2010.01) H05B 01//00
SAGEM DEFENSE SECURITE,
FRANCE
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
].4[
]5.[
222
180235
‫ מעגל חשמלי‬,‫שיטה לניהול הספקה של חשמל‬
‫להספקת חשמל ושיטה להפעלת מכשיר קר‬
]22[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method of managing a supply of electrical power to an appliance that is delivered by
means of at least a first battery and a second battery, said method comprising the
following steps: powering the appliance by means of the first battery so long as said
first battery has a level of charge sufficient for powering the appliance; when the
battery has a level of charge that is insufficient, powering the appliance by means of
the second battery; and powering the appliance with both of the batteries in parallel
when the levels of charge of both batteries are substantially equal and insufficient for it
to be possible to power the appliance using a single one of the batteries.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
180365
‫קרבורנילפורפרינים והשימוש בהם להדמייה‬
‫ולטיפול בסרטן‬
]54[
CARBORANYLPORPHYRINS AND
USES THEREOF IN IMAGING
AND IN THE TREATMENT OF
CANCER
]11[
]22[
]52[
].2[
22.06.2005
10/878138
]21[ 28.06.2004
]22[ US
Int. Cl.(2010.01) A61B 05//055, A61K 06//083, 31//40, 31//555, C07F 05//00
BROOKHAVEN SCIENCE
ASSOCIATES, U.S.A.
WO/2006/012140
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]7.[
].4[
]5.[
223
The present invention is directed to low toxicity boronated compounds and methods
for their use in the treatment, visualization, and diagnosis of tumors. More specifically,
the present invention is directed to low toxicity carborane-containing 5, 10,20tetraphenylporphyrin compounds and methods for their use particularly in boron
neutron capture therapy (BNCT) and photodynamic therapy (PDT) for the treatment of
tumors of the brain, head, neck, and surrounding tissue. The invention is also directed
September 27, 2011-‫כ"ח באלול התשע"א‬
to using these carborane-containing tetraphenyl porphyrin compounds to methods of
tumor imaging and/or diagnosis such as MRI SPECT, or PET.
__________________
]22[]12[
180451
‫שיטה ותכשיר לחיטוי ברמה גבוהה בשימוש‬
‫תרכובות אמוניום רביעוניות‬
]54[
METHOD AND COMPOSITION
FOR HIGH LEVEL DISINFECTION
EMPLOYING QUATERNARY
AMMONIUM COMPOUNDS
]11[
]22[
]52[
].2[
07.07.2005
2004903796
]21[ 09.07.2004
]22[ AU
Int. Cl.(2010.01) A61L 02//04
NANOSONICS PTY LIMITED,
AUSTRALIA
WO/2006/005108
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
Methods and compositions for high level disinfection (as herein defined) of a surface.
Methods include treating the surface with a composition including a quaternary
ammonium compound in a concentration which exceeds 1 % w/w and the temperature
of treatment is in the range of from 30 °C to 80 °C. A log (6) reduction in
Mycobacterium terrae is achieved on the surface in less than 10 minutes. The
temperature may be produced by a physical chaotrope, a chemical chaotrope such as
boron or a boron compound or complex or a combination of chaotropic agents.
Sequestering agents and enzymes may be added.
]7.[
].4[
]5.[
__________________
]22[]12[
180479
‫תהליך סינתזה ללקוסאמיד‬
]54[
SYNTHESIS SCHEME FOR
LACOSAMIDE
]11[
]22[
]52[
30.09.2005
04023556.6
]21[ 02.10.2004
]22[ EP
Int. Cl.(2010.01) C07C 22/7/14, 22/9/22, 23/1/10
224
September 27, 2011-‫כ"ח באלול התשע"א‬
].2[
]7.[
].4[
]5.[
UCB PHARMA GMBH, GERMANY
WO/2006/037574
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention is concerned with an improved method of producing (R)-2acetamido-N-benzyl-3-methoxypropionamide (lacosamide) comprising the 0methylation of a compound of formula (I) to produce a compound of formula (II) in a
single step reaction.
__________________
]22[]12[
180588
]54[
HUMANIZED ANTI-C-MET
ANTIBODIES
]11[
]22[
]52[
].2[
]7.[
].4[
04.08.2005
60/598991
]21[ 05.08.2004
Int. Cl.(2010.01) C07K 16//00, 16//28
GENENTECH, INC., U.S.A.
WO/2006/015371
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
Therapeutic anti-c-met antibodies, and compositions comprising and methods of using
these antibodies.
225
C–MET ‫נוגדנים ממקור אנושי נוגדי‬
]22[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
2021/0/
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
]54[
GRIPPING TOOL
]11[
]22[
]52[
].2[
09.01.2007
2006-7828
]21[ 16.01.2006
Int. Cl.(2010.01) A61B 17//06
SHERWOOD SERVICES AG,
SWITZERLAND
NIPPON SHERWOOD MEDICAL
INDUSTRIES LTD, JAPAN
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
].4[
]5.[
180610
‫מכשיר לאחיזה‬
]22[
JP
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A gripping tool for attachment to one end of a flexible drainage tube used for
discharging fluids in the body, the gripping tool being arranged to be gripped with a
removal member for pulling the end of said drainage tube remaining in a patient's body
out of the body, the gripping tool comprising a main body for attachment to one end of
said drainage tube, a gripping part that is to be gripped by said removal member, and a
connecting part that can bend and which connects said main body and said gripping
part, eh hen ise hsen ap e esi sn ennh i as h os r resr as hi reh
enie h pa ise ei es ah r ah sn sn p rh i as h os r resr ei h opih rp
re p ae esnnhh osiiena -reh p rie h pa ise ei es ah r ah sn s osii
ha pone end of said main body to an opposite end , ise pnnh rena os r ahena
re p ae esnnhh i e resr s - eiopih re p ae reh sap hhhnrepnh osii
ae ir hn reh hpa ei opierepnh enie h ise ei es ah r ah sn ise
226
September 27, 2011-‫כ"ח באלול התשע"א‬
eh hpa sn sr ise ae ir hn s a eooena os r ei pnnh rh rp s ih pn hn r
irpo ei srrs eh rp o hhhnr eihnasahhhnr pa reh ise pnnh rena os r
3a ph ise hsen ap e ae hnasaena en ise hsen ap e
__________________
]22[]12[
180659
‫שיטה להשגת גישה למידע על אובייקט בעל‬
,‫ תוכנית‬,ONS ‫ הרשאת‬,‫ שרת מקומי‬,‫תווית‬
,‫ התקן בעל כתיבת תווית‬,‫שיטת יצירת תווית‬
‫ ותוכנית לשליטה על ההתקן בעל כתיבת‬,‫תווית‬
‫התווית‬
]54[
METHOD FOR ACCESSING
INFORMATION ON OBJECT
HAVING TAG, LOCAL SERVER,
ONS PROXY, PROGRAM, TAG
CREATION METHOD, DEVICE
HAVING TAG WRITER, TAG,
AND PROGRAM FOR
CONTROLLING DEVICE HAVING
TAG WRITER
]11[
]22[
]52[
].2[
]7.[
].4[
13.07.2005
2004-208935 ]21[ 15.07.2004
]22[ JP
Int. Cl.(2010.01) G06F 21//00, 21//24, G06K 17//00, 19//07, 19//10, H04L 09//32
IBM CORPORATION, U.S.A.
WO/2006/009040
IBM LABORATORIES,
,‫מעבדות יבמ מחלקת קנין רוחני‬
HAIFA UNIVERSITY,
‫אוניברסיטת חיפה הר הכרמל‬
HAIFA 31905
‫חיפה‬
There is provided a method including: a step that a local server uses a tag reader to
read a virtual ID encrypted; a step that the local server transmits an ONS service
request including the virtual ID to an ONS proxy; a step that the ONS proxy decrypts
the virtual ID by using a key K so as to acquire the object ID; a step that the ONS
proxy generates a network address request; a step that the local server receives the
network address of a PML server returned from the ONS server according to the
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
227
network address request; a step that the local server uses the network address of the
PML server to transmit the PML service request including the virtual ID to the PML
server; and a step that the PML server provides information on the object related to the
tag identified by using the object ID obtained by decrypting the virtual ID by using the
key K, to the local server.
__________________
]22[]12[
180690
‫ התקן ושיטת הזנה ליצירת מבנה‬,‫אמצעי מילוי‬
‫תומך בחלל בעצם‬
]54[
FILLER MEANS, FEEDING
DEVICE AND METHOD FOR THE
FORMING OF A SUPPORT
STRUCTURE IN A BONE CAVITY
]11[
]22[
]52[
].2[
]7.[
].4[
14.07.2005
04405451.8
]21[ 14.07.2004
]22[ EP
Int. Cl.(2010.01) A61B 17//68, 17//88, A61F 02//44, A61L 27//50
AKROSS AG, SWITZERLAND
WO/2005/094735
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to dry free-flowing filler (1) for forming a support structure in a
bone cavity (4a). Said filler comprises a plurality of biocompatible support bodies (2)
which are resistant to deformation or fracture under the physiological loads usually
occurring in the bone cavity (4a). Said support bodies (2) have a size between 2 mm
and 10 mm and an axis (A) and two opposite abutments (2g) spaced apart in the
direction of the axis (A).
]5.[
228
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
180691
‫תכשירי אורגנו–ג'ל ליישומים רפואיים‬
]54[
ORGANO-GEL FORMULATIONS
FOR THERAPEUTIC
APPLICATIONS
]11[
]22[
11.10.2005
10/960516
]21[ 08.10.2004
]22[ US
226100475
1731131115
US
226251154
2231031115
US
Int. Cl.(2010.01) A61K 09//70, 31//74, 35//00, 47//10, 47//14
MEDIQUEST THERAPEUTICS, INC.,
U.S.A.
WO/2006/042059
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A composition suitable for the local delivery of cosmetic and/or pharmaceutical agents
into the skin containing at least two biocompatible organic solvents, a polar lipid, a
surfactant, water, urea and a thickener wherein the organic solvents include an ester
and a dihydric and/or polyhydric alcohol is provided. Also disclosed are compositions
that further contain a cosmetic and/or pharmaceutical agent, along with the preparation
and use thereof.
]52[
].2[
]7.[
].4[
]5.[
__________________
]22[]12[
229
180809
September 27, 2011-‫כ"ח באלול התשע"א‬
]54[
TRANSPARENT LAMINATED
STRUCTURE HAVING PEELAWAY FILM LAYERS FOR USE
ON AIRCRAFT WINDSCREENS
]11[
]22[
]52[
].2[
27.05.2005
10/909129
]21[ 30.07.2004
Int. Cl.(2010.01) B60J 01//20
UNITED PROTECTIVE
TECHNOLOGIES, LLC, U.S.A.
BRENT W. BARBEE, ANDREW E.
HOUGH
WO/2006/028532
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
].1[
]7.[
].4[
]5.[
‫מבנה למינציה שקוף שיש לו שכבות עם פילם‬
‫הניתן לקילוף לשימוש במגן רוח של כלי טיס‬
]22[
US
,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
A transparent laminated structure having multiple peel-away laminated film layers for
protecting windscreens, particularly windscreens of rotary aircraft, from environmental
conditions. The laminated structure includes at least one laminated layer wherein each
layer includes a film, a bonding layer on a first major side of the film for releaseably
attaching the film to either the windscreen or to an adjacent laminated film layer, a
conductive material on a second major side of the film for dissipating electrostatic
charging in the laminated structure that may occur due to accumulated precipitation
static during aircraft fight, and a hard coat layer for protecting the relatively softer film
against abrasion. As the outermost film layer becomes degraded below acceptable
levels, that film may be easily removed, exposing a subsequent unblemished film
layer.
__________________
]22[]12[
]54[
230
FLOW REGULATOR
PARTICULARLY FOR MEDICAL
PURPOSES
180877
‫וסת זרימה בעיקר עבור שימושים רפואיים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]11[
]52[
].2[
].4[
]5.[
231
22.01.2007
Int. Cl.(2010.01) G05D 07//01
MFS MEDICAL FLOW SYSTEMS
‫ שלומי‬,‫ אס מוצרים רפואיים בע"מ‬.‫ אפ‬.‫אמ‬
LTD.
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A flow regulator for a wide range of low fluid flows, comprising:
an inner non-revolving core element (102);
an outer housing (110), having a hollow base section and being revolvably supported
co-axially with said core element;
first (14) and secondary (16) chambers disposed between said core element and said
outer housing, each camber having an inlet and an outlet, said outlet of said first
chamber and said inlet of said secondary chamber being connected by a flow
restriction path (34);
an at least partly elastic diaphragm (18) separating the two chambers and sealing an
inlet to a discharge tube when pressure at said first chamber is higher then pressure in
said secondary chamber' said diaphragm comprising an outer ring (64), a central disk
(66), and a flexible intermediate section connecting said outer ring to said central disk;
and
a circular spring placed in the secondary chamber below said diaphragm and around
said discharge tube; and
said discharge tube having said inlet connected to said outlet of said secondary
chamber when said central disk is spaced apart from said inlet, and having a lower
outlet connectable for infusion to a patient;
the major improvement being the addition of graduated flow-rate locking ring (116)
housing a disk like body (118) disposed between the outlet of said discharge tube and
said base portion of said outer housing, wherein when said locking ring is in its open
position a lock key (124) is in a low position freeing said outer housing to be revolved
to any position within its range including a priming position while said locking ring
can be revolved to select any flow-rate within the regulator range, whereas when said
locking ring is in its locked position said lock key is raised to its upper position and
said outer sleeve is restricted to the regulating and closed positions and said locking
ring is locked at the selected flow rate.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
180894
–‫–דיאוקסי‬2–‫–דיפלורו‬2,2–‫אלפא–הלו‬8 ‫תולדות‬
‫–ריבופוראניזה ושיטות להכנתן‬D
]54[
1-ALPHA-HALO-2,2-DIFLUORO-2DEOXY-D-RIBOFURANOSE
DERIVATIVES AND PROCESSES
FOR THE PREPARATION
THEREOF
]11[
]22[
21.06.2005
10-2004]21[ 29.07.2004
]22[ KR
0059623
21-11152.31531115
KR
11421.7
Int. Cl.(2010.01) C07H 03//08
HANMI HOLDINGS CO., LTD.,
REPUBLIC OF KOREA
WO/2006/011713
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
1-alpha-halo-2,2-difluoro-2-deoxy-D-ribofuranose derivative of formula (I) having the
3-hydroxy group protected with a biphenylcarbonyl group is a solid which can be
easily purified by a simple procedure such as recrystallization, and therefore, it can be
advantageously used as an intermediate in the preparation of gemcitabine in a large
scale. Further, the 1-alpha-halo-2,2-difluoro-2-deoxy-D-ribofuranose derivative of
formula (I) can be prepared with high stereoselectivity using the compound of formula
(V) as an intermediate.
]52[
].2[
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
SOLAR ABSORBER
]11[
]22[
]52[
].2[
]7.[
].4[
05.08.2005
102004038233.6 ]21[ 05.08.2004
Int. Cl.(2010.01) F24J 02//48
SCHOTT AG, GERMANY
WO/2006/015815
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
232
181111
‫קולט קרינת שמש‬
]22[
DE
,‫ריינהולד כהן ושותפיו‬
September 27, 2011-‫כ"ח באלול התשע"א‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a solar absorber comprising an absorber body (10) provided
with an absorption layer (17) on the side thereof on which the radiation concentrated
by a concentrator is incident, and an absorption layer (18) on the opposite side. The
absorption layer on the side facing the concentrator has a higher boundary wavelength
than the opposing absorption layer. In this way, in the region of higher irradiance, the
limit of the radiation emission of the absorber body is shifted to longer wavelengths
such that both sides of the absorber body are operated with the respectively highest
possible directivity.
RAMAT HACHAYAL 69710
]5.[
__________________
]22[]12[
181156
–‫–מותמרים‬3 ‫אמידים של חומצה קרבוקסילית‬
‫ אנלוגים‬,2–‫–אמינואלקיל אינדול‬6 –‫– ו‬5
‫ תרכובות רוקחות ושימושיהן‬,‫משויכים‬
ε I ‫כמעכבים של קזאין קינאז‬
]54[
3-SUBSTITUTED-5-AND 6AMINOALKYL INDOLE-2CARBOXYLIC ACID AMIDES
AND RELATED ANALOGS,
PHARMACEUTICAL
FORMULATIONS AND USES
THEREOF AS INHIBITORS OF
CASEIN KINASE I-EPSILON
]11[
]22[
]52[
16.08.2005
60/603380
]21[ 19.08.2004
]22[ US
Int. Cl.(2010.01) A61K 31//404, 31//4045, 31//438, 31//47, 31//497, 31//506,
31//5377, 31//551, A61P 25//00, 25//24, C07D 20/9/42, 40/1/10, 40/1/12, 40/3/12,
40/3/14, 40/5/14, 40/9/12, 41/3/10, 49/1/113
AVENTIS PHARMACEUTICALS
INC., U.S.A.
WO/2006/023467
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
].2[
]7.[
].4[
233
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
HERZLIYA 46733
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
The present invention discloses and claims compounds of formula (I) and formula (II)
as inhibitors of human casein kinase Iepsilon, and methods of using said compounds of
formula (I) and formula (II) for treating central nervous system diseases and disorders
including mood disorders and sleep disorders. Pharmaceutical compositions
comprising compounds of formula (I) or formula (II) are also disclosed and claimed.
__________________
]22[]12[
]54[
APPARATUS, SYSTEM AND
METHOD FOR
AUTOMATICALLY
DISCOVERING AND
GROUPING RESOURCES
USED BY A BUSINESS
PROCESS
]11[
]22[
]52[
].2[
]7.[
].4[
20.07.2005
10/915146
]21[ 10.08.2004
Int. Cl.(2010.01) G06F 09//40
IBM CORPORATION, U.S.A.
WO/2006/015935
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
181244
‫ מערכת ושיטה‬,‫התקן‬
‫לגילוי וסיווג אוטומטי של‬
‫משאבים בהם עושה‬
‫שימוש תהליך עסקי‬
]22[
US
‫מעבדות יבמ מחלקת‬
,‫קנין רוחני‬
‫אוניברסיטת חיפה הר‬
‫הכרמל‬
‫חיפה‬
An apparatus, system, and method are provided for automatically
discovering and grouping files and other resources used by a business
process. The present invention includes a monitoring module that
collects trace data representative of operational behaviour of software
applications. An analysis module analyzes the trace data to discover
resources affiliated with the business process. A determination module
defines a logical application corresponding to the business process and
includes the resources discovered by the analysis module. The logical
application is automatically defined such that business policies may be
readily implemented on the logical application as a whole. Manual
234
September 27, 2011-‫כ"ח באלול התשע"א‬
identification of resources for a business process is eliminated or
substantially reduced.
__________________
]22[]12[
]54[
]11[
]22[
]52[
].2[
METHODS AND APPARATUS FOR
HYBRID OUTLIER DETECTION
20.02.2007
11/535851
]21[ 27.09.2006
Int. Cl.(2010.01) G01R 31//28, 31//317
TEST ADVANTAGE, INC., U.S.A.
272444
‫שיטה והתקן עבור זיהוי משולב של נקודות‬
‫רחוקות במקבץ סטטיסטי‬
]22[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
].4[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
A test data analysis system for analyzing test data for multiple components fabricated on
a wafer, comprising: a memory configured to store a test data; and a hybrid outlier
system having access to the memory and configured to, for each of a plurality of test
data for each of a plurality of selected components: select a component as a central
component; identify a plurality of local components in a local area near the central
component; determine a derived value of the test data for the plurality of local
components; compare the test data for the central component to the derived value for the
plurality of local components; and identify whether the test data for the central
component represents a hybrid outlier according to the comparison of the test data for
the central component to the derived value for the plurality of local components.
235
September 27, 2011-‫כ"ח באלול התשע"א‬
----------------------------]22[]12[
181469
‫התקן ושיטה לייצור אות מקודד רב–ערוצי‬
‫והתקן ושיטה לפענוח אות מקודד רב–ערוצי‬
]54[
DEVICE AND METHOD FOR
GENERATING A CODED MULTICHANNEL SIGNAL AND DEVICE
AND METHOD FOR DECODING A
CODED MULTI-CHANNEL SIGNAL
]11[
]22[
]52[
].2[
29.08.2005
102004042819.0 ]21[ 03.09.2004
]22[ DE
Int. Cl.(2010.01) G10L 19//00
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V., GERMANY
JURGEN HERRE, RALPH
SPERSCHNEIDER, JOHANNES
HILPERT, KARSTEN LINZMEIER,
HARALD POPP
WO/2006/027138
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
In a multichannel encoder producing several different sets of parameters for restoring a
multichannel output signal using at least one transmission channel, a data flow (26) is
described (25) in such a way that two parameter sets are decodable independently from
each other, thereby enabling a multichannel decoder, while reading the data flows, to
drop a parameter set which is defined as optional and possibly has a higher version
number and to carry out a valid multichannel restoration using a data set defined as
absolutely necessary or a data set whose version number is sufficiently low, thereby
making it possible to obtain a flexible and suitable for future actualisation
encoder/decoder concept which is characterised by a reverse compatibility and an
].1[
]7.[
].4[
]5.[
236
September 27, 2011-‫כ"ח באלול התשע"א‬
operational reliability.
__________________
]22[]12[
181527
‫מחסנית למיימון בקנה מידה מעבדתי עבור‬
‫מיימון בתכשיר נוזלי רב רכיבי שוטף‬
]54[
LABORATORY-SCALE
HYDROGENATION CARTRIDGE
REACTOR FOR
HYDROGENATING AN
INFLOWING MULTICOMPONENT FLUID
COMPOSITION
]11[
]22[
]52[
].2[
]7.[
].4[
23.08.2005
P0401726
]21[ 23.08.2004
Int. Cl.(2010.01) B01J 08//02
THALESNANO ZRT, HUNGARY
WO/2006/021822
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
The invention relates to a cartridge reactor (10) for a flow-type hydrogenation
apparatus. The cartridge reactor (10) has a casing equipped with an inlet (18), an outlet
(20) and a closed expanded portion enclosing a reaction volume (16) spreading
between the inlet (18) and the outlet (20). The cartridge reactor (10) according to the
invention is prepared in a laboratory size and its reaction volume (16) is at most 10
cm3 in size. The reaction volume (16) is filled with an immobilized packing medium
(29) that increases flow resistance and facilitates mixing. The inlet (18) and the outlet
(20) of the cartridge reactor (10) are formed with a structure enabling a detachable
connection to the hydrogenation apparatus.
237
]22[
HU
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
181558
‫פורמולציות נוזליות להגנת צמחים המכילות‬
‫דיפלופניקאן‬
]54[
LIQUID PLANT PROTECTION
FORMULATIONS COMPRISING
DIFLUFENICAN
]11[
]22[
]52[
03.09.2005
102004045371.3 ]21[ 18.09.2004
]22[ DE
Int. Cl.(2010.01) A01N 25//02, 37//40, 43//36, 43//40, C07C 23/5/12, 23/5/28,
23/5/70, 27/5/00, C07D 20/7/267, 21/3/82
BAYER CROPSCIENCE AG,
GERMANY
WO/2006/029736
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to liquid plant protection formulations comprising a) 0.1 to 8 %
diflufenican in dissolved form, b) 1 to 80 % of a solvent, with both polar and non-polar
groups, or a mixture of such solvents, c) 1 to 30 % of a detergent or detergent mixture,
d) 0 to 70 % of one or more further agrochemical agents, e) 0 to 50 % of a non-polar
solvent, f) 0 to 15 % of a dipolar solvent and g) 0 to 20 % of one or more adjuncts.
Said plant protection formulations are suitable for the prevention of pests.
].2[
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
238
FLEXIBLE NANO-IMPRINT
STAMP
181718
‫חותם גמיש להדפסה זעירה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]11[
]22[
]52[
].2[
]7.[
].4[
]5.[
07.09.2005
PA200401354 ]21[ 08.09.2004
016021511
1431331114
Int. Cl.(2010.01) B82B 01//00
NIL TECHNOLOGY APS, DENMARK
WO/2006/026993
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]22[
DK
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a nano-imprinting stamp for imprinting nanometersized to mm-sized structures, the stamp (1) having a base part and a first and a second
imprinting section (2,3), the first and second impríntíng sections having a lithographic
pattern (7) intended for imprinting in a receiving substrate. In a first aspect, the first
and the second. imprinting sections (2,3) are independently displaceable in a direction
substantially parallel to an imprinting direction of the imprinting stamp. In a second
aspect, the first and the second imprinting sections (2,3) are mechanically weakly
coupled in a direction substantially parallel to an imprintíng direction of the imprinting
stamp. The stamp limits the effect of imperfections in or on the substrate to be
imprinted with a lithographic pattern (7) and imperfections in or on the stamp and any
combinations of such imperfections by localising the bending of the stamp to the base
part (5) in-between the imprinting sections (2,3).
__________________
]22[]12[
]54[
METHODS AND SYSTEMS FOR
CRYOGENIC COOLING
]11[
]22[
]52[
].2[
26.09.2005
10/952531
]21[ 27.09.2004
Int. Cl.(2010.01) A61F 07//00
CRYODYNAMICS, LLC, U.S.A.
239
181805
‫שיטות ומערכות לקירור קריוגני‬
]22[
US
September 27, 2011-‫כ"ח באלול התשע"א‬
]7.[
].4[
]5.[
WO/2006/137887
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Methods and systems are provided for cooling an object with a cryogen having a
critical point defined by a critical-point pressure and a critical-point temperature. A
pressure of the cryogen is raised above a pressure value determined to provide the
cryogen at a reduced molar volume that prevents vapor lock. Thereafter, the cryogen is
placed in thermal communication with the object to increase a temperature of the
cryogen along a thermodynamic path that maintains the pressure greater than the
critical-point pressure for a duration that the cryogen and object are in thermal
communication.
The applications for division
from this application have
not yet been published
20212/120212//
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
]54[
METHOD AND APPARATUS FOR
DETERMINING AND MANAGING
CONGESTION IN A WIRELESS
COMMUNICATIONS SYSTEM
]11[
]22[
]52[
].2[
13.09.2005
10/939785
]21[ 13.09.2004
Int. Cl.(2010.01) H04W 48//12, 48//18
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2006/031834
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
240
181894
‫שיטה ומכשיר לקביעה וניהול צפיפות במערכת‬
‫תקשורת אלחוטית‬
]22[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An improved method of network management, particularly in the context of standards
September 27, 2011-‫כ"ח באלול התשע"א‬
IEEE802.11 and IEEE802.11k, through two new MAC measurements, with attendant
advantages. The two new measurements include WTRU uplink traffic loading
measurement, and an AP service loading measurement and is generally applicable at
least to layers 1 and 2 as applied to a least 802.11k in the context of OFDM and
CDMA 2000 systems, but is applicable to other scenarios as well. A method for
determining and advertising congestion is also provided for a Wireless Local Area
Network (WLAN) system. The present invention also introduces a method for
managing congestion when congestion is detected. This aspect of the present invention
applies primarily to wireless systems that use the Carrier Sense Multiple Access/
Collision Avoidance (CSMA/CA) mechanism. The methods are advantageously
implemented in selectively configured WTRUs of various forms.
__________________
]22[]12[
181927
‫שיטות לסקירת ספריית נוגדנים והשימוש בהן‬
‫או בידוד מולקולות מטרה‬/‫לזיהוי ו‬
]54[
METHODS FOR ANTIBODY
LIBRARY SCREENING AND USES
THEREOF FOR IDENTIFYING
AND/OR SELECTING TARGET
ENTITIES
]11[
]22[
]52[
].2[
07.10.2005
0422431.7
]21[ 08.10.2004
]22[ GB
Int. Cl.(2010.01) C07K 16//00, C40B 30//04, G01N 33//68
AFFITECH RESEARCH AS,
NORWAY
WO/2006/038022
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
241
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
The present invention provides an improved method of screening a library of
molecules to identify or select one or more members thereof which are candidate
binding partners for one or more target entities: (a) contacting an expression library
with one or more target entities; (b) subjecting said target entities to at least one
washing step; (c) separating target entities which have become bound to one or more
members of the expression library from unbound members of the expression library by
separation through an organic phase, thereby separating candidate binding partners for
said target entities from other library members.
__________________
]22[]12[
]54[
METHOD AND DEVICE FOR
QUESTIONING A PLURALITY OF
COMPUTERIZED DEVICES
]11[
]22[
29.09.2005
164402
]21[ 04.10.2004
0160.1151
2731431115
0160.11.1
2731431115
0160.1145
2731431115
0160.1140
2731431115
226110452
2531331115
Int. Cl.(2010.01) G06F 15//16
PROMISEC LTD.
]52[
].2[
182013
‫שיטה והתקן לשאילתה של מספר התקנים‬
‫ממוחשבים‬
]22[
IL
US
US
US
US
US
‫ י מולכו‬,‫ שמרון‬:‫פרומיסק בע"מ אצל‬
‫ אביב‬-‫ תל‬,‫פרסקי‬
]7.[
].4[
WO/2006/038210
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
Some embodiments of the present invention may relate to a device and a method of
questioning computerized devices within an organization's network. The device, in
accordance with some embodiments of the present invention, may include a
questioning module and an agentless module. The questioning module may be adapted
to receive data specifying a plurality of computerized devices to be questioned, and to
receive data indicating which one or more questioning subjects are selected to be
questioned on the specified computerized devices. The agentless module may be
adapted to invoke and configure at least a remote access process, to question at least a
registry of a remote computerized device. In accordance with some embodiments of
the present invention, the questioning module may be adapted to utilize multiple
threads of the agentless module to invoke and configure a plurality of remote access
242
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
processes to question in parallel and without using agents at least a registry of the
specified computerized devices, in accordance with the selected questioning subjects.
__________________
]22[]12[
182078
‫מערכת לחיבור אלמנט חיתוך לכלי חיתוך‬
]54[
SYSTEM FOR ATTACHING A
CUTTING MEMBER TO A
CUTTER
]11[
]52[
].2[
].1[
].4[
20.03.2007
Int. Cl.(2010.01) B23C 05//06, 05//26
ISCAR LTD.
‫ תפן‬,‫ישקר בע"מ‬
GIL HECHT
‫גיל הכט‬
ISCAR LTD.,
,‫ישקר בע"מ‬
P.O.B. 11,
‫תפן‬11 .‫ד‬.‫ ת‬,
TEFEN 24959
System for attaching a cutting member to a cutter body comprising: a pin having a
longitudinal axis the pin comprising at least a first attachment bore and a second
attachment bore, a clamping bolt having a clamping section which is formed to
releasably secure the cutting member to the cutter body and having a first attachment
section which is formed to be releasably secured in the first attachment bore of the pin;
and an adjustement bolt having an adjustment section which is formed to adjust the
position of the cutting member to the cutter body and having a second attachment
section which is formed to be releasably secured in the second attachment bore of the
pin.
]5.[
__________________
]22[]12[
]54[
243
MOISTURE BARRIER
182484
‫נשם חוסם לחות‬
September 27, 2011-‫כ"ח באלול התשע"א‬
BREATHING DEVICE
]11[
]52[
].2[
].1[
].4[
]5.[
12.04.2007
Int. Cl.(2010.01) A62B 01//00
YEFIM KERETH
‫ רחובות‬,‫יפים קרת‬
YEFIM KERETH
‫יפים קרת‬
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A moisture-barrier breathing device, comprising: a rigid housing configured to contain
at least one moisture-sensitive device; an opening formed in a wall of said housing for
accommodating therethrough a water vapor barrier tube of predetermined geometry
and being adapted to be sealed to an exterior of said tube, and at least one pressureinfluenced member having a body of expandable and retractable -volume hermetically
connected to an end of said tube for containing gas that diffuses therein, while
equalizing pressure on both ends of said tube thus ensuring that the tube behaves as an
efficient barrier; wherein the geometry of the tube is such that a ratio of a length of the
tube to a cross-section of the tube is at least 10:1.
__________________
]22[]12[
182712
‫חומצות (ביפניל)קרבוקסיליות ותולדותיהן‬
]54[
(BIPHENYL)CARBOXYLIC ACIDS
AND DERIVATIVES THEREOF
]11[
]22[
21.10.2005
04025003.7
]21[ 21.10.2004
]22[ EP
141102153.
1432231114
EP
016041211
2131231115
US
Int. Cl.(2010.01) A61K 31//185, A61P 25//00, C07C 23/3/54, 23/5/42, 31/1/29,
31/7/22, 59//68, 59//72, C07D 26/1/08, 29/5/192, 30/9/06
CELLZOME LIMITED, UNITED
KINGDOM
WO/2006/045554
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
].2[
]7.[
].4[
]5.[
244
The present invention relates to compounds having the general formula (I) with the
definitions of A, X, R1-R6 given below, and/or a salt or ester thereof. Furthermore the
invention relates to the use of said compounds for the treatment of Alzheimer's disease
September 27, 2011-‫כ"ח באלול התשע"א‬
and their use for the modulation of gamma-secretase activity.
__________________
]22[]12[
182725
‫שיטה והתקן לקביעת זוית גלגול של גוף משוגר‬
‫מסתובב‬
]54[
METHOD AND DEVICE FOR
DETERMINATION OF ROLL
ANGLE OF ROTATING
LAUNCHED BODY
]11[
]22[
]52[
].2[
26.10.2005
0402611-8
]21[ 28.10.2004
]22[ SE
Int. Cl.(2010.01) F41G 07//00, F42B 15//01
BAE SYSTEMS BOFORS AB,
SWEDEN
OLOF LONN
WO/2006/046912
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a method and device for the determination of the roll angle phi
of a rotating body, such as a shell, utilizing sensors for the detection of rotation signals
in a body-fixed coordinate system. According to the invention, a new filter device is
proposed to handle moment interferences to which the body is subjected, for example,
caused by wind turbulence in the atmosphere or similar phenomena. The interferences
are eliminated by useful measurement signals emitted by the sensors being mixed
down to the frequency zero and by the sensors' rotation signals thereafter being lowpass filtered (13, 14) .
].1[
]7.[
].4[
]5.[
__________________
245
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
182992
‫שיטה ומערכת תקשורת אל–חוטית ליישום‬
‫העברה בלתי תלויית מדיה בין מערכות תקשורת‬
‫בעלות טכנולוגיות גישה מגוונות‬
]54[
WIRELESS COMMUNICATION
METHOD AND SYSTEM FOR
IMPLEMENTING MEDIA
INDEPENDENT HANDOVER
BETWEEN TECHNOLOGICALLY
DIVERSIFIED ACCESS
NETWORKS
]11[
]22[
]52[
].2[
01.11.2005
60/625611
]21[ 05.11.2004
]22[ US
Int. Cl.(2010.01) H04W 24//00, 36//00, 36//14, 48//16
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2006/052563
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
246
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A wireless communication system including at least one IDDD 802 multi-stack
wireless transmt/receive unit (WTRU) (110) and a plurality of technologically
diversified acess networks, such as IEEE 802.X networks and Third Generation
Partnership Project (3GPP) networks, that are concurrently deployed. Both the multistack WTRU (110) and the technologically diversified networks includ a media
indipendent handover (MIH) function. The WTRU is configured to read MIH
information transmitted from one of the IEEE 802.X networks, trigger 3GPP
authentication and atuhorization procedures based on the MIH information, obtain a
local Internet Protocol (IP) address, establish a tunnel to a packet data gateway (PDG)
un a 3GPP core network, constructed a care of address (CoA) and register the CoA
with a home agent (142) of the WTRU, whereby data destined for the WTRU (110) is
routed via the home agent (142) through a new tunnel established between the home
agent (142) and a foreign agent (136) based on the CoA..
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
]54[
INTERWORKING OF CELLULAR
NETWORKS AND WIRELESS
LANS
]11[
]22[
09.12.2005
60/634679
]21[ 09.12.2004
226175074
1132231115
Int. Cl.(2010.01) H04W 36//14, 84//12
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2006/063330
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
].2[
]7.[
].4[
]5.[
183452
LANS ‫עבודה בין רשתות תאיות ורשתות‬
‫אלחוטיות‬
]22[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method and system for interworking between cellular networks (120) and wireless
local area networks (WLANs) (110) are disclosed. At least one cellular network (120),
at least one WLAN (110) and an EP network (140) are deployed. A wireless
transmit/receive unit (WTRU) (102) first establishes a connection to a WLAN (110)
and a tunnel between an access point (AP) (132a, 132b) and a packet data gateway
(PDG) (129) is established. The PDG (129) further establishes a tunnel to an IP
network (140). The WTRU (102) then invokes a service which is delivered through the
WLAN (110). As signal quality from the AP (132a, 132b) degrades below a
predetermined threshold, a handover from the WLAN (110) to the cellular network
(120) is performed.
__________________
]22[]12[
247
183518
September 27, 2011-‫כ"ח באלול התשע"א‬
]54[
PHARMACEUTICAL
COMPOSITION IN THE FORM OF
OILY ISOTROPES INCLUDING AT
LEAST ONE OIL, AT LEAST ONE
SURFACTANT AND AN AQUEOUS
PHASE
]11[
]22[
]52[
].2[
]7.[
].4[
01.12.2005
0452838
]21[ 02.12.2004
Int. Cl.(2010.01) A61K 09//10, 39//39
SAVETOQUINOL, FRANCE
WO/2006/059009
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]5.[
‫הרכבים פרמצבטיים בצורה של איזוטרופ שומני‬
‫ לפחות סורפקטנט‬,‫המכילים לפחות שמן אחד‬
‫ופאזה מימית‬
]22[
FR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention concerns the field of pharmaceutical compositions, in particular in the
field of vaccines. More precisely, the invention concerns a pharmaceutical composition
useful as vaccine (or vaccine composition). The invention also concerns a method for
preparing said inventive vaccine composition.
__________________
]22[]12[
]54[
AMIDE PRODRUG OF
GEMCITABINE,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME AND USE THEREOF
IN THE MANUFACTURE OF
MEDICAMENTS FOR
TREATMENT OF SUSCEPTIBLE
NEOPLASMS
]11[
]22[
]52[
].2[
]7.[
].4[
30.11.2005
60/637422
]21[ 17.12.2004
Int. Cl.(2010.01) C07H 19//073
ELI LILLY AND COMPANY, U.S.A.
WO/2006/065525
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
248
183666
‫ תכשירים‬,‫קדם–תרופה אמיד של ג'מסיטאבין‬
‫רוקחיים הכוללים אותו ושימושו בהכנת תרופות‬
‫לטיפול בגידולים רגישים‬
]22[
US
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
September 27, 2011-‫כ"ח באלול התשע"א‬
‫‪The present invention relates to novel amide prodrugs of gemcitabine, compositions‬‬
‫‪thereof and methods for using.‬‬
‫[‪]5.‬‬
‫__________________‬
‫‪183857‬‬
‫מכונת אוטומטית לקלייה ולמכירה גרעינים‬
‫ובוטנים‬
‫[‪]22[]12‬‬
‫‪AUTOMATIC ROASTING AND‬‬
‫‪VENDING MACHINE FOR‬‬
‫‪MIXED NUTS AND SEEDS‬‬
‫[‪]54‬‬
‫‪12.06.2007‬‬
‫‪Int. Cl.(2010.01) A23N 12//00, A47J 37//00‬‬
‫‪DORON GABAY‬‬
‫‪MEIR DAHAN,‬‬
‫‪43 GIVATI ST., RAMAT CHEN‬‬
‫[‪]11‬‬
‫[‪]52‬‬
‫[‪].2‬‬
‫[‪].4‬‬
‫מכונה אוטומטית לקלייה ומכירה של גרעינים ‪ ,‬בוטנים או אגוזים (להלן "המוצרים")‬
‫המורכבת מהמרכיבים הבאים‪ :‬מארז (‪ )2‬המשמש מעטפת חיצונים של המכונה‬
‫תא (‪ )2‬אחד או יותר המיועדים להכיל את המוצרים באופן שכל אחד מהתאים כולל פתח‬
‫בחלק התחתון שלו אשר סגור על ‪-‬ידי גליל (‪ )7‬אשר ניתן לפתיחה וסגירה;‬
‫משטח קלייה (‪ )0‬המיועד לקליית המוצרים ואשר מצוי מתחת לפני הגובה של החלק‬
‫התחתון של התאים (‪ )2‬באופן שמאפשר למוצרים לגלוש מכוח הכובד העצמי שלהם‬
‫מהתאים (‪ )2‬ישירות למשטח הקלייה; מסילה (‪ )22‬המשמשת מסלול לגלישת המוצרים‬
‫מהתאים אל משטח הקלייה ; גופי חימום (‪ )02‬הצמודים למשטח הקלייה המיועדים‬
‫לחמם אותו בעת שהמוצרים גולשים אליו;משטח הקלייה כולל פתח (‪ )01‬במרכזו אשר‬
‫נפתח בתום פעולת הקלייה ואשר דרכו המוצרים הקלויים גולשים דרך מסילה (‪)02‬‬
‫לפתח יציאה (‪;).‬קוצב זמן (‪ )51‬המפסיק את הזרם החשמלי המפעיל את גופי החימום‬
‫לאחר חלוף פרק זמן המתאים לכמות ולסוג המוצר שנבחר על ידי המשתמש; מנגנון‬
‫לתשלום (‪)4‬התמורה בעד המוצר שהמשתמש מעוניין לרכוש ; בורר מצבים (‪)5‬‬
‫באמצעותו המשתמש בוחר וקבוע את הכמות ואת סוג המוצר מתוך מגוון המוצרים‬
‫שבמכונה אשר המשתמש מעוניין לרכוש‪ ,‬בורר במצבים כולל לוח (‪ )52‬כפתורים או‬
‫לחצנים באמצעותו המשתמש בוחר את המוצר ואת הכמות המבוקשת; יחידת פיקוד (‪)52‬‬
‫הכוללת מנגנון לזיהוי המוצר הנבחר על ‪-‬ידי המשתמש אשר מעבירה פקודה לפתיחת‬
‫הפתח התחתון של התא הרלבנטי וסגירתו לאחר גלישת הכמות הנבחרת‪ ,‬הפעלה של‬
‫גופי החימום‪ ,‬ופתיחת הפתח שבמשטח הקלייה בתום פעולת הקלייה‪3‬‬
‫[‪]5.‬‬
‫דורון גבאי‪ ,‬אשדוד‬
‫מאיר דהאן עו"ד‪,‬‬
‫גבעתי ‪42‬‬
‫רמת חן‬
‫האמורה;‬
‫כ"ח באלול התשע"א‪September 27, 2011-‬‬
‫‪249‬‬
__________________
]22[]12[
183951
,‫ מערכת לעיבוד מדיע‬,‫התקן שידור תקשורת‬
‫שיטת בקרה ותכנית‬
]54[
COMMUNICATION RELAY
DEVICE, INFORMATION
PROCESSING SYSTEM,
CONTROL METHOD AND
PROGRAM
]11[
]22[
]52[
].2[
]7.[
].4[
15.12.2005
2004-366847 ]21[ 17.12.2004
]22[ US
Int. Cl.(2010.01) H04L 29//10
IBM CORPORATION, U.S.A.
WO/2006/064872
SUZANNE EREZ, IBM R&D
,R&D ‫ מעבדות יבמ‬,‫סוזן ארז‬
LABORATORIES,
‫ הר הכרמל‬,‫אוניברסיטת חיפה‬
HAIFA UNIVERSITY,
‫חיפה‬
HAIFA 31905
To safely and easily perform power cable communication with a server providing a
desired service. There is provided a communication relay device for relaying
communication data between an information processing device and a communication
network by utilizing a power cable where a communication signal is superimposed on
a power signal. The communication relay device includes: an authentication
information storage unit for storing authentication information for the communication
relay device; a power plug which can be detachably attached to a power socket for
connecting an electric device to the power cable; a connection detection unit for
detecting that the power plug is connected to the power socket; an authentication unit
]5.[
250
September 27, 2011-‫כ"ח באלול התשע"א‬
for transmitting authentication information to the server via the power cable if the
power plug is connected to the power socket so that the server authenticates the
communication relay device; and a communication relay unit for relaying the
communication data from the information processing device for the communication
network if the authentication by the authentication unit is sucessful.
__________________
]22[]12[
184206
‫תולדות של בנזוייל–טטרהידרופירידין כמעכבים‬
GLYT–1 ‫של‬
]54[
BENZOYLTETRAHYDROPYRIDINE
DERIVATIVES AS GLYT-1
INHIBITORS
]11[
]22[
]52[
].2[
27.12.2005
05100027.1
]21[ 04.01.2005
]22[ EP
Int. Cl.(2010.01) A61K 31//4427, 31//444, A61P 25//28, C07D 21/1/70, 41/3/10
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2006/072432
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to compounds of the general formula (I); Wherein R 1 is a
non aromatic heterocycle or OR'; R’ is lower alkyl, lower alkyl substituted by halogen
or is -(CH2)n-cycloalkyl; R2 is NO2, CN or SO2R'; R' is lower alkyl; Ar is phenyl,
optionally substituted by halogen, cyano, lower alkyl substituted by halogen or SO 2 R ';
n is 0, 1 or 2; and to pharmaceutically active acid addition salts and to their use in the
treatment of neurological and neuropsychiatric disorders.
]7.[
].4[
]5.[
251
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
184338
]54[
PROCESS FOR PRODUCING (Z)-1-PHENYL1-(N,N-DIETHYLAMINOCARBONYL)-2PHTHALIMIDOMETHYLCYCLOPROPANE
]11[
]22[
26.01.2006
2005-022188
]21[
28.01.2005
]22[ JP
1115-2457.5
2731531115
JP
Int. Cl.(2010.01) C07D 20/9/48, 30/7/93
SUMITOMO CHEMICAL COMPANY,
LIMITED., JAPAN
WO/2006/080555
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A process for producing (Z)-1-phenyl-1-(N,N-diethylaminocarbonyl)-2phthalimidomethylcyclopropane which comprises reacting (Z)-1-phenyl-1-(N,Ndiethylaminocarbonyl)-2-hydroxymethylcyclopropane with an orthoester and a
BrDnsted acid and then reacting the reaction product with a phthalimidizing agent. Also
provided is a process for producing (Z)-1-phenyl-1-(N,N-diethylaminocarbonyl)-2aminomethylcyclopropane hydrochloride via that process.
]52[
].2[
]7.[
].4[
]5.[
–8–‫ פאניל‬Z)–1( ‫תהליך עבור הפקת‬
–2–)‫–דיאתילאמינוקרבוניל‬N, N(
‫פתאלימידומתילציקלופרופן‬
__________________
]22[]12[
]54[
252
WOVEN MATERIAL
184604
‫חומר ארוג הכולל שתי וערב הדומים לסרט‬
September 27, 2011-‫כ"ח באלול התשע"א‬
COMPRISING TAPE-LIKE WARP
AND WEFT
]11[
]22[
]52[
].2[
]7.[
].4[
]5.[
17.01.2006
0500114-4
]21[ 17.01.2005
Int. Cl.(2010.01) D03D 15//00
TAPE WEAVING SWEDEN AB,
SWEDEN
WO/2006/075962
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]22[
SE
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
Novel woven materials, producible by a new weaving method, are described that
comprise single or doubled warps and wefts in the form of tapes that are preferably
partially stabilized type of fibrous tape. These fibres are caused to occur in a non-linear
arrangement during the weaving process. The non-linear fibres can be subsequently
straightened by pulling the tape longitudinally. The doubled warps and wefts comprise
disconnected tapes. Such separateness of constituent tapes of doubled warp and weft
tapes enables them to be slid/slipped relative to each other by pulling longitudinally
and laterally without causing any alteration in the woven structure. These novel fabrics
solve the problem of uneven fibre distribution and orientation arising from
crumples/wrinkles due to compression and stretches due to extension, at the inner and
outer sides respectively, when tape- woven fabrics are curved into shapes. Further, by
using doubled warps and wefts fabrics with relatively flat/planar sections and
thicker/raised wide rib sections can be also created that resemble a bit like a profiled
material in its cross-section. Other fabrics like those comprising slant/oblique weft
tapes, shaped warp and weft tapes, formed shape within its body are also producible.
__________________
]22[]12[
]54[
253
METHOD FOR PRODUCING
ARTICLES WHICH ARE NOT FLAT
184636
‫שיטה לייצור פריטים לא שטוחים באמצעות‬
‫ערמה של הצטברות אנאורגני ושרף מקשיח‬
September 27, 2011-‫כ"ח באלול התשע"א‬
‫ופריטים הנובעים מכך‬
USING AGGLOMERATES OF
INORGANIC AGGREGATES AND
HARDENING RESINS AND
RESULTANT ARTICLES
]11[
]22[
]52[
].2[
]7.[
].4[
]5.[
26.01.2006
TV2005A000019 ]21[ 08.02.2005
]22[ IT
Int. Cl.(2010.01) B28B 07//36
DARIO TONCELLI, ITALY
WO/2006/084794
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Method for producing articles which are not flat from a mix consisting of granulated
inorganic materials and a hardening resin. After being compacted by means of vacuum
vibrocompression on a flat forming support, the mix is transferred onto a form (300),
the surface (350) of which has the same curvature as the article (100) to be obtained,
and is left there until hardening of the mix is achieved. The articles made using this
method and able to be used in various industrial and civil applications are also claimed.
__________________
]22[]12[
]54[
INTEGRATED SMART POWER
SWITCH
]11[
]22[
]52[
].2[
]7.[
].4[
21.03.2006
11/098033
]21[ 01.04.2005
Int. Cl.(2010.01) H03K 17//082
RAYTHEON COMPANY, U.S.A.
WO/2006/107579
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
254
184796
‫מתג כוח חכם משולב‬
]22[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
A device (100) including a controllable semiconductor (102), sensor (106), and
controller (104) is provided. The controllable semiconductor (102) is associated with a
first operating parameter and a second operating parameter, wherein the first operating
parameter is controllable. The sensor (106) is in communication with the controllable
semiconductor device (102) and acquires data relating to the second operating
parameter. The controller (104) is in communication with the controllable
semiconductor device (102) and the sensor (106). The controller (104) is configured to
access device data associated with the controllable semiconductor (102), control the
first operating parameter, and receive data from the first sensor (106) relating to the
second operating parameter. The controller (104) determines a first predicted value
dependent on the device data, compares the data relating to the second operating
parameter with the first predicted value, and, if a first condition is detected based on
this comparison, dynamically modifies the first operating parameter.
__________________
]22[]12[
184797
‫גוף חילוט עם פתח כניסה מרכזי‬
]54[
BREWING ELEMENT WITH A
CENTRAL INLET
]11[
]22[
]52[
].2[
].1[
]7.[
].4[
26.01.2006
60/647378
]21[ 26.01.2005
]22[ US
Int. Cl.(2010.01) A23F 05//24, A47J 31//06
CONCEPT & DESIGN LTD.
‫ עתלית‬,‫רעיון ותכן בע"מ‬
SHALOM LEVIN
‫שלום לוין‬
WO/2006/080016
EDWARD LANGER,
,‫אדוארד לנגר‬
MERKAZ GERON H. 312
‫רעננה‬410 .‫ד‬.‫ ת‬,
P.O.B. 410,
RAANANNA 43103
A brewing element comprising an envelope for storing at least one comestible brewing
ingredient therein; and an attachment means for removably attaching the element to a
container, the element having formed therein a central inlet for admitting pressurized,
heated water and a peripheral outlet for releasing a mixture of the at least one
]5.[
255
September 27, 2011-‫כ"ח באלול התשע"א‬
comestible brewing ingredient with the pressurized, heated water, wherein when the
brewing element is incorporated into an operating beverage brewing system, the
capsule releases the mixture multi-directionally through the peripheral outlet to
provide a brewed beverage into the container.
__________________
]22[]12[
184970
]54[
METHOD AND SYSTEM FOR
DIAGNOSING AN AIRCRAFT
FROM MEASUREMENTS
PERFORMED ON THE AIRCRAFT
]11[
]22[
]52[
].2[
].4[
31.07.2007
0607926
]21[ 11.09.2006
]22[
Int. Cl.(2010.01) B64F 05//00, G01R 23//16
EUROCOPTER, FRANCE
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]5.[
‫שיטה ומערכת לאבחון כלי טייס ממדידות‬
‫הנעשות על כלי הטייס‬
FR
,'‫ד"ר שלמה כהן ושות‬
154 ‫אבן גבירול‬
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
A method of diagnosing an aircraft by analyzing at least one spectrum obtained from
measurements taken on the aircraft, in particular from vibration measurements, in
which the spectrum (spectra) to be analyzed is/are input to a calculation module ( 23 )
together with at least one first reference spectrum, the calculation module determining
a diagnosis value (Diag) as a function of the spectrum (spectra) to be analyzed, of the
reference spectrum (spectra), and of parameters determined from at least two reference
spectra including the first reference spectrum.
__________________
256
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
185047
‫כלי חיתוך‬
]54[
CUTTING TOOL
]11[
]52[
].2[
].1[
].4[
05.08.2007
Int. Cl.(2010.01) B23C 01//00
ISCAR LTD.
‫ תפן‬,‫ישקר בע"מ‬
GIL HECHT, OLEG KERTSMAN
‫ אולג קרצמן‬,‫גיל הכט‬
ISCAR LTD.,
,‫ישקר בע"מ‬
P.O.B. 11,
‫תפן‬11 .‫ד‬.‫ ת‬,
TEFEN 24959
A cutting tool having a tool body and a cutting insert releasably retained in a pocket of
the tool body. The cutting insert having first and second rear insert abutment surfaces
and a third forward insert abutment surface and the pocket having first and second rear
pocket abutment surfaces and a third forward pocket abutment surface, the first and
second abutment surfaces being separated from the third abutment surface by a bore.
The third forward pocket abutment surface can be either a socket recessed in a pocket
base surface or a protrusion protruding from the base surface and the third forward
insert abutment surface can be correspondingly either a protrusion protruding from an
inner surface of the insert or a socket recessed in the inner surface. The abument forces
generate a torque that presses an abument surface of the insert against an abument
surface of the tool body thereby substantially fixing the orientation of the insert
relative to the tool body.
]5.[
__________________
]22[]12[
185423
]54[
ANTILOCK AND ANTISKID
HYDRAULIC TORQUE DISK
BRAKE SYSTEM AND METHODS
THEREFOR
]11[
]52[
].2[
21.08.2007
Int. Cl.(2010.01) B60T 08//52, B62L 01//00
P. & P. SAFETY BRAKING (2004)
LTD.
ZALMAN PELES
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
].1[
].4[
257
‫מערכת בלימה של דיסק הידראולי המשחררת‬
‫ מונעת החלקה ושיטות ליישומן‬,‫נעילה‬
‫ ) בע"מ‬5004( ‫ בלמי בטיחות‬.‫ את פ‬.‫פ‬
‫זלמן פלס‬
,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]5.[
The present invention provides an anti-lock hydraulic torque brake system for
decelerating or ending the rotation of a wheel. The system comprises braking means
for mechanically lowering and maintaining an applied braking force to a level that is
lower than the forward torque force of the wheel such that unsafe wheel locking is
prevented.
__________________
]22[]12[
‫פורמולציות אוקטראוטיד בעלות שחרור מבוקר‬
]54[
CONTROLLED RELEASE
FORMULATIONS OF
OCTREOTIDE
]11[
]22[
]52[
].2[
10.03.2006
60/660930
]21[ 11.03.2005
Int. Cl.(2010.01) A61K 09//50, 38//31
ENDO PHARMACEUTICALS
SOLUTIONS INC., U.S.A.
WO/2006/099288
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]7.[
].4[
]5.[
]22[
US
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
A formulation of octreotide or pharmaceutically acceptable salts thereof, which
provides controlled release of a therapeutically effective amount of octreotide for a
period of at least about two months. Methods of treating acromegaly, decreasing
growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid
tumors and VIPomas by administering a controlled release formulation of octreotide
are provided herein.
The applications for division
from this application have
258
185800
202102/
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
September 27, 2011-‫כ"ח באלול התשע"א‬
not yet been published
__________________
]22[]12[
185881
]54[
CQICH ALLOCATION REQUEST
HEADER FOR COMMUNICATING
FEEDBACK INFORMATION
]11[
]22[
13.03.2006
10-2005]21[ 12.03.2005
]22[ KR
0020831
016002124
2.31231115
US
21-11151031431115
KR
11244..
0160..07.
1231531115
US
Int. Cl.(2010.01) H04L 29//06, H04W 72//04, 74//08, 76//04
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/098574
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A method of communicating feedback information between a mobile station and a
base station by determining a need to request bandwidth allocation; providing
information to a base station according to the determining, wherein the information
indicates bandwidth allocation for a fast feedback channel, which is a robust channel;
and performing communication with the base station upon bandwidth allocation
according to the provided information.
]52[
].2[
]7.[
].4[
]5.[
‫ (ערוץ להעברת‬CQICH ‫כותרת לבקשת הקצאת‬
‫מידע על איכות הערוץ) עבור העברת משוב‬
__________________
259
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
186023
–‫תצורות גבישיות של מלחי תרכובת קווינולינון‬
‫ תהליכים‬,‫ סולבטים שלהם‬,‫קרבוקסאמידים‬
‫ תכשירי רוקחות המכילים אותם‬,‫להכנתם‬
‫והשימוש בה‬
]54[
CRYSTALLINE SALT FORMS OF
QUINOLINONE-CARBOXAMIDES,
SOLVATES THEREOF,
PROCESSES FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USES THEREOF
]11[
]22[
]52[
].2[
]7.[
].4[
05.04.2006
60/668780
]21[ 06.04.2005
Int. Cl.(2010.01) C07D 45/1/04
THERAVANCE, INC., U.S.A.
WO/2006/108127
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
The invention provides a crystalline hydrochloride salt of 1-isopropyl-2-oxo-1,2dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[(R)-2-hydroxy-3(methanesulfonyl-methyl-amino)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide or a
solvate thereof. The invention also provides pharmaceutical compositions comprising
such crystalline salt forms, methods of using such crystalline salt forms to treat
diseases associated with 5 HT4 receptor activity, and processes useful for preparing
such crystalline salt forms.
]22[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
186216
‫מערכת שטח סינתטית בעלת מבנה לכידה‬
]54[
SYNTHETIC TURF SYSTEM
HAVING AN INFILL TRAPPING
STRUCTURE
]11[
]22[
]52[
].2[
14.11.2005
60/594267
]21[ 24.03.2005
]22[ US
Int. Cl.(2010.01) A41G 01//00, E01C 13//08, E02B 11//00
FIELDTURF TARKETT INC.,
CANADA
WO/2006/100543
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
]7.[
].4[
260
,‫ריינהולד כהן ושותפיו‬
September 27, 2011-‫כ"ח באלול התשע"א‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention is directed to a synthetic turf system including a backing
member having a plurality of monofilament ribbons-soft and stiff-projecting there
from. A layer of particulate material lies above the backing member and among the
mono filament ribbons wherein the soft monofilament ribbons facilitates the
stabilization or trapping of the particulate material.
RAMAT HACHAYAL 69710
]5.[
__________________
]22[]12[
186314
‫שסתום אשר בדרך כלל סגור במצב חופשי‬
]54[
VALVE THAT IS NORMALLY
CLOSED IN THE FREE STATE
]11[
]22[
]52[
].2[
].4[
25.09.2007
60/847159
]21[ 26.09.2006
]22[ US
Int. Cl.(2010.01) F16K 01//12
ALCON, INC., SWITZERLAND
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A valve system comprising: a housing containing a fluid inlet channel and a fluid
outlet channel wherein the two channels are connected by a through hole and an
elastomeric valve boss having a hollow elastomeric cylindrical portion forming an
interior cavity and a head portion, the cavity including an opening at a first end of the
elastomeric cylindrical portion opposite the head portion, the elastomeric cylindrical
portion extending concentrically through the through hole such that under static
conditions, a rim on an underside of the head portion of the valve boss forms a valve
seal face that maintains contact with a rim of the through hole preventing fluid flow
through the through hole, the rim of the through hole forming a valve seat, the valve
boss having an open position wherein the elastomeric cylindrical portion is axially
stretched by application of a force to an interior surface of the cavity to displace the
valve seal face from the valve seat to form a gap therebetween resulting in a fluid
]5.[
261
September 27, 2011-‫כ"ח באלול התשע"א‬
connection through the through hole between the fluid inlet channel and the fluid
outlet channel.
__________________
]22[]12[
186421
‫מתג לחיצת–כפתור‬
]54[
PUSH- BUTTON SWITCH
]11[
]22[
]52[
].2[
]7.[
].4[
03.04.2006
RM2005A000163 ]21[ 07.04.2005
]22[ IT
Int. Cl.(2010.01) H01H 13//14
BTICINO S.P.A., ITALY
WO/2006/106554
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to a push-button switch comprising: - a box-like
supporting structure (2) defining an inner chamber (8), the box- like structure (2)
having at least one opening (9) communicating with the inner room (8) and having an
opening axis (Z-Z) ; - a push-button (21) to be matched with the supporting structure
(2) at said opening (9) ; - mechanical coupling means (22) for coupling the pushbutton (21) to said structure (2) such that the push- button (21) is allowed to be
fastened to the supporting structure (2) while being movable relative thereto in a
direction substantially parallel to the opening axis (Z- Z). The push-button switch is
characterized in that the mechanical coupling means include a holding and guide frame
(22) for the push-button (21), which can be fixed to the supporting structure (2) and
can be interposed between the push-button (21) and the structure (2).
]5.[
262
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
]54[
METHOD AND APPARATUS FOR
VECTOR QUANTIZING OF A
SPECTRAL ENVELOPE
REPRESENTATION
]11[
]22[
03.04.2006
60/667901
]21[ 01.04.2005
0160.2305
1131431115
Int. Cl.(2010.01) G10L 19//06
QUALCOMM INCORPORATED,
U.S.A.
WO/2006/107833
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
].2[
]7.[
].4[
]5.[
263
186438
‫שיטה ומתקן לקוונטיזציה של ייצוג מעטפה‬
‫ספקטראלית‬
]22[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A quantizer according to an embodiment is configured to quantize a smoothed value of
an input value (e.g., a vector of line spectral frequencies) to produce a corresponding
output value, where the smoothed value is based on a scale factor and a quantization
error of a previous output value.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
186574
‫שיטה למתן תצורה מחודשת לכתובת פרוטוקול‬
‫אינטרנט בהעברה בין רשתות מעורבות‬
]54[
METHOD OF RECONFIGURING
AN INTERNET PROTOCOL
ADDRESS IN HANDOVER
BETWEEN HETEROGENEOUS
NETWORKS
]11[
]22[
14.04.2006
10-2005]21[ 14.04.2005
]22[ KR
0031202
21-11151731431115
KR
1125.70
21-11152231531115
KR
114110.
21-11151531.31115
KR
1153375
21-11102731131110
KR
1125351
Int. Cl.(2010.01) H04L 29//06, H04W 36//00, 36//14, 80//04
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/110016
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method of communicating information in a wireless mobile communication system
is disclosed. More specifically, the method includes a network for establishing
handover management modules in a source network and a target network and
transmitting a handover request message from the handover management module of
the source network to the handover management module of the target network.
Furthermore, the network is used for receiving a handover response message from the
handover management module of the target network to the handover management
module of the source network, wherein the handover response message includes an
internet protocol address information and transmitting a handover confirmation
message from the handover management module of the source network to a mobile
terminal, wherein the handover confirmation message includes the internet protocol
address information.
]52[
].2[
]7.[
].4[
]5.[
264
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
186575
‫שיטה לתמיכה בהעברה בתחנה מכפל–מודים‬
‫ניידת‬
]54[
METHOD OF SUPPORTING
HANDOVER IN A MULTI-MODE
MOBILE STATION
]11[
]22[
02.05.2006
10-2005]21[ 02.05.2005
]22[ KR
0036664
21-11152031531115
KR
114143.
Int. Cl.(2010.01) H04L 29//06
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/118410
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method of discovering at least one of a homogeneous and a heterogeneous network
module to perform handover with in a wireless mobile communication network is
disclosed. More specifically, the method includes establishing a network handover
module for converging information from at least one network interface module
associated with at least one of a homogeneous and a heterogeneous network handover
module into a unified presentation and transmitting a broadcast request message from a
mobile station (MS) to a source point of attachment (PoA) which transmits the
broadcast request message to at least one interface module to identify whether the at
least one interface module supports at least one of the homogeneous and the
heterogeneous network handover module and a capability of the at least one of the
homogeneous and the heterogeneous network handover module. The method further
includes initiating a timer for a specified time period when the broadcast request
message is transmitted and receiving at least one response message from the at least
one interface module via the source PoA prior to expiration of the timer, wherein the
response message indicates that the at least one interface module supports at least one
of the homogeneous and the heterogeneous network handover module and the
September 27, 2011-‫כ"ח באלול התשע"א‬
]52[
].2[
]7.[
].4[
]5.[
265
capability of the at least one of the homogeneous and the heterogeneous network
handover module.
__________________
]22[]12[
186836
]54[
HYBRID ORTHOGONAL
FREQUENCY DIVISION
MULTIPLE ACCESS SYSTEM
AND METHOD
]11[
]22[
20.04.2006
60/673872
]21[ 22.04.2005
]22[
2264107.7
2331431110
Int. Cl.(2010.01) H04B 07//208, H04J 13//00
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2006/116003
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
].2[
]7.[
].4[
]5.[
266
‫מערכת ושיטה רבת כניסות לחלוקת תדירות‬
‫מעורבת אורתוגונלית‬
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A hybrid orthogonal frequency division multiple access (OFDMA) system including a
transmitter 100 and a receiver 200 IF disclosed. The transmitter 100 includes a first
spread OFDMA subassembly 130, a first non-spread OFDMA subassembly 140 and a
f irst common subassembly 150. The f irst spread OFDMA subassembly 130 spreads
input data 101 and maps the spread data 103 to a first group of subcarriers 105. The
first non-spread OFDMA subassembly 140 maps input data 111 to a second group of
subcarriers 115. The first common subassembly 150 transmits the input data mapped
to the first and second group of subcarriers using OFDMA. The receiver includes a
second spread OFDMA subassembly 230, a second non-spread OFDMA subassembly
240 and a second common subassembly 250. The second common subassembly 250
processes received data to recover data mapped to the subcarriers using OFDMA. The
second spread OFDMA subassembly 230 recovers the first input data by separating
user data in a code domain and the second non-spread OFDMA subassembly 240
recovers the second input data.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
186940
‫ציפויים בעלי חיכוך נמוך לשימוש במכשירים‬
‫רפואיים ודנטלים‬
]54[
LOW FRICTION COATINGS FOR
USE IN DENTAL AND MEDICAL
DEVICES
]11[
]22[
]52[
].2[
17.05.2006
60/681443
]21[ 17.05.2005
]22[ US
Int. Cl.(2010.01) A61B 08//14, A61C 03//00, 05//00, 07//00
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
,‫הדסית שרותי מחקר רפואי ופיתוח בע"מ‬
HADASIT MEDICAL RESEARCH
‫ירושלים‬
SERVICES & DEVELOPMENT LTD.
‫חולון‬
,‫חולון‬
‫טכנולוגי‬
‫אקדמי‬
‫מכון‬
HOLON ACADEMIC INSTITUTE OF
TECHNOLOGY
WO/2006/123336
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]7.[
].4[
]5.[
267
The present invention provides an article, at least part of it being coated by inorganic
fullerene-like (IF) nanoparticles or composite containing such nanoparticles.
Preferably, the invention provides an article made of metal, for use in dentistry or
medicine e.g. archwire, needle or catheter, having a friction-reducing film, and
methods for coating such articles with a friction-reducing film.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
187127
‫תהליך ליצירת כלורידים של נגזרות‬
‫פטאלוציאנינים המכילים לפחות קבוצת‬
‫אמוניום רבעוני אחת‬
]54[
PROCESS FOR PREPARING
CHLORIDES OF
PHTHALOCYANINE DERIVATIVES
COMPRISING AT LEAST ONE
QUATERNARY AMMONIUM
GROUP
]11[
]22[
]52[
].2[
04.05.2006
FI2005A000093 ]21[ 05.05.2005
]22[ IT
Int. Cl.(2010.01) C07D 48/7/22
L. MOLTENI & C. DEI FRATELLI
ALITTI SOCIETA' DI ESERCIZIO
S.P.A., ITALY
GABRIO RONCUCCI, GIACOMO
CHITI, DONATA DEI, DANIELE
NISTRI, ALDO HENDRIKUS
VELDERS, SALVATORE DEMARTIS,
VALENTINA PASCHETTA
WO/2006/117396
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A process is described for preparing chlorides of phthalocyanine derivatives
comprising at least a quaternary ammonium group, products useful as photosensitising
agents in photodynamic therapy.
].1[
]7.[
].4[
]5.[
__________________
268
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
187337
‫אבקת ניוביום סאב אוקסיד המכילה חלקיקי‬
‫ניוביום סאב אוקסיד בעלי תכולת חנקן של בין‬
PPM 1000 ‫ ל‬8000
]54[
NIOBIUM SUBOXIDE POWDER
COMPRISING NIOBIUM
SUBOXIDE PARTICLES HAVING
A BULK NITROGEN CONTENT
OF BETWEEN 1000 AND 8000 PPM
]11[
]22[
31.05.2006
0511321.2
]21[ 03.06.2005
]22[
101122132
1031131110
Int. Cl.(2010.01) C01G 33//00, H01G 04//10
H.C. STARCK GMBH, GERMANY
WO/2006/128687
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
].2[
]7.[
].4[
]5.[
GB
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Disclosed is a niobium suboxide powder for the manufacture of capacitors with higher
break down voltages, higher temperatures of operation and elongated lifetimes. The
powder is doped with nitrogen which is at least partly present in the form
homogeneously distributed, x-ray detectable Nb2N-crystal domains.
__________________
]22[]12[
]54[
DISPERSIBLE BOSERTAN TABLET
]11[
]22[
]52[
].2[
15.05.2006
PCT/EP2005/05367 ]21[ 17.05.2005
Int. Cl.(2010.01) A61K 09//20, 31//513
ACTELION PHARMACEUTICALS LTD.,
SWITZERLAND
WO/2006/123285
]7.[
269
187383
‫טבלת בוסרטן המתפרקת בצורת תבדיר‬
]22[
WO
September 27, 2011-‫כ"ח באלול התשע"א‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
].4[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
The invention relates to dispersible tablets comprising the compound 4-tert-butyl-N-[6(2- hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(pyrimidin-2-yl)-pyrimidin-4-yl]benzenesulfonamide.
__________________
]22[]12[
]54[
APPARATUS FOR MOVING A
CONTROL SURFACE DURING
OPERATION OF AN AIRCRAFT
]11[
]22[
]52[
].2[
].4[
20.11.2007
11/603360
]21[ 21.11.2006
Int. Cl.(2010.01) B64C 13//34
EATON CORPORATION, U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
187505
‫התקן להזזת משטח בקרה במהלך פעילות כלי‬
‫הטיס‬
]22[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An apparatus for use in moving a control surface during operation of an aircraft
includes a flexible drive shaft to be connected with an actuator assembly by a coupling
assembly. Operation of the actuator assembly operates a force transmission apparatus
to move a control surface on an aircraft. The coupling assembly includes an input
member connected with the flexible drive shaft and an output member which may be
connected with the actuator assembly. A plurality of balls interconnect the input and
output members and are rotatable to accommodate relative movement between the
input and output members.
__________________
]22[]12[
]54[
270
3-AMINOCARBAZOLE
COMPOUNDS, PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
187713
‫ תכשירים‬,‫–אמינוקרבזוליות‬3 ‫תרכובות‬
‫רוקחיים המכילים אותן ושיטות להכנתן‬
September 27, 2011-‫כ"ח באלול התשע"א‬
SAME AND METHOD FOR THE
PREPARATION THEREOF
]11[
]22[
]52[
].2[
]7.[
].4[
]5.[
25.07.2006
MI2005A001523 ]21[ 03.08.2005
]22[ IT
Int. Cl.(2010.01) A61K 31//403, A61P 09//00, 25//28, 35//00, C07D 20/9/88
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.P.A., ITALY
WO/2007/147687
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
A compound of formula (I), in which R1 , R2, R3, R4, R5, R6, X and Y have the
meanings indicated in the description, and the pharmaceutically acceptable salts
thereof. A pharmaceutical composition containing a compound of formula (I) or a
pharmaceutically acceptable salt thereof. A method for preparing the abovementioned
compound of formula (I) and the pharmaceutically acceptable salts thereof.
__________________
]22[]12[
187718
‫פיצול תמונה במערכות בדיקה אופטיות‬
]54[
IMAGE SPLITTING IN OPTICAL
INSPECTION SYSTEMS
]11[
]22[
]52[
].2[
].4[
28.11.2007
60/861303
]21[ 28.11.2006
]22[
226344074
103223111.
Int. Cl.(2010.01) G01N 21//95, H01L 21//66
NEGEVTECH, LTD.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
An inspection system configured to create an image of an object at a focal plane, the
271
US
US
‫ רחובות‬,‫ בע"מ‬,‫נגבטק‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
semiconductor inspection system comprising:
a set of imaging optics configured to create an image of an object at a focal plane; at
least two two-dimensional detectors; and one splitting apparatus positioned at the
focal plane and configured to split the image of the object at the focal plane into a
plurality of portions and direct at least one portion to a two-dimensional detector,
wherein the splitting apparatus comprises two sequential arrays, each array comprising
a plurality of at least partially cylindrical lenses positioned alongside one another.
__________________
]22[]12[
188000
‫שיטה והתקן לבדיקת מאפיינים של תא גביש‬
‫נוזלי על בסיס מדידות מלאות של מטריצת‬
MUELLER
]54[
METHOD AND APPARATUS FOR
DETERMINING LIQUID
CRYSTAL CELL PARAMETERS
FROM FULL MUELLER MATRIX
MEASUREMENTS
]11[
]22[
]52[
].2[
09.06.2006
11/150363
]21[ 10.06.2005
]22[ US
Int. Cl.(2010.01) G01B 11//16
AXOMETRICS, INCORPORATED,
U.S.A.
MATTHEW H. SMITH
WO/2006/135681
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
Method and apparatus for testing of LCD panels is disclosed. An LCD panel under lest
(30) may be mounted to a translatable table (40) between polarization state generator
(10) and polarization state analyzer (16). For each location on cell (30) to be tested, a
variety of known polarization states (22) are launched through the LCD cell (30) and
detected by the polarization state analyzer (16). Electrical signals representative of
polarization states are acquired by a computer. Within the computer, a model of
polarization properties of the LCD cell (30) is developed based on estimations of what
the physical parameters of the LCD cell (30) are believed to be. RMS differences
between simulated polarization properties and measured polarization properties are
minimized by iteratively refining the modeled physical cell properties, at which point
cell thickness and other physical parameters of the LCD cell may be deduced.
].1[
]7.[
].4[
]5.[
272
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
188115
–‫–אלקוקסי או ציקלואלקוקסי‬1 ‫תרכובות אמין‬
,‫–איל‬2–‫–דיהידרו–קווינאזולין‬4,3–‫–מתיל‬4
‫תהליך להכנתן ותרופות המכילות אותן ושימושן‬
‫בהכנת תרופות‬
]54[
8-ALKOXY OR CYCLOALKOXY4-METHYL-3,4-DIHYDROQUINAZOLIN-2-YL AMINE
COMPOUNDS, A PROCESS FOR
PREPARING THE SAME AND
MEDICAMENTS COMPRISING
THEM AND THEIR USE IN THE
PREPARATION OF
MEDICAMENTS
]11[
]22[
]52[
].2[
16.06.2006
05105699.2
]21[ 27.06.2005
]22[ EP
Int. Cl.(2010.01) A61K 31//517, A61P 01//04, 15//04, 25//00, C07D 23/9/84
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2007/000393
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to compounds of formula (I) wherein R 1 is hydrogen,
halogen or lower alkyl; R2 is lower alkyl or cycloalkyl; R3 is hydrogen, lower alkyl,
lower alkyl substituted by halogen, cycloalkyl or is benzyl, optionally substituted by
halogen; n is 0, 1 or 2; and pharmaceutically acceptable acid addition salts thereof. The
compounds of formula (I) may be used for the treatment of 5-HT5A receptor
antagonists related diseases, which are depression, anxiety disorders, schizophrenia,
panic disorders, agoraphobia, social phobia, obsessive compulsive disorders, posttraumatic stress disorders, pain, memory disorders, disorders of eating behaviors,
sexual dysfunction, sleep disorders, withdrawal from abuse of drugs, motor disorders
such as Parkinson's disease, dementia in Parkinson's disease, neuroleptic-induced
]7.[
].4[
]5.[
273
September 27, 2011-‫כ"ח באלול התשע"א‬
Parkinsonism and tardive dyskinesias, as well as other psychiatric disorders and
gastrointestinal disorders such as irritable bowel syndrome.
__________________
]22[]12[
188224
‫חיזוק למכונת הלחמה‬
]54[
REINFORCING BAR BINDING
MACHINE
]11[
]22[
]52[
].2[
]7.[
].4[
28.06.2006
2005-194206 ]21[ 01.07.2005
]22[
Int. Cl.(2010.01) B21F 15//04, E04G 21//12
MAX CO. LTD., JAPAN
WO/2007/004491
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
A reinforcing bar binding machine comprising: a binding wire feeding mechanism that
feeds a binding wire which is wound around a reel to a binding wire guiding nose and
forms a binding wire loop around a reinforcing bar; a binding wire twisting mechanism
that twists the binding wire loop formed around the reinforcing bar, by grasping and
rotating the binding wire loop; a CPU; a power supply voltage detecting device; a
device for comparing the detected voltage with a predetermined CPU operation
voltage, and a control device that drives a motor in a reverse direction, when the
voltage has dropped below the predetermined CPU operation voltage, thereby to return
the binding wire twisting mechanism to an initial position.
274
JP
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
188333
‫שיטה לבקרת גישה לנתונים מוצפנים‬
]54[
METHOD FOR CONTROLLING
ACCESS TO ENCRYPTED DATA
]11[
]22[
]52[
].2[
06.07.2006
05106186.9
]21[ 07.07.2005
]22[ EP
Int. Cl.(2010.01) G11B 20//00, H04L 09//00, 09//18, H04N 07//167
NAGRAVISION S.A.,
SWITZERLAND
WO/2007/006736
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The invention concerns a method for controlling access to encrypted data (CT) by
control words (CW), said control words being received by a security module in control
messages (ECM) and returned to a unit operating on the encrypted data. Said control
messages (ECM) contain at least one first control word (CW1) and a second control
word (CW2), said control words each allowing access to the encrypted data (CT)
during a predetermined period called cryptoperiod (CP). Said method includes the
following steps: sending said encrypted data to at least one operating unit; and sending
control messages (ECM) to said control unit, such a control message (ECM)
containing at least two specific control words (CW1, CW2) being sent to the operating
unit after sending the data encrypted by said first control word (CW1) and before
sending the data encrypted by said second control word (CW2). Said method is
characterized in that the time shift between sending to the operating unit the data
encrypted by said first control word (CW1) and sending the control message (ECM)
containing said first control word (CW1) and said second control word (CW2) is more
than 75 % of the cryptoperiod.
]7.[
].4[
]5.[
275
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
188384
‫תמסורת עם הגנת הצמד אינטגרלי על ידי גלגל‬
‫שילוב מכוון סיבוב‬
]54[
GEAR WITH INTEGRAL
OVERCOUPLE PROTECTION
USING A ROTATABLY GUIDED
PINION
]11[
]22[
]52[
].2[
].4[
24.12.2007
0655988
]21[ 27.12.2006
]22[ FR
Int. Cl.(2010.01) F16H 35//10, 57//00, 57//02
HISPANO-SUIZA, FRANCE
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Gear comprising a pinion (20) being integral with a shaft (201) rotatably mounted in a
support (100) by means of a cleavable element (40, 50) arranged to disengage the
pinion from the shaft in case of an overcouple between the pinion and the shaft,
characterized by the fact that a guiding bearing (80, 90) being pending between the
pinion and the shaft is arranged to rotatably guide the pinion around the shaft in case of
a disengagement of the pinion from the shaft.
]5.[
276
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
188461
‫מצע תאי ושיטות לאחסון תאים אנימליים‬
]54[
CELL MEDIUM AND METHODS
FOR STORAGE OF ANIMAL CELLS
]11[
]22[
]52[
].2[
30.06.2006
102005031532.1 ]21[ 01.07.2005
]22[ DE
Int. Cl.(2010.01) A01N 01//02
CYTONET GMBH &CO. KG,
GERMANY
WO/2007/003382
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Methods for storing especially human cells, cell media for storing cells, and the use of
such cell media for storing cells, whose vitality is preserved during the storage period 3
]7.[
].4[
]5.[
277
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
188655
‫מערכת ושיטה להנחיית כלי רכב מעבר‬
‫למכשולים בשלט רחוק‬
]54[
SYSTEM AND METHOD FOR
NAVIGATING A REMOTE
CONTROL VEHICLE PAST
OBSTACLES
]11[
]52[
].2[
08.01.2008
Int. Cl.(2010.01) B62D 01//00, G05D 01//00, G06T 07//20
RAFAEL ADVANCED DEFENSE
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
SYSTEMS LTD.
‫חיפה‬
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A method for navigating a remote control vehicle carrying a video camera which
produces a sequence of images, the method comprising:
(a) tracking a current position of the vehicle as the vehicle moves along a path motion;
(b) determining a location of said current position within a prior image, said prior
image having been acquired by the video camera at a previously visited point along
the path of motion; and
(c) displaying to the operator a graphic display including a representation of the
vehicle shown at said location within the prior image.
].4[
]5.[
__________________
]22[]12[
188667
‫תא פונדקאי מודבק ע"י נגיף וציניה אנקארה‬
MVA –‫) ותכשיר הכולל את ה‬MVA( ‫ששונה‬
‫הנ"ל‬
]54[
HOST CELL INFECTED BY A
MODIFIED VACCINIA VIRUS
ANKARA (MVA) AND A
COMPOSITION COMPRISING
SAID MVA
]11[
]22[
]52[
]01[
].2[
10.03.2001
PA200000410 ]21[ 14.03.2000
]22[ DK
Int. Cl.(2010.01) A61K 39//285, C12N 07//00, 07//08, 15//863
DIVISION FROM 150736
BAVARIAN NORDIC A/S,
DENMARK
278
September 27, 2011-‫כ"ח באלול התשע"א‬
]7.[
].4[
WO/2001/068820
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
The invention provides new strains of the Modified Vaccinia Virus Ankara (MVA)
that have a strongly reduced virulence for most mammals, especially humans, but
nevertheless grows in cells of a continuous cell line approved for the production of a
therapeutic agent such as a vaccine. The invention also provides a method for
producing said adapted MVA strains. The adapted MVA can be used e.g. for
parenteral immunization, as a vector system, or in the active or inactivated from as an
adjuvant or as a regulator of the unspecific components of the immune system.
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
188731
‫מערכת ליירט טיל‬
]54[
SYSTEM FOR INTERCEPTING A
PROJECTILE
]11[
]22[
]52[
].2[
12.07.2006
11/179152
]21[ 12.07.2005
]22[ US
Int. Cl.(2010.01) F41H 11//02, F42D 05//00
SCV QUALITY SOLUTION, LLC,
U.S.A.
WO/2007/008960
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
System has a containment blanket (300). The system further has a launcher (200)
configured to launch the containment blanket and logic configured to deploy the
containment blanket. The containment blanket is configured to encompass an
incoming projectile (2043)
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
279
ERADICATION OF
PIGMENTATION AND SCAR
TISSUE
189082
‫השמדת פיגמנטציה ורקמה מצולקת‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]11[
]22[
]52[
].2[
].1[
]7.[
].4[
]5.[
27.07.2006
170020
]21[ 01.08.2005
]22[ IL
Int. Cl.(2010.01) A61M 37//00
HAWK MEDICAL TECHNOLOGIES
‫ רעננה‬,‫הוק מדיקל טכנולוג'יס בע"מ‬
LTD.
NOAM DANENBERG, ORI NESHER
‫ אורי נשר‬,‫נועם דננברג‬
WO/2007/015232
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention is a non-surgical method for the eradication of pigmentation and scar
tissue from an area of skin. The method comprises repeatedly puncturing the area of
skin with an array of needles. As the needles are inserted into the skin, the needles and
surface of the skin are washed with a clean solution. As the needles are withdrawn
from the skin, the flow of clean solution ceases and the dirty solution, which contains
cellular fluids and pigments released by the action of the needles, is removed from the
surface. The invention is also a solution, which is used to clean the needles and to aid
in destroying the pigment containing cells, and an apparatus, which is especially
designed to move the needles into and out of the surface of the skin and to provide
synchronization of the motion of the needles and flow of the solution such as to
maximize the effectiveness of the method.
__________________
]22[]12[
]54[
PROCESS FOR PREPARING AN
IMMUNOGENIC COMPOSITION
COMPRISING THE STEPS OF
COMBINING A VIRAL SURFACE
ANTIGEN COMPONENT THAT
INCLUDES A SURFACTANT AND
A FATTY ADJUVANT
COMPONENT
]11[
]22[
02.08.2006
0515906.6
]21[ 02.08.2005
151153331
1432231115
151231232
1432231115
Int. Cl.(2010.01) A61K 39//39
NOVARTIS VACCINES AND
DIAGNOSTICS S.R.L,, ITALY
]52[
].2[
280
189102
‫תהליך להכנת תכשיר אימונוגי הכולל את‬
‫השלבים של צירוף מרכיב של אנטיגן פני–שטח‬
‫ הכולל חומר פעיל שטח ומרכיב של חומר‬,‫ויראלי‬
‫מסייע שומני‬
]22[
GB
GB
GB
September 27, 2011-‫כ"ח באלול התשע"א‬
]7.[
].4[
WO/2007/015167
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
Inclusion of fatty adjuvants in vaccine compositions can cause difficulties with certain
antigenic components, particularly with antigens that include a surfactant component.
A method for preparing an immunogenic composition comprising an antigen and a
fatty adjuvant involves purification of the antigen substantially in the absence of
surfactant. Where surfactants cannot be avoided, the following are combined: (i) an
antigen component that includes a surfactant and (ii) a fatty adjuvant component, to
give a composition in which the weight ratio of said fatty adjuvant to said surfactant is
less than 1000:1.
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
189196
]54[
MULTIPLE CHAMBER
CONTAINER
]11[
]22[
]52[
].2[
02.08.2006
60/704555
]21[ 02.08.2005
]22[
Int. Cl.(2010.01) A61J 01//00, B65D 81//32
BAXTER INTERNATIONAL INC.,
U.S.A.
BAXTER HEALTHCARE S.A.,
SWITZERLAND
WO/2007/037793
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
281
‫מיכל המכיל מספר תאים‬
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A multiple chamber container for separately storing components of a parenteral
nutritional formulation is provided. The multiple chamber container may include
frangible barriers, preferably peelable seals separating the chambers from each other.
The container preferably facilitates the selective activation of the peelable seals to
permit the admixing of less than all the separately stored components. The container
may include a chamber positioned at each of the opposite lateral ends of the container
and at least one additional chamber between the lateral chambers. The at least one
additional chamber may have a longitudinal length substantially less than the
longitudinal length of at least one of the lateral chambers. This configuration allows
for selective opening of the seals since when rolling the container from the top avoids
pressurizing the at least one additional chamber and inadvertent activation of a seal.
The longitudinal length of the at least one additional chamber may be from about twoSeptember 27, 2011-‫כ"ח באלול התשע"א‬
thirds to about three-fourths the longitudinal length of at least one of the lateral
chambers. Alternatively, the container may include a hanger flap extending from a top
end of the container towards the bottom end a substantially greater distance relative to
the at least one additional chamber than the lateral chambers.
__________________
]22[]12[
189311
‫שיפור חוזק כוללני של מוצרי מלט וגבס‬
]54[
COMPREHENSIVE STRENGTH
IMPROVEMENT OF CEMENT
AND GYPSUM PRODUCTS
]11[
]22[
]52[
].2[
]7.[
].4[
29.08.2006
60/711694
]21[ 29.08.2005
]22[ US
Int. Cl.(2010.01) C04B 28//04, 28//14
JOSEF ATOON
‫ רמת הגולן‬.‫נ‬.‫ ד‬,‫יוסף אטון‬
WO/2007/026352
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
The invention relates generally to a cement or gypsum composition having improved
properties, which is prepared by incorporating an enzyme into a cement material such
as a cement, mortar, or concrete, or into a gypsum product. The invention also relates
to methods of manufacturing improved cement compositions and gypsum products,
methods of improving the compressive strength of cement compositions and gypsum
products, and methods of reducing the cost of such compositions by enabling the use
of less expensive aggregates in the manufacturing process. More specifically, the
invention relates to a cement composition or a gypsum composition, optionally
including at least one aggregate and optionally including at least one pozzolan,
comprising a cement material or gypsum optionally including aggregate(s) and
pozzolan(s) having blended therein an enzyme.
]5.[
282
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
189986
–8–‫–דימתוקסי‬6,5([–4–‫–בנזיל‬8 ‫תהליך לייצור‬
‫–איל] מתילפיפרידין או הידרוכלוריד‬2–)‫אינדנון‬
‫שלו‬
]54[
PROCESS FOR PRODUCING 1BENZYL-4-[(5,6-DIMETHOXY-1INDANON)-2YL]METHYLPIPERIDINE OR
HYDROCHLORIDE THEREOF
]11[
]22[
05.10.2006
2005-299526
]21[ 14.10.2005
]22[ JP
016.21744
1732131115
US
Int. Cl.(2010.01) C07D 21/1/32
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
WO/2007/043440
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
1-Benzyl-4-[(5,6-dimethoxy-1-indanon)-2-ylidene]methylpiperidine or a solvate
thereof is catalytically hydrogenated in the presence of a palladium-alumina catalyst.
According to need, the resultant reaction product is converted to a hydrochloride.
Thus, 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine or a
hydrochloride thereof, which are useful as a medicine, can be produced as a highpurity compound by a safer and easy operation suitable for industrial production.
]52[
].2[
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
COLLIMATED OPTICAL SYSTEM
]11[
]22[
]52[
].2[
07.11.2006
11/268784
]21[ 08.11.2005
Int. Cl.(2010.01) G02B 07//02, 23//18
ITT MANUFACTURING
ENTERPRISES, INC., U.S.A.
WO/2007/056385
SANFORD T.COLB & CO.,
P.O.B. 2273,
]7.[
].4[
283
190238
‫מערכת אופטית מכווננת‬
]22[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
September 27, 2011-‫כ"ח באלול התשע"א‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
An optical system (100) provides a lens cell (150) having a generally- cylindrical lens
cell body and an optical lens system therein. The lens cell body has a lens cell central
longitudinal axis and a lens cell optical axis, eccentrically offset from the lens cell
central longitudinal axis. A sleeve (130) has a generally cylindrical sleeve body, an
outer surface with a first longitudinal axis, and an inner surface with a second
longitudinal axis, eccentrically offset from the first longitudinal axis. The lens cell is
inserted into the sleeve. A housing (110) has a generally cylindrical body into which
the sleeve is at least partially inserted. The lens cell and the sleeve are rotated relative
to each other and to the housing such that the lens cell optical axis is aligned in a
desired location. After the lens cell optical axis is aligned in the desired location, the
lens cell is fixedly connected to the sleeve and the sleeve is connected to the housing to
prevent rotation of the sleeve relative to the housing.
REHOVOT 76122
]5.[
220/106
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
__________________
]22[]12[
]54[
LEAKPROOF BOTTLE FOR
FEEDING A CHILD
]11[
]22[
]52[
].2[
15.09.2006
202005015828.3 ]21[ 08.10.2005
Int. Cl.(2010.01) A61J 11//04
MAPA GMBH GUMMI-UND
PLASTIKWERKE,, GERMANY
WO/2007/042117
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
284
190257
‫בקבוק חסין בפני נזילות להאכלת תינוקות‬
]22[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Leakproof bottle for feeding a child with a bottle, with a first external thread around a
September 27, 2011-‫כ"ח באלול התשע"א‬
bottle opening, a lower closure ring, with a first internal thread, which is screwed onto
the first external thread and has at least one first throughflow hole, with an upper
closure ring, with a second external thread on which the lower closure ring sits in a
sealing manner and which has at least one second throughflow hole which, by rotation
of the upper closure ring in relation to the lower closure ring, can be brought into
coinciding and non-coinciding positions in relation to the first throughflow hole,
locking elements which can rotate the lower closure ring and the upper closure ring
relative to each other and lock them releasably to each other, with a drinking teat and a
screw ring with a second internal thread, which is screwed onto the second external
thread of the upper closure ring and secures a lower edge region of the drinking teat
releasably to the upper closure ring.
__________________
]22[]12[
190413
‫חפץ הניתן לצוף חופשי בחלל ללא נקודת עגינה‬
‫ושיטת תמיכה של חפץ כאמור‬
]54[
OBJECT ADAPTED TO FLOAT
FREELY IN SPACE WITHOUT
REQUIRING AN ANCHORING
POINT AND METHOD FOR
SUPPORTING SUCH AN OBJECT
]11[
]22[
]52[
].2[
].1[
]7.[
].4[
20.09.2006
0519849.4
]21[ 29.09.2005
]22[ GB
Int. Cl.(2010.01) A63H 27//10
NEW CREATE LTD.
‫ תל אביב‬,‫ניו קריאט בע"מ‬
OZ SHENHAR
‫עוז שנהר‬
WO/2007/036930
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Device for supporting an object is freely in space without requiring an anchoring point
connected to ground, by attaching the object to a support structure (10) adapted to float
in air when filled with a gas having lower specific gravity than air at a controlled
pressure that provides sufficient buoyancy for different weight objects. The support
]5.[
285
September 27, 2011-‫כ"ח באלול התשע"א‬
structure is released together with the attached object so as to reach an equilibrium
position where a buoyancy force of the support structure counteracts a combined
weight of the enclosure and attached object. The object may be integral with the
support structure and may be a self-powered electrical device operating on a battery or
solar energy. The enclosure may be a floating platform or may be part of an object.
__________________
]22[]12[
190719
‫תצמידים ביולוגיים הכוללים פוליסכרידים‬
‫גופרתיים ושימושיהם‬
]54[
BIOCONJUGATES COMPRISING
SULFATED POLYSACCHARIDES
AND THEIR USES
]11[
]22[
]52[
].2[
15.10.2006
11/374279
]21[ 11.10.2005
]22[ US
Int. Cl.(2010.01) A61K 47//48
BEN GURION UNIVERSITY OF THE
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
NEGEV RESEARCH AND
‫שבע‬-‫ באר‬,‫למחקר ופיתוח‬
DEVELOPMENT AUTHORITY
SMADAR COHEN, INBAR
‫ ענבר פרימן‬,‫סמדר כהן‬
FREEMAN
WO/2007/043050
BEN-AMI & ASSOCIATES,
,'‫בן עמי ושות‬
8 MENACHEM PLAUT ST.,
1 ‫מנחם פלאוט‬
PARK TAMAR,
‫רחובות‬64 .‫ד‬.‫ ת‬,
P.O.B. 94,
REHOVOT 76100
The present invention provides bioconjugates comprising a sulfated polysaccharide
such as alginate sulfate and hyaluronan sulfate and at least one bioactive polypeptide
capable of binding a sulfate group of said sulfated polysaccharide. The bioactive
polypeptide can be a heparin-binding polypeptide or a positively-charged polypeptide
and is preferably a peptide growth factor or a cytokine. The bioconjugates serve as
delivery systems for sustained release of the bioactive polypeptides. Also provided are
pharmaceutical compositions comprising the bioconjugates or comprising the sulfated
].1[
]7.[
].4[
]5.[
286
September 27, 2011-‫כ"ח באלול התשע"א‬
polysaccharides.
__________________
]22[]12[
190885
‫הרכבים אימונוגניים ושיטות לשימוש‬
]54[
IMMUNOGENIC COMPOSITIONS
AND METHODS OF USE
]11[
]22[
]52[
].2[
25.10.2006
60/729828
]21[ 25.10.2005
]22[
Int. Cl.(2010.01) A61K 39//00, C07K 17//00
ARTIFICIAL CELL
TECHNOLOGIES, INC., U.S.A.
WO/2007/050702
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]7.[
].4[
]5.[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Disclosed herein are immunogenic compositions comprising a multilayer film
comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise
oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an
antigenic polypeptide comprising one or more surface adsorption regions covalently
linked to one or more antigenic determinant regions, wherein the antigenic polypeptide
and the one or more surface adsorption regions have the same polarity. The
immunogenic compositions may be employed in methods of eliciting an immune
response in a vertebrate organism.
__________________
]22[]12[
]54[
METHODS OF FABRICATING AN
ANNULAR FIBER STRUCTURE
AND INSTALLATIONS FOR
FABRICATING AN ANNULAR
FIBER STRUCTURE
]11[
]22[
]52[
25.08.2006
0510811
]21[ 24.10.2005
Int. Cl.(2010.01) D04H 03//02
287
190990
‫שיטות להכנת מבנה סיב טבעתי והתקנים‬
‫להכנת מבנה סיב טבעתי‬
]22[
FR
September 27, 2011-‫כ"ח באלול התשע"א‬
].2[
]7.[
].4[
]5.[
MESSIER-BUGATTI, FRANCE
WO/2007/048946
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention concerns a method whereby a first fibrous web formed by substantially
unidirectional elements is brought (by device 300) and raised (by shuttle 322)
alternately in one direction and in the other between coaxial outer (100) and inner
(200) circular crowns, while being maintained at said crowns by picots (102, 202), and
a second fibrous web formed by substantially unidirectional elements and deposited
(by device 400) in a circumferential direction between said outer and inner crowns, the
transverse and circumferential annular webs are bound together by a binding device
(500) and are driven in rotation about the axis of the outer and inner crowns by
completing three full cycles to obtain a thick annular fibrous structure having layers
formed by the transverse web which alternate and are bound to layers formed by the
circumferential web.
__________________
]22[]12[
191180
‫התקן שליפה עבור מהדקים כירורגיים‬
]54[
EXTRACTING DEVICE FOR
SURGICAL FASTENERS
]11[
]22[
]52[
].2[
02.11.2006
60/732101
]21[ 02.11.2005
Int. Cl.(2010.01) A61B 17//00
I.B.I. ISRAEL BIOMEDICAL
INNOVATIONS LTD.
]7.[
].4[
WO/2007/052276
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
The application provides a device (2) for extracting from a body tissue surgical
fasteners (20) having a crown, a baseplate and prongs extending from the crown to the
baseplate. The device includes a shaft having a lumen with a cross-sectional shape and
dimensions to allow the crown to enter the lumen while preventing the baseplate from
entering the lumen.
288
]22[
US
‫איי ישראל ביומדיקל אינוביישנס‬.‫בי‬.‫איי‬
‫בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
191785
‫אנטנה חד–קוטבית פרקטלית‬
]54[
FRACTAL MONOPOLE ANTENNA
]11[
]22[
]52[
].2[
]7.[
].4[
04.12.2006
11/293369
]21[ 05.12.2005
Int. Cl.(2010.01) H01Q 09//40
ELTA SYSTEMS LTD.
WO/2007/066327
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
A monopole fractal antenna and a method of manufacturing thereof are described. The
antenna includes a ground plane having a cavity recessed therein, a radiating arm
backed by the cavity and coupled to a feed line arranged at the cavity, and at least one
pair of electrical shunts configured for connecting at least two points selected within
the fractal portion of the radiating arm to the ground plane. At least a portion of the
radiating arm has a fractal geometric shape. The radiating arm is extended from the
cavity along an axis disposed in relation to the ground plane.
]22[
US
‫ אשדוד‬,‫אלתא מערכות בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
191982
‫נוגדן קושר לחלבון המקנה עמידות בפני סרטן‬
‫) ושיטות ניפוי המבוססות עליו‬BCRP( ‫השד‬
]54[
ANTIBODY BINDING TO BREAST
CANCER RESISTANCE PROTEIN
(BCRP) AND SCREENING
METHODS USING THE SAME
]11[
]22[
]52[
05.02.1999
60/073763
]21[ 05.02.1998
]22[
Int. Cl.(2010.01) C07K 16//18, C12Q 01//02
289
US
September 27, 2011-‫כ"ח באלול התשע"א‬
]01[
].2[
]7.[
].4[
]5.[
DIVISION FROM 177612
UNIVERSITY OF MARYLAND,
BALTIMORE, U.S.A.
WO/1999/040110
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An isolated monoclonal antibody which specifically binds to SEQ ID NO: 1
__________________
]22[]12[
192757
‫יחידת קיווטה לאנאליזה של נוזל ביולוגי‬
‫ומכשיר אוטומטי לאנאליזה חוץ גופית‬
]54[
UNIT CUVETTE FOR ANALYSING
A BIOLOGICAL FLUID AND
AUTOMATIC DEVICE FOR IN
VITRO ANALYSIS
]11[
]22[
]52[
].2[
17.01.2007
0600670
]21[ 25.01.2006
]22[ FR
Int. Cl.(2010.01) B01L 03//00, G01N 35//00, 35//02
IMMUNODIAGNOSTIC SYSTEMS
FRANCE, FRANCE
ALAIN ROUSSEAU, FRANCE
WO/2007/085715
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]7.[
].4[
]5.[
290
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The bottom of the cuvette (1) comprises a curved raceway placed so as to guide the
oscillating movement of a ball inserted into the cuvette. In addition, the cuvette
comprises means of attachment, in two perpendicular directions, to adjacent unit
cuvettes. The cuvettes can thus be stored as plates (19) in a feed magazine (27) of an
analytical device (22). The analytical device comprises several stations (29-37) placed
around a rotary ring (25). Only where it is desired to determine the clotting time of the
blood contained in the cuvette a ball is introduced into the latter, at a ball distribution
post (36). The cuvette equipped in this way is then brought to a station (37) where the
test is carried out. The major advantage of the invention is the polyvalence of the
cuvette and of the analytical device.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
193148
‫שימוש בשילוב חומרים להכנת תכשירים‬
B ‫רוקחיים לטיפול בוירוס צהבת מסוג‬
]54[
USE OF COMBINATIONS OF
AGENTS FOR THE
PREPARATION OF
MEDICAMENTS FOR
TREATMENT OF HEPATITIS B
VIRUS
]11[
]22[
]52[
]01[
].2[
]7.[
].4[
02.11.1999
60/106664
]21[ 02.11.1998
]22[ US
Int. Cl.(2010.01) A61K 31//513, 31//52, 31//675, C07D 47/3/16
DIVISION FROM 142910
GILEAD SCIENCES, INC., U.S.A.
WO/2000/025797
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]5.[
Use of synergistically effective amount of 2'-fluoro-5- methyl-p-Larabinofuranolyluridine (L-FMAU), or a pharmaceutically acceptable salt, ester, or
prodrug thereof in a synergistic combination with an effective amount of a second antihepatitis B agent selected from the group consisting of a compound of the formula
wherein R is NH2, OH, Cl, or H, or a pharmaceutically acceptable salt, ester or
prodrug thereof, penciclovir, and 9- 2- (phosphonomethoxy) ethyl] adenine (PMEA),
or a pharmaceutically acceptable salt, ester or prodrug thereof, for the treatment of
Hepatitis B virus
The applications for division
291
206121/
‫בקשות חלוקה מבקשה זו‬
September 27, 2011-‫כ"ח באלול התשע"א‬
9‫שטרם פורסמו‬
from this application have
not yet been published
__________________
]22[]12[
193378
‫מתקן אטימה לפתח גז של תנור או הדומה לו‬
]54[
SEALING DEVICE FOR A GAS
INLET TO AN OVEN OR THE
LIKE
]11[
]22[
]52[
].2[
]7.[
].4[
13.02.2007
0650528
]21[ 14.02.2006
]22[ FR
Int. Cl.(2010.01) F27B 05//16
MESSIER-BUGATTI, FRANCE
WO/2007/093584
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A pipe (12) for feeding a gas into an oven, a furnaces, or the like (such as a CVI /CVD
oven), and in particular into a reaction chamber structure (16) inside the oven, is
provided with a gastight tubular sealing device (32) extending radially outside the pipe
and defining a path that is practically gastight, along which there extends the as feed
pipe. The tubular sealing device is preferably at least partially flexible in the transverse
direction and/or the axial direction so as to accommodate positioning defects between
a location situated in the reaction chamber and a location where the gas feed pipe
penetrates into the oven (which defects may be due, for example, to asymmetrical
thermal expansion/contraction).
]5.[
__________________
]22[]12[
292
193470
September 27, 2011-‫כ"ח באלול התשע"א‬
–‫–אנ‬2–‫–אריל–פרופ‬3–‫–אלקיל‬2 ‫תהליך להכנת‬
‫–אולים‬8
]54[
PROCESS FOR PREPARATION OF
2-ALKYL-3-ARYL-PROP-2-ENE-1OLS
]11[
]22[
]52[
].2[
08.11.2007
06123706.1
]21[ 08.11.2006
]22[ EP
Int. Cl.(2010.01) C07C 23/1/12, 29//36, 41//20, 43//23
SPEEDEL EXPERIMENTA AG,
SWITZERLAND
WO/2008/055941
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Process for preparing a compound of the formula (I) in which R 1 and R2 are each
independently H, C1-C8-alkyl, halogen, polyhalo-C1-C8-alkoxy, polyhalo-C1-C8-alkyl,
C1-C8-alkoxy, C1-C8-alkoxy-C1-C8-alkyl, or C1-C8-alkoxy-C1-C8-alkoxy, where R1 and
R2 are not both H, and R3 is C1-C8-alkyl, which is characterized in that a) a compound
of the formula (II) in which R1 and R2 are each as defined above and X is Br, I, triflate,
toyslate or mesylate is reacted with prop-2-yn-1-ol to give the compound of the
formula (III), b) the compound of the formula (III) is reacted with an alkyl-metal
compound in which 'alkyl' is as defined above for R3 to give a compound of the
formula (I).
]7.[
].4[
]5.[
__________________
]22[]12[
]54[
MANUALLY ACTUATED TONGS
FORCE MONITORING
]11[
]52[
].2[
25.08.2006
Int. Cl.(2010.01) B25B 07//00
HANS OETIKER AG MASCHINENUND APPARATEFABRIK,
293
193583
‫מלקחיים המופעלים ידנית בעלי פיקוח כח‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]7.[
].4[
]5.[
SWITZERLAND
WO/2008/022649
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
For the signaling of a force exerted by means of manually actuated tongs, one of the
tong limbs 10 is configured of an interior lever 15 and an exterior lever 16, wherein
the interior lever 15 carries one of the tong jaws 14 and is pretensioned by means of
compression springs 20, 21 against the exterior lever 16 grasped by the hand of the
user. Both levers 15, 16 have contact elements 36, 38 which are positioned opposite of
each other and come in contact with each other if the actuating force acting against the
pretension of the compression springs 20, 21 reaches a predetermined value, and
which activate a vibrator 31 accommodated in the tong limb 10.
__________________
]22[]12[
193647
]54[
HAIR STYLING TOOL WITH
ROTATABLE CYLINDER
]11[
]22[
26.02.2007
60/776476
]21[ 24.02.2006
]22[
2260.7553
123113111.
Int. Cl.(2010.01) A45D 01//00, 06//02, 06//04
M. M. & R. PRODUCTS, INC., U.S.A.
WO/2007/100842
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
].2[
]7.[
].4[
]5.[
294
‫מכשיר לעיצוב שיער עם גליל מסתובב‬
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A hair styling tool includes a body, a cylinder extending from the body, the cylinder
rotatable relative to the body, a motor for rotating the cylinder, a heater to heat the
September 27, 2011-‫כ"ח באלול התשע"א‬
cylinder, and a styling arm pivotally attached to the body. The hair styling tool may
have a generally clam shell configuration, wherein the styling arm is movable between
an open position in which the styling arm does not contact the cylinder and a closed
position in which the styling arm contacts the cylinder. The styling arm may also
include a brush head with fixed or retractable bristles and/or a smoothing plate.
__________________
]22[]12[
193676
‫שיטות להכנת פירות אבטיח טריפלואידים חסרי‬
‫זרעים‬
]54[
METHOD FOR PRODUCING
TRIPLOID, SEEDLESS
WATERMELON FRUIT
]11[
]22[
25.02.2003
10/091154
]21[ 05.03.2002
]22[ US
216243513
1131231112
US
Int. Cl.(2010.01) A01H 01//00, 05//00
DIVISION FROM 163770
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND
WO/2003/075641
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method for producing a triploid, seedless watermelon fruit comprising the steps of:
)a) planting triploid watermelon plants and diploid watermelon plants in the same
field, wherein the diploid plants are homozygous for a gene e; and
)b) allowing pollination of said triploid watermelon plants by pollen of said diploid
watermelon plant to obtain triploid, seedless watermelon fruit.
]52[
]01[
].2[
]7.[
].4[
]5.[
__________________
295
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
193777
‫טוקסינים של בוטולינום שעברו שינוי ותכשירי‬
‫רוקחות המכילים אותם‬
]54[
MODIFIED BOTULINUM TOXINS
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]11[
]22[
]52[
].2[
15.03.2007
06005300.6
]21[ 15.03.2006
]22[ EP
Int. Cl.(2010.01) A61K 38//16, C07K 14//33
MERZ PHARMA GMBH & CO.
KGAA, GERMANY
WO/2007/104567
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The invention relates to a modified botulinum toxin which has a naturally occurring
heavy chain and a modified light chain. The invention is characterized in that the
modification of the light chain is that it comprises (i) on its N terminus an extension of
the chain which has the structure -(C)n-(tag)m-(X)l- in the direction from the N
terminus to the C terminus, C representing a cysteine group, tag representing any tag
and X representing a group of any naturally occurring amino acid, n being an integer
from 1 to 50, m being 0 or 1 and l being 0 or an integer from 1 to 50, and (ii) that at
least one of the cysteine groups in the extension of the chain is coupled to at least one
chain PEG3
]7.[
].4[
]5.[
__________________
]22[]12[
194136
‫מסחטת פרי הדר עם גלאי שחרור חומר בלתי‬
‫רצוי ושיטות קשורות‬
]54[
CITRUS JUICE APPARATUS
WITH UNDESIRED MATERIAL
RELEASE DETECTOR AND
RELATED METHODS
]11[
]22[
]52[
16.09.2008
11/859232
]21[ 21.09.2007
]22[ US
Int. Cl.(2010.01) A23L 02//04, 02//06, 02//70, 02//72, A23N 01//00, A47J 17//04,
19//02, G01N 33//02
JOHN BEAN TECHNOLOGIES
CORPORATION, U.S.A.
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
September 27, 2011-‫כ"ח באלול התשע"א‬
].2[
].4[
296
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
A fruit juiice apparatus comprising: at least one fruit juice processing device
comprising at least one fruit juice output having a flow of fruit juice therethrough; said
at least one fruit juice processing device upon a malfunction causing an undesired
material release along with the flow of fruit juice into said at least one fruit juice
output; characterized in that: at least one undesired material release detector is coupled
to the at least one fruit juice output for detecting the undesired material release.
__________________
]22[]12[
194325
,‫תרכובת פפטידית אנטימיקרוביאלית‬
‫ תכשירים רוקחיים המכילים אותה‬,‫הכנתה‬
‫ תמרוק או דבר‬,‫ושימוש בה להכנת תרופה‬
‫מאכל‬
]54[
ANTIMICROBIAL PEPTIDE
COMPOUND, PREPARATION
THEREOF, PHARMACEUTICAL
COMPOSITIONS COMPRISING THE
SAME AND USE THEREOF IN THE
PREPARATION OF A
MEDICAMENT, COSMETIC OR
FOODSTUFF
]11[
]22[
]52[
].2[
]7.[
].4[
06.04.2007
MI2006A000678 ]21[ 06.04.2006
]22[
Int. Cl.(2010.01) C07K 14//32, 14//415, 14//43
SANOFI-AVENTIS SPA, ITALY
WO/2007/113691
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]5.[
IT
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A peptide compound with biological activity, which in particular possesses
antimicrobial properties, its preparation and its applications.
__________________
]22[]12[
]54[
MATERIALS HANDLING AND
TREATMENT
]11[
13.06.2007
297
195888
‫טיפול בחומרים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[
]52[
].2[
].1[
]7.[
].4[
]5.[
2006903180
]21[ 13.06.2006
]22[ AU
Int. Cl.(2010.01) B65G 15//08
Z-FILTER PTY LTD., AUSTRALIA
NEIL DERYCK BRAY GRAHAM,
ARTHUR DERRICK BRAY
GRAHAM
WO/2007/143780
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A belt filter apparatus (10) for treating material to separate solid and liquid
components thereof. The apparatus (10) comprises an endless belt structure (11)
adapted to circulate along a path (12) incorporating guide roller structures (13) around
which the belt structure (11) passes. The endless belt structure (11) comprises an
elongate belt portion (15) formed of water permeable material. The belt portion (15)
has two opposed longitudinal edges (17, 18). The endless belt structure (11) further
comprises a zipper (19) for releasably connecting the two longitudinal edges (17, 18)
together so as to form a tubular structure (21) having a flexible side wall (22). The
circulating path (12) includes an assembly zone (33) at which the longitudinal edges
(17, 18) of the belt portion (15) are brought together and interconnected by way of the
zipper (19) to form the tubular structure (21), and a disassembly zone (35) at which the
zipper (19) is released to separate the longitudinal edges (17, 18) and the tubular
structure (21) subsequently opened. Means (90, 110) are provided for compressing the
tubular structure (21) along a portion thereof to express liquid from the material
contained in the tubular structure (21). The liquid so released can discharge from the
tubular structure (21) through the water permeable belt portion (15).
__________________
]22[]12[
]54[
298
CONTAINER FOR THE STORAGE
OF PRODUCTS
196215
‫מיכל לאחסון מוצרים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]11[
]22[
]52[
].2[
]7.[
].4[
]5.[
29.06.2007
0605910
]21[ 30.06.2006
]22[ FR
Int. Cl.(2010.01) B65D 53//02, 81//24, E06B 07//23
JANNY SARL, FRANCE
WO/2008/000971
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A container (1) for storing products comprises a tub (2) and a cover (3) which is
equipped with a seal (20) positioned in a peripheral groove (10) formed in the inner
face (8) of the cover (3). The container (1) is characterized in that the tub (2)
comprises an inner (5) and outer (6) flat peripheral rim, the cover (3) comprising a
vertical peripheral rim (7) designed to cover the outer peripheral rim (6) upon closure
of the cover (3), and in that the inner (5) and outer (6) peripheral rims are in different
planes and constitute a shouldered shape, the cover (3) comprising, between its vertical
peripheral rim (7) and its inner face (8), a clearance (9) with a shape matching said
shouldered shape of the tub (2), the distance between the plane of the clearance (9) and
the plane of the inner face (8) of the cover (3) being less than the distance separating
the planes of the peripheral rims of the tub (2).
__________________
]22[]12[
]54[
ENHANCED PRODUCTION OF
LIPIDS CONTAINING
POLYENOIC FATTY ACIDS BY
HIGH DENSITY CULTURES OF
EUKARYOTIC MICROBES IN
FERMENTORS
]11[
26.01.2001
299
196776
‫תהליך לייצור מוגבר של ליפידים המכילים‬
‫חומצות שומניות פוליאנויות באמצעות תרביות‬
‫בריכוז גבוה של מיקרובים יוקריוטיים במתקנים‬
‫מתסיסים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[
]52[
]01[
].2[
]7.[
].4[
]5.[
60/178588
]21[ 28.01.2000
]22[ US
Int. Cl.(2010.01) A23B 07//10, A23D 09//00, C12N 01//00
DIVISION FROM 171408
MARTEK BIOSCIENCES
CORPORATION, U.S.A.
WO/2001/054510
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A process for producing lipids containing polyenoic fatty acids from microorganisms
of the order Thraustochytriales capable of producing at least about 15% of the total
lipids produced by said microorganisms as polyunsaturated lipids comprising
conducting a fermentation of the microorganisms in a medium comprising a nonalcohol carbon source and a limiting nutrient source: wherein non-alcohol carbon
source and limiting nutrient source are added to the medium to increase the biomass
density of the fermentation medium to at least about 100g/L on a dry cell weight basis;
and wherein the fermentation of the medium having a biomass density of at least about
100 g/L on a dry cell weight basis produces lipids containing polyenoic fatty acids.
__________________
]22[]12[
198294
,‫תכשיר רוקחות בעל תכונות אנטי פסיכוטיות‬
‫ נוגדות אפילפסיה עם תופעות‬,‫נוגדות דיכאון‬
‫לוואי מופחתות‬
]54[
PHARMACEUTICAL
COMPOSITION HAVING
ANTIPSYCHOTIC,
ANTIDEPRESSANT OR
ANTIEPILEPTIC ACTIVITY WITH
REDUCED SIDE EFFECT
]11[
]22[
23.07.2007
60/856177
]21[ 02.11.2006
]22[ US
22607.354
233123111.
US
Int. Cl.(2010.01) A61K 31//19, 31//40, 31//4545, 31//519, 31//554, A61P 25//08,
25//18, 25//24
N-GENE RESEARCH
LABORATORIES INC., U.S.A.
WO/2008/053257
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
].2[
]7.[
].4[
]5.[
300
The side effect leading to overweight or obesity in medication with a known
antipsychotic, antidepressant or antiepileptic drug is reduced by the administration of
September 27, 2011-‫כ"ח באלול התשע"א‬
O-(3- piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime or a pharmaceutically
acceptable acid addition salt thereof.
__________________
]22[]12[
]54[
REDUCTION OF OVERWEIGHT
OR OBESITY
]11[
]22[
23.07.2007
60/856117
]21[ 02.11.2006
22607.345
233123111.
Int. Cl.(2010.01) A61K 31//4545
N-GENE RESEARCH
LABORATORIES INC., U.S.A.
WO/2008/053256
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
].2[
]7.[
].4[
]5.[
198296
‫הפחתת משקל יתר או השמנת יתר‬
]22[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention refers to the use O-(3-piperidino-2-hydroxy-1- propyl)-nicotinic
amidoxime or a pharmaceutically acceptable acid addition salt thereof for the
prevention of abnormal body weight gain or reduction of overweight or obesity.
__________________
]22[]12[
198400
‫מתקני חיתוך כירורגיים‬
]54[
SURGICAL CUTTING DEVICES
]11[
]22[
]52[
].2[
]7.[
].4[
30.10.2007
60/855325
]21[ 30.10.2006
]22[ US
Int. Cl.(2010.01) A61B 17//16, 17//58
DGIMED ORTHO, INC., U.S.A.
WO/2008/054752
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The present invention provides surgical drilling devices and methods. An exemplary
]5.[
301
September 27, 2011-‫כ"ח באלול התשע"א‬
surgical drilling device in accordance with the present invention comprises a housing,
a retractable guide tube assembly, and a flexible cable drill. The retractable guide tube
assembly comprises an arcuate guide tube slidingly positioned in a first arcuate
channel of the housing. The arcuate guide tube is operatively connected to an actuating
rod slidingly positioned in a second channel of the housing wherein the actuating rod
controllably advances and retracts the arcuate guide tube. The flexible cable drill
comprises a first portion slidingly positioned in the arcuate guide tube and a second
portion slidingly positioned in a third channel of the housing.
__________________
]22[]12[
198863
‫העברת גנים וביטויים בתאי יונקים ביעילות‬
‫גבוהה ע"י טרנספקציות מרובות של רצפי‬
MAR
]54[
HIGH EFFICIENCY GENE
TRANSFER AND EXPRESSION IN
MAMMALIAN CELLS BY A
MULTIPLE TRANSFECTION
PROCEDURE OF MAR
SEQUENCES
]11[
]22[
22.10.2004
60/513574
]21[ 24.10.2003
]22[ US
14111.1133
1031131114
EP
Int. Cl.(2010.01) C12N 15//113, 15//67, C12P 21//00
DIVISION FROM 175142
SELEXIS S.A., SWITZERLAND
NICOLAS MERMOD, PIERRE
ALAIN GIROD, PHILIPP BUCHER,
DUC-QUANG NGUYEN, DAVID
CALABRESE, DAMIEN SAUGY,
STEFANIA PUTTINI
WO/2005/040377
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A purified and isolated DNA sequence having protein production increasing
activity that is
]52[
]01[
].2[
].1[
]7.[
].4[
]5.[
302
September 27, 2011-‫כ"ח באלול התשע"א‬
(a) DNA sequence characterized by a MAR nucleotide sequence selected from the
group comprising the sequences SEQ ID 24 to 27 , a sequence complementary thereof
and a part thereof sharing at least 70% nucleotides in length; or
(b) DNA sequence characrh eth en resr er i airsnreshhe p hiopn i rp s
eitce hhhhhnr p a sahhnr pho eiena sr hhsir pnh haepn ihhh rh
3a ph e, F sn K haepni
2//210
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬
__________________
]22[]12[
198869
]54[
ANTI-HUMAN PDGFR-ALPHA
ANTIBODY FOR USE IN THE
TREATMENT OF SECONDARY
BONE TUMORS
]11[
]22[
]52[
]01[
].2[
19.06.2006
60/691920
]21[ 17.06.2005
]22[ US
Int. Cl.(2010.01) A61K 38//17
DIVISION FROM 188151
IMCLONE, LLC, U.S.A.
PHILADELPHIA HEALTH AND
EDUCATION CORPORATION
D/B/A/ DREXEL UNIVERSITY
COLLEGE OF MEDICINE, U.S.A.
WO/2006/138729
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An antibody of fragment thereof for use as a medicament for treating a subkect having
a secondary bone tumor, wherein said antibody or fragment thereof is specific for
human PDGFRa and comprises SSSYY (SEQ ID NO:2) at CDRH1;
SFFYTGSTYYNPSLRS (SEQ ID NO:4) at CDRH2; QSTYYYGSGNYYGWFDR
(SEQ ID NO:6) at CDRH3; RASQSVSSYLA (SEQ ID NO:10) at CDRL1;
DASNRAT (SEQ ID NO:2) at CDRL2; and QQQRSNWPPA (SEQ ID NO:14) at
CDRL3.
]7.[
].4[
]5.[
The parent application from which
this application has been divided has
303
‫ אנושי לשימוש‬PDGFRalpha ‫נוגדן כנגד‬
‫בטיפול של גידולים משניים בעצמות‬
2112/2
‫בקשת הורה לבקשה זו שטרם פורסמה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
not yet been published
__________________
]22[]12[
198903
‫שיטה ליצירת מעבר באמעצות מסיכה יחידה‬
‫והתקן‬
]54[
SINGLE MASK VIA METHOD
AND DEVICE
]11[
]22[
]52[
]01[
].2[
]7.[
].4[
20.10.2004
10/688910
]21[ 21.10.2003
]22[ US
Int. Cl.(2010.01) H01L 21//768
DIVISION FROM 175044
ZIPTRONIX, INC., U.S.A.
WO/2005/043584
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A structure, comprising: a first element having a first substrate and a first contact
structure; a second element having a second substrate and a second contact structure; a
non-metallic region in said first element directly bonded to a non-metallic region in
said second element; a via formed in said first substrate; said first contact structure
exposed to said via and directly connected to said second contact structure; and a metal
contact member disposed in said via connected to said first contact structure.
]5.[
__________________
]22[]12[
199189
‫שיטה ומערכת לזיהוי עקוף של ציוד משתמש‬
]54[
METHOD AND SYSTEM FOR
IMPLICIT USER EQUIPMENT
IDENTIFICATION
]11[
]22[
08.05.2002
60/290740
]21[ 14.05.2001
]22[ US
016224332
1431731112
US
016245257
1532131112
US
216125..2
1032131112
US
Int. Cl.(2010.01) H03M 13//09, H04B 01//707, H04L 01//00
DIVISION FROM 158859
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2002/093296
September 27, 2011-‫כ"ח באלול התשע"א‬
]52[
]01[
].2[
]7.[
304
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
].4[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
A wide-band code division multiple (WCDMA) user equipment comprising: circuitry
configuration to receive a first wireless signal of control channel associated with
WCDMA high speed downlink packet access, wherein the first wireless signal
comprises an N bit cyclic redundancy check (CRC) modulo two added to an N bit UE
identity wherein the value of N is a positive integer and the UE identity refers
specifically to the UE and circuitry configured not to use control information included
in the first wireless signal to process a second wireless signal of the WCDMA high
speed downlink packet access on a condition that the CRC is not correct.
__________________
]22[]12[
200825
]54[
PARTIALLY IMAGED PANELS
WITH SUPERIMPOSED LAYERS
AND METHODS OF MAKING
PARTIALLY IMAGED PANELS
]11[
]22[
]52[
].2[
10.03.2008
60/893768
]21[ 08.03.2007
]22[
Int. Cl.(2010.01) B41J 03//407, B44F 01//06
CONTRA VISION LTD., UNITED
KINGDOM
WO/2008/107863
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]7.[
].4[
]5.[
305
‫פנלים מדומים חלקית עם שכבות מגובבות‬
‫ושיטות עשיית פנלים מדומים חלקית‬
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A panel and method for making the panel are disclosed. The panel includes a substrate
sheet partially imaged with a print pattern. The print pattern subdivides the panel into a
plurality of discrete printed areas and/or a plurality of discrete unprinted areas. The
design is superimposed on or forms a part of said print pattern. The design comprises a
design layer. The print pattern includes a base layer. The print pattern includes
elongate printed areas orientated lengthways in one direction. The design layer and
base layer include inkjet printable ink in elongate ink deposits orientated lengthways in
the one direction. The elongate ink deposits may have an aspect ratio of length:width
greater than 1.5 : 1. The base layer may include white ink. The panel may be made
using a digital inkjet cylindrical printer that prints the base layer during at least 10
revolutions of the cylinder.
September 27, 2011-‫כ"ח באלול התשע"א‬
__________________
]22[]12[
201850
‫הכנת נגזרי קרבונט וקרבמט המותמרים‬
‫בקוינולין‬
]54[
PREPARATION OF QUINOLINESUBSTITUTED CARBONATE AND
CARBAMATE DERIVATIVES
]11[
]22[
]52[
]01[
].2[
]7.[
].4[
15.06.2000
60/141042
]21[ 24.06.1999
]22[ US
Int. Cl.(2010.01) C07D 21/5/12
DIVISION FROM 146475
ABBOTT LABORATORIES, U.S.A.
WO/2001/000582
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The invention relates to a process for preparing quinoline-substituted carbonate and
carbamate compounds, which are important intermediates in the synthesis of 6-Osubstituted macrolide antibiotics. The process employs metal-catalyzed coupling
reactions to provide a carbonate or carbamate of formula (I) or (II) or a substrate that
can be reduced to obtain the same.
]5.[
__________________
]22[]12[
]54[
306
ADMINISTRATION FEEDING SET
201860
‫מערך למתן הזנה‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]11[
]22[
]52[
]01[
].2[
]7.[
].4[
]5.[
25.05.2005
10/853958
]21[ 25.05.2004
Int. Cl.(2010.01) A61M 05//00
DIVISION FROM 178949
SHERWOOD SERVICES AG,
SWITZERLAND
WO/2005/115501
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]22[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An administration feeding set in combination with a flow control apparatus to deliver
fluid from at least one fluid source to a patient, the flow control apparatus comprising a
recess, upper and lower sensing devices near the recess for detecting magnetic
components or magnetically-susceptible metallic components, and a microprocessor
operatively associated with a software subsystem; the administration feeding set
comprising: tubing for flow of fluid along a fluid pathway; a mounting member on the
tubing receivable in the recess of said flow control apparatus, said mounting member
having upper and lower receiving portions co-axial with said fluid pathway, each
receiving portion being adapted to receive an identification member; and one or more
identification members selectively positioned on one or both of said upper and lower
receiving portions of the mounting member, each identification member comprising a
magnetic component or a magnetically-susceptible metallic component; the
arrangement being such that when the administration set is loaded on the flow control
apparatus with the mounting member properly positioned in said recess, the upper and
lower sensing devices are positioned for detecting any identification members on the
receiving portions of the mounting member to permit identification of the
administration feeding set as having a particular functional configuration different
from another functional configuration; wherein said software system identifies said
functional configuration based on said positioning of said one or more identification
members as sensed by said upper and lower sensing devices.
__________________
]22[]12[
]54[
307
METHODS OF PROCESSING
NICKEL-TITANIUM SHAPE
MEMORY ALLOYS
203162
‫שיטות לעיבוד סגסוגת של ניקל–טיטניום‬
September 27, 2011-‫כ"ח באלול התשע"א‬
]11[
]22[
]52[
]01[
].2[
]7.[
].4[
07.04.2004
10/427783
]21[ 01.05.2003
]22[ US
Int. Cl.(2010.01) C22C 14//00, 19//00, C22F 01//00
DIVISION FROM 171390
ATI PROPERTIES, INC., U.S.A.
WO/2004/099456
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
A method of processing a nickel-titanium alloy including regions of varying
compositions comprising from greater than 50 up to 55 atomic percent nickel such that
each region has a desire austenite transformation temperature, the method comprising
thermally processing the nickel-titanium alloy to adjust an amount of nickel in solid
solution in a TiNi phase in each region of the nickel-titanium alloy wherein after
processing the nickel-titanium alloy, each of the regions of the nickel-titanium has a
stable austenite transformation temperature that is essentially equal to the desired
austenite transformation temperature.
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
203166
‫שיטות לעיבוד סגסוגת של ניקל–טיטניום‬
]54[
METHODS OF PROCESSING
NICKEL-TITANIUM SHAPE
MEMORY ALLOYS
]11[
]22[
]52[
]01[
].2[
]7.[
].4[
07.04.2004
10/427783
]21[ 01.05.2003
]22[ US
Int. Cl.(2010.01) C22C 14//00, 19//00, C22F 01//00
DIVISION FROM 171390
ATI PROPERTIES, INC., U.S.A.
WO/2004/099456
REINHOLD COHN AND PARTNERS,
308
,‫ריינהולד כהן ושותפיו‬
September 27, 2011-‫כ"ח באלול התשע"א‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]5.[
A method of processing at least two nickel-titanium alloys having varying
compositions comprising from greater than 50 up to 55 atomic percent nickel to
achieve a desired austenite transformation temperature, the method comprising :
selecting the desired austenite transformation temperature; and subjecting the nickeltitanium alloys to similar thermal processing such that after thermal processing, the
nickel-titanium alloys have stable austenite transformation temperatures, the stable
austenite transformation temperature being essentially equal to the desired austenite
transformation temperature.
__________________
]22[]12[
203955
‫נוגדן בעל ספציפיות דואלית הקושר שני‬
‫פרוטאינים שונים בעלי מבנה דומה ושיטה‬
‫להשגתו‬
]54[
DUAL SPECIFICITY ANTIBODY
THAT BINDS TWO DIFFERENT
BUT STRUCTURALLY RELATED
PROTEINS, SUCH AS IL-1A AND
IL-1B AND METHOD OF
OBTAINING THE SAME
]11[
]22[
]52[
28.06.2001
60/215379
]21[ 29.06.2000
]22[ US
Int. Cl.(2010.01) A61K 39//395, 51//10, A61P 37//06, C07K 16//24, C12N 15//13,
C40B 30//04, 40//10, G01N 33//577, 33//68
DIVISION FROM 153567
ABBOTT LABORATORIES, U.S.A.
WO/2002/002773
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Antibodies having dual specificity for two different but structurally related antigens
are provided. The antibodies can be, for example, entirely human antibodies,
September 27, 2011-‫כ"ח באלול התשע"א‬
]01[
].2[
]7.[
].4[
]5.[
309
recombinant antibodies, or monoclonal antibodies. Preferred antibodies have dual
specificity for IL-1α and IL-1β and neutralize IL-1α and IL-1β activity in vitroand in
vivo. An antibody of the invention can be a full-length antibody or an antigen-binding
portion thereof. Methods of making and methods of using the antibodies of the
invention are also provided. The antibodies, or antibody portions, of the invention are
useful for detecting two different but structurally related antigens (e.g., IL-1α and IL1β) and for inhibiting the activity of the antigens, (e.g., in a human subject suffering
from a disorder in which IL-1α and/or IL-1β activity is detrimental.
__________________
]22[]12[
204284
‫שיטה והתקן לבקשת מקרי פרוטוקול נקודה‬
‫לנקודה מרשת שירותי מדע פקט‬
]54[
METHOD AND APPARATUS FOR
REQUESTING POINT-TO-POINT
PROTOCOL (PPP) INSTANCES
FROM A PACKET DATA
SERVICES NETWORK
]11[
]22[
]52[
]01[
].2[
03.01.2001
09/477278
]21[ 04.01.2000
]22[ US
Int. Cl.(2010.01) H04L 12//28, 12//58, H04W 36//00, 80//00
DIVISION FROM 150467
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/050783
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]7.[
].4[
]5.[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A method and apparatus for requesting PPP instances from a packet data services
network includes a mobile station configured to send an origination message to a
packet data service node (PDSN) at which it has arrived upon leaving the vicinity of
another PDSN. The message informs the new PDSN of the new location of the mobile
station and indicates both the number of dormant PPP instances associated with the
mobile station and a service reference identifier for each such PPP instance. A flag
within the message may be used to indicate whether the PPP instances are dormant
(i.e., whether the mobile station is engaged in a call).
__________________
310
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
204356
]54[
METHOD COMPRISING USE OF
POLY-D-LYSINE FOR
CULTURING HUMAN NEURAL
STEM CELLS
]11[
]22[
]52[
]01[
].2[
]7.[
].4[
17.11.2005
62/629220
]21[ 17.11.2004
]22[
Int. Cl.(2010.01) C12N 05//00, 05//0797
DIVISION FROM 183092
NEURALSTEM, INC., U.S.A.
WO/2006/055685
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]5.[
‫–ליזין לגידול‬D–‫שיטה הכוללת שימוש של פולי‬
‫תאי גזע עצביים אנושיים‬
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A method of culturing human neural stem cells, said method comprising: providing
human neural
1 mg/mL solution of poly-D-lysine for about 5 minutes to about 3 hours; washing and
drying the culture vessel to form a pre-coated culture vessel; seeding the neural stem
cells in said pre-coated culture vessel in absence of serum; adding a fibronectin
solution and at least one mitogen to the pre-coated culture vessel and culturing the
neural stem cells in absence of serum; further culturing the neural stem cells with at
least one mitogen; and passaging the cultured neural stem cells prior to confluence.
21/600
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם פורסמה‬
__________________
]22[]12[
]54[
USE OF A PAK INHIBITOR FOR
THE PRODUCTION OF A
MEDICAMENT FOR THE
TREATMENT OF A JOINT PAIN
AND USE OF A PAK OR PAK
GENE FOR THE DISCOVERY OF
A PAK INHIBITOR
]11[
]22[
15.07.2004
03016303.4
311
]21[
18.07.2003
204861
‫ קינאז מופעל לייצור‬28–‫שימוש של המעכב פי‬
‫תרופה לטיפול בכאבי פרקים והשימוש במעכב‬
‫ קינאז מופעל‬28–‫ קינאז מופעל או בגן פי‬28–‫פי‬
‫ קינאז מופעל‬28–‫למציאת מעכב של פי‬
]22[
EP
September 27, 2011-‫כ"ח באלול התשע"א‬
]52[
]01[
].2[
]7.[
].4[
]5.[
Int. Cl.(2010.01) A61K 38//08, 38//43, A61P 19//02, C07K 16//40, G01N 33//68
DIVISION FROM 173145
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2005/011721
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Use of a p22 -activated kinase (PAK) inhibitor for the treatment of a joint pain 3
__________________
]22[]12[
204885
, ‫תרכובות פיפרידין ותרכובות הטרואריל‬
‫הרכבים רוקחיים המכילים אותן ושימושיהן‬
‫ביצור תרופות לטיפול או מניעה של מחלות‬
‫בבעלי חיים‬
]54[
PIPERIDINE-HETEROARYL
COMPOUNDS,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND USE THEREOF IN
THE MANUFACTURE OF
MEDICAMENTS FOR TREATING
OR PREVENTING DISEASES IN
ANIMALS
]11[
]22[
]52[
23.07.2004
60/489515
]21[ 24.07.2003
]22[ US
Int. Cl.(2010.01) A61K 31//4523, 31//4545, A61P 29//00, C07D 40/1/04, 41/3/12,
41/7/14
DIVISION FROM 173343
EURO-CELTIQUE S.A.,
LUXEMBOURG
WO/2005/009987
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Piperidine compounds; compositions comprising a piperidine compound; and methods
for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder,
Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic
condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function,
Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle
spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising
administering to an animal in need thereof an effective amount of a Piperidine
Compound are disclosed. In embodiment, the piperidine compound has the formula
September 27, 2011-‫כ"ח באלול התשע"א‬
]01[
].2[
]7.[
].4[
]5.[
312
(I): and pharmaceutically acceptable salts thereof, wherein Ar 1, Ar2, X, R3, R4, and m
are as disclosed herein.
__________________
]22[]12[
206445
‫)משתנה‬8–33( 4–‫תצמדי פפטידי של אקסנדין‬
‫בצירוף עם גורם נוגד כלייתי לשימוש בטיפול‬
2 ‫בסוכרת מסוג‬
]54[
PEPTIDE CONJUGATE OF
EXENDIN-4(1-39)VARIANT IN
COMBINATION WITH AN
ANTIDIABETIC AGENT FOR USE
IN THE TREATMENT OF TYPE 2
DIABETES MELLITUS
]11[
]22[
12.07.2000
60/143591
]21[ 12.07.1999
]22[ US
3302114234
1331732333
EP
Int. Cl.(2010.01) A61K 38//22, 47//48, C07K 14//575, 19//00, C12P 21//02
DIVISION FROM 185763
ZEALAND PHARMA A/S,
DENMARK
WO/2001/004156
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]01[
].2[
]7.[
].4[
]5.[
The present invention relates to novel peptide conjugates which have increased
stability and are useful in the treatment of excess levels of blood glucose.
The parent application from which
this application has been divided has
not yet been published
313
21//0/
‫בקשת הורה לבקשה זו שטרם פורסמה‬
__________________
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
207566
‫העברה באמצעות אנטנה במערכת תקשורת‬
CDMA
]54[
TRANSMISSION USING AN
ANTENNA ARRAY IN A CDMA
COMMUNICATION SYSTEM
]11[
]22[
]52[
]01[
].2[
17.08.2000
09/394452
]21[ 10.09.1999
]22[ US
Int. Cl.(2010.01) H04B 01//707, 07//04, 07//216, H04J 13//04, H04W 52//00, 52//42
DIVISION FROM 181375
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2001/018993
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]7.[
].4[
]5.[
The invention provides for transmission and reception of a data signal using a plurality
of transmitting antennas. Each antenna transmits a different pilot signal having a
pseudo random chip code sequence. A receiver filters each transmitted pilot using that
pilot's chip code. The filtered pilots are weighted and combined. Each pilot signal's
weight is adaptively adjusted in part on a signal quality of the combined signal. A data
signal is transmitted such that different spread spectrum versions of the data signal are
transmitted from each transmitting antenna. Each version having a different chip code
identifier. Upon reception, each version is filtered with its associated chip code. The
filtered versions are weighted in accordance with the adjusted weights associated with
the pilot signal of the respective antenna.
__________________
314
September 27, 2011-‫כ"ח באלול התשע"א‬
]22[]12[
207635
‫מערכת התראה הממוקמת במעבר לציון בעיה‬
‫בטיחותית‬
]54[
CROSSING LOCATED ALERT
SYSTEM FOR INDICATING A
SAFETY PROBLEM
]11[
]52[
]01[
].2[
].1[
].4[
14.05.2007
Int. Cl.(2010.01) G08G 01//095
DIVISION FROM 183173
RED WALL (D.S) LTD.
‫ באר שבע‬,‫ס) בע"מ‬.‫רד וול (ד‬
DAVID EDUARD SITBON
‫דוד אדוארד סיטבון‬
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An alert system for generating, in the vicinity of an intersection, a wide-area image
which is indicative of the state of a corresponding traffic light or of an actual or
impending traffic safety problem, comprising one or more traffic lights deployed at an
intersection, each of the traffic lights provided with a plurality of sequentially
illuminating lamps; at least one wide-area image generating device mounted in the
vicinity of the intersection; means for mounting each of the traffic lights and each of
the wide-area image generating devices; and means for synchronizing operation of
each of the wide-area image generating devices and of corresponding traffic light
lamps, wherein each of the wide-area image generating devices is adapted to generate
a wide-area image that is indicative of the state of a corresponding traffic light or of an
actual or impending traffic safety problem.
]5.[
The parent application from which
this application has been divided
has not yet been published
21/2//
‫בקשת הורה לבקשה זו שטרם פורסמה‬
__________________
315
September 27, 2011-‫כ"ח באלול התשע"א‬
‫פטנטים‬
PATENTS
‫פטנטים שניתנו‬
PATENTS GRANTED
22.12.
2..272
2.7172
2.3235
271414
272425
272..1
272132
20132.
204711
2752.7
27..42
277712
231522
2000.0
207012
2033.2
234054
2302.1
254142
2.1722
2.42..
2.501.
233745
316
250171
2..2.5
2.7400
2.3574
271472
2724.3
27271.
272540
202257
204710
27514.
27..57
273213
231522
200.30
207.44
2.1227
235171
230444
255105
2.2104
2.4.72
2.5017
233323
25..15
2..511
2.7501
2.3021
2715.2
272523
271402
240222
201102
205155
275132
27713.
27320.
2427..
20..71
2032.1
2.1152
2352.2
23.204
2551.3
2.2105
2.471.
2.5.17
112240
253215
2...21
2.75.0
2.3052
271020
272515
271355
243150
201231
27272.
275214
277223
273124
242315
20.70.
20342.
2.1501
235440
23.371
2.130.
2.22.1
2.5114
2.5315
111221
201222
2..370
2.7531
2.3347
2722.5
272525
272123
243150
202120
272325
27023.
277152
2732.7
245027
207110
203414
2.1023
23544.
237222
2.2257
2.22.7
2.5230
2.0101
112.17
2..122
2.7141
2.7.10
2.3351
2721.2
272572
272132
243437
204111
272321
270250
277214
273057
245.11
207224
203553
2.1314
235447
237450
2.2034
2.2732
2.5413
2.0411
112.31
2..120
2.7144
2.7305
271242
2721..
27207.
272227
251547
204230
274201
270052
277222
231123
24531.
207241
203502
232715
2350..
2513.3
2.2.2.
2.2315
2.5401
2.0.07
114005
2..244
2.7251
2.3111
271414
272421
272.50
272254
201.4.
204.22
274020
270724
27727.
231235
200007
207520
203570
232207
2353.2
2511.1
2.1407
2.4175
2.5010
233742
September 27, 2011-‫כ"ח באלול התשע"א‬
‫פטנטים שחודשו‬
‫‪PATENTS RENEWED‬‬
‫‪210357‬‬
‫‪21.157‬‬
‫‪21.254‬‬
‫‪212.10‬‬
‫‪212.33‬‬
‫‪212302‬‬
‫‪21..37‬‬
‫‪217.11‬‬
‫‪217751‬‬
‫‪217301‬‬
‫‪213102‬‬
‫‪213241‬‬
‫‪213102‬‬
‫‪242100‬‬
‫‪2454.0‬‬
‫‪245.1.‬‬
‫‪243012‬‬
‫‪252572‬‬
‫‪254103‬‬
‫‪254017‬‬
‫‪254.13‬‬
‫‪254.47‬‬
‫‪254711‬‬
‫‪25435.‬‬
‫‪2551.2‬‬
‫‪255224‬‬
‫‪25.321‬‬
‫‪201147‬‬
‫‪201701‬‬
‫‪205117‬‬
‫‪20.5.1‬‬
‫‪203002‬‬
‫‪2.1233‬‬
‫‪2.1.22‬‬
‫‪2.22.7‬‬
‫‪2.10.3‬‬
‫‪2.4221‬‬
‫‪2.5.17‬‬
‫‪2.0.0.‬‬
‫‪2..527‬‬
‫‪2.7412‬‬
‫‪2.73.7‬‬
‫‪271141‬‬
‫‪210345‬‬
‫‪21.152‬‬
‫‪21.211‬‬
‫‪212.12‬‬
‫‪212.30‬‬
‫‪2127.1‬‬
‫‪21.255‬‬
‫‪217.12‬‬
‫‪217722‬‬
‫‪217302‬‬
‫‪213127‬‬
‫‪213223‬‬
‫‪213142‬‬
‫‪241300‬‬
‫‪245445‬‬
‫‪245035‬‬
‫‪243530‬‬
‫‪252507‬‬
‫‪252105‬‬
‫‪254010‬‬
‫‪254070‬‬
‫‪254.4.‬‬
‫‪254712‬‬
‫‪254351‬‬
‫‪255145‬‬
‫‪255117‬‬
‫‪250541‬‬
‫‪201270‬‬
‫‪201407‬‬
‫‪205134‬‬
‫‪20.103‬‬
‫‪203014‬‬
‫‪2.12.1‬‬
‫‪2.1053‬‬
‫‪2.2207‬‬
‫‪2.1527‬‬
‫‪2.4104‬‬
‫‪2.5012‬‬
‫‪2.0.21‬‬
‫‪2..275‬‬
‫‪2.7237‬‬
‫‪2.7313‬‬
‫‪2.37.3‬‬
‫‪210314‬‬
‫‪21.147‬‬
‫‪21.22.‬‬
‫‪212031‬‬
‫‪212.35‬‬
‫‪212700‬‬
‫‪210122‬‬
‫‪217072‬‬
‫‪217711‬‬
‫‪217301‬‬
‫‪213111‬‬
‫‪213225‬‬
‫‪213141‬‬
‫‪241431‬‬
‫‪245414‬‬
‫‪245002‬‬
‫‪247.40‬‬
‫‪252410‬‬
‫‪252241‬‬
‫‪2545.1‬‬
‫‪254002‬‬
‫‪254.40‬‬
‫‪254711‬‬
‫‪254345‬‬
‫‪255111‬‬
‫‪255277‬‬
‫‪250515‬‬
‫‪201207‬‬
‫‪202.41‬‬
‫‪204213‬‬
‫‪20.102‬‬
‫‪203421‬‬
‫‪2.1243‬‬
‫‪2.1570‬‬
‫‪2.2214‬‬
‫‪2.1515‬‬
‫‪2.23.2‬‬
‫‪2.5423‬‬
‫‪2.0.1.‬‬
‫‪2..130‬‬
‫‪2.7107‬‬
‫‪2.7311‬‬
‫‪2.3725‬‬
‫‪210730‬‬
‫‪21.127‬‬
‫‪21.220‬‬
‫‪212070‬‬
‫‪212.32‬‬
‫‪212705‬‬
‫‪210213‬‬
‫‪217051‬‬
‫‪217.00‬‬
‫‪21735.‬‬
‫‪213120‬‬
‫‪213224‬‬
‫‪213274‬‬
‫‪222142‬‬
‫‪245217‬‬
‫‪245011‬‬
‫‪247521‬‬
‫‪252211‬‬
‫‪252223‬‬
‫‪254503‬‬
‫‪254051‬‬
‫‪254.22‬‬
‫‪254721‬‬
‫‪254311‬‬
‫‪255127‬‬
‫‪255202‬‬
‫‪250203‬‬
‫‪201241‬‬
‫‪2021.3‬‬
‫‪2041.7‬‬
‫‪200.34‬‬
‫‪2032.5‬‬
‫‪2.1127‬‬
‫‪2.154.‬‬
‫‪2.2150‬‬
‫‪2.1417‬‬
‫‪2.2342‬‬
‫‪2.5204‬‬
‫‪2.0574‬‬
‫‪2..2..‬‬
‫‪2.72.1‬‬
‫‪2.7.42‬‬
‫‪2.3532‬‬
‫כ"ח באלול התשע"א‪September 27, 2011-‬‬
‫‪2107.2‬‬
‫‪21.121‬‬
‫‪21.215‬‬
‫‪2120..‬‬
‫‪212.03‬‬
‫‪212704‬‬
‫‪210220‬‬
‫‪217505‬‬
‫‪217.50‬‬
‫‪217350‬‬
‫‪213110‬‬
‫‪213222‬‬
‫‪2132.1‬‬
‫‪222121‬‬
‫‪245211‬‬
‫‪245512‬‬
‫‪24.311‬‬
‫‪251374‬‬
‫‪252227‬‬
‫‪254554‬‬
‫‪254014‬‬
‫‪254.17‬‬
‫‪254.77‬‬
‫‪254321‬‬
‫‪255110‬‬
‫‪255251‬‬
‫‪255511‬‬
‫‪253.50‬‬
‫‪201335‬‬
‫‪204114‬‬
‫‪200501‬‬
‫‪203232‬‬
‫‪203350‬‬
‫‪2.1513‬‬
‫‪2.2114‬‬
‫‪2.11.4‬‬
‫‪2.2.74‬‬
‫‪2.435.‬‬
‫‪2.0212‬‬
‫‪2.0737‬‬
‫‪2.7115‬‬
‫‪2.70.2‬‬
‫‪2.342.‬‬
‫‪210.23‬‬
‫‪21.11.‬‬
‫‪21.17.‬‬
‫‪212512‬‬
‫‪212.52‬‬
‫‪212701‬‬
‫‪215.25‬‬
‫‪217454‬‬
‫‪217.4.‬‬
‫‪217342‬‬
‫‪217333‬‬
‫‪213135‬‬
‫‪213245‬‬
‫‪213..1‬‬
‫‪245123‬‬
‫‪24552.‬‬
‫‪24.101‬‬
‫‪243374‬‬
‫‪251245‬‬
‫‪254524‬‬
‫‪254011‬‬
‫‪254.27‬‬
‫‪254.74‬‬
‫‪254750‬‬
‫‪254304‬‬
‫‪255224‬‬
‫‪255413‬‬
‫‪25320.‬‬
‫‪201341‬‬
‫‪202477‬‬
‫‪200255‬‬
‫‪207052‬‬
‫‪203312‬‬
‫‪2.1512‬‬
‫‪2.2251‬‬
‫‪2.2.30‬‬
‫‪2.2042‬‬
‫‪2.4341‬‬
‫‪2.023.‬‬
‫‪2.0721‬‬
‫‪2...57‬‬
‫‪2.7507‬‬
‫‪2.3245‬‬
‫‪210100‬‬
‫‪210372‬‬
‫‪21.1.0‬‬
‫‪211352‬‬
‫‪212.22‬‬
‫‪212724‬‬
‫‪214221‬‬
‫‪217242‬‬
‫‪217.21‬‬
‫‪217774‬‬
‫‪217332‬‬
‫‪213175‬‬
‫‪213244‬‬
‫‪213232‬‬
‫‪245127‬‬
‫‪245471‬‬
‫‪24.134‬‬
‫‪243.27‬‬
‫‪251215‬‬
‫‪254423‬‬
‫‪254027‬‬
‫‪254.20‬‬
‫‪254.01‬‬
‫‪254747‬‬
‫‪254302‬‬
‫‪255133‬‬
‫‪25541.‬‬
‫‪257.13‬‬
‫‪201311‬‬
‫‪202244‬‬
‫‪205017‬‬
‫‪207555‬‬
‫‪203773‬‬
‫‪2.1443‬‬
‫‪2.2141‬‬
‫‪2.2500‬‬
‫‪2.2240‬‬
‫‪2.4570‬‬
‫‪2.0271‬‬
‫‪2.0713‬‬
‫‪2...12‬‬
‫‪2.7521‬‬
‫‪2.3125‬‬
‫‪210221‬‬
‫‪2103.2‬‬
‫‪21.103‬‬
‫‪21.272‬‬
‫‪212.21‬‬
‫‪212714‬‬
‫‪212.35‬‬
‫‪217241‬‬
‫‪217.17‬‬
‫‪2177.1‬‬
‫‪2173.2‬‬
‫‪213100‬‬
‫‪213242‬‬
‫‪213137‬‬
‫‪242.22‬‬
‫‪2454..‬‬
‫‪24.132‬‬
‫‪243051‬‬
‫‪252022‬‬
‫‪25420.‬‬
‫‪254022‬‬
‫‪254.22‬‬
‫‪254.53‬‬
‫‪254742‬‬
‫‪254302‬‬
‫‪25517.‬‬
‫‪255225‬‬
‫‪257501‬‬
‫‪20142.‬‬
‫‪2022.3‬‬
‫‪2055.0‬‬
‫‪20.57.‬‬
‫‪203747‬‬
‫‪2.1412‬‬
‫‪2.2112‬‬
‫‪2.255.‬‬
‫‪2.2214‬‬
‫‪2.4244‬‬
‫‪2.570.‬‬
‫‪2.0717‬‬
‫‪2..021‬‬
‫‪2.74.4‬‬
‫‪2.3121‬‬
‫‪317‬‬
‫‪271.14‬‬
‫‪272111‬‬
‫‪272.13‬‬
‫‪272774‬‬
‫‪271222‬‬
‫‪2712.4‬‬
‫‪271723‬‬
‫‪272351‬‬
‫‪274054‬‬
‫‪270177‬‬
‫‪277112‬‬
‫‪277223‬‬
‫‪23152.‬‬
‫‪235211‬‬
‫‪233.40‬‬
‫‪2710.7‬‬
‫‪272221‬‬
‫‪272.17‬‬
‫‪2727.5‬‬
‫‪271132‬‬
‫‪271212‬‬
‫‪27104.‬‬
‫‪272.45‬‬
‫‪274507‬‬
‫‪275741‬‬
‫‪27..23‬‬
‫‪277214‬‬
‫‪231411‬‬
‫‪234524‬‬
‫‪233.45‬‬
‫‪2710.4‬‬
‫‪272132‬‬
‫‪272071‬‬
‫‪2727.4‬‬
‫‪2723.1‬‬
‫‪271213‬‬
‫‪27150.‬‬
‫‪272.12‬‬
‫‪274474‬‬
‫‪275237‬‬
‫‪27.420‬‬
‫‪277171‬‬
‫‪231255‬‬
‫‪23451.‬‬
‫‪233.44‬‬
‫‪271425‬‬
‫‪272101‬‬
‫‪272044‬‬
‫‪272747‬‬
‫‪27234.‬‬
‫‪27113.‬‬
‫‪271500‬‬
‫‪272547‬‬
‫‪274211‬‬
‫‪27522.‬‬
‫‪27.214‬‬
‫‪277103‬‬
‫‪273.14‬‬
‫‪234523‬‬
‫‪233.42‬‬
‫‪114041‬‬
‫כ"ח באלול התשע"א‪September 27, 2011-‬‬
‫‪271270‬‬
‫‪272111‬‬
‫‪272015‬‬
‫‪272741‬‬
‫‪272310‬‬
‫‪271112‬‬
‫‪271513‬‬
‫‪272257‬‬
‫‪2741.3‬‬
‫‪274351‬‬
‫‪270331‬‬
‫‪277102‬‬
‫‪273014‬‬
‫‪232.24‬‬
‫‪237515‬‬
‫‪114211‬‬
‫‪271225‬‬
‫‪271314‬‬
‫‪272435‬‬
‫‪272722‬‬
‫‪272317‬‬
‫‪271120‬‬
‫‪271513‬‬
‫‪272251‬‬
‫‪274117‬‬
‫‪274322‬‬
‫‪270315‬‬
‫‪277232‬‬
‫‪273552‬‬
‫‪23171.‬‬
‫‪23.145‬‬
‫‪111112‬‬
‫‪271203‬‬
‫‪271751‬‬
‫‪272252‬‬
‫‪272711‬‬
‫‪272732‬‬
‫‪271121‬‬
‫‪271471‬‬
‫‪272113‬‬
‫‪274200‬‬
‫‪274705‬‬
‫‪270502‬‬
‫‪2772.4‬‬
‫‪273100‬‬
‫‪231472‬‬
‫‪230017‬‬
‫‪112132‬‬
‫‪271151‬‬
‫‪271.3.‬‬
‫‪272224‬‬
‫‪272.70‬‬
‫‪272731‬‬
‫‪271111‬‬
‫‪271234‬‬
‫‪271740‬‬
‫‪274210‬‬
‫‪274712‬‬
‫‪27027.‬‬
‫‪277242‬‬
‫‪277423‬‬
‫‪23211.‬‬
‫‪230513‬‬
‫‪111010‬‬
‫‪318‬‬
‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
214144
214412
214541
214.2.
215143
215127
215205
21545.
215017
215.75
210111
251012
251..2
2517.5
2513.4
252154
252142
251731
221741
25142.
25155.
2053.3
200.23
207522
223324
211110
211221
211144
212127
241517
241014
2413.5
242457
253.25
24517.
202152
27.100
319
2141.2
214412
214501
214.2.
215172
2151..
2152.2
215404
215042
215727
210227
251015
251710
251777
2513..
252155
2521..
2.1334
247225
251442
251557
205333
200737
2032.3
223344
21111.
211224
211143
2124.2
241500
2410..
241334
24255.
2...2.
245023
2022.3
2141.4
214415
214571
214..4
215170
215171
215231
2154.4
215045
215750
210277
251.21
251727
251315
252122
2521.1
252137
2.2010
243001
251443
251505
200177
200321
203301
223350
211121
21125.
211155
212024
2415.1
241.2.
242227
255.27
2.3002
245041
272.23
214225
21441.
214575
214..0
215214
215175
215411
2154.0
215034
21570.
21.212
251.27
251712
251351
252123
252137
252215
2.42.0
243322
251404
251500
200213
200343
2.1211
2233.1
211122
211274
21115.
21275.
2415.2
241.04
242250
255.05
2711.1
245.5.
272.11
214217
214452
214577
214212
215210
215170
215411
2154..
215.22
2157.0
217223
251.17
251710
251301
252120
25221.
252210
2.4012
2511.1
251400
2515.1
20020.
20.232
230052
2233..
211140
211235
211101
212311
241532
241711
242124
250415
225200
245322
27523.
2142..
2144.2
214014
214724
2152.1
215222
215420
215524
215.24
2157..
217531
251.44
251744
251307
252127
252223
252221
2.5242
251222
2514.1
205412
200203
20.411
223731
223371
211154
21111.
2111.3
212342
241533
241722
242131
250.10
242155
20211.
275770
214271
214430
214055
214705
215274
215252
215441
215541
215.47
215730
251010
251.52
2517.1
2513.1
252142
2522.1
252222
2.5..0
251412
251510
205312
200044
20.77.
223732
223371
21110.
211111
211171
227.07
241011
241723
24213.
25.242
242...
201.17
27.101
214275
214510
2140.1
2147.3
215124
215204
215445
215544
215..2
21530.
251017
251.52
2517.2
2513.2
252152
252121
251117
221450
251413
251517
205323
200077
207117
223317
223372
2111.2
211123
211170
227.03
241024
24175.
242211
25.320
245131
202221
27.102
September 27, 2011-‫כ"ח באלול התשע"א‬
‫פטנטים שחודשו לעשרים שנה‬
PATENTS RENEWED FOR 20 YEARS
2.3312
‫צווי הארכה שחודשו‬
EXTENSION ORDERS RENEWED
75435
‫פטנטים שפג תוקפם‬
PATENTS EXPIRED
30..0
30742
3031.
3.127
3.1.2
3.242
3.27.
3.111
3.225
320
30.34
307.3
3031.
3.114
3.174
3.245
3.273
3.124
221211
30714
3077.
30324
3.117
3.170
3.240
3.232
3.1.0
221043
30713
30732
30354
3.125
3.132
3.24.
3.232
3.1..
2222.4
30720
30734
30331
3.141
3.223
3.254
3.124
3.171
22200.
30713
30735
30335
3.152
3.210
3.202
3.120
3.174
2242.5
30727
30311
3.124
3.105
3.221
3.207
3.12.
3.175
30723
30315
3.120
3.103
3.22.
3.270
3.123
3.131
September 27, 2011-‫כ"ח באלול התשע"א‬
‫הודעה‬
NOTICE
‫ לחוק‬10 ‫לפי סעיף‬
1611-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
2/2/1/
1/066/
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
)0626( ‫לייזר דיטקט סיסטמס‬
I.T.L.OPTRONICS LTD.
:‫שם האמצאה‬
‫מערכת לגילוי וזיהוי חומר נפץ‬
EXPLOSIVE DETECTION AND IDENTIFICATION SYSTEM
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
65 ‫ לחוק ובתקנה‬11 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
1611
Title of invention:
321
September 27, 2011-‫כ"ח באלול התשע"א‬
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
322
September 27, 2011-‫כ"ח באלול התשע"א‬
‫תיקונים ביומן‬
Gournal Corrections
Patent application No
No. of Patent:
20000/
/0622
No. of Patent:
WO 2004/017897
20/001
/0622
No. of Patent:
CORRECT THE DATE OF
EXPIRATION OF EXTENSION
ORDER TO :
16.02.2013
323
'‫בקשת פטנט מס‬
:‫מספר יומן בו נפלה טעות‬
‫תקן דין קדימה‬
CORRECT PRIORITY NUMBER
US 60/399070 26.07.2002
Patent application No
:‫מספר יומן בו נפלה טעות‬
‫תקן מספר פרסום בינלאומי‬
CORRECT
INTERNATIONL PUBILCATION
NO.
WO 2004/017897
Patent application No
'‫בקשת פטנט מס‬
US 60/399070 26.07.2002
260661
10622
'‫בקשת פטנט מס‬
:‫מספר יומן בו נפלה טעות‬
:‫יש לתקן את מועד תום צו הארכה ל‬
8620222083
September 27, 2011-‫כ"ח באלול התשע"א‬
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
Class
47051
3)12(
1.32131113
‫טבע תעשיות פרמצבטיות בע"מ‬
TEVA PHARMACEUTICAL
INDUSTRIES, LTD.
Packaging for medicines
Convention date (OHIM)
Class
‫סוג פרסום‬
2131031113
47004
3)12(
2132131113
‫אריזה לתרופות‬
)‫תאריך האמנה (אוהיים‬
‫סוג פרסום‬
XL ENERGY MARKETING SP. ZO.O3
‫פחית‬
Can
Class
RAN NAOR
ORTECH DEFENCE SYSTEMS
LTD.
Blast attenuation barrier
324
47722
13)11(
1.32131113
‫סוג פרסום‬
‫נאור רן‬
‫אורטק מערכות מיגון בע"מ‬
‫מחסום המעטת הדף‬
September 27, 2011-‫כ"ח באלול התשע"א‬
47742
0)21(
1031231121
Class
‫סוג פרסום‬
HUNTER DOUGLAS INC3
‫מגן לחלון‬
Window covering
5137. ,47743
10)11(
2131231121
Class
3MAG
Flashlight
Convention date (U.S.A.)
Class
‫סוג פרסום‬
INSTRUMENT, INC
‫פנס‬
)‫תאריך האמנה (ארצות הברית‬
2231.31113
47701
1)12(
2231231121
‫סוג פרסום‬
EQUMEN PTY LTD3
Underpants
Convention date (Australia)
Class
‫תחתונים‬
)‫תאריך האמנה (אוסטרליה‬
2231.31113
47327
3)12(
1431231121
‫סוג פרסום‬
UNILEVER PLC
Bottle
Convention date (Great Britain)
Class
2131731113
47327
3)1.(
1531231121
‫בקבוק‬
‫תאריך האמנה (הממלכה‬
)‫המאוחדת‬
‫סוג פרסום‬
COLGATE-PALMOLIVE COMPANY
325
September 27, 2011-‫כ"ח באלול התשע"א‬
Cap for a container
Convention date (U.S.A.)
Class
‫מכסה עבור מיכל‬
)‫תאריך האמנה (ארצות הברית‬
2231.31113
47344
10)15(
1.31231121
‫סוג פרסום‬
‫עופר מקבלי‬
‫גוף תאורה‬
MAKBLY OFER
Lighting fuxture
Class
43522
12)12(
22315321
‫סוג פרסום‬
‫דוד פל‬
‫מיכל למיחזור מים‬
DAVID PEL
Container for water recycling
Class
43502
12)12(
1031031121
‫סוג פרסום‬
‫דוד פל‬
‫מיכל למיחזור מים‬
DAVID PEL
Container for water recycling
Class
43230 ,43234 ,43232
43237 ,4323.
1)14(
1431231121
BANANA SHOES INDUSTRY LTD.
Shoe
‫סוג פרסום‬
‫בננה תעשיות נעליים בע"מ‬
‫נעל‬
47352
326
September 27, 2011-‫כ"ח באלול התשע"א‬
Class
‫סוג פרסום‬
3)12(
1731231121
UNILEVER PLC
Bottle
Convention date (Great Britain)
Class
2131731113
47375
12)12(
1.31131121
‫בקבוק‬
‫תאריך האמנה (הממלכה‬
)‫המאוחדת‬
‫סוג פרסום‬
‫מירי ברגר‬
‫משחק שח‬
MIRI BERGER
Chess game
Class
43124
.)1.(
2731131121
‫סוג פרסום‬
‫דוד בכר‬
‫דרור בכר‬
‫מצע‬
DAVID BACHAR
DROR BACHAR
Mat
Class
43205
2)12(
1231231121
‫סוג פרסום‬
‫שוגון עיצובים בע"מ‬
‫תיק ספורט‬
SHUGON CREATIVE LTD.
Sport bag
Class
43170
25)17(
2531431121
‫סוג פרסום‬
SANTOS
Blender
Convention date (OHIM)
327
2532131113
‫מערבל מזון‬
)‫תאריך האמנה (איחוד אירופי‬
September 27, 2011-‫כ"ח באלול התשע"א‬
Class
43421
25)17(
1531531121
‫סוג פרסום‬
SOCIETE DES PRODUITS NESTLE S.A3
Coffee machine
Convention date (Switzerland)
Class
‫מכונת קפה‬
)‫תאריך האמנה (שוויץ‬
2531131121
43470
3)12(
1231531121
‫סוג פרסום‬
‫יפאורה תבורי בע"מ‬
‫בקבוק‬
JAFORA TABORI LTD.
Bottle
Class
43511
3)12(
1031531121
‫סוג פרסום‬
UNILEVER PLC
Jar
Convention date (Great Britain)
Class
‫צנצנת‬
‫תאריך האמנה (הממלכה‬
)‫המאוחדת‬
2432131113
43514 ,43512
3)12(
1031531121
‫סוג פרסום‬
UNILEVER PLC
Bottle
Convention date (Great Britain)
2432131113
‫בקבוק‬
‫תאריך האמנה (הממלכה‬
)‫המאוחדת‬
43527 ,4352.
328
September 27, 2011-‫כ"ח באלול התשע"א‬
Class
‫סוג פרסום‬
3)12(
1231031121
UNILEVER PLC
Bottle
Convention date (Great Britain)
Class
‫בקבוק‬
‫תאריך האמנה (הממלכה‬
)‫המאוחדת‬
2432131113
43021 ,43017 ,43015
522.3
7)15(
2.31031121
‫סוג פרסום‬
LEATHERMAN TOOL GROUP, INC3
Hand tool
Convention date (U.S.A.)
Class
2732131113
43052
0)14(
1131031121
KETER PLASTIC LTD.
Cabinet
Convention date (OHIM)
Class
1232131113
43.12
12)14(
2131031121
‫כלי עבודה ידני‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
‫כתר פלסטיק בע"מ‬
‫ארון‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
‫טויטופלסט בע"מ‬
‫טבעת הידוק‬
TWITOPLAST LTD.
Band
Class
PHOTAX MOLDS LTD.
Connection box
329
43721
22)12(
2731.31121
‫סוג פרסום‬
‫פוטקס תבניות בע"מ‬
‫קופסת חיבורים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
Class
43722
12)12(
1131.31121
‫סוג פרסום‬
‫רוטוניב טכנולוגיות בע"מ‬
‫מגלשה‬
ROTONIV LTD.
Slide
Class
51221 ,51222
7)10(
2132131121
‫סוג פרסום‬
F.M.N. MARTINELLI S.R.L3
‫ידית‬
Handle
Class
51257 ,5125. ,51250
7)10(
2432131121
3J. JOSE
‫סוג פרסום‬
VERGES S.A
‫ידית‬
Handle
Class
51121
7)10(
1032131121
‫סוג פרסום‬
COLOMBO DESIGN S.P.A3
‫ידית‬
Handle
Class
51444
21)22(
1232131121
‫סוג פרסום‬
SINBAR
Bicycle
330
‫אופניים‬
September 27, 2011-‫כ"ח באלול התשע"א‬
Convention date (OHIM)
)‫תאריך האמנה (איחוד אירופי‬
1431031121
51552 ,51551 ,51552
51550 ,51555 ,51554
Class
‫סוג פרסום‬
7)10(
2331231122
‫ ידיות ופרופילים בע"מ‬-‫אברהם כהן‬
ABRAHAM COHEN - HANDLES &
PROFILES LTD.
‫ידית‬
Handle
Class
51572 ,51571
7)10(
1.31231122
‫סוג פרסום‬
J. JOSE VERGES S.A3
‫ידית‬
Handle
Class
51012
21)20(
1331131122
‫סוג פרסום‬
SAFECAR THEFT PREVANTION
SYSTEMS LTD.
‫סייף קאר מערכות מניעת גניבה בע"מ‬
Defensive equipment for igniting computer
‫מתקן הגנה למחשב הצתה‬
Class
YADIDYA ASIF
Profile
331
52124 ,52122 ,5155.
15)12(
1131231122
‫סוג פרסום‬
‫ידידיה אסיף‬
‫פרופיל‬
September 27, 2011-‫כ"ח באלול התשע"א‬
Class
47345
22)12(
1.31231121
‫סוג פרסום‬
‫עופר מקבלי‬
‫מסגרת לשקע חשמלי‬
MAKBLY OFER
Frame for electrical outlet
Class
51255
3)12(
2432131121
‫סוג פרסום‬
GUERLAIN S.A3
Jar
Convention date (OHIM)
Class
2031431121
51212
2)12(
1232231121
‫צנצנת‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
‫סלבה וינוגרדוב‬
‫ממתק‬
SLAVA WINOGRADOW
Candy
Class
514.5
.)11(
1131231122
‫סוג פרסום‬
‫אבישי שושני‬
‫אמיר שושני‬
‫כונן לחימום מזון‬
AVISHAY SHOSHANI
AMIR SHOSHANI
Rack for warming food
Class
51211 ,51212
7)1.(
1232231121
RAV BARIACH (08) INDUSTRIES
LTD.
Key
332
‫סוג פרסום‬
‫) תעשיות בע"מ‬01( ‫רב בריח‬
‫מפתח‬
September 27, 2011-‫כ"ח באלול התשע"א‬
51451
1)14(
1.32131121
Class
‫סוג פרסום‬
‫דורית פיליפ‬
‫סנדל‬
DORIT FILIP
SANDAL
‫מדגמים שבוטלו‬
DESIGNS VOID
10.24
10.23
10.11
24.32
24741
24745
‫מדגמים שחודשו‬
DESIGNS RENEWED
25017
42251
45221
4107.
42112
45222
42153
42212
45221
42101
42214
45222
‫ רשם‬Asa Kling
‫וסימני‬Commissioner of Patents,
Designs and Trade Marks
333
42102
42527
45224
42103
42554
45225
421..
44222
42134
45213
‫אסא קלינג‬
‫ המדגמים‬,‫הפטנטים‬
‫מסחר‬
September 27, 2011-‫כ"ח באלול התשע"א‬
‫שינויים בפרטים רשומים בפנקס‬
‫‪CHANGES IN PARTICULARS ENTERED IN REGISTER‬‬
‫שינוי מען למסירת הודעות‬
‫‪CHANGES IN ADDRESS FOR SERVICE‬‬
‫מס' מדגם ‪21045‬‬
‫מען קודם‪ :‬בדנר‪ ,‬פלום‪ ,‬קלס – עו"ד‬
‫מען חדש – ריינהולד כהן ושות' – עו"ד‬
‫כ"ח באלול התשע"א‪September 27, 2011-‬‬
‫‪334‬‬
‫תיקונים ביומן‬
GOURNAL GORRECTIONS
47502
DESIGN APPLICATION NO.
'‫בקשת מדגם מס‬
15622
:‫מספר יומן בו נפלה טעות‬
: ‫תקן שם מבקש‬
CORRECT NAME APPLICANT :
GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH & CO KG
DESIGNS APPLICATION NO.
47551,47552
12622
CORRECT NAME APPLICANT :
S.I.E ASHKELON LTD.
335
'‫בקשות מדגמים מס‬
:‫מספר יומן בו נפלה טעות‬
:
‫תקן שם מבקש‬
‫א אשקלון בע"מ‬3‫י‬3‫ש‬
September 27, 2011-‫כ"ח באלול התשע"א‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫אבנר אמיר ‪111162 -‬‬
‫אוניברסיטת בן‪-‬גוריון בנגב‪ ,‬הרשות למחקר‬
‫ופיתוח ‪160116 -‬‬
‫אורסנס בע"מ ‪115450 -‬‬
‫איי‪.‬בי‪.‬איי ישראל ביומדיקל אינוביישנס בע"מ‬
‫ ‪161110‬‬‫אייל ארליך ‪111162 -‬‬
‫איתן בידרמן ‪111151 -‬‬
‫אלונים אחזקות אגש"ח בע"מ ‪111412 -‬‬
‫אלתא מערכות בע"מ ‪161115 -‬‬
‫אמ‪ .‬אפ‪ .‬אס מוצרים רפואיים בע"מ ‪-‬‬
‫‪110111‬‬
‫אמיר תבואה ‪114152 -‬‬
‫אקטיב‪-‬בייס בע"מ ‪111015 -‬‬
‫ב‪ .‬ורטיקובסקי בע"מ ‪115121 -‬‬
‫גילי ג'ורג' ‪111161 -‬‬
‫ד‪ .‬סיט סחר בע"מ ‪501125 -‬‬
‫דורון גבאי ‪112151 -‬‬
‫‪NAME INDEX‬‬
‫‪115064‬‬
‫ידע חברה למחקר ופיתוח בע"מ ‪111640 -‬‬
‫יוסף אטון ‪116211 -‬‬
‫יפים קרת ‪115414 -‬‬
‫ישקר בע"מ ‪115041 , 115011 -‬‬
‫מכון אקדמי טכנולוגי חולון ‪111640 -‬‬
‫נגבטק‪ ,‬בע"מ ‪111111 -‬‬
‫נטפים בע"מ ‪111111 -‬‬
‫ניו קריאט בע"מ ‪160412 -‬‬
‫ניסים משיח ‪111161 -‬‬
‫סופרסיל בע"מ ‪112011 -‬‬
‫עופר תבואה ‪114152 -‬‬
‫עמיטק בע"מ ‪115011 -‬‬
‫פ‪ .‬את פ‪ .‬בלמי בטיחות (‪ ) 5004‬בע"מ ‪-‬‬
‫‪115452‬‬
‫פרומיסק בע"מ אצל‪ :‬שמרון‪ ,‬י מולכו פרסקי‬
‫‪115012 -‬‬
‫הדסית שרותי מחקר רפואי ופיתוח בע"מ ‪-‬‬
‫‪111640‬‬
‫הוק מדיקל טכנולוג'יס בע"מ ‪116015 -‬‬
‫רד וול (ד‪.‬ס) בע"מ ‪501125 -‬‬
‫רותם אמפרט נגב בע"מ ‪114515 -‬‬
‫רעיון ותכן בע"מ ‪114161 -‬‬
‫רפאל מערכות לחימה מתקדמות בע"מ ‪-‬‬
‫‪111155 , 114152 , 111025 , 115115‬‬
‫ידע חברה למחקר ופיתוח בע"מ ‪, 124552 -‬‬
‫שמעון ויינר ‪111412 -‬‬
‫זלמן פלס ‪115452 -‬‬
‫כ"ח באלול התשע"א‪September 27, 2011-‬‬
‫‪336‬‬
ABBOTT LABORATORIES - 0621/6
ABBOTT LABORATORIES - 203955
ABLYNX N.V. - 168357
ACTELION PHARMACEUTICALS LTD.
- 187383
ACTIVE-BASE LTD. - 168062
AFFITECH RESEARCH AS - 181927
AGENSYS, INC. - 166532
AGILE THERAPEUTICS, INC. - 173152
AKROSS AG - 180690
ALAIN ROUSSEAU - 192757
ALCON, INC. - 186314
ALERE SWITZERLAND GMBH - 175629
ALONIM HOLDINGS AGRICULTURAL
COOPERATIVE SOCIETY LTD. - 177413
ALPHAVAX, INC. - 170607
AMGEN, INC. - 130396
AMIR TVOUA - 164853
AMITECH LTD. - 175011
ANALYTECON S.A. - 177307
ARCHIBALD JEREMY BRAIN - 162985
ARCSIGHT, INC. - 178861
ARTIFICIAL CELL TECHNOLOGIES,
INC. - 190885
ASEMBLON, INC. - 175920
ASTERION LIMITED - 162433
ASTRAZENECA AB - 173522 , 175065
ASTRAZENECA UK LIMITED - 166626
ATI PROPERTIES, INC. - 203162 , 203166
AVENTIS PHARMACEUTICALS INC. 181156
AVNER AMIR - 176893
AXOMETRICS, INCORPORATED 188000
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.p.A. - 187713
B. VARTICOVSCHI LTD. - 175631
BAE SYSTEMS BOFORS AB - 182725
BASF SE - 179296 , 180180
BAVARIAN NORDIC A/S - 188667
BAXTER HEALTHCARE S.A. - 189196
337
BAXTER INTERNATIONAL INC. 189196
BAYER CROPSCIENCE AG - 181558
BAYHILL THERAPEUTICS, INC. 168715
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY - 190719
BIN WANG - 108449
BIOSENSE WEBSTER, INC. - 162037 ,
176792
BIOTECON THERAPEUTICS GMBH 193777
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG - 156351
BRISTOL-MYERS SQUIBB COMPANY 168691
BROOKHAVEN SCIENCE ASSOCIATES
- 180365
BTICINO S.P.A. - 186421
C. STEVEN MCDANIEL - 174122
CANBAS CO. LTD. - 162836
CANBAS CO., LTD. - 162836
CDM OPTICS, INC. - 170697
CELLZOME AG - 182712
CELLZOME LIMITED - 182712
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE - 176095
CHEMOCENTRYX, INC. - 168661
CILAG GMBH INTERNATIONAL 179450
CONCEPT & DESIGN LTD. - 184797
CONSEJO SUPERIOR DE
INVESTIGACIONES CIENTIFICAS 176847
CONTRA VISION LTD. - 200825
CPFILMS INC. - 175795
CRYODYNAMICS, LLC - 181805
CYTONET GMBH &CO. KG - 188461
D. SIT TRADE L.T.D - 207635
DAIICHI SANKYO COMPANY,
September 27, 2011-‫כ"ח באלול התשע"א‬
LIMITED - 159438
DARIO TONCELLI - 184636
DAVID B. WEINER - 108449
DGIMED ORTHO, INC. - 198400
DONALD TEMPLETON HAYNIE 190885
DORON GABAY - 183857
DOW AGROSCIENCES LLC - 178714
E.I.DU PONT DE NEMOURS AND
COMPANY - 155599
EATON CORPORATION - 187505
EISAI R&D MANAGEMENT CO., LTD. 178766 , 180024 , 189986
ELI LILLY AND COMPANY - 183666
ELTA SYSTEMS LTD. - 191785
ENDO PHARMACEUTICALS
SOLUTIONS INC. - 185800
ETHYPHARM - 177593
EURO-CELTIQUE S.A. - 173343 , 173344
, 204885
EUROCOPTER - 184970
EYAL ERLICH - 176893
EYTAN BIDERMAN - 176757
F. HOFFMANN-LA ROCHE AG - 177704
, 184206 , 188115
FIELDTURF TARKETT INC. - 186216
FLORIDA STATE UNIVERSITY
RESEARCH FOUNDATION, INC. 177372
FORMATION, INC. - 172532
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V. - 181469
FRESENIUS KABI DEUTSCHLAND
GMBH - 168854
GENENTECH, INC. - 168754 , 180588
GILEAD SCIENCES, INC. - 193148
GILI GEORGE - 177696
GLAXO GROUP LIMITED - 162700 ,
177691
GLAXOSMITHKLINE LLC - 164973
GLYCOLOGIC LIMITED - 179238
H.C. STARCK GMBH - 187337
338
HADASIT MEDICAL RESEARCH
SERVICES & DEVELOPMENT LTD. 186940
HAMAMATSU PHOTONICS K.K. 171315
HANMI HOLDINGS CO., LTD. - 180894
HANMI PHARM. CO., LTD. - 180894
HANS OETIKER AG MASCHINENUND APPARATEFABRIK - 193583
HAWK MEDICAL TECHNOLOGIES
LTD. - 189082
HEMOTEQ AG - 177321
HISPANO-SUIZA - 188384
HOLON ACADEMIC INSTITUTE OF
TECHNOLOGY - 186940
I.B.I. ISRAEL BIOMEDICAL
INNOVATIONS LTD. - 191180
IBM CORPORATION - 169138 , 180659 ,
181244
IBM CORPORATION - 183951
IMCLONE, LLC - 198869
IMMUNODIAGNOSTIC SYSTEMS
FRANCE - 192757
INDIAN OCEAN MEDICAL INC. 162985
INTERDIGITAL TECHNOLOGY
CORPORATION - 181894 , 182992 ,
183452 , 186836 , 199189 , 207566
INTERNATIONAL PATENTS INC. 162985
ISCAR LTD. - 182078 , 185047
ITT MANUFACTURING ENTERPRISES,
INC. - 190238
JANNY SARL - 196215
JANSSEN PHARMACEUTICA, N.V. 170114
JAPAN SCIENCE AND TECHNOLOGY
AGENCY - 172499
JOHN BEAN TECHNOLOGIES
CORPORATION - 194136
JOSEF ATOON - 189311
KIRIN HOLDINGS KABUSHIKI
KAISHA - 176508
KNORR-BREMSE SYSTEME FUR
September 27, 2011-‫כ"ח באלול התשע"א‬
SCHIENENFAHRZEUGE GMBH 178571
KYOWA HAKKO KIRIN CO., LTD. 176508
L. MOLTENI & C. DEI FRATELLI
ALITTI SOCIETA' DI ESERCIZIO S.P.A.
- 187127
L. PERRIGO COMPANY - 179194
LES LABORATOIRES SERVIER 174860
LESLIE R. CONEY - 108449
LG ELECTRONICS INC. - 180227 ,
186574 , 186575
LG ELECTRONICS INC. - 185881
LOCATA CORPORATION - 173229
LUPIN LIMITED - 174860
M. M. & R. PRODUCTS, INC. - 193647
MAPA GMBH GUMMI-UND
PLASTIKWERKE, - 190257
MARTEK BIOSCIENCES
CORPORATION - 196776
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY - 179972
MAX CO. LTD. - 188224
MAXYGEN, INC. - 155599
MEDIQUEST THERAPEUTICS, INC. 180691
MEDIVIR AB - 176740
MERCK SERONO S.A. - 164463
MERCK SERONO S.A. - 164463
MERIDIAN MEDICAL
TECHNOLOGIES, INC. - 175429
MERZ PHARMA GMBH & CO. KGAA 193777
MESSIER-BUGATTI - 190990 , 193378
METABASIS THERAPEUTICS, INC. 167984
MFS MEDICAL FLOW SYSTEMS LTD. 180877
MICHAEL J. MERVA - 108449
MICROSOFT CORPORATION - 168907 ,
174023
MORPHOSYS AG - 177242
MOTOROLA MOBILITY, INC. - 177171 ,
179477
339
MOTOROLA, INC. - 177171 , 179477
NAGRAVISION S.A. - 188333
NANOCO TECHNOLOGIES LIMITED 178874
NANOSONICS PTY LIMITED - 180451
NEGEVTECH, LTD. - 187718
NERVIANO MEDICAL SCIENCES S.R.L.
- 172923
NETAFIM LTD. - 177686
NEURALSTEM, INC. - 204356
NEW CREATE LTD. - 190413
N-GENE RESEARCH LABORATORIES
INC. - 198294 , 198296
NIHON NOHYAKU CO. LTD. - 179369
NIL TECHNOLOGY APS - 181718
NIPPON SHERWOOD MEDICAL
INDUSTRIES LTD - 180610
NISIM MASSIAH - 177696
NOVARTIS AG - 170138
NOVARTIS VACCINES AND
DIAGNOSTICS S.R.L, - 189102
NOVARTIS VACCINES AND
DIAGNOSTICS, INC. - 167469
NOVOZYMES BIOPHARMA DK A/S 178701
NOVOZYMES BIOPOLYMER A/S 178701
OC OERLIKON BALZERS AG - 179554
OERLIKON TRADING AG, TRUBBACH
- 179554
OFER TVOUA - 164853
ONYX THERAPEUTICS, INC. - 179020
ORSENSE LTD. - 175450
P. & P. SAFETY BRAKING (2004) LTD. 185423
PAUL A. CHAMBERS - 159575
PEEERFECT FIT LLC - 164853
PFIZER ITALIA S.R.L. - 172923
PHILADELPHIA HEALTH AND
EDUCATION CORPORATION D/B/A/
DREXEL UNIVERSITY COLLEGE OF
MEDICINE - 198869
PIONEER HI-BRED INTERNATIONAL,
INC. - 155599
September 27, 2011-‫כ"ח באלול התשע"א‬
PLEXXIKON, INC. - 173079
POLYMER TECHNOLOGY SYSTEMS,
INC. - 177226
PROBIODRUG AG - 174372
PROMETHEUS LABORATORIES INC. 163588
PROMETIC BIOSCIENCES INC. - 158322
, 170057
PROMISEC LTD. - 182013
QUALCOMM INCORPORATED - 186438
QUALCOMM INCORPORATED - 204284
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 165812 , 168035 ,
174723 , 188655
RAYTHEON COMPANY - 169630 ,
171486 , 184796
RED WALL (D.S) LTD. - 207635
RICHARD J. BIES - 166278
ROTEM AMFERT NEGEV LTD. - 174212
S.I.P. TECHNOLOGIES L.L.C. - 178720
SAGEM DEFENSE SECURITE - 180235
SANOFI - 158558
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 204861
SANOFI-AVENTIS SPA - 194325
SAVETOQUINOL - 183518
SCHOTT AG - 179261 , 181111
SCV QUALITY SOLUTION, LLC 188731
SELEXIS S.A. - 198863
SHERWOOD SERVICES AG - 180610 ,
201860
SHIMON VAINER - 178413
SIDLER, BRUNO - 180690
SILVERBROOK RESEARCH PTY. LTD.
- 168417
SNECMA - 178754
SPEEDEL EXPERIMENTA AG - 193470
SUMITOMO CHEMICAL COMPANY,
LIMITED. - 170094 , 176179 , 184338
SUMITOMO ELECTRIC HARDMETAL
CORP. - 180049
SUNTORY HOLDINGS LIMITED 176054
340
SUNTORY LIQUORS LIMITED - 176054
SUPERSEAL LTD. - 173077
SYNGENTA LIMITED - 178649
SYNGENTA PARTICIPATIONS AG 161007 , 193676
SYNGENTA PARTICIPATIONS AG 178649
TAKEDA PHARMACEUTICAL
COMPANY LIMITED - 162836
TAPE WEAVING SWEDEN AB - 184604
TARO PHARMACEUTICALS U.S.A.
INC. - 174803
TELECOM ITALIA S.P.A. - 176645
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL) - 174819
TEST ADVANTAGE, INC. - 181444
THALESNANO ZRT - 181527
THE BOARD OF TRUSTEES OF THE
LELAND STANFORD JUNIOR
UNIVERSITY - 168715
THE PROCTER & GAMBLE COMPANY
- 179863
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA - 172827
THE UNIVERSITY COURT OF THE
UNIVERSITY OF EDINBURGH - 179919
THERAVANCE, INC. - 178086 , 186023
UCB PHARMA GMBH - 180479
UNITED PROTECTIVE
TECHNOLOGIES, LLC - 180809
UNIVERSIDAD PUBLICA DE
NAVARRA - 176847
UNIVERSITY OF MARYLAND,
BALTIMORE - 191982
UNIVERSITY OF WASHINGTON 198869
VERDIA, INC. - 155599
VINCENT R. ZURAWSKI, JR. - 108449
VIROGEN LTD. - 158558
W.R. GRACE & CO. -CONN. - 177295
WARNER-LAMBERT COMPANY LLC 179614
WELLSTAT THERAPEUTICS
September 27, 2011-‫כ"ח באלול התשע"א‬
CORPORATION - 171269
WILLIAM LYLE WARKE - 176974
WILLIAM V. WILLIAMS - 108449
WYETH LLC - 176162
ZALMAN PELES - 185423
ZEALAND PHARMA A/S - 206445
Z-FILTER PTY LTD. - 195888
ZIPTRONIX, INC. - 198903
YEDA RESEARCH AND
DEVELOPMENT CO. LTD. - 134523 ,
162094
YEDA RESEARCH AND
DEVELOPMENT CO. LTD. - 186940
YEFIM KERETH - 182484
341
September 27, 2011-‫כ"ח באלול התשע"א‬
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A01B - 176974
A01G - 177686
A01H - 193676
A01N - 176179, 181558, 188461
A23D - 196776
A41D - 159575
A41G - 186216
A43B - 164853
A45D - 193647
A47C - 176893
A47H - 175795
A47J - 183857, 184797
A61B - 175450, 176792, 180610,
180690, 191180, 198400
A61C - 186940
A61F - 173152, 181805
A61J - 189196, 190257
A61K - 158322, 164463, 167469,
168357, 168715, 168854,
174372, 174803, 176740,
177372, 178701, 179194,
180365, 180691, 183518,
185800, 187383, 189102,
190719, 190885, 193148,
198294, 198296, 198869,
203955, 204861
A61L - 177321, 180451
A61M - 162700, 162985, 175429,
179450, 189082, 201860
A62B - 182484
A63H - 177696, 190413
B01J - 177593, 181527
B01L - 192757
B21F - 188224
342
B23B - 180049
B23C - 182078,
B23K - 178413
B24D - 175631
B25B - 193583
B28B - 184636
B44F - 200825
B60J - 180809
B60T - 185423
B61H - 178571
B62D - 188655
B63H - 174723
B64C - 187505
B64F - 184970
B65D - 177691,
B65G - 179554,
B67D - 176757
B82B - 176095,
185047
196215
195888
178874, 181718
C01B - 175920
C01G - 187337
C04B - 189311
C05B - 174212
C07C - 161007, 164973, 168661,
170057, 171269, 173522,
178649, 179614, 180479,
182712, 193470
C07D - 156351, 158558, 159438,
166626, 170114, 170138,
172923, 173079, 173343,
173344, 174860, 175065,
176162, 177307, 177704,
178086, 178714, 178766,
179369, 180024, 180180,
181156, 184206, 184338,
September 27, 2011-‫כ"ח באלול התשע"א‬
186023,
188115,
204885
C07F - 167984,
C07H - 180894,
C07K - 130396,
162836,
177242,
191982,
206445
C08G - 179296
C09D - 174122
C09K - 173077
C10G - 177295
C11C - 176054
C12N - 108449,
168754,
179238,
198863,
C12Q - 163588
C22C - 203162,
C25D - 177413
C40B - 181927
187127, 187713,
189986, 201850,
168691,
183666
134523,
170607,
179020,
193777,
162433,
176508,
180588,
194325,
155599, 162094,
172499, 176847,
179919, 188667,
204356
203166
D03D - 184604
D04H - 179863, 190990
F01D - 178754
F16H - 188384
F16K - 186314
F24J - 179261, 181111
F25D - 178720
F27B - 193378
F41F - 165812
F41H - 188731
F42B - 182725
343
170094
G01B - 188000
G01J - 171486
G01N - 166532,
179972,
G01R - 181444
G01S - 173229
G01V - 162037
G02B - 170697,
G05D - 180877
G06F - 168062,
174023,
G06K - 168035
G06Q - 166278
G08G - 207635
G10L - 181469,
175629, 177226,
187718, 194136
190238
168417, 168907,
181244, 182013
186438
H01H - 186421
H01L - 169138, 171315, 175011,
198903
H01Q - 191785
H03K - 169630, 184796
H03M - 199189
H04B - 172827
H04J - 177171, 180227, 186836
H04L - 176645, 178861, 180659,
183951, 186575
H04N - 188333
H04W - 174819, 179477, 181894,
182992, 183452, 185881,
186574, 204284, 207566
H05B - 180235
H05K - 172532
September 27, 2011-‫כ"ח באלול התשע"א‬
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
344
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Code
MX
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Country or Organization
Mexico
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property
Organization (W.I.P.O.)
South Africa
September 27, 2011-‫כ"ח באלול התשע"א‬
KR
LK
LU
LV
Republic of Korea
Sri Lanka
Luxembourg
Latvia
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
345
September 27, 2011-‫כ"ח באלול התשע"א‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
346
September 27, 2011-‫כ"ח באלול התשע"א‬